{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "sys.path.append('../scripts')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import spacy\n",
    "import os\n",
    "from pathlib import Path\n",
    "from xml.dom import minidom\n",
    "from charsplit import Splitter\n",
    "from rules.ellipticCompounds import exchangeLemmas\n",
    "from evaluation import error_analysis, get_scores\n",
    "\n",
    "nlp = spacy.load(\"de_core_news_lg\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import hydra\n",
    "from hydra import compose, initialize\n",
    "\n",
    "hydra.core.global_hydra.GlobalHydra.instance().clear()\n",
    "initialize(config_path=Path('..'), job_name='foo', version_base='1.1')\n",
    "config = compose(config_name='experiment.yaml')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [],
   "source": [
    "tmp_path = Path('../tmp/baseline_files')\n",
    "tmp_path.mkdir(exist_ok=True, parents=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "path_xml_file = tmp_path / 'Original.xml'\n",
    "path_output_file = tmp_path / 'Output.xml'\n",
    "path_gertwol_file = tmp_path / 'gertwol.txt'\n",
    "path_word_freqs = tmp_path / 'wordFreqs.txt'\n",
    "tagged_path = '../compoundListTagged.txt'\n",
    "\n",
    "path_tokens = Path('..') / config.data.ggponc_plain_text"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Load the Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "ellipses = pd.read_csv(Path('..') / config.data.cnf_tsv_path, sep='\\t')\n",
    "not_ellipses = pd.read_csv(Path('..') / 'data/ellipses/ggponc_no_ellipses_small.tsv', sep='\\t')\n",
    "\n",
    "not_ellipses['full_resolution'] = not_ellipses.raw_sentence\n",
    "#ellipses = ellipses[ellipses.split == 'test']\n",
    "#not_ellipses = not_ellipses[not_ellipses.split == 'test']\n",
    "\n",
    "# Train and Test split?\n",
    "\n",
    "data = pd.concat([ellipses[['file', 'sentence_id', 'raw_sentence', 'full_resolution']], not_ellipses[['file', 'sentence_id', 'raw_sentence', 'full_resolution']]]).sort_values(by='file').reset_index(drop=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "166870"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.raw_sentence.str.split(' ').apply(len).sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7696"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data[['file', 'sentence_id']].drop_duplicates())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(7696, 4)"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>file</th>\n",
       "      <th>sentence_id</th>\n",
       "      <th>raw_sentence</th>\n",
       "      <th>full_resolution</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>00_mundhoehlenkarzinom_0002.tsv</td>\n",
       "      <td>1</td>\n",
       "      <td>Hauptrisikofaktoren für das Auftreten eines Mu...</td>\n",
       "      <td>Hauptrisikofaktoren für das Auftreten eines Mu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>00_mundhoehlenkarzinom_0002.tsv</td>\n",
       "      <td>2</td>\n",
       "      <td>Bei chronischem Tabak- oder Alkoholabusus ist ...</td>\n",
       "      <td>Bei chronischem Tabakabusus oder Alkoholabusus...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>00_mundhoehlenkarzinom_0005.tsv</td>\n",
       "      <td>12</td>\n",
       "      <td>Die hohe Diskrepanz zwischen p16 Immunhistoche...</td>\n",
       "      <td>Die hohe Diskrepanz zwischen p16 Immunhistoche...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>00_mundhoehlenkarzinom_0005.tsv</td>\n",
       "      <td>18</td>\n",
       "      <td>Die Prävalenz von HPV16 E6 oder E7 Antikörpern...</td>\n",
       "      <td>Die Prävalenz von HPV16 E6 Antikörpern oder HP...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>00_mundhoehlenkarzinom_0005.tsv</td>\n",
       "      <td>10</td>\n",
       "      <td>Der Nachweis von Hochrisiko HPV-DNA in der Mun...</td>\n",
       "      <td>Der Nachweis von Hochrisiko HPV-DNA in der Mun...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                              file  sentence_id  \\\n",
       "0  00_mundhoehlenkarzinom_0002.tsv            1   \n",
       "1  00_mundhoehlenkarzinom_0002.tsv            2   \n",
       "2  00_mundhoehlenkarzinom_0005.tsv           12   \n",
       "3  00_mundhoehlenkarzinom_0005.tsv           18   \n",
       "4  00_mundhoehlenkarzinom_0005.tsv           10   \n",
       "\n",
       "                                        raw_sentence  \\\n",
       "0  Hauptrisikofaktoren für das Auftreten eines Mu...   \n",
       "1  Bei chronischem Tabak- oder Alkoholabusus ist ...   \n",
       "2  Die hohe Diskrepanz zwischen p16 Immunhistoche...   \n",
       "3  Die Prävalenz von HPV16 E6 oder E7 Antikörpern...   \n",
       "4  Der Nachweis von Hochrisiko HPV-DNA in der Mun...   \n",
       "\n",
       "                                     full_resolution  \n",
       "0  Hauptrisikofaktoren für das Auftreten eines Mu...  \n",
       "1  Bei chronischem Tabakabusus oder Alkoholabusus...  \n",
       "2  Die hohe Diskrepanz zwischen p16 Immunhistoche...  \n",
       "3  Die Prävalenz von HPV16 E6 Antikörpern oder HP...  \n",
       "4  Der Nachweis von Hochrisiko HPV-DNA in der Mun...  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Create XML Document"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [],
   "source": [
    "root = minidom.Document()\n",
    "\n",
    "xml = root.createElement('corpus')\n",
    "xml.setAttribute('id', 'corpus')\n",
    "root.appendChild(xml)\n",
    "\n",
    "for i, f in enumerate(data[['file', 'raw_sentence']].groupby('file').first().index.to_list()):\n",
    "    file = root.createElement('file')\n",
    "    file.setAttribute('n', str(i))\n",
    "    xml.appendChild(file)\n",
    "\n",
    "    div = root.createElement('div')\n",
    "    file.appendChild(div)\n",
    "\n",
    "    for j, s in enumerate(data[data['file']==f]['raw_sentence']):\n",
    "        sentence = root.createElement('s')\n",
    "        sentence.setAttribute('lang', 'de')\n",
    "        sentence.setAttribute('n', f'{i}-{j}')\n",
    "        div.appendChild(sentence)\n",
    "\n",
    "        doc = nlp(s)\n",
    "        for k, token in enumerate(doc):\n",
    "            word = root.createElement('w')\n",
    "            word.setAttribute('lemma', token.lemma_)\n",
    "            word.setAttribute('n', f'{i}-{j}-{k}')\n",
    "            word.setAttribute('pos', token.tag_)\n",
    "            word.setAttribute('whitespace', token.whitespace_)\n",
    "            sentence.appendChild(word)\n",
    "            word.appendChild(root.createTextNode(token.text))\n",
    "\n",
    "with open(path_xml_file, \"wb\") as f:\n",
    "    f.write(root.toprettyxml(indent =\"\\t\", encoding=\"utf-8\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Produce Gertwol-like List and Gather Word Frequencies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [],
   "source": [
    "freq = {}\n",
    "dict = {}\n",
    "splitter = Splitter()\n",
    "special_characters = \"!@#$%^&*()-+?_=,<>/.[] \"\n",
    "\n",
    "for filename in os.listdir(path_tokens):\n",
    "    with open(path_tokens / filename , encoding='utf8') as f:\n",
    "        for word in f.readlines():\n",
    "            word = word[:-1]\n",
    "\n",
    "            # Gertwol Split\n",
    "            split = splitter.split_compound(word)[0]\n",
    "            if split[0] != 0:\n",
    "                dict[word] = '#'.join([split[1]] + [subword.lower() for subword in split[2:]])\n",
    "\n",
    "            # Word Freq\n",
    "            if word in special_characters:\n",
    "                continue\n",
    "            if word in freq:\n",
    "                freq[word] += 1\n",
    "            else:\n",
    "                freq[word] = 1\n",
    "\n",
    "with open(path_gertwol_file, 'w', encoding='utf-8') as f:\n",
    "    for key, value in dict.items():\n",
    "        f.write(f'{key}\\t{value}\\n')\n",
    "\n",
    "with open(path_word_freqs, 'w', encoding='utf-8') as f:\n",
    "    for key, value in freq.items():\n",
    "        f.write(f'{key}\\t{value}\\n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Run Aepli Baseline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Alkohol#abusus\n",
      "Alkohol#abusus\n",
      "Hals#tumoren\n",
      "Farb#markierung\n",
      "Funktions#erhalt\n",
      "Schluck#funktion\n",
      "Gesichts#chirurgen\n",
      "Gesichts#chirurgen\n",
      "Nährstoff#aufnahme\n",
      "Nikotin#assoziierte\n",
      "Kar#zinome\n",
      "Innenspangenre#sektion\n",
      "Nikotin#assoziierte\n",
      "Kar#zinome\n",
      "Knochen#transplantation\n",
      "Knochen#transplantation\n",
      "Schluck#funktion\n",
      "Schluck#funktion\n",
      "Mund#bodenkarzinom\n",
      "Chemotherapie#bedingte\n",
      "Chemotherapie#bedingte\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Mund#bodenkarzinoms\n",
      "Knochen#nekrosen\n",
      "Nerv#infiltration\n",
      "Radio#chemotherapie\n",
      "Mund#pflege\n",
      "ggf.\n",
      "Geschmacks#störungen\n",
      "Geschmacks#störungen\n",
      "Schlund#muskulatur\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Hals#haut\n",
      "Hals#haut\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Mund#höhlenkarzinomen\n",
      "Mund#höhlenkarzinomen\n",
      "Leistungs#zustand\n",
      "Immun#zellen\n",
      "Immun#zellen\n",
      "Leistungs#zustand\n",
      "Leistungs#zustand\n",
      "Gesamt#überleben\n",
      "Konvention#ell\n",
      "Radio#chemotherapie\n",
      "Schluck#störungen\n",
      "Schluck#störungen\n",
      "Körper#haltung\n",
      "Schluck#störung\n",
      "Schluck#störung\n",
      "Behandlungs#bedingten\n",
      "Beeinträchtig#ungen\n",
      "Schluck#rehabilitation\n",
      "Sprech#vermögen\n",
      "Proteom#ebene\n",
      "Ref#lux\n",
      "Umwelt#faktoren\n",
      "Tonsillen#karzinome\n",
      "Nicht#kardiakarzinom\n",
      "Peutz-Jeghers#syndrom\n",
      "Eier#stockkrebs\n",
      "Familien#anamnese\n",
      "Missense#mutationen\n",
      "Familien#anamnese\n",
      "Pankreassaftref#lux\n",
      "Kohorten#studien\n",
      "Ausschluss#kriterien\n",
      "Nar#row\n",
      "Nar#row\n",
      "Blutgefäß#invasion\n",
      "Blutgefäß#invasion\n",
      "Gesamt#überleben\n",
      "Gesamt#überleben\n",
      "Magenre#sektionen\n",
      "auch\n",
      "Dyspnö#symptomatik\n",
      "Pankreas#fisteln\n",
      "Chemo#therapie\n",
      "Mortalitäts#raten\n",
      "Ausschluss#kriterien\n",
      "Post#operativen\n",
      "Mort#alität\n",
      "N#downstaging\n",
      "Magen#karzinom\n",
      "Therapie#rbaren\n",
      "Tox#izität\n",
      "Ver#gleich\n",
      "Progressions#freien\n",
      "Über#leben\n",
      "Retro#spektiven\n",
      "Stu#dien\n",
      "Meta#chron\n",
      "Bila#terale\n",
      "Nebennieren#metastasen\n",
      "Bila#terale\n",
      "Krukenberg#tumoren\n",
      "Viertlinien#situation\n",
      "Muskel#masse\n",
      "Muskel#erhalt\n",
      "Schluck#störungen\n",
      "Geschmack#störungen\n",
      "Fett#trägern\n",
      "Absorptions#störungen\n",
      "Resorptions#möglichkeiten\n",
      "Strahlen#therapie\n",
      "Erkrankungs#inzidenz\n",
      "Radio#therapie\n",
      "Post#operative\n",
      "Post#operative\n",
      "Appli#kation\n",
      "Post#operative\n",
      "Gabe\n",
      "Nieren#erkrankungen\n",
      "Nieren#störung\n",
      "63\n",
      "Kontroll#patienten\n",
      "Ernährungs#therapie\n",
      "auch\n",
      "Psycho#therapeuten\n",
      "Protein#aufnahme\n",
      "Schulungs#angebot\n",
      "Muskelaufbau#training\n",
      "Spezi#elles\n",
      "Behandlungs#verlauf\n",
      "Behandlungs#verlauf\n",
      "Ösophagus#karzinom\n",
      "Familien#interventionen\n",
      "Körper#orientierte\n",
      "Verf#ahren\n",
      "Trauer#phase\n",
      "Computer#version\n",
      "Strahlen#therapieinduzierten\n",
      "Tumor#bedingte\n",
      "Schm#erzen\n",
      "Strahlen#therapie\n",
      "Aroma#massage\n",
      "Gemüse#reiche\n",
      "Ern#ährung\n",
      "Strahlen#therapie\n",
      "Strahlen#therapie\n",
      "Strahlen#therapie\n",
      "Strahlen#therapie\n",
      "Magen#karzinom\n",
      "Magen#karzinom\n",
      "Umwelt#faktoren\n",
      "Umwelt#faktoren\n",
      "Gemüse#konsum\n",
      "Gemüse#konsums\n",
      "Gemüse#verzehr\n",
      "Gemüse#verzehr\n",
      "Mr#kolonographie\n",
      "Mr#kolonographie\n",
      "Mr#kolonographie\n",
      "Indikations#problem\n",
      "Perforations#risiko\n",
      "Tumor#grading\n",
      "Angel#punkt\n",
      "High-Risk#gruppe\n",
      "Polypektomie#präparat\n",
      "4#fache\n",
      "Risiko#steigerung\n",
      "Ver#gleich\n",
      "Dünndarm#karzinome\n",
      "Dünndarm#karzinome\n",
      "Amsterdam-I#\n",
      "Amsterdam#kriterien\n",
      "Talgdrüsen#adenome\n",
      "Urothel#karzinome\n",
      "Dritt#karzinome\n",
      "Papillen#adenome\n",
      "Ovarial#karzinome\n",
      "Hnpcc#syndrom\n",
      "Ovarial#karzinome\n",
      "Blutungs#risiko\n",
      "Familien#basierte\n",
      "Untersuch#ungen\n",
      "Erkrankungs#risiko\n",
      "Haut#karzinome\n",
      "Haut#karzinome\n",
      "Bmpr1A#gen\n",
      "Schilddrüsen#karzinome\n",
      "Rektum#karzinome\n",
      "Mr#kolonografie\n",
      "Mr#kolonografie\n",
      "Rektum#karzinomen\n",
      "Radio#chemotherapie\n",
      "Tubul#ärer\n",
      "Res#ektion\n",
      "auch\n",
      "Rektum#operationen\n",
      "Diagnose#qualität\n",
      "auch\n",
      "Ekel#gefühle\n",
      "Geruchs#ängste\n",
      "Anpassungs#störungen\n",
      "Onko#logischen\n",
      "Zen#tren\n",
      "Nach#teile\n",
      "Tumor#charakteristika\n",
      "Blutgefäß#invasion\n",
      "Fernmetastasen#raten\n",
      "Pcr#raten\n",
      "Fernmetastasen#raten\n",
      "Peri#operativ\n",
      "Patientenbezo#gener\n",
      "Krit#erien\n",
      "Therapie#bezogenen\n",
      "Lebens#qualität\n",
      "Braf#mutationen\n",
      "Braf#mutationsstatus\n",
      "Braf#mutationsstatus\n",
      "Braf#mutationen\n",
      "Braf#mutationsstatus\n",
      "Braf#mutationsstatus\n",
      "Braf#mutationsstatus\n",
      "Braf#mutationsstatus\n",
      "Patienten#charakteristika\n",
      "Links#seitigen\n",
      "Tum#oren\n",
      "Braf#mutationsstatus\n",
      "Bolus\n",
      "Toxizitäts#daten\n",
      "Mik#rowellenablation\n",
      "Tumor#lokalisation\n",
      "Nachversorgungsverl#aufs\n",
      "Nachsorge#verlaufs\n",
      "Karzinom#rezidiven\n",
      "Wechsel#wirkungen\n",
      "Geschlechts#spezifische\n",
      "Mortalitäts#rate\n",
      "Geschlechts#spezifische\n",
      "Mortalitäts#rate\n",
      "Kohlenmonoxid#gehalt\n",
      "Kohlenmonoxid#gehalt\n",
      "Thorium#nuklide\n",
      "Druckfarben#industrie\n",
      "Löse#mitteln\n",
      "Löse#mitteln\n",
      "Stahl#erzeugung\n",
      "Pechhal#tiger\n",
      "Materia#lien\n",
      "Tonstein#industrie\n",
      "Korrosions#beständigkeit\n",
      "Wolfram#carbidhaltige\n",
      "Strahlenschutz#verordnung\n",
      "Sekundär#prävention\n",
      "Molekular#biologische\n",
      "Nieren#parameter\n",
      "Geräte#adaptierten\n",
      "Peri#kardkarzinose\n",
      "Nebennieren#metastasen\n",
      "Gefäßresektionsrän#der\n",
      "Gefäßresektionsrän#der\n",
      "Ros1#translokationen\n",
      "Leicht#rauchern\n",
      "Duplex#sonographie\n",
      "Duplex#sonographie\n",
      "Empathie#fähig\n",
      "Fehlverständ#nissen\n",
      "Strahlen#therapie\n",
      "Palliativ#beratung\n",
      "Palliativ#beratung\n",
      "Palliativ#beratung\n",
      "Palliativ#beratung\n",
      "Post#therapeutischen\n",
      "Gewebe#entnahmen\n",
      "Überlebens#zeit\n",
      "Rezidiv#freien\n",
      "R2#resektionen\n",
      "Letalitäts#raten\n",
      "5-Jahres#überlebens\n",
      "Strahlen#chemotherapie\n",
      "Letalitäts#muster\n",
      "Mamma#karzinom\n",
      "Fach#arzt\n",
      "Ernährungs#beratung\n",
      "Gesamt#überlebens\n",
      "Dreifach#therapie\n",
      "III\n",
      "Pfs#vorteil\n",
      "Herz#funktion\n",
      "Car#boplatinhaltige\n",
      "Chemo\n",
      "Kombinations#erstlinientherapie\n",
      "Dritt#linie\n",
      "OS\n",
      "Zweit-Generations#tki\n",
      "Zweit-Generations#tki\n",
      "Zweit-Generations#tki\n",
      "Zweitgenerations#tki\n",
      "auch\n",
      "z.B.\n",
      "Ros1#fusionen\n",
      "Pall#iativen\n",
      "Pall#iativen\n",
      "Induktions#chemotherapie\n",
      "Kontra#laterale\n",
      "Mediastialbe#strahlung\n",
      "Strahlen#therapie\n",
      "Strahlen#therapie\n",
      "Strahlentherapie#applikation\n",
      "Fünf#jahresüberleben\n",
      "Etoposid#dosierung\n",
      "Stammzell#transplantation\n",
      "Zweiwöchentli#chen\n",
      "Abstän#den\n",
      "Car#boplatinhaltige\n",
      "Voll#remission\n",
      "Organ#metastasen\n",
      "Voll#remission\n",
      "Carbo#platin\n",
      "Fünf#jahresüberlebensraten\n",
      "Zwei-Jahres#überlebensraten\n",
      "Irin#otecanhaltige\n",
      "Iv#toxizitäten\n",
      "Iv#hämorrhagien\n",
      "Polyvenylalkohol#partikel\n",
      "Laser#therapie\n",
      "Selbstexpandier#ende\n",
      "Metalls#tents\n",
      "Bewegungs#therapie\n",
      "Therapie#bedingte\n",
      "Defiz#ite\n",
      "Akupressur#verfahren\n",
      "Therapie#bedingte\n",
      "Beschw#erden\n",
      "Achtsamkeits#verfahren\n",
      "Strahlen#therapie\n",
      "Panik#reaktion\n",
      "Drittlinien#therapie\n",
      "Panik#komponente\n",
      "Hand#ventilatoren\n",
      "Aroma#therapie\n",
      "Gefühls#erlebnis\n",
      "Buprenorphin#trägersysteme\n",
      "Lebens#stunden\n",
      "Funktions#störungen\n",
      "Kranken#pflege\n",
      "Entspannungs#training\n",
      "Ergebnis#qualitäten\n",
      "Ergebnis#qualitäten\n",
      "Hyper#plastischer\n",
      "Läs#ionen\n",
      "Intraobserver#variabilität\n",
      "Screening#registern\n",
      "Zytologie#basierter\n",
      "Sekundär#prävention\n",
      "Screening#intervall\n",
      "Fünfjähri#ges\n",
      "Ausschluss#parameter\n",
      "Hochrisiko#situation\n",
      "Langzeit#studien\n",
      "Zwei#stufige\n",
      "Abklärungs#strategien\n",
      "Langzeit#studie\n",
      "Rna#testverfahren\n",
      "--\n",
      "Kolposkopie#registern\n",
      "60#jährigen\n",
      "29#jährigen\n",
      "30#jährigen\n",
      "65#jährigen\n",
      "Behandlungs#daten\n",
      "Behandlungs#daten\n",
      "Register#gesetz\n",
      "Zervixkarzinom#inzidenz\n",
      "Krebs#/histologieregister\n",
      "Krebs#/histologieregister\n",
      "Wiedervorstellung#algorithmen\n",
      "Wiedervorstellung#algorithmen\n",
      "auch\n",
      "Ablations#verfahren\n",
      "Post#operativer\n",
      "Blut#ung\n",
      "Ablations#verfahren\n",
      "Kurzzeit#komplikation\n",
      "Vaginal#karzinomen\n",
      "Spät#komplikationen\n",
      "Vitamin#mangel\n",
      "Hand#diagnostik\n",
      "Hand#diagnostik\n",
      "Hand#diagnostik\n",
      "Nieren#schwäche\n",
      "Melanin#pigmenten\n",
      "Sucht#mitteln\n",
      "auch\n",
      "auch\n",
      "Kontroll#gruppe\n",
      "Nach#teile\n",
      "Hilfs#angebote\n",
      "Hilfs#angebote\n",
      "Sach#kompetente\n",
      "Therapie#optionen\n",
      "Sekundär#prävention\n",
      "Haus#ärzte\n",
      "Haus#ärzte\n",
      "Stuhl#kontrolle\n",
      "Versorgungs#kette\n",
      "Versorgungs#kette\n",
      "Aufklärungs#pflichten\n",
      "Abklärungs#algorithmen\n",
      "Schadens#aspekte\n",
      "Flüssigzytologie#verfahren\n",
      "Flüssigzytologie#verfahren\n",
      "Immunzyto#chemische\n",
      "Färb#ungen\n",
      "Ressourcen#aufwand\n",
      "Mortalitäts#raten\n",
      "Quadrivalenten-Hpv#impfstoff\n",
      "Früh#stadien\n",
      "Ster#berate\n",
      "Adenos#quamöse\n",
      "Karzi#nom\n",
      "Klein#zellige\n",
      "Gestagen#komponente\n",
      "Gestagen#komponente\n",
      "Onko#gene\n",
      "Hpv#subtypen\n",
      "Sach#kompetente\n",
      "Therapie#optionen\n",
      "Stuhl#kontrolle\n",
      "auch\n",
      "Meta#stasierten\n",
      "Sit#uation\n",
      "Versorgungs#kette\n",
      "Versorgungs#kette\n",
      "Fern#metastasen\n",
      "Makro#invasive\n",
      "Kar#zinome\n",
      "Prognose#definition\n",
      "Prognose#definition\n",
      "Therapie#wahl\n",
      "Fern#metastasen\n",
      "Fern#metastasen\n",
      "Isoecho#gene\n",
      "Raum#forderung\n",
      "Spekulum#untersuchung\n",
      "Klein#zellige\n",
      "Tnm#klassifikation\n",
      "Mehr#zahl\n",
      "für\n",
      "Perineuralscheiden#invasion\n",
      "Perineuralscheiden#invasion\n",
      "Perineuralscheiden#invasion\n",
      "Perineuralscheiden#invasion\n",
      "Perineuralscheiden#invasion\n",
      "Perineuralscheiden#invasion\n",
      "Diathermie#methoden\n",
      "Vaginal#karzinom\n",
      "Adeno#karzinom\n",
      "Plattenepithel#karzinom\n",
      "Makro#metastasen\n",
      "Makro#metastasen\n",
      "Adeno#karzinomen\n",
      "Unter#therapien\n",
      "Langzeit#folgen\n",
      "Langzeit#folgen\n",
      "Unter#therapien\n",
      "Prognose#faktoren\n",
      "Prognose#faktoren\n",
      "Prognose#faktoren\n",
      "Prognose#faktoren\n",
      "Post#operativen\n",
      "Komplikations#rate\n",
      "Endometrium#karzinom\n",
      "Nach#teile\n",
      "Therapie#prinzipien\n",
      "Fett#gewebes\n",
      "Lymph#bahnen\n",
      "Ureter#verletzungen\n",
      "Becken#entzündungen\n",
      "Brachy#therapie\n",
      "Erkrankungs#freien\n",
      "Über#lebens\n",
      "Post#menopause\n",
      "Knap#per\n",
      "R0#resektion\n",
      "Palliativ#situation\n",
      "Adeno#karzinom\n",
      "Über#leben\n",
      "Krankheits#freie\n",
      "Krankheits#freie\n",
      "Über#leben\n",
      "Gesamt#überlebens\n",
      "Zervix#karzinom\n",
      "Endometrium#karzinom\n",
      "Endometrium#karzinom\n",
      "Tuben#karzinom\n",
      "Tuben#karzinom\n",
      "Tuben#karzinom\n",
      "Krebs#selbsthilfegruppen\n",
      "Behandlungs#folgestörungen\n",
      "Risiko#faktoren\n",
      "Kranken#versicherungen\n",
      "Sport#therapie\n",
      "Sport#therapie\n",
      "Risiko#faktoren\n",
      "Behandlungs#folgestörungen\n",
      "Gruppen#angeboten\n",
      "Physio#therapeutisches\n",
      "Trainings#programm\n",
      "Chemo#therapie\n",
      "Mischinkonti#nenz\n",
      "Mischinkonti#nenz\n",
      "Becken#bodentraining\n",
      "Mischinkonti#nenz\n",
      "Therapie#angebote\n",
      "Therapie#folgen\n",
      "Metastasen#diagnose\n",
      "Rektos#kopie\n",
      "Organ#metastasen\n",
      "Leber#metastasen\n",
      "Radio#therapie\n",
      "Ovarial#karzinom\n",
      "Kombinations#therapie\n",
      "Stuhl#ableitung\n",
      "Lymphknoten#metastasen\n",
      "Chemo#therapie\n",
      "Adeno#karzinom\n",
      "Lebendgeburten#raten\n",
      "Früh#geburt\n",
      "Tumor#stadium\n",
      "Plattenepithel#karzinom\n",
      "Hämato#genen\n",
      "Fern#metastasen\n",
      "Darmkrebs#zentren\n",
      "Therapie#algorithmus\n",
      "Dysplasie#sprechstunde\n",
      "Histologie#befunde\n",
      "Ergebnis#qualität\n",
      "Ergebnis#qualität\n",
      "#registergesetz\n",
      "Krebsfrüherkennungs#\n",
      "Daten#dokumentation\n",
      "Uicc#stadien\n",
      "Weiter#bildung\n",
      "Schutz#faktoren\n",
      "Lebenswelt#orientierten\n",
      "Ans#atz\n",
      "Sozial#wissenschaftlicher\n",
      "Diszip#linen\n",
      "Konsum#muster\n",
      "Umwelt#bedingungen\n",
      "Umwelt#bedingungen\n",
      "Verhältnis#prävention\n",
      "Verhältnis#prävention\n",
      "Uva#anteil\n",
      "Ver#hindert\n",
      "Uva#strahlung\n",
      "Uva#induzierter\n",
      "Dna#schäden\n",
      "Leber#transplantation\n",
      "Querschnitt#studien\n",
      "Außen#segmente\n",
      "Macro#umgebung\n",
      "Plattenepithel#karzinome\n",
      "Krankheits#bedingter\n",
      "Erh#öhung\n",
      "Prostata#krebs\n",
      "Brust#krebs\n",
      "Brust#krebs\n",
      "Expositions#verhaltens\n",
      "Alkohol#konsum\n",
      "Expositions#verhaltens\n",
      "Gesundheits#bezogene\n",
      "Mot#ive\n",
      "Nutzen#abwägungen\n",
      "Interventions#programme\n",
      "Interventions#projekte\n",
      "Verhaltens#ebene\n",
      "Kommunikations#angebote\n",
      "Theorie#basierten\n",
      "Konzept#ualisierung\n",
      "Interventions#maßnahme\n",
      "Interventions#maßnahmen\n",
      "Interventions#maßnahmen\n",
      "Lang#fristige\n",
      "Effe#kte\n",
      "Analyse#verfahren\n",
      "Verhaltens#bezogenen\n",
      "Outcome#variablen\n",
      "Schulungs#material\n",
      "Schulungs#angebote\n",
      "Verhaltens#ebene\n",
      "Interventions#maßnahme\n",
      "Verhaltens#ebene\n",
      "Verhaltens#relevanten\n",
      "Interventions#maßnahme\n",
      "Verhaltens#bezogenen\n",
      "Out#comes\n",
      "Verhaltens#ebene\n",
      "Meeres#temperatur\n",
      "Brom#haltige\n",
      "Che#mikalien\n",
      "Hitze#bedingter\n",
      "Erkrank#ungen\n",
      "Nord#deutschlands\n",
      "Herzkreislauf#erkrankungen\n",
      "Sommer#monaten\n",
      "Angebots#vorsorge\n",
      "Mortalitäts#risiko\n",
      "Aufklärungs#pflichten\n",
      "#registergesetz\n",
      "Krebsfrüherkennungs#\n",
      "Leistungs#umfang\n",
      "Bösarti#gen\n",
      "Läs#ionen\n",
      "Bestätigungs#diagnostik\n",
      "Mortalitäts#reduktion\n",
      "Geschlechts#krankheiten\n",
      "Screening#maßnahmen\n",
      "Ergebnis#evaluation\n",
      "Zweit#untersuchung\n",
      "Geschlechts#krankheiten\n",
      "Geschlechts#krankheiten\n",
      "Tumor#dicke\n",
      "Lungen#krebs\n",
      "Lang#fristige\n",
      "Lang#fristige\n",
      "Vermittlungs#leistung\n",
      "Informations#darbietung\n",
      "Verhaltens#parameter\n",
      "Vermittlungs#parameter\n",
      "Interventions#programmen\n",
      "Risiko#gruppenspezifischen\n",
      "Ressour#cen\n",
      "Bösar#tiger\n",
      "Läs#ionen\n",
      "Unterstützungs#angeboten\n",
      "Selbstuntersuchungs#verhaltens\n",
      "Nutzen#abwägungen\n",
      "Interventions#programme\n",
      "Lang#fristige\n",
      "Lang#fristige\n",
      "Wir#ksamkeit\n",
      "Interventions#projekte\n",
      "Interventions#maßnahme\n",
      "Theorie#basierten\n",
      "Konzept#ualisierung\n",
      "Kommunikations#angebote\n",
      "Verhaltens#ebene\n",
      "Interventions#maßnahmen\n",
      "Analyse#verfahren\n",
      "Lang#fristige\n",
      "Effe#kte\n",
      "Interventions#maßnahmen\n",
      "Verhaltens#bezogenen\n",
      "Outcome#variablen\n",
      "Verhaltens#relevanten\n",
      "Interventions#maßnahme\n",
      "Verhaltens#ebene\n",
      "Nach#teile\n",
      "Interventions#maßnahme\n",
      "Verhaltens#ebene\n",
      "Verhaltens#bezogenen\n",
      "Out#comes\n",
      "Verhaltens#ebene\n",
      "Schulungs#material\n",
      "Schulungs#angebote\n",
      "Nach#teile\n",
      "Familien#anamnese\n",
      "Entscheidungs#prozess\n",
      "Patienten#gruppen\n",
      "Nagel#veränderungen\n",
      "Bösarti#gen\n",
      "Haut#tumoren\n",
      "Nach#teile\n",
      "Exzisions#biopsien\n",
      "56\n",
      "Plattenepithelkarzinom#fällen\n",
      "Tertiärpräventions#maßnahmen\n",
      "Lang#fristigen\n",
      "Schadensout#comes\n",
      "Langfristi#gen\n",
      "Kon#sequenzen\n",
      "Per#sönlichen\n",
      "Ana#mnese\n",
      "Weiter#bildung\n",
      "Weiter#bildung\n",
      "Informations#verbreitung\n",
      "Schulungs#programmen\n",
      "Gesic#herten\n",
      "Dia#gnosen\n",
      "Nagel#veränderungen\n",
      "Lang#fristiges\n",
      "Screen#ing\n",
      "Gelenk#befall\n",
      "R2#situation\n",
      "R2#resektion\n",
      "R2#situation\n",
      "R2#residualtumoren\n",
      "R2#residualtumoren\n",
      "R2#resezierten\n",
      "R2#situation\n",
      "R2#situation\n",
      "Orthovolt#bereich\n",
      "Orthovolt#bereich\n",
      "2-Jahres#überlebensraten\n",
      "Fernmetastasen#rezidive\n",
      "Melanom#zellen\n",
      "Behandlungs#verlauf\n",
      "Schwer#behindertenrecht\n",
      "Aufklärungs#gesprächen\n",
      "Hinweis#zeichen\n",
      "Bewältigungs#bezogene\n",
      "Aspe#kte\n",
      "Unterstützungs#bedürfnisse\n",
      "Drittlinien#therapien\n",
      "Hirn#metastasen\n",
      "Hirn#metastasen\n",
      "Mamma#karzinom\n",
      "Mamma#karzinom\n",
      "Hirn#metastasen\n",
      "Hirn#metastasen\n",
      "-Iv#patienten\n",
      "Iii#\n",
      "Leisten#bereich\n",
      "Lymph#invasion\n",
      "Makro#metastasierung\n",
      "Glabella#bereich\n",
      "aus\n",
      "Schulter#bereich\n",
      "Schulter#bereich\n",
      "Hals#bereich\n",
      "Hüft#bereich\n",
      "Kopf#haut\n",
      "Placebo#gruppe\n",
      "In-Transit#metastasen\n",
      "In-Transit#metastasen\n",
      "25#mal\n",
      "In-Transit#metastasen\n",
      "In-Transit#metastasen\n",
      "Subkuta#nen\n",
      "Met#astasen\n",
      "Fern#metastasen\n",
      "Fern#metastasen\n",
      "Subkutan#metastasen\n",
      "Vis#zeralen\n",
      "Met#astasen\n",
      "Tumor#entwicklung\n",
      "Referenz#therapeutikum\n",
      "Grad-3#\n",
      "Berufs#leben\n",
      "Ziel#gerichtete\n",
      "The#rapien\n",
      "Mykoplasma#infektionen\n",
      "Mykoplasma#infektionen\n",
      "Befund#abhängig\n",
      "Hyperthyreose#symptome\n",
      "Behandlungs#prozesses\n",
      "Mono#therapie\n",
      "Lymphknoten#metastasen\n",
      "Lymphknoten#metastasen\n",
      "Lymphknoten#metastasen\n",
      "Knochen#metastasen\n",
      "Knochen#metastasen\n",
      "Knochen#metastasen\n",
      "Lymphknoten#metastasen\n",
      "Lymphknoten#metastasen\n",
      "auch\n",
      "Lymphknoten#metastasen\n",
      "Beratungs#bedarf\n",
      "Dritt#rezidive\n",
      "Ziel#gerichteten\n",
      "The#rapien\n",
      "Kosten-Nutzen#abwägung\n",
      "Teilhabe#störungen\n",
      "Sport#therapeuten\n",
      "Staging#systeme\n",
      "Staging#system\n",
      "R2#resezierten\n",
      "Fall#berichte\n",
      "Poly#chemotherapie\n",
      "Wechsel#wirkungen\n",
      "Gemüse#reiche\n",
      "Ern#ährung\n",
      "Strahlen#therapie\n",
      "Selbst#verantwortung\n",
      "Kog#nitive\n",
      "Fakt#oren\n",
      "Überwachungs#strategien\n",
      "Lebens#partner\n",
      "Therapie#bedingter\n",
      "Chemo#therapie\n",
      "Puva#keratosen\n",
      "Hals#tumoren\n",
      "Haut#tumoren\n",
      "Haut#tumoren\n",
      "Haut#tumoren\n",
      "Shave#biopsie\n",
      "Shave#biopsie\n",
      "Patienten#wunsch\n",
      "Co2#laser\n",
      "8\n",
      "PDT\n",
      "Konvention#elle\n",
      "Skalp#bereich\n",
      "Sekundär#prophylaxe\n",
      "Placebo#creme\n",
      "42,9\n",
      "%\n",
      "9\n",
      "R2#resektion\n",
      "R2#resektion\n",
      "R2#resektion\n",
      "R2#situation\n",
      "R2#lokalisation\n",
      "Makro#metastase\n",
      "Berichts#wesen\n",
      "Pechhauterkrankung\n",
      "Angebots#vorsorge\n",
      "Kon#sensbasierte\n",
      "Maß#nahmen\n",
      "Therapie#optionen\n",
      "Folge#wirkungen\n",
      "Daten#speicherung\n",
      "Spät#folgen\n",
      "Aufklärungs#bedürfnisse\n",
      "Sterbe#risiko\n",
      "Patientinnen#information\n",
      "-2-positiv\n",
      "Brca1#\n",
      "Zweit#befundung\n",
      "Vakuum#biopsien\n",
      "Aufklärungs#gespräch\n",
      "Biopsie#rate\n",
      "Eier#stockkrebs\n",
      "Eier#stockkrebs\n",
      "Eier#stockkrebs\n",
      "Brca2#mutation\n",
      "Krankheits#themen\n",
      "Behandlungs#optionen\n",
      "Her2#negativität\n",
      "Her2#negativität\n",
      "Inzidenz#raten\n",
      "Ergebnis#qualität\n",
      "Ergebnis#qualität\n",
      "Eier#stockkrebs\n",
      "Prozess#qualität\n",
      "Screening#zentren\n",
      "Nach#teile\n",
      "Brca2#genmutation\n",
      "Nach#teile\n",
      "Brca2#genmutation\n",
      "Brca2#genmutation\n",
      "Brca2#genmutation\n",
      "Brca2#genmutation\n",
      "Vergrößerungs#aufnahmen\n",
      "Vakuum#biopsie\n",
      "Vakuum#biopsie\n",
      "Vakuum#biopsie\n",
      "Vakuum#biopsie\n",
      "Vakuum#biopsie\n",
      "Vakuum#biopsie\n",
      "Kontra#lateral\n",
      "Vakuum#biopsien\n",
      "System#therapie\n",
      "Nach#teile\n",
      "Seed#markierung\n",
      "Vakuum#biopsien\n",
      "Vakuum#biopsien\n",
      "Progesteronrezeptor#status\n",
      "Progesteronrezeptor#status\n",
      "Her2#status\n",
      "Inter#ner\n",
      "Kont#rollen\n",
      "Quetsch#artefakte\n",
      "Quetsch#artefakte\n",
      "Pgr#negativ\n",
      "Fal#sch\n",
      "Pgr#negativ\n",
      "Contra#argumente\n",
      "Pgr#status\n",
      "Her2#status\n",
      "6\n",
      "Vakuum#biopsien\n",
      "Vakuum#biospien\n",
      "Vakuum#biopsien\n",
      "Vakuum#biopsien\n",
      "63\n",
      "Vakuum#biopsien\n",
      "Post#operative\n",
      "Bestrahlungs#behandlung\n",
      "R2#\n",
      "Infra#klavikulären\n",
      "Lymph#knoten\n",
      "Infra#klavikulären\n",
      "Lymph#knoten\n",
      "Infra#klavikulären\n",
      "Lymph#knoten\n",
      "Infra#klavikulären\n",
      "Lymph#knoten\n",
      "Infra#klavikulären\n",
      "Lymph#knoten\n",
      "Infra#klavikuläre\n",
      "Infra#klavikulären\n",
      "Infra#klavikulären\n",
      "Hormon#therapie\n",
      "Brustwand#infiltrationen\n",
      "Pgr#negativ\n",
      "Kontralatera#len\n",
      "Rezidiv#häufigkeiten\n",
      "Pgr#negativ\n",
      "Pgr#negativ\n",
      "Sterbe#risiken\n",
      "Häm#angiosis\n",
      "Krebs#therapiebasierten\n",
      "Knochendichte#unabhängigen\n",
      "Ver#ringerung\n",
      "auch\n",
      "Hormon#therapie\n",
      "Sensomotoris#chem\n",
      "Sensomotoris#chem\n",
      "Train#ing\n",
      "Sensomotoris#chem\n",
      "Sensomotoris#chem\n",
      "Train#ing\n",
      "auch\n",
      "Ausdauer#training\n",
      "Physik#alische\n",
      "The#rapie\n",
      "Steht#raining\n",
      "Zucker#reiche\n",
      "Fernmetastasierungs#rate\n",
      "Er#positiv\n",
      "Nach#teile\n",
      "Chemo#therapien\n",
      "Kyphoplas#tie\n",
      "Weichteil#metastasen\n",
      "Lebens#zielen\n",
      "Therapie#möglichkeiten\n",
      "Therapie#möglichkeiten\n",
      "Langzeit#therapien\n",
      "Behandlungs#folgen\n",
      "Gruppen#intervention\n",
      "Behandlungs#phasen\n",
      "Tanz#therapie\n",
      "Tanz#therapie\n",
      "Krebs#erkrankung\n",
      "Tumor#typ\n",
      "Chemo#therapie\n",
      "Sensomotoris#chem\n",
      "Sensomotoris#chem\n",
      "Train#ing\n",
      "Steht#raining\n",
      "Spät#toxizität\n",
      "Spät#folgen\n",
      "Langzeit#nebenwirkungen\n",
      "Gelenk#schmerzen\n",
      "Müdigkeits#syndrom\n",
      "Radio#therapie\n",
      "Strahlen#therapie\n",
      "auch\n",
      "Kraft#training\n",
      "Ausdauer#training\n",
      "Bewegungs#therapie\n",
      "Hand#schuhförmigen\n",
      "Dysästhe#sien\n",
      "Tertiär#prävention\n",
      "Bewegungs#therapie\n",
      "Gedächtnis#trainings\n",
      "Zeit#aufwand\n",
      "Tumor#assoziierte\n",
      "Renten#versicherung\n",
      "Selbst#verantwortung\n",
      "Alternativ#medizinische\n",
      "Strahlen#therapie\n",
      "Strahlen#therapie\n",
      "Gemüse#reiche\n",
      "Ern#ährung\n",
      "Taxol#therapie\n",
      "Strahlen#therapie\n",
      "Pr#negativem\n",
      "Mamma#karzinom\n",
      "Sequenz#regime\n",
      "Axilla#befunden\n",
      "Langzeit#nebenwirkungen\n",
      "Versorgungs#kette\n",
      "Vakuum#biopsie\n",
      "Vakuum#biopsien\n",
      "Vakuum#biopsie\n",
      "B4#kategorie\n",
      "Vakuum#biopsie\n",
      "Vakuumbiopsie#material\n",
      "Vakuum#biopsie\n",
      "Vakuumbiopsie#material\n",
      "Her2#negativ\n",
      "Her2#negativ\n",
      "Vakuumbiopsie#material\n",
      "Her2#überexpression\n",
      "Pr#positiv\n",
      "Vakuumbiopsie#material\n",
      "Her2#überexpression\n",
      "Pr#positiv\n",
      "Her2#überexpression\n",
      "Vakuum#biopsien\n",
      "Progesteronrezeptor#status\n",
      "Progesteronrezeptor#status\n",
      "Pr#positiv\n",
      "Patientinnen#information\n",
      "Metastasen#diagnostik\n",
      "Gemüse#aufnahme\n",
      "Gemüse#verzehr\n",
      "Gemüse#konsums\n",
      "Gemüse#konsum\n",
      "Gemüse#verzehr\n",
      "Leber#erkrankungen\n",
      "Zigarren#rauchen\n",
      "Rücken#schmerzen\n",
      "Verdachts#leveladaptiertes\n",
      "Vor#gehen\n",
      "Rücken#schmerzen\n",
      "Gallengangs#karzinome\n",
      "Rücken#schmerzen\n",
      "Kernspintomographie#untersuchungen\n",
      "Lymphgefäß#invasion\n",
      "Chemotherapie#dosis\n",
      "Zerebr#ale\n",
      "Met#astasen\n",
      "Sekundär#prävention\n",
      "Radiotherapie#expertenpanels\n",
      "Extra#hepatische\n",
      "Met#astasen\n",
      "Mrt#merkmale\n",
      "Nebenbild#merkmalen\n",
      "5-Jahres#überleben\n",
      "5-Jahres#überleben\n",
      "Tumor#größe\n",
      "Anz#ahl\n",
      "Subsegment#grenzen\n",
      "Mortalitäts#rate\n",
      "Mortalitäts#raten\n",
      "5-Jahres#überleben\n",
      "5-Jahres#überlebensraten\n",
      "Langzeit#ergebnisse\n",
      "5-Jahres#überlebensrate\n",
      "Langzeit#ergebnisse\n",
      "5-Jahres#überleben\n",
      "Segment#grenzen\n",
      "Kryo#ablation\n",
      "Mäßig#gradiger\n",
      "Por#taler\n",
      "Extrahepati#schen\n",
      "Sta#gings\n",
      "Mrt#merkmale\n",
      "Drittlinien#therapie\n",
      "Sep#aration\n",
      "Muskelaufbau#training\n",
      "Spezi#elles\n",
      "Extrahepati#schen\n",
      "Cholangio#karzinomen\n",
      "Nach#teile\n",
      "auch\n",
      "Hypo#echogen\n",
      "Pankreas#karzinom\n",
      "T1A#tumoren\n",
      "T3#läsionen\n",
      "4-Jahres#überlebensrate\n",
      "Risiko#gruppen\n",
      "Gallen#blasenkarzinom\n",
      "Gemüse#konsum\n",
      "Haar#veränderungen\n",
      "Zweit#gradiger\n",
      "Verw#andter\n",
      "Cava#beteiligung\n",
      "Perfusions#untersuchungen\n",
      "Aspirationsbiop#sie\n",
      "20-Gauge#nadel\n",
      "Therapie#verlaufs\n",
      "Post#operativ\n",
      "5-Jahres#rezidivfreiheit\n",
      "5-Jahres#rezidivfreiheit\n",
      "5-Jahres#rezidivfreiheit\n",
      "5-Jahres#rezidivfreiheit\n",
      "Tumorspezi#fisches\n",
      "Über#leben\n",
      "And#ere\n",
      "Met#astasen\n",
      "Progress#ionsraten\n",
      "Volumen#zunahme\n",
      "Kryoablat#ion\n",
      "Mrt#gestützten\n",
      "Nach#sorge\n",
      "Tumorspezi#fischen\n",
      "Über#leben\n",
      "Langzeit#ergebnisse\n",
      "Mrt#diagnostik\n",
      "Über#lebens\n",
      "Krebsspezi#fischen\n",
      "Doxorubi#cin\n",
      "Leber#filiae\n",
      "Weichteil#metastasen\n",
      "Nach#teile\n",
      "Chemo#therapie\n",
      "Chemo#therapie\n",
      "Mtor#inhibitoren\n",
      "Bevacizumab#behandlung\n",
      "Bevacizumab#behandlung\n",
      "Mtor#basierte\n",
      "The#rapie\n",
      "Peri#operative\n",
      "Ris#iko\n",
      "5#jahresüberlebensraten\n",
      "5-Jahres#überleben\n",
      "Leber­#metastasen\n",
      "Radio#therapie\n",
      "Post#operativen\n",
      "Kompli#kationen\n",
      "Post#operativen\n",
      "Kompli#kationen\n",
      "Gpa#index\n",
      "5-Jahres#überleben\n",
      "5-Jahres#überleben\n",
      "poor\n",
      "Prognosis#patienten\n",
      "75\n",
      "Neuro#logischen\n",
      "Zust#and\n",
      "Kraft#training\n",
      "Palliativ#angebote\n",
      "Palliativ­#angeboten\n",
      "Sterbe#phase\n",
      "Leber#funktion\n",
      "Physio#therapie\n",
      "Umgebungs#faktoren\n",
      "Paar#gespräche\n",
      "Therapie#bedingten\n",
      "Problema#tik\n",
      "Therapie#bedingte\n",
      "Defiz#ite\n",
      "Wahl#recht\n",
      "Berufs#leben\n",
      "Behandlungs#bedingt\n",
      "Behandlungs­#verlauf\n",
      "Behandlung#sassoziierten\n",
      "Eins#chränkungen\n",
      "Angst#störungen\n",
      "Depres#sive\n",
      "Stör#ungen\n",
      "Zeit#nahe\n",
      "Unter#stützung\n",
      "Aufklärungs#gespräch\n",
      "Physio#therapie\n",
      "Alkohol#konsum\n",
      "23,9-fache\n",
      "Laugen#verätzungen\n",
      "Laugen#ingestion\n",
      "Stoff\n",
      "Magen#karzinoms\n",
      "Bronchialkarzinom#inzidenz\n",
      "Kardia#karzinomen\n",
      "Fern#metastasen\n",
      "Eus#staging\n",
      "Speise#wege\n",
      "Hoch#gradig\n",
      "Adeno#karzinom\n",
      "Tnm#klassifikation\n",
      "auch\n",
      "auch\n",
      "Übergangs#karzinom\n",
      "Adeno#karzinom\n",
      "Blutgefäß#infiltration\n",
      "Schneide#technik\n",
      "Mortalitäts#konferenzen\n",
      "Koloninterpo#nats\n",
      "auch\n",
      "Nieren#insuffizienz\n",
      "Radio#therapie\n",
      "Post#operative\n",
      "Radio#chemotherapie\n",
      "Peri#operativen\n",
      "Chemo#therapie\n",
      "Peri#operativen\n",
      "The#rapie\n",
      "Post#operativ\n",
      "Plattenepithel#karzinomen\n",
      "Radio#chemotherapie\n",
      "Post#operativ\n",
      "Adeno#karzinome\n",
      "Therapie#bedingter\n",
      "Fol#gen\n",
      "Muskelaufbau#training\n",
      "Spezi#elles\n",
      "Dreifach#kombination\n",
      "Fluoro#pyrimidinbasierten\n",
      "Fluoro#pyrimidinhaltige\n",
      "Dreifach#kombination\n",
      "Leber#metastasen\n",
      "27\n",
      "Pati#enten\n",
      "Behandlung#sassoziierten\n",
      "Eins#chränkungen\n",
      "Angst#störungen\n",
      "Ster#berate\n",
      "Rachen#karzinom\n",
      "Alkohol#abusus\n",
      "Alkohol#abusus\n",
      "Emissions#belasteter\n",
      "Umge#bung\n",
      "Teer#produkten\n",
      "Kiefer#heilkunde\n",
      "Kiefer#heilkunde\n",
      "Perineuralscheiden#invasion\n",
      "Perineuralscheiden#invasion\n",
      "Farb#markierung\n",
      "Tumor#lokalisation\n",
      "Erhöh#ten\n",
      "Alkohol#konsum\n",
      "Früh#stadien\n",
      "Atem#störungen\n",
      "Nacken#region\n",
      "Respirations#stellung\n",
      "Speise#weg\n",
      "Hypo#pharynx\n",
      "Total#entfernung\n",
      "Nach#teile\n",
      "Chemo#therapie\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "auch\n",
      "Radio#chemotherapie\n",
      "Nephro#toxizität\n",
      "Radio#chemotherapie\n",
      "Beidsei#tige\n",
      "Neck\n",
      "Radio#chemotherapie\n",
      "Ausschluss#kriterien\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Schluck#funktion\n",
      "Strahlen#therapie\n",
      "Platin#basierte\n",
      "Chemo#therapie\n",
      "Funktions#erhalts\n",
      "auch\n",
      "Modalitäts#intensivierung\n",
      "Beidsei#tige\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Stimm#funktion\n",
      "Hypopharynxteilre#sektion\n",
      "Radio#chemotherapie\n",
      "Taschen#band\n",
      "Radio#chemotherapie\n",
      "Rezidiv#situation\n",
      "Schluck#funktion\n",
      "Rezidiv#tumoren\n",
      "Radio#chemotherapie\n",
      "Chemo#therapie\n",
      "Unterstützungs#möglichkeiten\n",
      "Hals#bereich\n",
      "Speise#weg\n",
      "Speise#weg\n",
      "Stimm#training\n",
      "Unterstützungs#möglichkeiten\n",
      "Ernährungs#therapie\n",
      "Ernährungs#therapie\n",
      "Therapie#bedingten\n",
      "Therapie#bedingten\n",
      "Rehabilitations#fähigkeit\n",
      "Schmerz#therapie\n",
      "Allgemein#zustand\n",
      "Hypo#pharynx\n",
      "Schluck#funktion\n",
      "N#kategorie\n",
      "Supraglotti#schen\n",
      "Aus#dehnung\n",
      "Blut#proben\n",
      "Hals#region\n",
      "Blut#proben\n",
      "Blut#proben\n",
      "Blut#proben\n",
      "Blut#proben\n",
      "Kohorten#studien\n",
      "Kohorten#studien\n",
      "Kohorten#studien\n",
      "Kohorten#studien\n",
      "Kohorten#studien\n",
      "Tee#konsum\n",
      "Genistein#anteil\n",
      "Kohorten#studien\n",
      "Kohorten#studien\n",
      "Kohorten#studien\n",
      "Kohorten#studien\n",
      "Parametrien#infiltration\n",
      "Blutgefäß#einbrüchen\n",
      "Hinter#wand\n",
      "Therapie#relevant\n",
      "Blutgefäß#einbrüchen\n",
      "Hinter#wand\n",
      "Makro#metastasen\n",
      "Makro#metastasen\n",
      "Zervix#karzinom\n",
      "Rezidiv#freien\n",
      "Über#leben\n",
      "R2#situation\n",
      "Ovarial#karzinom\n",
      "Häm#angiosis\n",
      "High-Risk#patientinnen\n",
      "Rezidiv#risiko\n",
      "High#risk\n",
      "High-Risk#tumoren\n",
      "Chemo#therapie\n",
      "Chemo#therapie\n",
      "Progressions#freien\n",
      "Über#leben\n",
      "Krankheitsspezi#fischen\n",
      "Über#lebens\n",
      "Darm#symptomen\n",
      "Figo#stadieneinteilungen\n",
      "4-Felder#technik\n",
      "Lebensqualitäts#profil\n",
      "Makro#hämaturien\n",
      "Schleim#abgänge\n",
      "Tumor#typ\n",
      "Überlebens#raten\n",
      "Scheiden#stumpfrezidiv\n",
      "Scheiden#stumpfrezidiv\n",
      "Scheiden#stumpfrezidivs\n",
      "Hormon#therapie\n",
      "Tele#therapie\n",
      "Östrogen#rezeptor\n",
      "Östrogen#rezeptor\n",
      "Neutropenie#rate\n",
      "Silikon#basis\n",
      "Silikon#basis\n",
      "Belastungs#harninkontinenz\n",
      "Beckenwand#rezidiv\n",
      "Bösar#tige\n",
      "Tum#oren\n",
      "Familien#anamnese\n",
      "Familien#anamnese\n",
      "Familien#anamnese\n",
      "Cs#patientinnen\n",
      "Cowden-Syndrom#patientinnen\n",
      "Nach#teile\n",
      "Perimeno#pausal\n",
      "Cs#patientinnen\n",
      "Cowden-Syndrom#anlageträgerinnen\n",
      "Nach#teilen\n",
      "Nach#teile\n",
      "Eier#stockkrebs\n",
      "Eier#stockkrebs\n",
      "Interaktions#fähigkeit\n",
      "Endometrium#karzinom\n",
      "Stuhl#inkontinenz\n",
      "Krisenbewältigungs#erfahrung\n",
      "Krisenbewältigungs#erfahrung\n",
      "Behandlungs#angebote\n",
      "Behandlungs#angebote\n",
      "Lebens#einstellung\n",
      "Progredienz#angst\n",
      "Behandlung#sassoziierten\n",
      "Eins#chränkungen\n",
      "Krankheits#bewältigung\n",
      "Harninkonti#nenz\n",
      "Therapie#optionen\n",
      "Sach#kompetente\n",
      "Aufklärungs#pflichten\n",
      "Aufklärungsfehlern\n",
      "Stuhl#kontrolle\n",
      "Infiltrations#symptomatik\n",
      "Therapie#folgestörungen\n",
      "Adhäsionsbesch#werden\n",
      "Darm#störungen\n",
      "Behandlungs#konzept\n",
      "Haus#ärzte\n",
      "Sport#therapeuten\n",
      "Behandlungs#folgestörungen\n",
      "Risiko#faktoren\n",
      "Anpassungs#störungen\n",
      "Mischinkonti#nenz\n",
      "Mischinkonti#nenz\n",
      "Chemo#therapie\n",
      "Mischinkonti#nenz\n",
      "Becken#bodentraining\n",
      "Krebs#patientinnen\n",
      "Darmkrebs#zentren\n",
      "Therapie#algorithmus\n",
      "Mortalitäts#risiko\n",
      "Brca2#mutationsträgerinnen\n",
      "Tast#untersuchung\n",
      "Therapie#optionen\n",
      "Lebens#planung\n",
      "Therapie#optionen\n",
      "Lebens#planung\n",
      "Daten#speicherung\n",
      "Versorgungs#kette\n",
      "Versorgungs#kette\n",
      "Eierstockkrebs#syndrom\n",
      "Eierstockkrebs#syndrom\n",
      "Lynch#syndrom\n",
      "Mlh1#mutation\n",
      "Mamma#karzinom\n",
      "Tuben#karzinom\n",
      "Tuben#karzinom\n",
      "Mamma#karzinom\n",
      "Mehr#jähriger\n",
      "Anw#endung\n",
      "Dosis#abhängige\n",
      "Effe#kte\n",
      "Menopausen#alter\n",
      "Mäßig#gradigen\n",
      "Zella#typien\n",
      "Drüsen#strukturen\n",
      "Mäßig#gradiger\n",
      "Zella#typie\n",
      "auch\n",
      "Keimstrang#tumoren\n",
      "Ausschluss#kriterien\n",
      "Interaortocaval#region\n",
      "Interaortocaval#region\n",
      "Interaortocaval#region\n",
      "Interaortocaval#region\n",
      "Action#studie\n",
      "Erhaltungs#therapie\n",
      "Konsolidierungs#therapie\n",
      "Konsolidierungs#therapie\n",
      "Progressions#diagnose\n",
      "--\n",
      "Komplett#remission\n",
      "Lebens#zielen\n",
      "Strahlen#therapie\n",
      "Androgenproduzier#ende\n",
      "Keimstrangstroma#tumoren\n",
      "Endokri#nen\n",
      "Endokri#nen\n",
      "The#rapie\n",
      "Milzgrößenab#schätzung\n",
      "Leber#größe\n",
      "Ins#besondere\n",
      "Leber#untersuchung\n",
      "Aberrations#status\n",
      "Milzgrößenab#schätzung\n",
      "Milzgrößenab#schätzung\n",
      "Milzgrößenab#schätzung\n",
      "Lymphknoten#biopsie\n",
      "Therapie#einleitung\n",
      "Milzgrößenab#schätzung\n",
      "Ins#besondere\n",
      "Leber#untersuchung\n",
      "Cmv#infektion\n",
      "Rezidiv#diagnostik\n",
      "Zwei#monatlichen\n",
      "Abstän#den\n",
      "Rezidiv#diagnostik\n",
      "Magnetresonanztomo#graphischen\n",
      "Bild#gebung\n",
      "Virus#serologie\n",
      "Nieren#funktion\n",
      "Nieren#funktion\n",
      "Wechsel#wirkungen\n",
      "Milzgrößenab#schätzung\n",
      "Milzgrößenab#schätzung\n",
      "Cmv#serologie\n",
      "Virus#serologie\n",
      "Zwei#monatlichen\n",
      "Abstän#den\n",
      "Infiltrations#bedingten\n",
      "Zyt#openien\n",
      "Bedürfnis#lage\n",
      "Fach#arzt\n",
      "Weiter#bildung\n",
      "Bedürfnis#lagen\n",
      "Krankheits#bedingter\n",
      "Krebs#erkrankung\n",
      "Krankheits#bedingte\n",
      "Schutz#faktoren\n",
      "Verlaufs#diagnostik\n",
      "Konsolidierungs#therapie\n",
      "Konsolidierungs#therapie\n",
      "Erhaltungs#therapie\n",
      "Chemoimmun#therapien\n",
      "Verlaufs#diagnostik\n",
      "Pi3K#inhibitors\n",
      "Pi3K#inhibitoren\n",
      "Alemtuzumab#therapie\n",
      "Fludarabinvorbehandel#ten\n",
      "Alem#tuzumabrefraktären\n",
      "Pati#enten\n",
      "Alem#tuzumabrefraktären\n",
      "Pati#enten\n",
      "Alem#tuzumabrefraktärer\n",
      "CLL\n",
      "Chemo#immuntherapie\n",
      "Chemo#immuntherapie\n",
      "Multi#morbidität\n",
      "Nahrungs#zufuhr\n",
      "His#tologie\n",
      "Behandlungs#verlaufs\n",
      "Seh#störungen\n",
      "Behandlungs#verlauf\n",
      "Alltagskompetenz#defizite\n",
      "Toxizitäts#risikos\n",
      "Organ#schädigungen\n",
      "Transplantations#spezifischen\n",
      "Krankheits#freie\n",
      "Über#leben\n",
      "Salvage#therapie\n",
      "Transplantations#risikos\n",
      "Rezidiv#therapiee\n",
      "Platin#haltige\n",
      "Proto#kolle\n",
      "Knochen#markaspiration\n",
      "Makro#zytärer\n",
      "Anä#mie\n",
      "Knochen#markaspiration\n",
      "Citrat#blut\n",
      "Milz#größe\n",
      "Thrombozyten#konzentrate\n",
      "Citrat#blut\n",
      "Autoimmun#anämie\n",
      "Hepati#tis\n",
      "Strahlen#therapie\n",
      "Kohlenhydrat#haltige\n",
      "Pul#ver\n",
      "Strahlen#therapie\n",
      "Krankheits#assoziierte\n",
      "Symp#tome\n",
      "Krankheits#assoziierte\n",
      "Symp#tome\n",
      "Spät#komplikationen\n",
      "Leber#werte\n",
      "Ros#mutationen\n",
      "Splenomega#lie\n",
      "Lungen#funktionsuntersuchungen\n",
      "Strahlen#therapie\n",
      "PFS\n",
      "Chemotherapie#auswahl\n",
      "Langzeit#auswertung\n",
      "RT\n",
      "Therapie#fernen\n",
      "Todes#ursachen\n",
      "Langzeit#auswertung\n",
      "Risiko#einteilung\n",
      "Nach#teile\n",
      "Folge#auswertung\n",
      "RT\n",
      "Rest#tumoren\n",
      "Langzeit#nebenwirkungen\n",
      "Langzeit#nebenwirkungen\n",
      "Vincristin#assoziierten\n",
      "Vincristin#assoziierten\n",
      "Neben#wirkungen\n",
      "Strahlen#therapie\n",
      "Strahlen#therapie\n",
      "Risiko#adaptierten\n",
      "The#rapie\n",
      "Strahlen#therapie\n",
      "Feta#ler\n",
      "Doppler#kontrolle\n",
      "Os#raten\n",
      "Feta#ler\n",
      "Doppler#kontrolle\n",
      "Persistenz#verdacht\n",
      "Persistenz#verdacht\n",
      "Gallium#scan\n",
      "Non#hodgkin\n",
      "Hochdosis#therapie\n",
      "Hochdosis#chemotherapie\n",
      "Doppel#transplantation\n",
      "57\n",
      "%\n",
      "Rezidiv#therapie\n",
      "Ges#tagenhaltige\n",
      "Verhütungs#mittel\n",
      "Therapie#bedingte\n",
      "Eins#chränkungen\n",
      "Rezidiv#ängste\n",
      "Therapie#bedingte\n",
      "Funktions#störungen\n",
      "Eier#stockkrebs\n",
      "Eier#stockkrebs\n",
      "Eier#stockkrebs\n",
      "Mamma#karzinoms\n",
      "Chemo#therapie\n",
      "auch\n",
      "Totalno#daler\n",
      "Best#rahlung\n",
      "Chemo#therapie\n",
      "Lebensstil#faktoren\n",
      "Apo#ptose\n",
      "Gen\n",
      "Fl#risiko\n",
      "Nieren#werte\n",
      "Hcv#infektionsstatus\n",
      "Hcv#infektionsstatus\n",
      "Nieren#werte\n",
      "Rezidiv#diagnose\n",
      "Multi#morbidität\n",
      "Mortalitäts#risiko\n",
      "Therapie#kontext\n",
      "Diffu#sem\n",
      "Radioimmunchemotherapie#protokollen\n",
      "Radioimmunchemotherapie#protokollen\n",
      "Erhaltungs#therapie\n",
      "vor\n",
      "Obinotuzumab#gaben\n",
      "38\n",
      "Pati#enten\n",
      "Darm#befall\n",
      "Bedürfnis#lage\n",
      "Bedürfnis#lagen\n",
      "Lang#zeitigen\n",
      "Jugend#alter\n",
      "Dritt#therapie\n",
      "Multi#fokal\n",
      "Langzeit#toxizität\n",
      "auf\n",
      "Erhaltungs#therapie\n",
      "in\n",
      "Nieren#werte\n",
      "Lungen#vorerkrankungen\n",
      "Erhaltungs#therapie\n",
      "Morbiditäts#risiko\n",
      "Fremdspender#transplantation\n",
      "Chemoradio#therapie\n",
      "Chemoradio#therapie\n",
      "Nachsorge#ct\n",
      "Bedürfnis#orientiert\n",
      "Hodgkin#lymphom\n",
      "Geschlechts#adaptierten\n",
      "Vergleichs#gruppe\n",
      "Geschlechts#adaptierten\n",
      "Vergleichs#gruppe\n",
      "Therapie#folgestörungen\n",
      "Rezidiv#therapie\n",
      "Lymphom#erkrankung\n",
      "Rehabilitations#ziele\n",
      "Lymphom#erkrankung\n",
      "Strahlentherapie#spezifische\n",
      "Folge#störungen\n",
      "Gruppen#angeboten\n",
      "Rezidiv#therapie\n",
      "Physio#therapeutisches\n",
      "Trainings#programm\n",
      "Therapie#durchführbarkeit\n",
      "Lymphom#erkrankung\n",
      "Therapie#durchführbarkeit\n",
      "Ordnungs#therapie\n",
      "Ordnungs#therapie\n",
      "Ordnungs#therapie\n",
      "Stoffwechsel#störungen\n",
      "Therapie#bedingte\n",
      "Defiz#ite\n",
      "Achtsamkeits#verfahren\n",
      "Therapie#bedingte\n",
      "Beschw#erden\n",
      "Versorgungs#möglichkeiten\n",
      "--\n",
      "Jugend#alter\n",
      "Geschlechts#abhängigen\n",
      "Inzidenz#raten\n",
      "Rezidiv#risiko\n",
      "Harn#traktes\n",
      "Fall#kontrollstudien\n",
      "Softdrink#konsum\n",
      "Softdrink#konsum\n",
      "Nierenzell#karzinom\n",
      "Urin#tests\n",
      "High#grade\n",
      "Progressions#risiko\n",
      "Uicc#klassifikation\n",
      "Tumor#gewebe\n",
      "Gewebe#spiegel\n",
      "Makro#hämaturie\n",
      "Mikro#hämaturie\n",
      "Weißlicht#zystoskopie\n",
      "Risiko#adaptierten\n",
      "Behand#lung\n",
      "Risiko#adaptierten\n",
      "Behand#lung\n",
      "Intraobserver#variabilität\n",
      "Progressions#risikos\n",
      "Post#operativen\n",
      "Hämoglobin#wertes\n",
      "Low#risk\n",
      "High#risk\n",
      "Kar#zinome\n",
      "Post#operative\n",
      "Hämoglobin#differenz\n",
      "Progress#ionsraten\n",
      "Rezidiv#raten\n",
      "Progress#ionsraten\n",
      "Progress#raten\n",
      "Primär#tumor\n",
      "Tumorspezi#fisches\n",
      "Tumorspezi#fisches\n",
      "Mortalitäts#risiko\n",
      "Rezidiv#risiko\n",
      "Progressions#risiko\n",
      "High#risk\n",
      "Erhaltungs#therapie\n",
      "Metastasierungs#risiko\n",
      "Progressions#senkung\n",
      "Erhaltungs#therapie\n",
      "Progress#ionsrate\n",
      "Erhaltungs#therapie\n",
      "Progress#ionsrate\n",
      "Erhaltungs#schema\n",
      "Erhaltungs#schema\n",
      "Fish#urinzytologie\n",
      "High#risk\n",
      "NMIBC\n",
      "Patienten#charakteristika\n",
      "9\n",
      "Pati#enten\n",
      "High#risk\n",
      "NMIBC\n",
      "Elektro#motiv\n",
      "Placebo#arm\n",
      "Patienten#charakteristika\n",
      "Rezidiv#tumor\n",
      "Mortalitäts#rate\n",
      "Prospekt#ive\n",
      "Stu#die\n",
      "Mortalitäts#rate\n",
      "Komplikations#risiko\n",
      "Gesamt#überleben\n",
      "Gesamt#überleben\n",
      "auch\n",
      "Über#leben\n",
      "Krankheits#spezifische\n",
      "Adjuv#ante\n",
      "Chemo#therapien\n",
      "Fern#metastasen\n",
      "Post#operativen\n",
      "Maß#nahmen\n",
      "Post#operativer\n",
      "Kompli#kationen\n",
      "Post#operative\n",
      "Morbidi#tät\n",
      "auch\n",
      "30-Tage#morbidität\n",
      "15#jahres\n",
      "Überlebens#rate\n",
      "Rezidiv#tumor\n",
      "Progressions#freies\n",
      "Über#leben\n",
      "Rezidiv#tumoren\n",
      "R2#status\n",
      "Konsolidierungs#therapie\n",
      "Allgemein#chirurgie\n",
      "Kolon#conduit\n",
      "auch\n",
      "Dick#darm\n",
      "Nach#teile\n",
      "Selbst#katheterismus\n",
      "Kolon#conduit\n",
      "Unter#bauch\n",
      "Entlassungs#managements\n",
      "Haut#komplikationen\n",
      "Ureteranasto#mose\n",
      "Rezidiv#risiko\n",
      "Rezidiv#risikos\n",
      "Zervix#karzinom\n",
      "Adeno#karzinom\n",
      "Radio#chemotherapie\n",
      "Immun#therapie\n",
      "Zweit#linie\n",
      "Tumor#infiltrierenden\n",
      "Immun#zellen\n",
      "Zweitlinien#chemotherapie\n",
      "Carboplatin#haltigen\n",
      "Chemo#therapien\n",
      "Mono#therapien\n",
      "Mono#therapien\n",
      "And#ere\n",
      "And#ere\n",
      "System#therapie\n",
      "Immun#zellen\n",
      "Immun#zellen\n",
      "Ema#zulassung\n",
      "Immun#zellen\n",
      "Immun#zellen\n",
      "Kombinations#chemotherapie\n",
      "Kombinations#chemotherapie\n",
      "Mono#chemotherapie\n",
      "Über#leben\n",
      "Progressions#freie\n",
      "Lebensqualität#daten\n",
      "Chemo#therapie\n",
      "Chemo#therapie\n",
      "Kombinations#chemotherapie\n",
      "Knochen#filiae\n",
      "Krankheitsspezi#fisches\n",
      "Über#leben\n",
      "Mamma#karzinom\n",
      "Nachbeobachtungs#dauer\n",
      "Best#rahlung\n",
      "Fraktion#ierten\n",
      "Fraktion#ierten\n",
      "Radio#therapie\n",
      "Mamma#karzinomen\n",
      "Interventions#strategien\n",
      "Urin#untersuchung\n",
      "#fähigkeit\n",
      "Gedächtnis#trainings\n",
      "Zeit#aufwand\n",
      "Tumor#assoziierte\n",
      "Chemotherapie#bedingte\n",
      "Hand#schuhförmigen\n",
      "Dysästhe#sien\n",
      "Ausdauer#training\n",
      "Chemo#therapie\n",
      "Behandlungs#phase\n",
      "5#stufigen\n",
      "Behandlungs#verlauf\n",
      "Darm#inkontinenz\n",
      "Sozial#dienste\n",
      "Familien#beziehung\n",
      "Orgasmus#störungen\n",
      "Orgasmus#störungen\n",
      "Therapie#angebote\n",
      "Zeit#nahe\n",
      "Unter#stützung\n",
      "Neuro#toxizität\n",
      "Haut#infektionen\n",
      "Progressions#risiko\n",
      "Progressions#risiko\n",
      "Progressions#risiko\n",
      "High#risk\n",
      "High#risk\n",
      "NMIBC\n",
      "Risiko#adaptierten\n",
      "Behand#lung\n",
      "Progress#ionsrate\n",
      "Progressions#risiko\n",
      "High#risk\n",
      "High#risk\n",
      "Kolon#anteilen\n",
      "Inkonti#nenz\n",
      "Tumor#markern\n",
      "Kontinenz#funktion\n",
      "Gesamt#überleben\n",
      "Spät#toxizitäten\n",
      "Chemo#therapie\n",
      "Beidsei#tige\n",
      "Gynäkomas#tie\n",
      "Strahlen#therapie\n",
      "Lungen#metastase\n",
      "Strahlen#therapie\n",
      "Lymph#gefäße\n",
      "Hoch#risikogruppe\n",
      "Chemo#therapie\n",
      "Über#leben\n",
      "Krankheits#spezifische\n",
      "Marker#konstellation\n",
      "Nach#teile\n",
      "Nach#teile\n",
      "Nephro#toxizität\n",
      "Serumtumormarkerkont#rollen\n",
      "Serumtumormarker#normalisierung\n",
      "Gefäß#invasion\n",
      "mit\n",
      "Pei#schema\n",
      "Pei#schema\n",
      "Knochen#metastasen\n",
      "Salvage#therapie\n",
      "Gesamt#überleben\n",
      "Sertolizell#tumoren\n",
      "Ct#gesteuerte\n",
      "Feinnadelbiop#sie\n",
      "Jugend#alter\n",
      "Estradiol#spiegeln\n",
      "Sertolizell#tumoren\n",
      "Pei#schema\n",
      "Sertolizell#tumore\n",
      "Nachsorge#gruppen\n",
      "Operati#ver\n",
      "The#rapie\n",
      "Blutdruck#werten\n",
      "Mrt#aufnahmen\n",
      "Mrt#plan\n",
      "Nachsorge#gruppen\n",
      "-Iib#seminom\n",
      "Iia#\n",
      "Chemo#therapie\n",
      "Langzeit#toxizität\n",
      "Langzeit#toxizität\n",
      "Alkohol#konsum\n",
      "Libido#störungen\n",
      "Zun#ahme\n",
      "Chemo#therapie\n",
      "Bauchspeicheldrüsen#krebs\n",
      "Etoposid#gefäßtoxizität\n",
      "Strumpf#parästhesie\n",
      "Kniestrumpf-Parästhesie\n",
      "The#rapie\n",
      "Konditions#minderung\n",
      "Behandlungs#phase\n",
      "Therapie#bedingte\n",
      "Kunst#therapie\n",
      "Bewegungs#angebote\n",
      "Life-Style#beratung\n",
      "Depres#sive\n",
      "Stör#ungen\n",
      "Behandlung#sassoziierten\n",
      "Eins#chränkungen\n",
      "Gemüse#sorten\n",
      "Schwellen#tests\n",
      "Referenz­#bereich\n",
      "Hyperecho#gene\n",
      "Ber#eiche\n",
      "auch\n",
      "Sekundär#biopsien\n",
      "Ct#befund\n",
      "Multi#fokales\n",
      "Auf#treten\n",
      "Symptom#vorbeugung\n",
      "Nach#teile\n",
      "Enddarm#beschwerden\n",
      "Therapie#verfahren\n",
      "Over#staging\n",
      "Intermediate-Risk#tumoren\n",
      "Komorbiditäts#struktur\n",
      "Betreuungs#intensiv\n",
      "Extra#peritoneal\n",
      "Potenz#raten\n",
      "Kontinenz#ergebnisse\n",
      "Extra#peritoneal\n",
      "Potenz#raten\n",
      "Lang#fristigen\n",
      "Kompli#kationen\n",
      "Bei#dseitig\n",
      "Potenz#raten\n",
      "Toxizität#daten\n",
      "Spät#toxizität\n",
      "Gesamt#dosierungen\n",
      "Gi#toxizitäten\n",
      "Ver#gleich\n",
      "Langzeit#androgendeprivationstherapie\n",
      "Hormonablati#ver\n",
      "The#rapie\n",
      "Spät#nebenwirkungen\n",
      "Spät#toxizitäten\n",
      "Allgemein#anästhesie\n",
      "Post#operative\n",
      "Kompli#kationen\n",
      "Ganzdrüsen#behandlung\n",
      "Salvage#therapie\n",
      "Perineal#schmerzen\n",
      "Krebs#spezifischen\n",
      "Überlebens#raten\n",
      "Helium#gas\n",
      "Krankheitsspezi#fischen\n",
      "Extra#zelluläre\n",
      "Eiskristall#bildung\n",
      "Nach#teile\n",
      "Zehn-Jahre#überlebens\n",
      "Nach#teile\n",
      "Drei#fach\n",
      "Spät#folgen\n",
      "Metastasen#freien\n",
      "Über#lebens\n",
      "Makro#metastasen\n",
      "Psa#adjustiert\n",
      "Hdr#brachytherapie\n",
      "Brachy#therapie\n",
      "Strahlen#therapie\n",
      "Krebs#spezifischen\n",
      "Überlebens#raten\n",
      "Brachy#therapie\n",
      "Low#volume\n",
      "Low#risk\n",
      "Kontroll#gruppe\n",
      "Enzalutamid#therapie\n",
      "Abirateron#arm\n",
      "Überlege#nheit\n",
      "Krebs#spezifischem\n",
      "Über#leben\n",
      "Radionuklid#therapie\n",
      "Radionuklid#therapie\n",
      "Placebo#arm\n",
      "Cyp3A4#inhibitoren\n",
      "Abirateron#arm\n",
      "Pankreas#karzinom\n",
      "Brca2#mutationen\n",
      "Nachbeobachtungs#dauer\n",
      "Placebo#gruppen\n",
      "Drei#fach\n",
      "Ober#grenzen\n",
      "Umgebungs#faktoren\n",
      "Behandlungs#bedarf\n",
      "Behandlungs#bedingt\n",
      "Therapie#bedarf\n",
      "Einzel#übungen\n",
      "Sechsmona#tiger\n",
      "Kontroll#untersuchungen\n",
      "Leukozy#ten\n",
      "Palliativ#therapie\n",
      "Stuhl#kontrolle\n",
      "Langzeit#toxizität\n",
      "Behandlungs#nutzen\n",
      "Stuhl#inkontinenz\n",
      "Mrt#techniken\n",
      "Therapie#optionen\n",
      "Sach#kompetente\n",
      "Behandlungs#verlauf\n",
      "Nicht-Hpv#assoziierte\n",
      "Prostata#karzinom\n",
      "Bila#teral\n",
      "Bila#terale\n",
      "Becken#lymphknoten\n",
      "Beidsei#tige\n",
      "vier\n",
      "Spät#komplikationen\n",
      "25\n",
      "Knochen#herde\n",
      "Knochen#herde\n",
      "T3#kategorien\n",
      "Funktionserhalt#ende\n",
      "Dioden#laser\n",
      "Dioden#laser\n",
      "Nd\n",
      "Tumor#größe\n",
      "Magnet#resonanztomografie\n",
      "Genitalö#dem\n",
      "Genitalö#dem\n",
      "Langzeit#komplikationen\n",
      "Taxan#haltige\n",
      "Blutgefäß#kompression\n",
      "Tumor#bedingten\n",
      "Neben#wirkungen\n",
      "Zwei#zeitige\n",
      "Bestrah#lungen\n",
      "Therapie#folgen\n",
      "Behandlungs#phase\n",
      "Konditions#minderung\n",
      "Therapie#bedingte\n",
      "Analrand#karzinome\n",
      "Analrand#karzinomen\n",
      "Analrand#karzinomen\n",
      "Nachsorge#empfehlungen\n",
      "Exzisions#biopsie\n",
      "Zytopatho#logische\n",
      "Sicher#ung\n",
      "Ct#befundes\n",
      "C#serologie\n",
      "Nieren#funktionsparameter\n",
      "Analrand#karzinomen\n",
      "Stoma#freien\n",
      "Nach#teile\n",
      "Hoch-Dosis#boost\n",
      "Hochdosis#boost\n",
      "Mitomycin#basierten\n",
      "Chemotherapie#studienarmen\n",
      "Über#lebens\n",
      "Krankheitsspezi#fischen\n",
      "Rezidiv#tumor\n",
      "Analrand#karzinom\n",
      "Rezidiv#tumor\n",
      "Rezidiv#tumor\n",
      "Rezidiv#tumor\n",
      "Rezidiv#tumor\n",
      "Rezidiv#tumor\n",
      "Analrand#karzinom\n",
      "Radiochemotherapie#regime\n",
      "#chemotherapie\n",
      "Drittliniensystem#\n",
      "Zweitlinien#therapie\n",
      "System#therapie\n",
      "Kohorten#studien\n",
      "Radio#therapeutische\n",
      "Ans#ätze\n",
      "Analrand#karzinom\n",
      "Erhebungs#kriterien\n",
      "Problem#belastung\n",
      "Exsudat#bildung\n",
      "Gruppen#angeboten\n",
      "Analrand#karzinomen\n",
      "Physio#therapeutisches\n",
      "Trainings#programm\n",
      "Behandlungs#angebote\n",
      "Krankenpfleger/#innen\n",
      "Supervisions#angeboten\n",
      "Folge#probleme\n",
      "Bewegungs#therapie\n",
      "Problem#orientiert\n",
      "Liaison#diensten\n",
      "Fähigkeits#störungen\n",
      "Behandlungs#angeboten\n",
      "Familien#beratung\n",
      "Imagi#native\n",
      "Verf#ahren\n",
      "Fach#ärzte\n",
      "Fach#ärzte\n",
      "Kontrollattribut#ionen\n",
      "Narben#schmerzen\n",
      "Durch#schlafstörungen\n",
      "Hof#fnungslosigkeit\n",
      "Geschmacks#empfinden\n",
      "Darm#inkontinenz\n",
      "Gedächtnis#probleme\n",
      "Gedächtnis#probleme\n",
      "Therapie#bedingten\n",
      "Symp#tomen\n",
      "Behandlungs#möglichkeiten\n",
      "Unterstützungs#möglichkeiten\n",
      "Schwellen#wert\n",
      "Fremd#gefährdung\n",
      "Behandlungs#bedingter\n",
      "Fakt#oren\n",
      "Fremd#beurteilung\n",
      "Gruppen#interventionen\n",
      "Familien#beratung\n",
      "Erlebnis#orientiert\n",
      "Hospiz#versorgung\n",
      "Hospiz#versorgung\n",
      "Muskel#abbau\n",
      "auch\n",
      "Ekel#gefühle\n",
      "Geruchs#ängste\n",
      "Uros#tomas\n",
      "Uros#tomas\n",
      "Geschmacks#sinns\n",
      "Erschöpfungs#bedingte\n",
      "Strahlen#therapie\n",
      "Kraft#training\n",
      "Bewegungs#therapie\n",
      "Krebs#therapie\n",
      "Entscheidungs#fähigkeit\n",
      "Hospiz#versorgung\n",
      "Ehren#amtliche\n",
      "Belastungs#zustand\n",
      "Krebs#erkrankung\n",
      "Hospiz#versorgung\n",
      "Belastungs#zustand\n",
      "Hospiz#bewegung\n",
      "Versorgungs#situtation\n",
      "Prozess#qualität\n",
      "Religions#gebundenen\n",
      "Wert#vorstellungen\n",
      "Weiter#bildung\n",
      "Entwicklungs#prozesse\n",
      "Handlungs#fähigkeit\n",
      "Weiter#bildung\n",
      "Weiter#bildung\n",
      "Schluck#störungen\n",
      "Schluck#störungen\n",
      "Schluck#störungen\n",
      "Sprech#hilfen\n",
      "Sprech#hilfen\n",
      "Fehlverständ#nissen\n",
      "Empathie#fähig\n",
      "Lebens#zeit\n",
      "Angehörigen#bedürfnissen\n",
      "Hospiz#versorgung\n",
      "Hospiz#angeboten\n",
      "gar\n",
      "Vier#teilung\n",
      "Therapie#zielfindung\n",
      "Angehörigen#bedürfnisse\n",
      "Erhebungs#kriterien\n",
      "Behandlungs#plan\n",
      "Angehörigen#situation\n",
      "Ergebnis#qualitätskriterien\n",
      "Ergebnis#qualitätskriterien\n",
      "Versorgungs#praxis\n",
      "Fort#bildungen\n",
      "Fort#bildungen\n",
      "Implementierungs#prozess\n",
      "Fehl#versorgung\n",
      "Fehl#versorgung\n",
      "Qualitäts#entwicklung\n",
      "Symptom#kontrolle\n",
      "Multi#disziplinären\n",
      "Spv#team\n",
      "Quasi#experimentellen\n",
      "Stu#dien\n",
      "Problem#belastung\n",
      "Therapie#angeboten\n",
      "Einsatz#bereitschaft\n",
      "Problem#belastung\n",
      "Problem#belastung\n",
      "Therapie#planung\n",
      "Therapie#angeboten\n",
      "Therapie#angeboten\n",
      "Ergebnis#qualitätskriterien\n",
      "Ergebnis#qualitätskriterien\n",
      "Palliativ-Erhebungs#register\n",
      "Voll#versorgung\n",
      "Versorgungs#formen\n",
      "Bedürfnis#komplexität\n",
      "Notfall#konsultationen\n",
      "Therapie#möglichkeiten\n",
      "Behandlungs#pflege\n",
      "Versorgungs#planung\n",
      "Versorgungs#aufgaben\n",
      "Versorgungs#planung\n",
      "Unterstützungs#möglichkeiten\n",
      "Mittel#gradiger\n",
      "Quali#tät\n",
      "Trauer#begleitung\n",
      "Trauer#begleitung\n",
      "Ehren#amtlich\n",
      "Trauer#begleitung\n",
      "Trauer#kultur\n",
      "Trauer#begleitung\n",
      "Behandlungs#situation\n",
      "Therapie#begrenzung\n",
      "Jugendlichen#palliativmedizin\n",
      "Therapie#begleitende\n",
      "Symp#tome\n",
      "Hormon#haushalts\n",
      "Strahlen#therapie\n",
      "Energie#mangel\n",
      "Therapie#bedingter\n",
      "Fati#gue\n",
      "Kraft#training\n",
      "Gefühls#erlebnis\n",
      "Nervenkompressions#schmerz\n",
      "Drei#stufige\n",
      "Vorgehens#weise\n",
      "Toleranz#profil\n",
      "Kokain#gruppe\n",
      "Hydromorphon#präparate\n",
      "Hydromorphon#präparate\n",
      "Buprenorphin#trägersysteme\n",
      "Herz#insuffizienz\n",
      "Herz#insuffizienz\n",
      "Weichteil#schmerzen\n",
      "Hospiz#einrichtungen\n",
      "Strahlen#therapie\n",
      "Multi#dimensionalen\n",
      "Instru#menten\n",
      "Tisch#ventilator\n",
      "Mehr#dimensionalen\n",
      "Ska#len\n",
      "Drittlinien#therapie\n",
      "Panik#komponente\n",
      "Panik#reaktion\n",
      "Herz#erkrankung\n",
      "Herz#erkrankung\n",
      "Erregungs#zustände\n",
      "Hand#ventilatoren\n",
      "Nicht#hypoxämischer\n",
      "Hand#ventilatoren\n",
      "Durch#schlafstörungen\n",
      "Schlaf#dauer\n",
      "Einschlaf#episoden\n",
      "Leistungs#vermögen\n",
      "Schlaf#gewohnheiten\n",
      "Bewegungs#störungen\n",
      "Durch#schlafstörungen\n",
      "Ruhe#phasen\n",
      "Aktivitäts#phase\n",
      "Durch#schlafen\n",
      "Schlaf#qualität\n",
      "Kontroll#gruppen\n",
      "Alternativ#medizin\n",
      "Internet#basierte\n",
      "Rem#schlafanteil\n",
      "Schlaf#quantität\n",
      "Kontroll#gruppe\n",
      "Baseline#schlafprobleme\n",
      "Sucht#potential\n",
      "Liquor#diagnostik\n",
      "Liquor#diagnostik\n",
      "Digitoxin#spiegel\n",
      "Schleimhaut#veränderungen\n",
      "Medikamenten#aufnahme\n",
      "Nahrungs#aufnahme\n",
      "Bauch#einreibungen\n",
      "Kümme#löl\n",
      "Kümme#löl\n",
      "Nahrungs#aufnahme\n",
      "Salz#sekretion\n",
      "Stuhl#menge\n",
      "Mrt#untersuchungen\n",
      "Kombinations#therapie\n",
      "Elektrolyt#haushalts\n",
      "Nieren#insuffizienz\n",
      "Obstipations#prophylaxe\n",
      "Präfinal#phase\n",
      "Blasen#karzinomen\n",
      "Blasen#karzinomen\n",
      "Blasen#karzinomen\n",
      "Gewichts#verlust\n",
      "Leber#werte\n",
      "Rektum#wand\n",
      "Mortalitäts#rate\n",
      "Experten#basierter\n",
      "Empfeh#lungen\n",
      "Luft#ableitung\n",
      "Gerinnungs#produkten\n",
      "Lymph#gefäße\n",
      "Fremd#einschätzung\n",
      "Wund#anamnese\n",
      "Exsudatmenge,-farbe\n",
      "Wund#bedingte\n",
      "Kri#sen\n",
      "Atem#therapie\n",
      "Kampfer#haltige\n",
      "Prä#parate\n",
      "Schmerz#reduktion\n",
      "Honig#haltige\n",
      "Ver#bände\n",
      "Stoma#beuteln\n",
      "Stoma#beutel\n",
      "Anästhesie#verfahren\n",
      "Nach#teilen\n",
      "Hydrofaserver#bände\n",
      "Fremd#stoffe\n",
      "Wund#rand\n",
      "Wundrand#schutz\n",
      "Drainage#beutel\n",
      "Kontakt#blutungen\n",
      "Spontan#blutung\n",
      "Entlastungs#möglichkeiten\n",
      "Dsm#kriterien\n",
      "Unterstützungs#möglichkeiten\n",
      "Angst#inhalte\n",
      "Krankheits#verlauf\n",
      "Unter#schätzung\n",
      "Hyper#glykämie\n",
      "Vertreibungs#erlebnissen\n",
      "Fremd#gefährdung\n",
      "Religions#spezifische\n",
      "Besonderhei#ten\n",
      "Religionsspezi#fischen\n",
      "Besonderhei#ten\n",
      "Psy#chiatrisch\n",
      "Struktur#modell\n",
      "Grenz#situationen\n",
      "Abwehr#mechanismen\n",
      "Flüssigkeits#aufnahme\n",
      "Commitment#therapie\n",
      "Klang#instrumente\n",
      "Verführungs#ziele\n",
      "Atem#fähigkeit\n",
      "Panik#zuständen\n",
      "Panik#störung\n",
      "Entwicklungsadä#quate\n",
      "Unter#stützung\n",
      "Kompetenz#erleben\n",
      "Beratungs#möglichkeiten\n",
      "Beratungs#möglichkeiten\n",
      "Jugendhospiz#dienste\n",
      "Schwer#gradig\n",
      "Ess#verhalten\n",
      "Behandlungs#bedingte\n",
      "Ätio#logien\n",
      "Gedächtnis#defizite\n",
      "Bekannten#kreis\n",
      "Vers#ündigung\n",
      "Krankheits#wahn\n",
      "Selbsttötungs#gedanken\n",
      "Fremd#gefährdung\n",
      "Trauer#arbeit\n",
      "Gruppen#therapie\n",
      "Lang#fristig\n",
      "Todeswunsch#häufigkeit\n",
      "Abneh#men\n",
      "Abn#ahme\n",
      "Lebens#wunsch\n",
      "Gesprächs#angebot\n",
      "Weiter#bildung\n",
      "Kontroll#gruppe\n",
      "Lang#fristigen\n",
      "Steiger#ung\n",
      "Behandlungs#optionen\n",
      "Behandlungs#strategien\n",
      "Würde#zentrierte\n",
      "The#rapie\n",
      "Mord#wünschen\n",
      "Mord#wünsche\n",
      "Todes#wünsche\n",
      "Sekret#mobilisation\n",
      "Flüssigkeits#zufuhr\n",
      "Oberkörper#hochlagerung\n",
      "Magen#sonde\n",
      "Nahrungs#zufuhr\n",
      "Aus#sprechen\n",
      "Tumor#typ\n",
      "Chemo#therapie\n",
      "Oper#ativen\n",
      "Transfusions#therapie\n",
      "Nach#teile\n",
      "auch\n",
      "Unter#therapie\n",
      "Qtc#zeit\n",
      "Astro#viren\n",
      "Astro#viren\n",
      "Astro#viren\n",
      "Klebs#iella\n",
      "Kolos#kopie\n",
      "And#ere\n",
      "Virus#infektionen\n",
      "Bitter#stoffen\n",
      "Kontroll#gruppe\n",
      "Placebo#gruppe\n",
      "Trink#nahrung\n",
      "Elektrolyt#transportes\n",
      "Flüssigkeits#ausgleich\n",
      "Elektrolyt#verlustes\n",
      "Epithel#gewebe\n",
      "Wirk#proteinen\n",
      "Flüssigkeits#aufnahme\n",
      "Radio#therapien\n",
      "Rachen#bereich\n",
      "Multi#chemotherapien\n",
      "Fremdbeobachtungs#skalen\n",
      "Nagelbett#veränderungen\n",
      "Wimpern#veränderungen\n",
      "Basis#maßnahmen\n",
      "Basis#maßnahmen\n",
      "Uvb#schutz\n",
      "Basis#maßnahmen\n",
      "Haut#trockenheit\n",
      "Basis#maßnahmen\n",
      "Hochpot#enten\n",
      "Blut-Calcium#werte\n",
      "Urin-Calcium#konzentrationen\n",
      "Therapie#optionen\n",
      "Fuß#rücken\n",
      "Basis#maßnahmen\n",
      "3\n",
      "Therapie#studien\n",
      "Placebo#gruppe\n",
      "Placebo#gruppe\n",
      "Nagel#toxizitäten\n",
      "Therapie#bedingte\n",
      "Hepato#toxizität\n",
      "Basis#maßnahmen\n",
      "Basis#maßnahmen\n",
      "Zehen#funktionen\n",
      "Vierzellen#bäder\n",
      "Magnesium#infusionen\n",
      "Sensomotoris#chem\n",
      "Sensomotoris#chem\n",
      "Train#ing\n",
      "auch\n",
      "Ausdauer#training\n",
      "Sensomotoris#chem\n",
      "Sensomotoris#chem\n",
      "Train#ing\n",
      "Steht#raining\n",
      "Physik#alische\n",
      "The#rapie\n",
      "Therapie#studie\n",
      "Schilddrüsen#karzinom\n",
      "Schilddrüsen#karzinom\n",
      "Schilddrüsen#karzinom\n",
      "Nerven#kompression\n",
      "Schluck#störung\n",
      "Schilddrüsen#karzinomen\n",
      "Schilddrüsen#karzinomen\n",
      "Immun#therapie\n",
      "Immun#therapie\n",
      "Immun#therapie\n",
      "Nieren#karzinom\n",
      "Tenden#ziell\n",
      "Strahlen#therapie\n",
      "Mammakarzinom#metastase\n",
      "Kyphoplas#tie\n",
      "0,3\n",
      "%\n",
      "Kyphoplas#tie\n",
      "Fraktionierungs#schemata\n",
      "Mamma#karzinom\n",
      "Mamma#karzinom\n",
      "3,0\n",
      "%\n",
      "Rücken#marktoxizität\n",
      "Mamma#karzinom\n",
      "Mamma#karzinom\n",
      "Mamma#karzinom\n",
      "Leukozyten#zahlen\n",
      "Andro#gensuppressiven\n",
      "The#rapie\n",
      "Fraktur#prophylaxe\n",
      "Osteoporose#fördernde\n",
      "Med#ikamente\n",
      "Fraktur#prophylaxe\n",
      "Andro#gensuppressiven\n",
      "The#rapie\n",
      "hin\n",
      "Katheter#assoziierte\n",
      "Risiko#faktoren\n",
      "Mitomy#cin\n",
      "Mitomy#cin\n",
      "Mitomy#cin\n",
      "Sauerstoff#gabe\n",
      "Haut#reaktion\n",
      "Radio#chemotherapie\n",
      "Elektrolyt#transportes\n",
      "Dick#darm\n",
      "Dünndarm#sonde\n",
      "Placebo#gruppe\n",
      "Rektumkarzinom#patienten\n",
      "Einfach#verblindet\n",
      "Spät#reaktion\n",
      "Natrium#alginat\n",
      "Spät#reaktion\n",
      "Zucker#haltige\n",
      "Lös#ungen\n",
      "Radio#chemotherapie\n",
      "Radio#chemotherapie\n",
      "Kom#binierte\n",
      "Ger#ingfügigen\n",
      "Beta-Adrenozeptoren#aktivität\n",
      "Strahlen#feldes\n",
      "Außer#halb\n",
      "Kontra#lateral\n",
      "Immuno#therapie\n",
      "Radio#protektoren\n",
      "Radio#chemotherapie\n",
      "Begleit#erkrankungen\n",
      "Intra#spinaler\n",
      "Tum#oren\n",
      "Paraesthe#sien\n",
      "Parästhe#sien\n",
      "Ödem#prophylaxe\n",
      "Behandlungs#theorie\n",
      "Körper#akupunktur\n",
      "Körper#akupunktur\n",
      "Ohra#kupunktur\n",
      "Ohra#kupunktur\n",
      "Ohra#kupunktur\n",
      "Gas#trointestinalen\n",
      "Sham#akupunktur\n",
      "Durch#schlafstörungen\n",
      "Elektroakupunk#tur\n",
      "Durch#schlafstörungen\n",
      "Ohra#kupunktur\n",
      "Sham#akupunktur\n",
      "Morphin#gruppe\n",
      "Sham#akupunktur\n",
      "Durch#schlafstörungen\n",
      "Sprach#therapie\n",
      "Durch#schlafstörung\n",
      "Sprach#therapie\n",
      "Anthroposophische#arzneimittel\n",
      "Cox#arthrose\n",
      "Wechsel#wirkungen\n",
      "Radio#therapie\n",
      "Radio#therapie\n",
      "Kontroll#gruppe\n",
      "Balneo#therapie\n",
      "Balneo#therapie\n",
      "Moor#bäder\n",
      "Balneo#therapie\n",
      "Bewegungs#therapie\n",
      "Bewegungs#therapie\n",
      "Erwartungs#effekte\n",
      "Pla#cebo\n",
      "Erwartungs#effekte\n",
      "Pla#cebo\n",
      "Pla#cebo\n",
      "Vergleichs#gruppe\n",
      "Erwartungs#effekte\n",
      "Erwartungs#effekte\n",
      "Erwartungs#effekte\n",
      "Kontroll#arm\n",
      "Yoga#arm\n",
      "Kontroll#arm\n",
      "Kontroll#arm\n",
      "Kontroll#arm\n",
      "Placebo#arms\n",
      "Placebo#arms\n",
      "Erwartungs#effekte\n",
      "Placebo#arms\n",
      "Erwartungs#effekte\n",
      "Placebo#arms\n",
      "Placebo#arm\n",
      "Erhebungs#beschreibung\n",
      "Kontroll#gruppe\n",
      "Kontroll#gruppe\n",
      "Kontroll#arm\n",
      "Kontroll#arm\n",
      "Vergleichs#therapie\n",
      "Kontroll#therapie\n",
      "Kontroll#gruppe\n",
      "Kontroll#gruppe\n",
      "Placebo#gruppe\n",
      "Kontroll#gruppe\n",
      "Kontroll#arm\n",
      "Kontroll#gruppe\n",
      "Vergleichs#therapie\n",
      "Erwartungs#effekte\n",
      "Kontroll#gruppe\n",
      "Ganzkörper#hyperthermie\n",
      "Ganzkörper#hyperthermie\n",
      "Chemo#therapie\n",
      "Kontroll#gruppe\n",
      "Urin#kreatinin\n",
      "Bronchialkrebs#patienten\n",
      "Durch#schlafstörungen\n",
      "Durch#schlafstörungen\n",
      "Durch#schlafstörungen\n",
      "Schmerz#symptomatik\n",
      "Schmerz#symptomatik\n",
      "Vibrationstherapie#gruppe\n",
      "Vibrationstherapie#gruppe\n",
      "Schmerz#symptomatik\n",
      "Schmerz#symptomatik\n",
      "Hea#ling\n",
      "Vibrationstherapie#gruppe\n",
      "Kopfmassage#gruppe\n",
      "Hea#ling\n",
      "Kontroll#gruppe\n",
      "Akt#iven\n",
      "Kontroll#gruppe\n",
      "Akt#ive\n",
      "Kontroll#gruppe\n",
      "Akt#iven\n",
      "Depressivitäts#werte\n",
      "Trate#angst\n",
      "Depressivitäts#werte\n",
      "Vibrationstherapie#gruppe\n",
      "Kontroll#gruppen\n",
      "Kontroll#gruppe\n",
      "Kontroll#gruppe\n",
      "Stimmungs#daten\n",
      "Depressivitäts#werte\n",
      "Langzeit#effekte\n",
      "Berührungs#effekte\n",
      "Ver#gleich\n",
      "Depressivitäts#werten\n",
      "Depressivitäts#werte\n",
      "Angst#werte\n",
      "Lang#fristigen\n",
      "Lang#fristigen\n",
      "Schmerz#linderung\n",
      "Lang#fristigen\n",
      "Follow#up\n",
      "Kontroll#gruppe\n",
      "Ein#fache\n",
      "Mas#sage\n",
      "Wechsel#wirkungen\n",
      "Stressveränderung\n",
      "Ovarial#karzinom\n",
      "Ovarial#karzinom\n",
      "Lungen#erkrankungen\n",
      "Gebärmutterschleim#hautkrebs\n",
      "Intensitäts#abhängigen\n",
      "Misch#ung\n",
      "Widerstands#training\n",
      "Konzentrations#übungen\n",
      "Konzentrations#übungen\n",
      "Durch#schlafstörungen\n",
      "Durch#schlafstörungen\n",
      "Sitz#meditation\n",
      "Durch#schlafstörungen\n",
      "Durch#schlafstörungen\n",
      "-0.57\n",
      "Ganzkörper#hyperthermie\n",
      "Mind-Body#medizin\n",
      "Durch#schlafstörungen\n",
      "Durch#schlafstörungen\n",
      "Durch#schlafstörungen\n",
      "Zwei#mal\n",
      "Meditations#techniken\n",
      "Meditations#techniken\n",
      "Prostata#karzinom\n",
      "Durch#schlafstörungen\n",
      "Durch#schlafstörungen\n",
      "Vini#yoga\n",
      "Spurenelement#produkte\n",
      "Kolokter#alem\n",
      "Karzi#nom\n",
      "Kontroll#gruppe\n",
      "Kontroll#gruppen\n",
      "Ergebnis#erstattung\n",
      "Placebo#kontrollgruppe\n",
      "Endometrium#karzinom\n",
      "Endometrium#karzinom\n",
      "Insulin#spiegels\n",
      "Endometrium#karzinom\n",
      "Endometriumkarzinom#patientinnen\n",
      "Leber#problemen\n",
      "Endometrium#karzinom\n",
      "Körperfett#verlust\n",
      "Stör#faktoren\n",
      "Brachy#therapie\n",
      "Gebärmutter#halskrebs\n",
      "Kontroll#gruppe\n",
      "Gebärmutter#halskrebs\n",
      "Alkohol#konsum\n",
      "Kontroll#gruppe\n",
      "Kontroll#gruppe\n",
      "Radio#therapie\n",
      "Placebo#gruppe\n",
      "Verblindungs#prozess\n",
      "2x\n",
      "1x\n",
      "2x\n",
      "Hoch#gradig\n",
      "Gebärmutter#halskrebs\n",
      "Kontroll#gruppe\n",
      "Nieren#funktion\n",
      "Nacken#schmerzen\n",
      "Neben#wirkungen\n",
      "Radio#therapie\n",
      "Wechsel#wirkungen\n",
      "Radio#therapie\n",
      "Gebärmutter#halskrebs\n",
      "Wechsel#wirkungen\n",
      "Progressions#freie\n",
      "Über#leben\n",
      "Progressions#freies\n",
      "Progressions#freien\n",
      "Über#leben\n",
      "Placebo#arm\n",
      "Fett#stoffwechsel\n",
      "Kontroll#arm\n",
      "Progressions#freie\n",
      "Progressions#freie\n",
      "Über#leben\n",
      "Fett#stoffwechsel\n",
      "Brustkrebs#patienten\n",
      "Brustkrebs#patienten\n",
      "Krankheits#freie\n",
      "Inter#vall\n",
      "Progressions#freies\n",
      "Rei#nen\n",
      "Chemotherapie#arm\n",
      "Rei#nen\n",
      "Chemotherapie#arm\n",
      "Glutamin#arm\n",
      "Progressions#freie\n",
      "Über#leben\n",
      "Progressions#freie\n",
      "Über#leben\n",
      "Shbg#entwicklung\n",
      "Progressions#freien\n",
      "Über#lebens\n",
      "Progress#ionsfreiem\n",
      "Über#leben\n",
      "Progressions#freie\n",
      "Über#leben\n",
      "Progressions#freies\n",
      "Progressions#freies\n",
      "Gleichgewichts#organes\n",
      "Radio#therapie\n",
      "Progressions#freies\n",
      "Magenkrebs#patienten\n",
      "Mesotheliom#patienten\n",
      "Mesotheliom#patienten\n",
      "Sport#therapie\n",
      "Kehl#bereich\n",
      "Placebo#gruppe\n",
      "Azulen#lösung\n",
      "Kontroll#gruppe\n",
      "Geschmacks#wahrnehmung\n",
      "Chemo#therapie\n",
      "Chemo#therapie\n",
      "Placebo#arm\n",
      "Wechsel#wirkungen\n",
      "Analgetikaverbr#auch\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "Radio#therapie\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "And#ere\n",
      "Chemo#therapie\n",
      "Hals#tumoren\n",
      "Hals#tumoren\n",
      "Chemotherapie#induzierte\n",
      "Stom#atitis\n",
      "Hals#tumors\n",
      "Wechsel#wirkungen\n",
      "Lebens#qualität\n",
      "Wechsel#wirkungen\n",
      "Placebo#behandlung\n",
      "Kontroll#gruppen\n",
      "Cr#einnahme\n",
      "Post#menopause\n",
      "Wechsel#wirkungen\n",
      "Ema#vorgaben\n",
      "Placebo#gruppe\n",
      "Verum#gruppe\n",
      "Verum#gruppe\n",
      "Wechsel#wirkungen\n",
      "Konzentrations#fähigkeit\n",
      "Flüssig#extrakt\n",
      "Nieren#werte\n",
      "Ausschluss#kriterien\n",
      "Wechsel#wirkungen\n",
      "Maus#modellen\n",
      "Placebo#gruppen\n",
      "Placebo#gruppe\n",
      "Zervix#karzinom\n",
      "Zervix#karzinom\n",
      "Zervix#karzinom\n",
      "Wechsel#wirkungen\n",
      "Brokkol#extrakt\n",
      "Brokkol#extrakt\n",
      "Brokkol#extrakt\n",
      "Eier#stockkrebs\n",
      "Eier#stockkrebs\n",
      "Placebo#gruppe\n",
      "in\n",
      "Darm#geschwüren\n",
      "Placebo#gruppe\n",
      "Placebo#gruppen\n",
      "Strahlen#therapie\n",
      "Strahlen#therapie\n",
      "Chemo#therapie\n",
      "Chemo#therapie\n",
      "Kli#nische\n",
      "Stu#dien\n",
      "Triterpen#saponine\n",
      "Bernstein#säure\n",
      "Endometrium#krebs\n",
      "Endometrium#krebs\n",
      "Wechsel#wirkungen\n",
      "Hoche#metogen\n",
      "Kontroll#gruppe\n",
      "Vergleichs#gruppe\n",
      "35\n",
      "%\n",
      "Wechsel#wirkungen\n",
      "Progress#ion\n",
      "Chemo#therapie\n",
      "Lang#fristigen\n",
      "Lang#fristigen\n",
      "Neben#wirkungen\n",
      "Wechsel#wirkungen\n",
      "Ana#phylaktische\n",
      "Rea#ktion\n",
      "Nieren#transplantation\n",
      "Nieren#transplantation\n",
      "Nieren#transplantationen\n",
      "Teil#narkose\n",
      "Kälte#empfindlichkeit\n",
      "Hals#bereich\n",
      "Hals#bereich\n",
      "Schluck#beschwerden\n",
      "Wechsel#wirkungen\n",
      "Chemotherapie#induzierte\n",
      "Hepatoprotekt#iven\n",
      "Eff#ekt\n",
      "Nieren#werte\n",
      "Chemo#therapie\n",
      "Wechsel#wirkungen\n",
      "Kolorektal#karzinom\n",
      "Fett#verlust\n",
      "Tier#experimente\n",
      "Tumor#freiheit\n",
      "Leber#enzyme\n",
      "Hypo#kalzämie\n",
      "Schwarz#tee\n",
      "Trauben#saft\n",
      "Zusatz#stoffen\n",
      "Tabak#genuss\n",
      "Behandlungs#optionen\n",
      "Rna#ebene\n",
      "Rezidiv#fall\n",
      "Gefäß#resektion\n",
      "Gefäß#resektion\n",
      "Gefäß#resektion\n",
      "Gesichts#bereich\n",
      "Resek#table\n",
      "Fern#metastasen\n",
      "Peri#operative\n",
      "Chemo#therapie\n",
      "Chemo#therapie\n",
      "R2#resektion\n",
      "Weichgewebe#rekonstruktion\n",
      "Gefäß#interponate\n",
      "Weichgewebe#rekonstruktion\n",
      "Post#operative\n",
      "Strahlen#therapie\n",
      "R2#resektion\n",
      "Post#operativen\n",
      "Strahlen#therapie\n",
      "Post#operative\n",
      "Strahlen#therapie\n",
      "Post#operativen\n",
      "Strahlen#therapie\n",
      "Post#operative\n",
      "Strahlen#therapie\n",
      "Enge#gefühl\n",
      "Sonografie#gesteuert\n",
      "Extremitäten#tumoren\n",
      "Radio#sensibilisierenden\n",
      "Eigen#schaften\n",
      "Sarkom#patienten\n",
      "Retro#peritonealen\n",
      "Gesamt#überleben\n",
      "Lebens#planung\n",
      "Kommunikations#möglichkeiten\n",
      "Post#operative\n",
      "Strahlen#therapie\n",
      "Post#operative\n",
      "Strahlen#therapie\n",
      "Post#operative\n",
      "Strahlen#therapie\n",
      "Nach#teile\n",
      "Kombinations#therapie\n",
      "Kombinations#therapie\n",
      "Liposar#kom\n",
      "Kombinations#therapie\n",
      "Osteosar#kome\n",
      "Ost#eosarkomen\n",
      "Hirn#metastasen\n",
      "Tumor#größe\n",
      "Weichgewebe#metastasen\n",
      "Therapie#bedingter\n",
      "Folge#störungen\n",
      "Therapie#bedingte\n",
      "Therapie#bedingten\n",
      "Folge#störungen\n",
      "Ergebnis#qualität\n",
      "Ergebnis#qualität\n",
      "Sport#therapie\n",
      "Hilfs#angebote\n",
      "Therapie#folgen\n",
      "auch\n",
      "Angehörigen#bedürfnisse\n",
      "Pdgfra#mutationen\n",
      "Pdgfra#mutationen\n",
      "Drittlinien#therapie\n",
      "Spät#ere\n",
      "Behand#lung\n",
      "Dritt#linie\n",
      "Dritt#linie\n",
      "Mik#rowellenablation\n",
      "Sunitinib#versagen\n",
      "Mrt#abdomen\n",
      "FLT4\n",
      "Leber#metastasen\n",
      "Mik#rowellen­ablation\n",
      "Ganzkörper#ct\n",
      "Folge#therapie\n",
      "Radio#therapie\n",
      "2459 lemmas have been changed in ../tmp/baseline_files/Original.xml.\n",
      "Function name & frequency of undecidable cases which have not been changed:\n",
      "findPattern_6        306\n",
      "splitCompound_B      84\n",
      "findPattern_8        17\n",
      "rvsdSplitCompound_B  6\n",
      "findPattern_4        5\n",
      "splitCompound_A      2\n"
     ]
    }
   ],
   "source": [
    "exchangeLemmas(path_xml_file, path_output_file, path_gertwol_file, path_word_freqs, tagged_path)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Reconstruct Complete Sentences"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [],
   "source": [
    "dom = minidom.parse(open(path_output_file))\n",
    "predictions = []\n",
    "\n",
    "sentences = dom.getElementsByTagName('s')\n",
    "for sentence in sentences:\n",
    "    tokens = sentence.getElementsByTagName('w')\n",
    "    sentence_tokens = []\n",
    "    for token in tokens:\n",
    "        word = token.childNodes[0].nodeValue\n",
    "        lemma = token.getAttribute('lemma')\n",
    "        if '+' in lemma:\n",
    "            word_parts = lemma.partition('+')\n",
    "            if token.getAttribute('pos') == 'TRUNC':\n",
    "                word = word.replace('-', word_parts[2])\n",
    "            else:\n",
    "                word = word.replace('-', word_parts[0])\n",
    "        whitespace = token.getAttribute('whitespace')\n",
    "        sentence_tokens.append(word + whitespace)\n",
    "\n",
    "    predictions.append(''.join(token for token in sentence_tokens))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Evaluate Baseline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "tp         0.689709\n",
       "fn         0.200494\n",
       "replace    0.041970\n",
       "delete     0.031575\n",
       "complex    0.021700\n",
       "insert     0.013903\n",
       "fp         0.000650\n",
       "Name: error_type, dtype: float64"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "errors_df = error_analysis(predictions, data.full_resolution, data.raw_sentence)\n",
    "errors_df.error_type.value_counts() / len(errors_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 8min 28s, sys: 321 ms, total: 8min 28s\n",
      "Wall time: 8min 31s\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'eval/tp': 0.6897089397089398,\n",
       " 'eval/tp_abs': 5308,\n",
       " 'eval/fn': 0.20049376299376298,\n",
       " 'eval/fn_abs': 1543,\n",
       " 'eval/fp': 0.0006496881496881497,\n",
       " 'eval/fp_abs': 5,\n",
       " 'eval/replace': 0.04196985446985447,\n",
       " 'eval/replace_abs': 323,\n",
       " 'eval/insert': 0.013903326403326404,\n",
       " 'eval/insert_abs': 107,\n",
       " 'eval/delete': 0.03157484407484407,\n",
       " 'eval/delete_abs': 243,\n",
       " 'eval/complex': 0.0216995841995842,\n",
       " 'eval/complex_abs': 167,\n",
       " 'eval/edit_distance_rel': 0.7660947866445874,\n",
       " 'eval/exact_match': 0.6897089397089398,\n",
       " 'eval/gleu': 0.9627338689499875}"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%%time\n",
    "scores = get_scores(errors_df, \"eval\")\n",
    "scores"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "from notebook_util import show_errors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "errors = pd.concat([errors_df, data[['file', 'sentence_id']].reset_index()], axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(5, 4)\n"
     ]
    }
   ],
   "source": [
    "fps = errors[errors.error_type == 'fp'][['file', 'sentence_id', 'ground_truth', 'pred']].rename(columns = {'ground_truth' : 'resolution'})\n",
    "print(fps.shape)\n",
    "#fps.to_excel('../potential_missing_2.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false,
    "jupyter": {
     "outputs_hidden": false
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [
    {
     "data": {
      "text/markdown": [
       "0;00_mundhoehlenkarzinom_0005.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die hohe Diskrepanz zwischen p16 Immunhistochemie bzw. HPV-RNA und HPV-DNA Nachweis zeigt, dass HPV-DNA in dieser Lokalisation zwar häufig nachweisbar ist, jedoch in der Mehrheit der Fälle wahrscheinlich nicht biologisch aktiv ist ( [REF] )."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1548__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die hohe Diskrepanz zwischen p16 Immunhistochemie bzw. HPV-RNA <span class=\"diff_sub\">Nachweis </span>und HPV-DNA Nachweis zeigt, dass HPV-DNA in dieser Lokalisation zwar häufig nachweisbar ist, jedoch in der Mehrheit der Fälle wahrscheinlich nicht biologisch aktiv ist ( [REF] ).</div><div nowrap=\"nowrap\">Die hohe Diskrepanz zwischen p16 Immunhistochemie bzw. HPV-RNA und HPV-DNA Nachweis zeigt, dass HPV-DNA in dieser Lokalisation zwar häufig nachweisbar ist, jedoch in der Mehrheit der Fälle wahrscheinlich nicht biologisch aktiv ist ( [REF] ).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "1;00_mundhoehlenkarzinom_0005.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Prävalenz von HPV16 E6 oder E7 Antikörpern in Mundhöhlenkarzinomen lag bei 0 bis 13,9% in Patienten, und zwischen 0,5 und 11,1% in gepaarten Kontrollen ( [REF], [REF], [REF] )."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1549__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Prävalenz von HPV16 E6 Antikörpern <span class=\"diff_sub\">oder HPV16 E7 Antikörpern </span>in Mundhöhlenkarzinomen lag bei 0 bis 13,9% in Patienten, und zwischen 0,5 und 11,1% in gepaarten Kontrollen ( [REF], [REF], [REF] ).</div><div nowrap=\"nowrap\">Die Prävalenz von HPV16 E6<span class=\"diff_add\"> oder E7</span> Antikörpern in Mundhöhlenkarzinomen lag bei 0 bis 13,9% in Patienten, und zwischen 0,5 und 11,1% in gepaarten Kontrollen ( [REF], [REF], [REF] ).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "2;00_mundhoehlenkarzinom_0028.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten mit fortgeschrittenem Mundhöhlenkarzinom (Stadium III, IV) soll zum Ausschluss eines pulmonalen Tumorbefalls (Filia, Zweitkarzinom) ein Thorax-CT durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1550__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten mit fortgeschrittenem Mundhöhlenkarzinom (Stadium III, <span class=\"diff_sub\">Stadium </span>IV) soll zum Ausschluss eines pulmonalen Tumorbefalls (Filia, Zweitkarzinom) ein Thorax-CT durchgeführt werden.</div><div nowrap=\"nowrap\">Bei Patienten mit fortgeschrittenem Mundhöhlenkarzinom (Stadium III, IV) soll zum Ausschluss eines pulmonalen Tumorbefalls (Filia, Zweitkarzinom) ein Thorax-CT durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "3;00_mundhoehlenkarzinom_0032.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Inzidenz synchroner Zweittumoren oder von Fernmetastasen liegt bei Karzinomen der Mundhöhle, abhängig von der Größe des Primärtumors, zwischen 4% und 33%, wobei die Stadien T3/T4 und Patienten mit Lymphknotenbefall in Level IV besonders häufig betroffen sind [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1551__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Inzidenz synchroner Zweittumoren oder von Fernmetastasen liegt bei Karzinomen der Mundhöhle, abhängig von der Größe des Primärtumors, zwischen 4% und 33%, wobei die Stadien T3/<span class=\"diff_sub\">Stadien </span>T4 und Patienten mit Lymphknotenbefall in Level IV besonders häufig betroffen sind [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Die Inzidenz synchroner Zweittumoren oder von Fernmetastasen liegt bei Karzinomen der Mundhöhle, abhängig von der Größe des Primärtumors, zwischen 4% und 33%, wobei die Stadien T3/T4 und Patienten mit Lymphknotenbefall in Level IV besonders häufig betroffen sind [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "4;00_mundhoehlenkarzinom_0047.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Weder für das frühe (Stadium I und II) noch für das fortgeschrittene Mundhöhlenkarzinom (Stadium III und IV) konnten prospektiv randomisierte kontrollierte Multicenterstudien identifiziert werden, die eine Aussage zur Überlegenheit der chirurgischen Therapie oder der Strahlentherapie zulassen [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1552__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Weder für das frühe (Stadium I und<span class=\"diff_sub\"> Stadium</span> II) noch für das fortgeschrittene Mundhöhlenkarzinom (Stadium III und<span class=\"diff_sub\"> Stadium</span> IV) konnten prospektiv randomisierte kontrollierte Multicenterstudien identifiziert werden, die eine Aussage zur Überlegenheit der chirurgischen Therapie oder der Strahlentherapie zulassen [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Weder für das frühe (Stadium I und II) noch für das fortgeschrittene Mundhöhlenkarzinom (Stadium III und IV) konnten prospektiv randomisierte kontrollierte Multicenterstudien identifiziert werden, die eine Aussage zur Überlegenheit der chirurgischen Therapie oder der Strahlentherapie zulassen [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "5;00_mundhoehlenkarzinom_0068.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Vorliegen einer cN1 oder N1 Subgruppe kann die selektive Neck Dissection lediglich bis Level III alternativ zu einer MRND bis Level V durchgeführt werden, sofern kein extranodales Wachstum vorliegt und die Neck Dissection mindestens ein Level kaudaler reicht, als das Level der LK-Metastasierung."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1553__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Vorliegen einer cN1 Subgruppe <span class=\"diff_chg\">oder N1 Su</span>b<span class=\"diff_chg\">gruppe kann die selektive Neck Dissection lediglich bis Level</span> III alternativ zu einer MRND bis Level V durchgeführt werden, sofern kein extranodales Wachstum vorliegt und die Neck Dissection mindestens ein Level kaudaler reicht, als das Level der LK-Metastasierung.</div><div nowrap=\"nowrap\">Bei Vorliegen einer cN1<span class=\"diff_add\"> oder N1</span> Subgruppe <span class=\"diff_chg\">kann die selektive Neck Dissection lediglich </span>b<span class=\"diff_chg\">is Level</span> III alternativ zu einer MRND bis Level V durchgeführt werden, sofern kein extranodales Wachstum vorliegt und die Neck Dissection mindestens ein Level kaudaler reicht, als das Level der LK-Metastasierung.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "6;00_mundhoehlenkarzinom_0075.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dabei werden Resektion und Rekonstruktion des Ober- und/oder Unterkiefers im Vorfeld virtuell geplant und Osteotomieschablonen hergestellt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1554__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dabei werden Resektion und Rekonstruktion des Ober<span class=\"diff_chg\">kiefers</span> und/oder<span class=\"diff_sub\"> des</span> Unterkiefers im Vorfeld virtuell geplant und Osteotomieschablonen hergestellt.</div><div nowrap=\"nowrap\">Dabei werden Resektion und Rekonstruktion des Ober<span class=\"diff_chg\">-</span> und/oder Unterkiefers im Vorfeld virtuell geplant und Osteotomieschablonen hergestellt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "7;00_mundhoehlenkarzinom_0075.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Rahmen der Tumorresektion beim Mundhöhlenkarzinom mit Knochenbeteiligung können ausgedehnte Defekte des Ober- und/oder Unterkiefers entstehen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1555__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Rahmen der Tumorresektion beim Mundhöhlenkarzinom mit Knochenbeteiligung können ausgedehnte Defekte des Ober<span class=\"diff_chg\">kiefers</span> und/oder<span class=\"diff_sub\"> des</span> Unterkiefers entstehen.</div><div nowrap=\"nowrap\">Im Rahmen der Tumorresektion beim Mundhöhlenkarzinom mit Knochenbeteiligung können ausgedehnte Defekte des Ober<span class=\"diff_chg\">-</span> und/oder Unterkiefers entstehen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "8;00_mundhoehlenkarzinom_0078.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Modifikationen sind die Hypo-, die Hyperfraktionierung sowie die akzelerierte Fraktionierung."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1556__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Modifikationen sind die Hypo<span class=\"diff_chg\">fraktionierung</span>, die Hyperfraktionierung sowie die akzelerierte Fraktionierung.</div><div nowrap=\"nowrap\">Modifikationen sind die Hypo<span class=\"diff_chg\">-</span>, die Hyperfraktionierung sowie die akzelerierte Fraktionierung.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "9;00_mundhoehlenkarzinom_0091.tsv;16"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "So kann bei einer knappen R0- oder einer R1-Resektion mit Dosen von mindestens 60 Gy eine lokale Tumorkontrolle von bis zu 92% erreicht werden [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1557__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">So kann bei einer knappen R0-<span class=\"diff_sub\">Resektion</span> oder einer R1-Resektion mit Dosen von mindestens 60 Gy eine lokale Tumorkontrolle von bis zu 92% erreicht werden [REF].</div><div nowrap=\"nowrap\">So kann bei einer knappen R0- oder einer R1-Resektion mit Dosen von mindestens 60 Gy eine lokale Tumorkontrolle von bis zu 92% erreicht werden [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "10;00_mundhoehlenkarzinom_0091.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zur Frage, ob beim pT1/2 pN1 Plattenepithelkarzinom der Mundhöhle bei vollständiger Tumorresektion (R0) und ohne extrakapsuläre Ausbreitung die Indikation zur adjuvanten Radio/Radiochemotherapie besteht, konnten in einer systematischen de novo Recherche keine randomisierten kontrollierten Studien ab 1994 eingeschlossen werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1558__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zur Frage, ob beim pT1/2 pN1 Plattenepithelkarzinom der Mundhöhle bei vollständiger Tumorresektion (R0) und ohne extrakapsuläre Ausbreitung die Indikation zur adjuvanten Radio<span class=\"diff_sub\">therapie</span>/Radiochemotherapie besteht, konnten in einer systematischen de novo Recherche keine randomisierten kontrollierten Studien ab 1994 eingeschlossen werden.</div><div nowrap=\"nowrap\">Zur Frage, ob beim pT1/2 pN1 Plattenepithelkarzinom der Mundhöhle bei vollständiger Tumorresektion (R0) und ohne extrakapsuläre Ausbreitung die Indikation zur adjuvanten Radio/Radiochemotherapie besteht, konnten in einer systematischen de novo Recherche keine randomisierten kontrollierten Studien ab 1994 eingeschlossen werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "11;00_mundhoehlenkarzinom_0097.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei der Behandlung des Mundhöhlenkarzinoms ist daher aus prophylaktischen Gründen eine frühzeitige zahnärztliche Betreuung essentiell, um bei geplanter oder zurückliegender Strahlentherapie dem sonst gehäuft auftretendem Zahnverlust oder einer Strahlenkaries entgegenzuwirken; hierzu gehört auch die Anfertigung einer Fluoridierungs- und ggf. einer Distanzschiene vor Beginn der Strahlentherapie [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1559__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei der Behandlung des Mundhöhlenkarzinoms ist daher aus prophylaktischen Gründen eine frühzeitige zahnärztliche Betreuung essentiell, um bei geplanter oder zurückliegender Strahlentherapie dem sonst gehäuft auftretendem Zahnverlust oder einer Strahlenkaries entgegenzuwirken; hierzu gehört auch die Anfertigung einer Fluoridierungs<span class=\"diff_chg\">schiene und</span> ggf. einer Distanzschiene vor Beginn der Strahlentherapie [REF], [REF].</div><div nowrap=\"nowrap\">Bei der Behandlung des Mundhöhlenkarzinoms ist daher aus prophylaktischen Gründen eine frühzeitige zahnärztliche Betreuung essentiell, um bei geplanter oder zurückliegender Strahlentherapie dem sonst gehäuft auftretendem Zahnverlust oder einer Strahlenkaries entgegenzuwirken; hierzu gehört auch die Anfertigung einer Fluoridierungs<span class=\"diff_chg\">- und</span> ggf. einer Distanzschiene vor Beginn der Strahlentherapie [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "12;00_mundhoehlenkarzinom_0119.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Da Patienten nach einer tumorbedingten Zahn- und/oder Kieferteilentfernung kaufunktionell behindert sind und eine signifikant geringere Lebensqualität aufweisen als prothetisch versorgte Patienten [REF], ist die Organisation der dentalen Rehabilitation eine wichtige Aufgabe der Tumornachsorge."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1560__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Da Patienten nach einer tumorbedingten Zahn<span class=\"diff_chg\">entfernung</span> und/oder Kieferteilentfernung kaufunktionell behindert sind und eine signifikant geringere Lebensqualität aufweisen als prothetisch versorgte Patienten [REF], ist die Organisation der dentalen Rehabilitation eine wichtige Aufgabe der Tumornachsorge.</div><div nowrap=\"nowrap\">Da Patienten nach einer tumorbedingten Zahn<span class=\"diff_chg\">-</span> und/oder Kieferteilentfernung kaufunktionell behindert sind und eine signifikant geringere Lebensqualität aufweisen als prothetisch versorgte Patienten [REF], ist die Organisation der dentalen Rehabilitation eine wichtige Aufgabe der Tumornachsorge.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "13;00_mundhoehlenkarzinom_0122.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Patienten sollten bereits vor Behandlungsbeginn bei entsprechend qualifizierten Therapeuten vorgestellt werden, wenn als Folge der geplanten chirurgischen oder konservativen Maßnahmen Kau-, Schluck- und/oder Sprechstörungen zu erwarten sind."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1561__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Patienten sollten bereits vor Behandlungsbeginn bei entsprechend qualifizierten Therapeuten vorgestellt werden, wenn als Folge der geplanten chirurgischen oder konservativen Maßnahmen Kaustörungen<span class=\"diff_sub\">, Schluckstörungen und/oder Sprechstörungen</span> zu erwarten sind.</div><div nowrap=\"nowrap\">Die Patienten sollten bereits vor Behandlungsbeginn bei entsprechend qualifizierten Therapeuten vorgestellt werden, wenn als Folge der geplanten chirurgischen oder konservativen Maßnahmen Kau<span class=\"diff_add\">-, Schluck- und/oder Sprech</span>störungen zu erwarten sind.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "14;00_mundhoehlenkarzinom_0124.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten, die wegen eines Mundhöhlenkarzinoms Probleme bei der Nahrungsaufnahme und beim Sprechen haben und/oder eine Radio/Radiochemotherapie erhalten, sollten vor, während und nach der Behandlung Zugang zu einem mit diesem Krankheitsbild erfahrenen Logopäden haben."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1562__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten, die wegen eines Mundhöhlenkarzinoms Probleme bei der Nahrungsaufnahme und beim Sprechen haben und/oder eine Radio<span class=\"diff_sub\">therapie</span>/Radiochemotherapie erhalten, sollten vor, während und nach der Behandlung Zugang zu einem mit diesem Krankheitsbild erfahrenen Logopäden haben.</div><div nowrap=\"nowrap\">Patienten, die wegen eines Mundhöhlenkarzinoms Probleme bei der Nahrungsaufnahme und beim Sprechen haben und/oder eine Radio/Radiochemotherapie erhalten, sollten vor, während und nach der Behandlung Zugang zu einem mit diesem Krankheitsbild erfahrenen Logopäden haben.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "15;00_mundhoehlenkarzinom_0125.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Lymphdrainage kann nach Beendigung der Radio/Radiochemotherapie zur Behandlung eines fazialen oder zervikalen Lymphödems sinnvoll sein."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1563__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Lymphdrainage kann nach Beendigung der Radio<span class=\"diff_sub\">therapie</span>/Radiochemotherapie zur Behandlung eines fazialen oder zervikalen Lymphödems sinnvoll sein.</div><div nowrap=\"nowrap\">Eine Lymphdrainage kann nach Beendigung der Radio/Radiochemotherapie zur Behandlung eines fazialen oder zervikalen Lymphödems sinnvoll sein.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "16;00_mundhoehlenkarzinom_0125.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Aus diesem Grunde sollte ein Therapiebeginn möglichst bereits ca. 14 Tage vor Einsetzten der Radio/Radiochemotheraoie angestrebt werden [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1564__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Aus diesem Grunde sollte ein Therapiebeginn möglichst bereits ca. 14 Tage vor Einsetzten der Radio<span class=\"diff_sub\">therapie</span>/Radiochemotheraoie angestrebt werden [REF].</div><div nowrap=\"nowrap\">Aus diesem Grunde sollte ein Therapiebeginn möglichst bereits ca. 14 Tage vor Einsetzten der Radio/Radiochemotheraoie angestrebt werden [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "17;01_magenkarzinom_0002.tsv;16"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das Risiko der Karzinomentstehung hängt allerdings auch von Wirts- [REF] [REF] [REF], Umwelt- [REF] und bakteriellen Virulenzfaktoren [REF] ab."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1565__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das Risiko der Karzinomentstehung hängt allerdings auch von Wirts<span class=\"diff_chg\">faktoren</span> [REF] [REF] [REF], Umwelt<span class=\"diff_chg\">faktoren</span> [REF] und bakteriellen Virulenzfaktoren [REF] ab.</div><div nowrap=\"nowrap\">Das Risiko der Karzinomentstehung hängt allerdings auch von Wirts<span class=\"diff_chg\">-</span> [REF] [REF] [REF], Umwelt<span class=\"diff_chg\">-</span> [REF] und bakteriellen Virulenzfaktoren [REF] ab.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "18;01_magenkarzinom_0003.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sie ist vor allem dann wirksam, wenn noch keine prä-/para-neoplastischen Veränderungen wie Atrophie oder intestinale Metaplasie vorliegen [REF] [REF] [REF], kann aber auch bei fortgeschrittenen Veränderungen, wie beispielsweise nach endoskopischer Resektion eines Magenfrühkarzinoms, noch effektiv sein [REF] [REF] [REF] [REF] [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1566__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sie ist vor allem dann wirksam, wenn noch keine prä-<span class=\"diff_sub\">neoplastischen</span>/para-neoplastischen Veränderungen wie Atrophie oder intestinale Metaplasie vorliegen [REF] [REF] [REF], kann aber auch bei fortgeschrittenen Veränderungen, wie beispielsweise nach endoskopischer Resektion eines Magenfrühkarzinoms, noch effektiv sein [REF] [REF] [REF] [REF] [REF] [REF].</div><div nowrap=\"nowrap\">Sie ist vor allem dann wirksam, wenn noch keine prä-/para-neoplastischen Veränderungen wie Atrophie oder intestinale Metaplasie vorliegen [REF] [REF] [REF], kann aber auch bei fortgeschrittenen Veränderungen, wie beispielsweise nach endoskopischer Resektion eines Magenfrühkarzinoms, noch effektiv sein [REF] [REF] [REF] [REF] [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "19;01_magenkarzinom_0036.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Obwohl die Sensitivität von Alarmsymptomen relativ niedrig ist [REF] [REF], wird weltweit als „Good Clinical Practice“– Übereinkunft (GCP) bei Patienten mit sogenannten „Warn-\" oder „Alarmsymptomen“ (progrediente/rezidivierende Dysphagie, GI-Blutung, Gewichtsabnahme, rezidivierendes Erbrechen, rezidivierende Aspirationspneumonie, Inappetenz) frühzeitig zu einer hochauflösenden Video-Endoskopie des oberen Verdauungstraktes mit Biopsie-Entnahme geraten [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1567__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Obwohl die Sensitivität von Alarmsymptomen relativ niedrig ist [REF] [REF], wird weltweit als „Good Clinical Practice“– Übereinkunft (GCP) bei Patienten mit sogenannten „Warn<span class=\"diff_chg\">symptomen</span>\" oder „Alarmsymptomen“ (progrediente/rezidivierende Dysphagie, GI-Blutung, Gewichtsabnahme, rezidivierendes Erbrechen, rezidivierende Aspirationspneumonie, Inappetenz) frühzeitig zu einer hochauflösenden Video-Endoskopie des oberen Verdauungstraktes mit Biopsie-Entnahme geraten [REF] [REF].</div><div nowrap=\"nowrap\">Obwohl die Sensitivität von Alarmsymptomen relativ niedrig ist [REF] [REF], wird weltweit als „Good Clinical Practice“– Übereinkunft (GCP) bei Patienten mit sogenannten „Warn<span class=\"diff_chg\">-</span>\" oder „Alarmsymptomen“ (progrediente/rezidivierende Dysphagie, GI-Blutung, Gewichtsabnahme, rezidivierendes Erbrechen, rezidivierende Aspirationspneumonie, Inappetenz) frühzeitig zu einer hochauflösenden Video-Endoskopie des oberen Verdauungstraktes mit Biopsie-Entnahme geraten [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "20;01_magenkarzinom_0054.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Distension des Magens mit (negativem) Kontrastmittel (z.B. Wasser als sog. „Hydro-CT“) ist in der aktuellen Literatur durchgehend empfohlen, da ohne zusätzliche Kosten der Lokalbefund wesentlich besser abgrenzbar ist und eine Infiltration in Nachbarorgane/-strukturen bzw. die Abgrenzung von anatomischen Strukturen jenseits der Magenwand wesentlich besser möglich ist."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1568__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Distension des Magens mit (negativem) Kontrastmittel (z.B. Wasser als sog. „Hydro-CT“) ist in der aktuellen Literatur durchgehend empfohlen, da ohne zusätzliche Kosten der Lokalbefund wesentlich besser abgrenzbar ist und eine Infiltration in Nachbarorgane/<span class=\"diff_chg\">Nachbar</span>strukturen bzw. die Abgrenzung von anatomischen Strukturen jenseits der Magenwand wesentlich besser möglich ist.</div><div nowrap=\"nowrap\">Die Distension des Magens mit (negativem) Kontrastmittel (z.B. Wasser als sog. „Hydro-CT“) ist in der aktuellen Literatur durchgehend empfohlen, da ohne zusätzliche Kosten der Lokalbefund wesentlich besser abgrenzbar ist und eine Infiltration in Nachbarorgane/<span class=\"diff_chg\">-</span>strukturen bzw. die Abgrenzung von anatomischen Strukturen jenseits der Magenwand wesentlich besser möglich ist.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "21;01_magenkarzinom_0070.tsv;25"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die nachfolgenden 3 Parameter werden in der UICC- und AJCC-TNM-Klassifikation von 2017 zwar als fakultative Parameter geführt, der Einheitlichkeit wegen soll in Pathologie-Berichten von S3-Leitlinien grundsätzlich zu diesen Klassifikationen Angaben gemacht werden:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1569__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die nachfolgenden 3 Parameter werden in der UICC-<span class=\"diff_chg\">Klassifikation und</span> AJCC-TNM-Klassifikation von 2017 zwar als fakultative Parameter geführt, der Einheitlichkeit wegen soll in Pathologie-Berichten von S3-Leitlinien grundsätzlich zu diesen Klassifikationen Angaben gemacht werden:</div><div nowrap=\"nowrap\">Die nachfolgenden 3 Parameter werden in der UICC-<span class=\"diff_chg\"> und</span> AJCC-TNM-Klassifikation von 2017 zwar als fakultative Parameter geführt, der Einheitlichkeit wegen soll in Pathologie-Berichten von S3-Leitlinien grundsätzlich zu diesen Klassifikationen Angaben gemacht werden:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "22;01_magenkarzinom_0072.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- differenziertes Mukosakarzinom (G1/2) ohne Ulceration und Größe >2cm"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1570__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- differenziertes Mukosakarzinom (G1/<span class=\"diff_sub\">G</span>2) ohne Ulceration und Größe &gt;2cm</div><div nowrap=\"nowrap\">- differenziertes Mukosakarzinom (G1/2) ohne Ulceration und Größe &gt;2cm</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "23;01_magenkarzinom_0073.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die En-bloc- und R0-Resektionsraten waren jedoch signifikant besser in der „Leitlinienkriterien“-Gruppe (98,6% und 97,1%) im Vergleich zur „erweiterten Kriterien“-Gruppe (93% und 91,1%) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1571__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die En-bloc-<span class=\"diff_sub\">Resektionsraten</span> und R0-Resektionsraten waren jedoch signifikant besser in der „Leitlinienkriterien“-Gruppe (98,6% und 97,1%) im Vergleich zur „erweiterten Kriterien“-Gruppe (93% und 91,1%) [REF].</div><div nowrap=\"nowrap\">Die En-bloc- und R0-Resektionsraten waren jedoch signifikant besser in der „Leitlinienkriterien“-Gruppe (98,6% und 97,1%) im Vergleich zur „erweiterten Kriterien“-Gruppe (93% und 91,1%) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "24;01_magenkarzinom_0073.tsv;27"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Analog zu den Daten in Japan konnte Probst et al. zeigen, dass kein Unterschied hinsichtlich Überleben in beiden Gruppen besteht, obwohl die en-bloc- und R0-Resektionsraten bei den „Leitlinienkriterien“ signifikant besser waren als bei den „erweiterten Kriterien“ (90,2% vs. 73,6%; p=<0,02) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1572__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Analog zu den Daten in Japan konnte Probst et al. zeigen, dass kein Unterschied hinsichtlich Überleben in beiden Gruppen besteht, obwohl die en-bloc-Resektionsraten <span class=\"diff_chg\">und R0-Resektionsraten bei den</span> „Leitlinienkriterien“ signifikant besser waren als bei den „erweiterten Kriterien“ (90,2% vs. 73,6%; p=&lt;0,02) [REF].</div><div nowrap=\"nowrap\">Analog zu den Daten in Japan konnte Probst et al. zeigen, dass kein Unterschied hinsichtlich Überleben in beiden Gruppen besteht, obwohl die en-bloc<span class=\"diff_add\">- und R0</span>-Resektionsraten <span class=\"diff_chg\">bei den</span> „Leitlinienkriterien“ signifikant besser waren als bei den „erweiterten Kriterien“ (90,2% vs. 73,6%; p=&lt;0,02) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "25;01_magenkarzinom_0087.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei einem Adenokarzinom des ösophagogastralen Überganges (Kardiakarzinom, AEG Typ II und III) wird zusätzlich zur Gastrektomie eine distale Ösophagusresektion notwendig."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1573__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei einem Adenokarzinom des ösophagogastralen Überganges (Kardiakarzinom, AEG Typ II und<span class=\"diff_sub\"> Typ</span> III) wird zusätzlich zur Gastrektomie eine distale Ösophagusresektion notwendig.</div><div nowrap=\"nowrap\">Bei einem Adenokarzinom des ösophagogastralen Überganges (Kardiakarzinom, AEG Typ II und III) wird zusätzlich zur Gastrektomie eine distale Ösophagusresektion notwendig.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "26;01_magenkarzinom_0090.tsv;22"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "im Stadium I blieb in der multivariaten Analyse der Abstand von 3,1-5cm positiv mit dem Gesamt­über­leben korreliert (HR 0,16; P = 0,01), in den Stadien 2 und 3 nicht mehr [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1574__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">im Stadium I blieb in der multivariaten Analyse der Abstand von 3,1-5cm positiv mit dem Gesamt­über­leben korreliert (HR 0,16; P = 0,01), in den Stadien 2 und <span class=\"diff_sub\">Stadien </span>3 nicht mehr [REF].</div><div nowrap=\"nowrap\">im Stadium I blieb in der multivariaten Analyse der Abstand von 3,1-5cm positiv mit dem Gesamt­über­leben korreliert (HR 0,16; P = 0,01), in den Stadien 2 und 3 nicht mehr [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "27;01_magenkarzinom_0092.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Unterschiede zwischen der 30-Tage- und 90-Tage-Mortalität bei Ösophaguskarzinomen (N=3.286) und Magenkarzinomen (N=7.910) wurden ebenfalls erfasst."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1575__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Unterschiede zwischen der 30-Tage-<span class=\"diff_sub\">Mortalität</span> und 90-Tage-Mortalität bei Ösophaguskarzinomen (N=3.286) und Magenkarzinomen (N=7.910) wurden ebenfalls erfasst.</div><div nowrap=\"nowrap\">Unterschiede zwischen der 30-Tage- und 90-Tage-Mortalität bei Ösophaguskarzinomen (N=3.286) und Magenkarzinomen (N=7.910) wurden ebenfalls erfasst.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "28;01_magenkarzinom_0092.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Mit zu­nehmender Anzahl der Fälle/Jahr fand sich ein lineares Absinken der 30-Tage und 90-Tage-Mortalität (p<0,001):"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1576__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Mit zu­nehmender Anzahl der Fälle/Jahr fand sich ein lineares Absinken der 30-Tage<span class=\"diff_sub\">-Mortalität</span> und 90-Tage-Mortalität (p&lt;0,001):</div><div nowrap=\"nowrap\">Mit zu­nehmender Anzahl der Fälle/Jahr fand sich ein lineares Absinken der 30-Tage und 90-Tage-Mortalität (p&lt;0,001):</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "29;01_magenkarzinom_0092.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die negative, lineare Korrelation zwischen Anzahl der Operationen/Jahr und der postoperativen Mortalität bestand sowohl für das Ösophagus- als auch das Magenkarzinom."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1577__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die negative, lineare Korrelation zwischen Anzahl der Operationen/Jahr und der postoperativen Mortalität bestand sowohl für das Ösophagus<span class=\"diff_chg\">karzinom</span> als auch das Magenkarzinom.</div><div nowrap=\"nowrap\">Die negative, lineare Korrelation zwischen Anzahl der Operationen/Jahr und der postoperativen Mortalität bestand sowohl für das Ösophagus<span class=\"diff_chg\">-</span> als auch das Magenkarzinom.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "30;01_magenkarzinom_0094.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nachstehend werden zwei Arbeiten zum Vergleich Pouch- vs. Roux-Y-Rekonstruktion vorgestellt und kommentiert."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1578__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nachstehend werden zwei Arbeiten zum Vergleich Pouch-<span class=\"diff_sub\">Rekonstruktion</span> vs. Roux-Y-Rekonstruktion vorgestellt und kommentiert.</div><div nowrap=\"nowrap\">Nachstehend werden zwei Arbeiten zum Vergleich Pouch- vs. Roux-Y-Rekonstruktion vorgestellt und kommentiert.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "31;01_magenkarzinom_0096.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Aufgrund der erhöhten Morbidität des transthorakalen Verfahrens votierten die Autoren gegen eine transthorakale Chirurgie bei Typ II und III-Karzinomen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1579__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Aufgrund der erhöhten Morbidität des transthorakalen Verfahrens votierten die Autoren gegen eine transthorakale Chirurgie bei Typ II<span class=\"diff_sub\">-Karzinomen</span> und<span class=\"diff_sub\"> Typ</span> III-Karzinomen [REF].</div><div nowrap=\"nowrap\">Aufgrund der erhöhten Morbidität des transthorakalen Verfahrens votierten die Autoren gegen eine transthorakale Chirurgie bei Typ II und III-Karzinomen [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "32;01_magenkarzinom_0100.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Deutschen Magenkarzinomstudie konnte insbesondere für die UICC-Stadien II und IIIa ein Prognosevorteil der D2-LAD festgestellt werden [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1580__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Deutschen Magenkarzinomstudie konnte insbesondere für die UICC-Stadien II und<span class=\"diff_sub\"> UICC-Stadien</span> IIIa ein Prognosevorteil der D2-LAD festgestellt werden [REF] [REF].</div><div nowrap=\"nowrap\">In der Deutschen Magenkarzinomstudie konnte insbesondere für die UICC-Stadien II und IIIa ein Prognosevorteil der D2-LAD festgestellt werden [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "33;01_magenkarzinom_0123.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies galt ebenso für die CT-Response (> 50% Reduktion der Magenwanddicke) und die klinische Response (Kombination aus endoskopischer und CT-Response) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1581__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies galt ebenso für die CT-Response (&gt; 50% Reduktion der Magenwanddicke) und die klinische Response (Kombination aus endoskopischer <span class=\"diff_sub\">Response </span>und CT-Response) [REF].</div><div nowrap=\"nowrap\">Dies galt ebenso für die CT-Response (&gt; 50% Reduktion der Magenwanddicke) und die klinische Response (Kombination aus endoskopischer und CT-Response) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "34;01_magenkarzinom_0123.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der prospektiven koreanischen Studie unter palliativer Chemotherapie erwies sich die Kombination aus endoskopischer und CT-Evaluation als besseres prognostisches Tool als das CT alleine [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1582__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der prospektiven koreanischen Studie unter palliativer Chemotherapie erwies sich die Kombination aus endoskopischer <span class=\"diff_sub\">Evaluation </span>und CT-Evaluation als besseres prognostisches Tool als das CT alleine [REF].</div><div nowrap=\"nowrap\">In der prospektiven koreanischen Studie unter palliativer Chemotherapie erwies sich die Kombination aus endoskopischer und CT-Evaluation als besseres prognostisches Tool als das CT alleine [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "35;01_magenkarzinom_0139.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Frage nach dem Vergleich der Kombinations- versus Monotherapie speziell bei älteren Patienten wurde in aktuellen Studien kaum untersucht [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1583__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Frage nach dem Vergleich der Kombinations<span class=\"diff_chg\">therapie</span> versus Monotherapie speziell bei älteren Patienten wurde in aktuellen Studien kaum untersucht [REF].</div><div nowrap=\"nowrap\">Die Frage nach dem Vergleich der Kombinations<span class=\"diff_chg\">-</span> versus Monotherapie speziell bei älteren Patienten wurde in aktuellen Studien kaum untersucht [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "36;01_magenkarzinom_0150.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Palliativsituation soll in der Erstlinientherapie eine Platin-/Fluoropyrimidin-haltige Kombinationstherapie durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1584__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Palliativsituation soll in der Erstlinientherapie eine Platin-<span class=\"diff_sub\">haltige</span>/Fluoropyrimidin-haltige Kombinationstherapie durchgeführt werden.</div><div nowrap=\"nowrap\">In der Palliativsituation soll in der Erstlinientherapie eine Platin-/Fluoropyrimidin-haltige Kombinationstherapie durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "37;01_magenkarzinom_0150.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Vorliegen von Kontraindikationen gegen Platin kann alternativ eine Irinotecan/Fluoropyrimidinhaltige Kombinationstherapie durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1585__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Vorliegen von Kontraindikationen gegen Platin kann alternativ eine Irinotecan<span class=\"diff_sub\">haltige</span>/Fluoropyrimidinhaltige Kombinationstherapie durchgeführt werden.</div><div nowrap=\"nowrap\">Bei Vorliegen von Kontraindikationen gegen Platin kann alternativ eine Irinotecan/Fluoropyrimidinhaltige Kombinationstherapie durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "38;01_magenkarzinom_0151.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Fluoropyrimidin-/Platin-haltige Kombinationen werden in den meisten aktuellen Phase III-Studien als Referenzarm eingesetzt [REF] [REF] [REF] [REF] [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1586__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Fluoropyrimidin-<span class=\"diff_sub\">haltige</span>/Platin-haltige Kombinationen werden in den meisten aktuellen Phase III-Studien als Referenzarm eingesetzt [REF] [REF] [REF] [REF] [REF] [REF].</div><div nowrap=\"nowrap\">Fluoropyrimidin-/Platin-haltige Kombinationen werden in den meisten aktuellen Phase III-Studien als Referenzarm eingesetzt [REF] [REF] [REF] [REF] [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "39;01_magenkarzinom_0151.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies entspricht medianen Überlebenszeiten von 8,3 vs. 6,7 Monaten für die mit Kombinations- versus Monotherapie behandelten Patienten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1587__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies entspricht medianen Überlebenszeiten von 8,3 vs. 6,7 Monaten für die mit Kombinations<span class=\"diff_chg\">therapie</span> versus Monotherapie behandelten Patienten.</div><div nowrap=\"nowrap\">Dies entspricht medianen Überlebenszeiten von 8,3 vs. 6,7 Monaten für die mit Kombinations<span class=\"diff_chg\">-</span> versus Monotherapie behandelten Patienten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "40;01_magenkarzinom_0151.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bereits eine systematische Aufarbeitung der bis einschließlich März 2009 publizierten Literatur in einer Meta-Analyse [REF] [REF] konnte einen statistisch signifikanten und konsistenten Überlebensvorteil für Cisplatin/Fluoropyrimidin-haltige Kombinationstherapien im Vergleich zur Monotherapie mit 5-FU nachweisen (N=1.914 Patienten in 13 Studien; HR für das Gesamtüberleben 0,82; 95% KI 0,74-0,90)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1588__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bereits eine systematische Aufarbeitung der bis einschließlich März 2009 publizierten Literatur in einer Meta-Analyse [REF] [REF] konnte einen statistisch signifikanten und konsistenten Überlebensvorteil für Cisplatin<span class=\"diff_sub\">-haltige</span>/Fluoropyrimidin-haltige Kombinationstherapien im Vergleich zur Monotherapie mit 5-FU nachweisen (N=1.914 Patienten in 13 Studien; HR für das Gesamtüberleben 0,82; 95% KI 0,74-0,90).</div><div nowrap=\"nowrap\">Bereits eine systematische Aufarbeitung der bis einschließlich März 2009 publizierten Literatur in einer Meta-Analyse [REF] [REF] konnte einen statistisch signifikanten und konsistenten Überlebensvorteil für Cisplatin/Fluoropyrimidin-haltige Kombinationstherapien im Vergleich zur Monotherapie mit 5-FU nachweisen (N=1.914 Patienten in 13 Studien; HR für das Gesamtüberleben 0,82; 95% KI 0,74-0,90).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "41;01_magenkarzinom_0155.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das progressionsfreie bzw. das Gesamtüberleben lag bei 5,3 bzw. 11,3 Monaten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1589__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das progressionsfreie <span class=\"diff_sub\">Überleben </span>bzw. das Gesamtüberleben lag bei 5,3 bzw. 11,3 Monaten.</div><div nowrap=\"nowrap\">Das progressionsfreie bzw. das Gesamtüberleben lag bei 5,3 bzw. 11,3 Monaten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "42;01_magenkarzinom_0155.tsv;25"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Allerdings war auch der Anteil an Grad 3/4 AEs signifikant mit mDCF erhöht (77,3% vs. 46,1%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1590__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Allerdings war auch der Anteil an Grad 3/<span class=\"diff_sub\">Grad </span>4 AEs signifikant mit mDCF erhöht (77,3% vs. 46,1%).</div><div nowrap=\"nowrap\">Allerdings war auch der Anteil an Grad 3/4 AEs signifikant mit mDCF erhöht (77,3% vs. 46,1%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "43;01_magenkarzinom_0155.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zusammenfassend sprechen die vorliegenden Ergebnisse einer Meta-Analyse und mehrerer Phase II-Studien für eine reduzierte hämatologische Toxizität der FLOT, T-PLF (TEX) und mDCF-Schemata."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1591__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zusammenfassend sprechen die vorliegenden Ergebnisse einer Meta-Analyse und mehrerer Phase II-Studien für eine reduzierte hämatologische Toxizität der FLOT<span class=\"diff_sub\">-Schemata</span>, T-PLF<span class=\"diff_sub\">-Schemata</span> (TEX) und mDCF-Schemata.</div><div nowrap=\"nowrap\">Zusammenfassend sprechen die vorliegenden Ergebnisse einer Meta-Analyse und mehrerer Phase II-Studien für eine reduzierte hämatologische Toxizität der FLOT, T-PLF (TEX) und mDCF-Schemata.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "44;01_magenkarzinom_0155.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Therapiearm mit DCF musste auf Grund von Toxizität (71% Grad 3/4 innerhalb der ersten 3 Monate) vorzeitig geschlossen werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1592__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Therapiearm mit DCF musste auf Grund von Toxizität (71% Grad 3/<span class=\"diff_sub\">Grad </span>4 innerhalb der ersten 3 Monate) vorzeitig geschlossen werden.</div><div nowrap=\"nowrap\">Der Therapiearm mit DCF musste auf Grund von Toxizität (71% Grad 3/4 innerhalb der ersten 3 Monate) vorzeitig geschlossen werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "45;01_magenkarzinom_0155.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auf Grund der erhöhten Nebenwirkungsrate mit dem klassischen DCF-Regime, insbesondere bei älteren Patienten, wurden alternative, besser verträgliche Therapieprotokolle wie das Gastro-Tax- und das FLOT-Regime evaluiert [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1593__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auf Grund der erhöhten Nebenwirkungsrate mit dem klassischen DCF-Regime, insbesondere bei älteren Patienten, wurden alternative, besser verträgliche Therapieprotokolle wie das Gastro-Tax-<span class=\"diff_chg\">Regime und das</span> FLOT-Regime evaluiert [REF] [REF].</div><div nowrap=\"nowrap\">Auf Grund der erhöhten Nebenwirkungsrate mit dem klassischen DCF-Regime, insbesondere bei älteren Patienten, wurden alternative, besser verträgliche Therapieprotokolle wie das Gastro-Tax-<span class=\"diff_chg\"> und das</span> FLOT-Regime evaluiert [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "46;01_magenkarzinom_0159.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Statistisch signifikante Vorteile traten im CS-Arm bei der Grad 3/4 Neutropenie (CS 18,6%; CF 40,0%) zu Tage, ebenso bei der febrilen Neutropenie (CS 1,7%; CF 6,9%), bei der Grad 3/4 Stomatitis (CS 1,3%; CF 13,6%), bei der Diarrhoe (alle Schweregrade: CS 29,2%; CF 38,4%) und bei renalen adverse Events (alle Grade: CS 18,8%; CF 33,5%),"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1594__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Statistisch signifikante Vorteile traten im CS-Arm bei der Grad 3/<span class=\"diff_sub\">Grad </span>4 Neutropenie (CS 18,6%; CF 40,0%) zu Tage, ebenso bei der febrilen Neutropenie (CS 1,7%; CF 6,9%), bei der Grad 3/<span class=\"diff_sub\">Grad </span>4 Stomatitis (CS 1,3%; CF 13,6%), bei der Diarrhoe (alle Schweregrade: CS 29,2%; CF 38,4%) und bei renalen adverse Events (alle Grade: CS 18,8%; CF 33,5%),</div><div nowrap=\"nowrap\">Statistisch signifikante Vorteile traten im CS-Arm bei der Grad 3/4 Neutropenie (CS 18,6%; CF 40,0%) zu Tage, ebenso bei der febrilen Neutropenie (CS 1,7%; CF 6,9%), bei der Grad 3/4 Stomatitis (CS 1,3%; CF 13,6%), bei der Diarrhoe (alle Schweregrade: CS 29,2%; CF 38,4%) und bei renalen adverse Events (alle Grade: CS 18,8%; CF 33,5%),</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "47;01_magenkarzinom_0159.tsv;22"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ein Hand-Fuß-Syndrom wurde nur gelegentlich berichtet und betrug in beiden Armen meist Grad 1 und 2. Die Rate der Therapie-bezogenen Todesfälle war im CS-Arm signifikant geringer als im CF-Arm (2,5% bzw. 4,9%; p<0,047)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1595__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ein Hand-Fuß-Syndrom wurde nur gelegentlich berichtet und betrug in beiden Armen meist Grad 1 und<span class=\"diff_sub\"> Grad</span> 2. Die Rate der Therapie-bezogenen Todesfälle war im CS-Arm signifikant geringer als im CF-Arm (2,5% bzw. 4,9%; p&lt;0,047).</div><div nowrap=\"nowrap\">Ein Hand-Fuß-Syndrom wurde nur gelegentlich berichtet und betrug in beiden Armen meist Grad 1 und 2. Die Rate der Therapie-bezogenen Todesfälle war im CS-Arm signifikant geringer als im CF-Arm (2,5% bzw. 4,9%; p&lt;0,047).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "48;01_magenkarzinom_0159.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zusätzlich liegt eine weitere, randomisierte Studie zum Vergleich Capecitabin- versus 5-FU-haltiger Kombinationstherapien vor [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1596__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zusätzlich liegt eine weitere, randomisierte Studie zum Vergleich Capecitabin-<span class=\"diff_sub\">haltiger</span> versus 5-FU-haltiger Kombinationstherapien vor [REF].</div><div nowrap=\"nowrap\">Zusätzlich liegt eine weitere, randomisierte Studie zum Vergleich Capecitabin- versus 5-FU-haltiger Kombinationstherapien vor [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "49;01_magenkarzinom_0160.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei HER2-überexprimierenden Tumoren soll eine Cisplatin-/Fluoropyrimidin-basierte Erstlinienchemotherapie um Trastuzumab ergänzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1597__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei HER2-überexprimierenden Tumoren soll eine Cisplatin-<span class=\"diff_sub\">basierte</span>/Fluoropyrimidin-basierte Erstlinienchemotherapie um Trastuzumab ergänzt werden.</div><div nowrap=\"nowrap\">Bei HER2-überexprimierenden Tumoren soll eine Cisplatin-/Fluoropyrimidin-basierte Erstlinienchemotherapie um Trastuzumab ergänzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "50;01_magenkarzinom_0166.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt von der Tumorlokalisation, –ausdehnung und Schwere der Symptomatik und der Vortherapie ab."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1598__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt von der Tumorlokalisation, <span class=\"diff_chg\">Tumor</span>ausdehnung und Schwere der Symptomatik und der Vortherapie ab.</div><div nowrap=\"nowrap\">Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt von der Tumorlokalisation, <span class=\"diff_chg\">–</span>ausdehnung und Schwere der Symptomatik und der Vortherapie ab.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "51;01_magenkarzinom_0169.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Thermale oder chemische Verfahren liefern vergleichbare Effekte bei der Dysphagie-Palliation, haben aber eine höhere Re-Interventions- und Nebenwirkungsrate."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1599__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Thermale oder chemische Verfahren liefern vergleichbare Effekte bei der Dysphagie-Palliation, haben aber eine höhere Re-Interventions<span class=\"diff_chg\">rate</span> und Nebenwirkungsrate.</div><div nowrap=\"nowrap\">Thermale oder chemische Verfahren liefern vergleichbare Effekte bei der Dysphagie-Palliation, haben aber eine höhere Re-Interventions<span class=\"diff_chg\">-</span> und Nebenwirkungsrate.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "52;01_magenkarzinom_0170.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Wahl des Therapieverfahrens zur Behandlung einer tumorbedingten Blutung hängt von der Blutungslokalisation und –stärke ab."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1600__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Wahl des Therapieverfahrens zur Behandlung einer tumorbedingten Blutung hängt von der Blutungslokalisation und <span class=\"diff_chg\">Blutungs</span>stärke ab.</div><div nowrap=\"nowrap\">Die Wahl des Therapieverfahrens zur Behandlung einer tumorbedingten Blutung hängt von der Blutungslokalisation und <span class=\"diff_chg\">–</span>stärke ab.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "53;01_magenkarzinom_0188.tsv;55"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Therapie wurde insgesamt gut toleriert mit Grad-III/IV-Toxizitäten in nur 12% der Fälle bei jedoch einem Hepatitis-assoziierten Todesfall."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1601__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Therapie wurde insgesamt gut toleriert mit Grad-III<span class=\"diff_sub\">-Toxizitäten</span>/<span class=\"diff_sub\">Grad-</span>IV-Toxizitäten in nur 12% der Fälle bei jedoch einem Hepatitis-assoziierten Todesfall.</div><div nowrap=\"nowrap\">Die Therapie wurde insgesamt gut toleriert mit Grad-III/IV-Toxizitäten in nur 12% der Fälle bei jedoch einem Hepatitis-assoziierten Todesfall.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "54;01_magenkarzinom_0188.tsv;46"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der gastrointestinalen Kohorte (20 Patienten), die ein ähnliches Nebenwirkungsprofil aufwies (Grad III/IV 50%) war bei allen Patienten mit partiellem Ansprechen nach RECIST der Primärtumor PD-L1 positiv [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1602__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der gastrointestinalen Kohorte (20 Patienten), die ein ähnliches Nebenwirkungsprofil aufwies (Grad III/<span class=\"diff_sub\">Grad </span>IV 50%) war bei allen Patienten mit partiellem Ansprechen nach RECIST der Primärtumor PD-L1 positiv [REF].</div><div nowrap=\"nowrap\">In der gastrointestinalen Kohorte (20 Patienten), die ein ähnliches Nebenwirkungsprofil aufwies (Grad III/IV 50%) war bei allen Patienten mit partiellem Ansprechen nach RECIST der Primärtumor PD-L1 positiv [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "55;01_magenkarzinom_0188.tsv;45"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Atezolizumab wurde in einer Phase-I-Studie für multiple solide Neoplasien (171 Patienten) untersucht und zeigte bei auffälliger Toxizität (NW v.a. Ausschlag, Kolitis und Hepatitis, Grad-III/IV-Toxizitäten 39%) ein medianes Ansprechen von 21% mit deutlicher Überlegenheit der PD-L1-positiven Tumore (39% vs. 13% PD-L1-negative Tumore) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1603__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Atezolizumab wurde in einer Phase-I-Studie für multiple solide Neoplasien (171 Patienten) untersucht und zeigte bei auffälliger Toxizität (NW v.a. Ausschlag, Kolitis und Hepatitis, Grad-III-Toxizitäten<span class=\"diff_sub\">/Grad-IV-Toxizitäten</span> 39%) ein medianes Ansprechen von 21% mit deutlicher Überlegenheit der PD-L1-positiven Tumore (39% vs. 13% PD-L1-negative Tumore) [REF].</div><div nowrap=\"nowrap\">Atezolizumab wurde in einer Phase-I-Studie für multiple solide Neoplasien (171 Patienten) untersucht und zeigte bei auffälliger Toxizität (NW v.a. Ausschlag, Kolitis und Hepatitis, Grad-III<span class=\"diff_add\">/IV</span>-Toxizitäten 39%) ein medianes Ansprechen von 21% mit deutlicher Überlegenheit der PD-L1-positiven Tumore (39% vs. 13% PD-L1-negative Tumore) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "56;01_magenkarzinom_0188.tsv;26"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer im asiatischen Raum durchgeführten placebo-kontrollierten Phase III-Studie (ATTRACTION-2) wurde Nivolumab an 493 Patienten mit fortgeschrittenem Adenokarzinom (AEG und Magen) unabhängig vom PD-L1-Status untersucht."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1604__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer im asiatischen Raum durchgeführten placebo-kontrollierten Phase III-Studie (ATTRACTION-2) wurde Nivolumab an 493 Patienten mit fortgeschrittenem Adenokarzinom (AEG und Magen<span class=\"diff_sub\">karzinom</span>) unabhängig vom PD-L1-Status untersucht.</div><div nowrap=\"nowrap\">In einer im asiatischen Raum durchgeführten placebo-kontrollierten Phase III-Studie (ATTRACTION-2) wurde Nivolumab an 493 Patienten mit fortgeschrittenem Adenokarzinom (AEG und Magen) unabhängig vom PD-L1-Status untersucht.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "57;01_magenkarzinom_0188.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Anteil an schwereren (CTC Grad-III/IV) immunvermittelten Nebenwirkungen war über alle Kohorten hinweg sehr gering (ca. 5%), ohne Zunahme bei der Kombination mit Chemotherapie (Kohorte 2)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1605__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Anteil an schwereren (CTC Grad-III/<span class=\"diff_sub\">CTC Grad-</span>IV) immunvermittelten Nebenwirkungen war über alle Kohorten hinweg sehr gering (ca. 5%), ohne Zunahme bei der Kombination mit Chemotherapie (Kohorte 2).</div><div nowrap=\"nowrap\">Der Anteil an schwereren (CTC Grad-III/IV) immunvermittelten Nebenwirkungen war über alle Kohorten hinweg sehr gering (ca. 5%), ohne Zunahme bei der Kombination mit Chemotherapie (Kohorte 2).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "58;01_magenkarzinom_0188.tsv;61"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Alle PD-L1-Antikörper wiesen insgesamt ähnliche Risikoprofile auf mit niedriger Rate an Grad-III/IV-Toxizitäten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1606__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Alle PD-L1-Antikörper wiesen insgesamt ähnliche Risikoprofile auf mit niedriger Rate an Grad-III<span class=\"diff_sub\">-Toxizitäten</span>/<span class=\"diff_sub\">Grad-</span>IV-Toxizitäten.</div><div nowrap=\"nowrap\">Alle PD-L1-Antikörper wiesen insgesamt ähnliche Risikoprofile auf mit niedriger Rate an Grad-III/IV-Toxizitäten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "59;01_magenkarzinom_0192.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Hierzu gehören die Vitamine C und E sowie Betacarotin."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1607__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Hierzu gehören die Vitamine C und <span class=\"diff_sub\">Vitamine </span>E sowie Betacarotin.</div><div nowrap=\"nowrap\">Hierzu gehören die Vitamine C und E sowie Betacarotin.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "60;01_magenkarzinom_0214.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer Untersuchung über einen Zeitraum von 2 Jahren nach Gastrektomie wurde eine verminderte Stuhlelastase bei 44% der Patienten nachgewiesen und die Patienten wiesen einen Mangel an den fettlöslichen Vitaminen A und E auf."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1608__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer Untersuchung über einen Zeitraum von 2 Jahren nach Gastrektomie wurde eine verminderte Stuhlelastase bei 44% der Patienten nachgewiesen und die Patienten wiesen einen Mangel an den fettlöslichen Vitaminen A und<span class=\"diff_sub\"> Vitaminen</span> E auf.</div><div nowrap=\"nowrap\">In einer Untersuchung über einen Zeitraum von 2 Jahren nach Gastrektomie wurde eine verminderte Stuhlelastase bei 44% der Patienten nachgewiesen und die Patienten wiesen einen Mangel an den fettlöslichen Vitaminen A und E auf.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "61;01_magenkarzinom_0226.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Im Rahmen der ärztlichen oder Pflege-Anamnese können Patienten mit hoher Belastung (insbesondere Depressivität) mithilfe einfacher Screeningfragen identifiziert werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1609__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Im Rahmen der ärztlichen <span class=\"diff_sub\">Anamnese </span>oder Pflege-Anamnese können Patienten mit hoher Belastung (insbesondere Depressivität) mithilfe einfacher Screeningfragen identifiziert werden.</div><div nowrap=\"nowrap\">- Im Rahmen der ärztlichen oder Pflege-Anamnese können Patienten mit hoher Belastung (insbesondere Depressivität) mithilfe einfacher Screeningfragen identifiziert werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "62;01_magenkarzinom_0245.tsv;351"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei HER2-überexprimierenden Tumoren soll eine Cisplatin-/Fluoropyrimidin-basierte Erstlinienchemotherapie um Trastuzumab ergänzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1610__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei HER2-überexprimierenden Tumoren soll eine Cisplatin-<span class=\"diff_sub\">basierte</span>/Fluoropyrimidin-basierte Erstlinienchemotherapie um Trastuzumab ergänzt werden.</div><div nowrap=\"nowrap\">Bei HER2-überexprimierenden Tumoren soll eine Cisplatin-/Fluoropyrimidin-basierte Erstlinienchemotherapie um Trastuzumab ergänzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "63;01_magenkarzinom_0245.tsv;349"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Vorgehen bei metastasierten Karzinomen mit HER-2-Überexpression/-Amplifikation"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1611__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Vorgehen bei metastasierten Karzinomen mit HER-2-Überexpression/<span class=\"diff_sub\">HER-2</span>-Amplifikation</div><div nowrap=\"nowrap\">Vorgehen bei metastasierten Karzinomen mit HER-2-Überexpression/-Amplifikation</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "64;01_magenkarzinom_0245.tsv;346"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Irinotecan/Fluropyrimidin-basierte Kombinationstherapie kann Patienten angeboten werden, bei denen aufgrund des Nebenwirkungsprofils eine Alternative zu einer platinhaltigen Kombination sinnvoll ist."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1612__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Irinotecan<span class=\"diff_sub\">-basierte</span>/Fluropyrimidin-basierte Kombinationstherapie kann Patienten angeboten werden, bei denen aufgrund des Nebenwirkungsprofils eine Alternative zu einer platinhaltigen Kombination sinnvoll ist.</div><div nowrap=\"nowrap\">Eine Irinotecan/Fluropyrimidin-basierte Kombinationstherapie kann Patienten angeboten werden, bei denen aufgrund des Nebenwirkungsprofils eine Alternative zu einer platinhaltigen Kombination sinnvoll ist.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "65;01_magenkarzinom_0245.tsv;321"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Vorliegen von Kontraindikationen gegen Platin kann alternativ eine Irinotecan/Fluoropyrimidinhaltige Kombinationstherapie durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1613__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Vorliegen von Kontraindikationen gegen Platin kann alternativ eine Irinotecan<span class=\"diff_sub\">haltige</span>/Fluoropyrimidinhaltige Kombinationstherapie durchgeführt werden.</div><div nowrap=\"nowrap\">Bei Vorliegen von Kontraindikationen gegen Platin kann alternativ eine Irinotecan/Fluoropyrimidinhaltige Kombinationstherapie durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "66;01_magenkarzinom_0245.tsv;320"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Palliativsituation soll in der Erstlinientherapie eine Platin-/Fluoropyrimidin-haltige Kombinationstherapie durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1614__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Palliativsituation soll in der Erstlinientherapie eine Platin-<span class=\"diff_sub\">haltige</span>/Fluoropyrimidin-haltige Kombinationstherapie durchgeführt werden.</div><div nowrap=\"nowrap\">In der Palliativsituation soll in der Erstlinientherapie eine Platin-/Fluoropyrimidin-haltige Kombinationstherapie durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "67;01_magenkarzinom_0245.tsv;359"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt vor allem von der Tumorlokalisation, –ausdehnung und Schwere der Symptomatik ab."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1615__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt vor allem von der Tumorlokalisation, <span class=\"diff_chg\">Tumor</span>ausdehnung und Schwere der Symptomatik ab.</div><div nowrap=\"nowrap\">Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt vor allem von der Tumorlokalisation, <span class=\"diff_chg\">–</span>ausdehnung und Schwere der Symptomatik ab.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "68;01_magenkarzinom_0245.tsv;318"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Indiziert ist eine systemische Platin/Fluoropyrimidin-haltige Kombinationstherapie."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1616__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Indiziert ist eine systemische Platin<span class=\"diff_sub\">-haltige</span>/Fluoropyrimidin-haltige Kombinationstherapie.</div><div nowrap=\"nowrap\">Indiziert ist eine systemische Platin/Fluoropyrimidin-haltige Kombinationstherapie.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "69;01_magenkarzinom_0245.tsv;162"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- differenziertes Mukosakarzinom (G1/2) ohne Ulceration und Größe >2cm"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1617__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- differenziertes Mukosakarzinom (G1/<span class=\"diff_sub\">G</span>2) ohne Ulceration und Größe &gt;2cm</div><div nowrap=\"nowrap\">- differenziertes Mukosakarzinom (G1/2) ohne Ulceration und Größe &gt;2cm</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "70;01_magenkarzinom_0245.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es gibt Hinweise auf eine Assoziation zwischen einer gastroösophagogealen Refluxkrankheit (GERD) und der Entstehung eines Adenokarzinoms des Magens (AEG II und III)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1618__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es gibt Hinweise auf eine Assoziation zwischen einer gastroösophagogealen Refluxkrankheit (GERD) und der Entstehung eines Adenokarzinoms des Magens (AEG II und<span class=\"diff_sub\"> AEG</span> III).</div><div nowrap=\"nowrap\">Es gibt Hinweise auf eine Assoziation zwischen einer gastroösophagogealen Refluxkrankheit (GERD) und der Entstehung eines Adenokarzinoms des Magens (AEG II und III).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "71;01_magenkarzinom_0245.tsv;360"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt von der Tumorlokalisation, –ausdehnung und Schwere der Symptomatik und der Vortherapie ab."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1619__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt von der Tumorlokalisation, <span class=\"diff_chg\">Tumor</span>ausdehnung und Schwere der Symptomatik und der Vortherapie ab.</div><div nowrap=\"nowrap\">Die Wahl des palliativen Therapieverfahrens einer symptomatischen Tumorstenose des Magens hängt von der Tumorlokalisation, <span class=\"diff_chg\">–</span>ausdehnung und Schwere der Symptomatik und der Vortherapie ab.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "72;02_kolorektales-karzinom_0010.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es besteht eine positive Korrelation zwischen einem hohen Alkoholkonsum und der Entstehung eines KRK [REF], [REF], [REF], [REF] insbesondere bei Menschen mit geringer Folsäure- und/oder Methioninaufnahme [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1620__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es besteht eine positive Korrelation zwischen einem hohen Alkoholkonsum und der Entstehung eines KRK [REF], [REF], [REF], [REF] insbesondere bei Menschen mit geringer Folsäureaufnahme <span class=\"diff_sub\">und/oder Methioninaufnahme </span>[REF].</div><div nowrap=\"nowrap\">Es besteht eine positive Korrelation zwischen einem hohen Alkoholkonsum und der Entstehung eines KRK [REF], [REF], [REF], [REF] insbesondere bei Menschen mit geringer Folsäure<span class=\"diff_add\">- und/oder Methionin</span>aufnahme [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "73;02_kolorektales-karzinom_0031.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine obere Altersbegrenzung für die Darmkrebs-Vorsorge/-Früherkennung kann bei steigender Lebenserwartung nicht gegeben werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1621__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine obere Altersbegrenzung für die Darmkrebs-Vorsorge/<span class=\"diff_sub\">Darmkrebs</span>-Früherkennung kann bei steigender Lebenserwartung nicht gegeben werden.</div><div nowrap=\"nowrap\">Eine obere Altersbegrenzung für die Darmkrebs-Vorsorge/-Früherkennung kann bei steigender Lebenserwartung nicht gegeben werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "74;02_kolorektales-karzinom_0035.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Personen, die an der Koloskopie- Vorsorge/-Früherkennung entsprechend dieser Richtlinie teilnehmen, erübrigt sich das FOBT-Vorsorge/Früherkennungsverfahren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1622__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Personen, die an der Koloskopie- Vorsorge/<span class=\"diff_sub\">Koloskopie</span>-Früherkennung entsprechend dieser Richtlinie teilnehmen, erübrigt sich das FOBT-Vorsorge/<span class=\"diff_sub\">FOBT-</span>Früherkennungsverfahren.</div><div nowrap=\"nowrap\">Bei Personen, die an der Koloskopie- Vorsorge/-Früherkennung entsprechend dieser Richtlinie teilnehmen, erübrigt sich das FOBT-Vorsorge/Früherkennungsverfahren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "75;02_kolorektales-karzinom_0035.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die komplette qualitätsgesicherte Koloskopie besitzt die höchste Sensitivität und Spezifität für das Auffinden von Karzinomen und Adenomen und sollte daher als Standardverfahren für die KRK-Vorsorge/-Früherkennung eingesetzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1623__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die komplette qualitätsgesicherte Koloskopie besitzt die höchste Sensitivität und Spezifität für das Auffinden von Karzinomen und Adenomen und sollte daher als Standardverfahren für die KRK-Vorsorge/<span class=\"diff_sub\">KRK</span>-Früherkennung eingesetzt werden.</div><div nowrap=\"nowrap\">Die komplette qualitätsgesicherte Koloskopie besitzt die höchste Sensitivität und Spezifität für das Auffinden von Karzinomen und Adenomen und sollte daher als Standardverfahren für die KRK-Vorsorge/-Früherkennung eingesetzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "76;02_kolorektales-karzinom_0040.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Kapsel-Koloskopie sollte nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1624__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Kapsel-Koloskopie sollte nicht für die Darmkrebs-Vorsorge/<span class=\"diff_sub\">Darmkrebs</span>-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div><div nowrap=\"nowrap\">Die Kapsel-Koloskopie sollte nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "77;02_kolorektales-karzinom_0049.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Stuhluntersuchungen auf DNA-Veränderungen sollten nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1625__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Stuhluntersuchungen auf DNA-Veränderungen sollten nicht für die Darmkrebs-Vorsorge/<span class=\"diff_sub\">Darmkrebs</span>-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div><div nowrap=\"nowrap\">Stuhluntersuchungen auf DNA-Veränderungen sollten nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "78;02_kolorektales-karzinom_0051.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der M2-PK Stuhltest sollte nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1626__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der M2-PK Stuhltest sollte nicht für die Darmkrebs-Vorsorge/<span class=\"diff_sub\">Darmkrebs</span>-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div><div nowrap=\"nowrap\">Der M2-PK Stuhltest sollte nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "79;02_kolorektales-karzinom_0053.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die CT-Kolonographie und die MR-Kolonographie sollten nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1627__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die CT-Kolonographie und die MR-Kolonographie sollten nicht für die Darmkrebs-Vorsorge/<span class=\"diff_sub\">Darmkrebs</span>-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div><div nowrap=\"nowrap\">Die CT-Kolonographie und die MR-Kolonographie sollten nicht für die Darmkrebs-Vorsorge/-Früherkennung in der asymptomatischen Bevölkerung eingesetzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "80;02_kolorektales-karzinom_0054.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Untersuchung geht mit einer Strahlenexposition einher, so dass sich der Einsatz bei vorhandenen Alternativmethoden in Deutschland als Früherkennungs-/Vorsorgemethode aufgrund der Strahlenschutzverordnung verbietet (StrlSchV §80)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1628__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Untersuchung geht mit einer Strahlenexposition einher, so dass sich der Einsatz bei vorhandenen Alternativmethoden in Deutschland als Früherkennungs<span class=\"diff_chg\">methode</span>/Vorsorgemethode aufgrund der Strahlenschutzverordnung verbietet (StrlSchV §80).</div><div nowrap=\"nowrap\">Die Untersuchung geht mit einer Strahlenexposition einher, so dass sich der Einsatz bei vorhandenen Alternativmethoden in Deutschland als Früherkennungs<span class=\"diff_chg\">-</span>/Vorsorgemethode aufgrund der Strahlenschutzverordnung verbietet (StrlSchV §80).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "81;02_kolorektales-karzinom_0055.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Anhand der DELBI-Kriterien wurden 2 Leitlinien zur KRK-Vorsorge/-Früherkennung eingeschlossen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1629__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Anhand der DELBI-Kriterien wurden 2 Leitlinien zur KRK-Vorsorge/<span class=\"diff_sub\">KRK</span>-Früherkennung eingeschlossen.</div><div nowrap=\"nowrap\">Anhand der DELBI-Kriterien wurden 2 Leitlinien zur KRK-Vorsorge/-Früherkennung eingeschlossen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "82;02_kolorektales-karzinom_0056.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sowohl FOBT als auch Sigmoidoskopie, Koloskopie und die Kombination aus Sigmoidoskopie und FOBT gelten als kosteneffektiv (im Vergleich zu Vorsorge-/Früherkennungsverfahren anderer Zielkrankheiten)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1630__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sowohl FOBT als auch Sigmoidoskopie, Koloskopie und die Kombination aus Sigmoidoskopie und FOBT gelten als kosteneffektiv (im Vergleich zu Vorsorge<span class=\"diff_chg\">verfahren</span>/Früherkennungsverfahren anderer Zielkrankheiten).</div><div nowrap=\"nowrap\">Sowohl FOBT als auch Sigmoidoskopie, Koloskopie und die Kombination aus Sigmoidoskopie und FOBT gelten als kosteneffektiv (im Vergleich zu Vorsorge<span class=\"diff_chg\">-</span>/Früherkennungsverfahren anderer Zielkrankheiten).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "83;02_kolorektales-karzinom_0062.tsv;29"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten mit stenosierenden Tumoren oder inkompletter Koloskopie aus anderen Gründen konnten in Fallserien mittels CT- [REF], [REF], [REF], [REF] oder MR-Kolonographie [REF], [REF] proximale Tumoren oder Polypen nachgewiesen werden, sodaß gemeinsame Leitlinien von ESGE und ESGAR von 2014 hier den Einsatz der CT-Kolographie empfehlen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1631__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Bei Patienten mit stenosierenden Tumoren oder inkompletter Koloskopie aus anderen Gründen konnten in Fallserien mittels CT-Kolonographie [REF], [REF], [REF], [REF] oder MR-Kolonographie [REF], [REF] proximale Tumoren oder Polypen nachgewiesen werden, sodaß gemeinsame Leitlinien von ESGE und ESGAR von 2014 hier den Einsatz der CT-Kolographie empfehlen [REF].</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Bei Patienten mit stenosierenden Tumoren oder inkompletter Koloskopie aus anderen Gründen konnten in Fallserien mittels CT- [REF], [REF], [REF], [REF] oder MR-Kolonographie [REF], [REF] proximale Tumoren oder Polypen nachgewiesen werden, sodaß gemeinsame Leitlinien von ESGE und ESGAR von 2014 hier den Einsatz der CT-Kolographie empfehlen [REF].</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "84;02_kolorektales-karzinom_0069.tsv;43"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Polypen >2 cm beträgt nach neueren Studien die Rest/Rezidivadenomrate bis zu 20% und mehr [REF], [REF], [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1632__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Polypen &gt;2 cm beträgt nach neueren Studien die Rest<span class=\"diff_sub\">adenomrate</span>/Rezidivadenomrate bis zu 20% und mehr [REF], [REF], [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Bei Polypen &gt;2 cm beträgt nach neueren Studien die Rest/Rezidivadenomrate bis zu 20% und mehr [REF], [REF], [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "85;02_kolorektales-karzinom_0069.tsv;33"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Zangen- versus Schlingenabtragung kleiner Polypen bis 5 mm"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1633__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Zangen<span class=\"diff_chg\">abtragung</span> versus Schlingenabtragung kleiner Polypen bis 5 mm</div><div nowrap=\"nowrap\">- Zangen<span class=\"diff_chg\">-</span> versus Schlingenabtragung kleiner Polypen bis 5 mm</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "86;02_kolorektales-karzinom_0076.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dabei soll die Invasionsfront mit 200-facher Vergrößerung mikroskopiert werden und die Grade 1 mit 0-4; 2 mit 5-9 und 3 mit >9 Buddings oder Tumorzell-Cluster bestimmt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1634__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dabei soll die Invasionsfront mit 200-facher Vergrößerung mikroskopiert werden und die Grade 1 mit 0-4; <span class=\"diff_sub\">Grade </span>2 mit 5-9 und <span class=\"diff_sub\">Grade </span>3 mit &gt;9 Buddings oder Tumorzell-Cluster bestimmt werden.</div><div nowrap=\"nowrap\">Dabei soll die Invasionsfront mit 200-facher Vergrößerung mikroskopiert werden und die Grade 1 mit 0-4; 2 mit 5-9 und 3 mit &gt;9 Buddings oder Tumorzell-Cluster bestimmt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "87;02_kolorektales-karzinom_0076.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ein Tumor-Budding Grad 2 oder 3, d.h. >4 Buddings oder Cluster an der Invasionsfront waren in mehreren Studien ein zusätzlicher Parameter für ein erhöhtes Risiko von Lymphknotenmetastasen [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1635__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ein Tumor-Budding Grad 2 oder<span class=\"diff_sub\"> Grad</span> 3, d.h. &gt;4 Buddings oder Cluster an der Invasionsfront waren in mehreren Studien ein zusätzlicher Parameter für ein erhöhtes Risiko von Lymphknotenmetastasen [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Ein Tumor-Budding Grad 2 oder 3, d.h. &gt;4 Buddings oder Cluster an der Invasionsfront waren in mehreren Studien ein zusätzlicher Parameter für ein erhöhtes Risiko von Lymphknotenmetastasen [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "88;02_kolorektales-karzinom_0079.tsv;25"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ergänzende wichtige Anmerkungen zum Resektions- (R-)Status:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1636__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ergänzende wichtige Anmerkungen zum Resektions<span class=\"diff_chg\">status</span> (R-)Status:</div><div nowrap=\"nowrap\">Ergänzende wichtige Anmerkungen zum Resektions<span class=\"diff_chg\">-</span> (R-)Status:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "89;02_kolorektales-karzinom_0083.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ausnahmen sind nichtneoplastische Polyposiserkrankungen (hyperplastische, juvenile, Peutz-Jeghers und SSA-Polypose) mit erhöhtem Risiko einer malignen Entartung [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1637__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ausnahmen sind nichtneoplastische Polyposiserkrankungen (hyperplastische<span class=\"diff_sub\"> Polypose</span>, juvenile<span class=\"diff_sub\"> Polypose</span>, Peutz-Jeghers <span class=\"diff_sub\">Polypose </span>und SSA-Polypose) mit erhöhtem Risiko einer malignen Entartung [REF].</div><div nowrap=\"nowrap\">Ausnahmen sind nichtneoplastische Polyposiserkrankungen (hyperplastische, juvenile, Peutz-Jeghers und SSA-Polypose) mit erhöhtem Risiko einer malignen Entartung [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "90;02_kolorektales-karzinom_0118.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Beispielhaft ist der Algorithmus für das HNPCC-/Lynch-Syndrom in Abbildung 1 dargestellt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1638__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Beispielhaft ist der Algorithmus für das HNPCC-<span class=\"diff_sub\">Syndrom</span>/Lynch-Syndrom in Abbildung 1 dargestellt.</div><div nowrap=\"nowrap\">Beispielhaft ist der Algorithmus für das HNPCC-/Lynch-Syndrom in Abbildung 1 dargestellt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "91;02_kolorektales-karzinom_0126.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Mikrosatelliteninstabilität lässt sich bei etwa 80% der Tumorgewebe von Patienten, die die Amsterdam I/II-Kriterien erfüllen, nachweisen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1639__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Mikrosatelliteninstabilität lässt sich bei etwa 80% der Tumorgewebe von Patienten, die die Amsterdam I<span class=\"diff_sub\">-Kriterien</span>/<span class=\"diff_sub\">Amsterdam </span>II-Kriterien erfüllen, nachweisen.</div><div nowrap=\"nowrap\">Eine Mikrosatelliteninstabilität lässt sich bei etwa 80% der Tumorgewebe von Patienten, die die Amsterdam I/II-Kriterien erfüllen, nachweisen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "92;02_kolorektales-karzinom_0144.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine familiäre Häufung (mindestens 2 Betroffene mit Magenkarzinomen) ließ sich in nur 26% der MLH1- und MSH2-Mutationsträger nachweisen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1640__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine familiäre Häufung (mindestens 2 Betroffene mit Magenkarzinomen) ließ sich in nur 26% der MLH1-<span class=\"diff_sub\">Mutationsträger</span> und MSH2-Mutationsträger nachweisen [REF].</div><div nowrap=\"nowrap\">Eine familiäre Häufung (mindestens 2 Betroffene mit Magenkarzinomen) ließ sich in nur 26% der MLH1- und MSH2-Mutationsträger nachweisen [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "93;02_kolorektales-karzinom_0159.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Nachweis von Duodenal-/Papillenadenomen ist die Indikation zur endoskopischen Polypektomie zu überprüfen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1641__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Nachweis von Duodenal<span class=\"diff_chg\">adenomen</span>/Papillenadenomen ist die Indikation zur endoskopischen Polypektomie zu überprüfen.</div><div nowrap=\"nowrap\">Bei Nachweis von Duodenal<span class=\"diff_chg\">-</span>/Papillenadenomen ist die Indikation zur endoskopischen Polypektomie zu überprüfen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "94;02_kolorektales-karzinom_0179.tsv;42"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei einigen Patienten mit HMPS wurden Mutationen im PTEN- oder BMPR1A-Gen nachgewiesen, diese Fälle sollten als (atypische) Varianten des Cowden-Syndroms bzw. der FJP betrachtet und entsprechend behandelt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1642__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei einigen Patienten mit HMPS wurden Mutationen im PTEN-<span class=\"diff_chg\">Gen oder</span> BMPR1A-Gen nachgewiesen, diese Fälle sollten als (atypische) Varianten des Cowden-Syndroms bzw. der FJP betrachtet und entsprechend behandelt werden.</div><div nowrap=\"nowrap\">Bei einigen Patienten mit HMPS wurden Mutationen im PTEN-<span class=\"diff_chg\"> oder</span> BMPR1A-Gen nachgewiesen, diese Fälle sollten als (atypische) Varianten des Cowden-Syndroms bzw. der FJP betrachtet und entsprechend behandelt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "95;02_kolorektales-karzinom_0208.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten vor Resektion von Lebermetastasen eines KRK hat eine ergänzende PET/PET-CT keinen Einfluss auf das krankheitsfreie oder Gesamtüberleben des Patienten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1643__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten vor Resektion von Lebermetastasen eines KRK hat eine ergänzende PET/PET-CT keinen Einfluss auf das krankheitsfreie <span class=\"diff_sub\">Überleben </span>oder Gesamtüberleben des Patienten.</div><div nowrap=\"nowrap\">Bei Patienten vor Resektion von Lebermetastasen eines KRK hat eine ergänzende PET/PET-CT keinen Einfluss auf das krankheitsfreie oder Gesamtüberleben des Patienten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "96;02_kolorektales-karzinom_0244.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei High-Grade-Tumoren (G3/4) ist ein größerer Sicherheitsabstand anzustreben."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1644__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei High-Grade-Tumoren (G3/<span class=\"diff_sub\">G</span>4) ist ein größerer Sicherheitsabstand anzustreben.</div><div nowrap=\"nowrap\">Bei High-Grade-Tumoren (G3/4) ist ein größerer Sicherheitsabstand anzustreben.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "97;02_kolorektales-karzinom_0270.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei T1-High-Risk-Karzinomen (G3/4 u./o. Lymphgefäßinvasion) und bei T2-Karzinomen liegt das Auftreten von Lymphknotenmetastasen bei 10 – 20%, sodass die alleinige lokale Exzision nicht empfohlen werden kann."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1645__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei T1-High-Risk-Karzinomen (G3/<span class=\"diff_sub\">G</span>4 u./o. Lymphgefäßinvasion) und bei T2-Karzinomen liegt das Auftreten von Lymphknotenmetastasen bei 10 – 20%, sodass die alleinige lokale Exzision nicht empfohlen werden kann.</div><div nowrap=\"nowrap\">Bei T1-High-Risk-Karzinomen (G3/4 u./o. Lymphgefäßinvasion) und bei T2-Karzinomen liegt das Auftreten von Lymphknotenmetastasen bei 10 – 20%, sodass die alleinige lokale Exzision nicht empfohlen werden kann.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "98;02_kolorektales-karzinom_0274.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Inzwischen wurden aber reife Langzeitergebnissen der britischen CLASICC-Studie publiziert, die trotz initial problematischer Surrogat-Parameter in der Untergruppe der Rektumkarzinome [REF] die onkologische Sicherheit der laparoskopischen Chirurgie sowohl für das Kolon- als auch das Rektumkarzinom belegen konnten [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1646__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Inzwischen wurden aber reife Langzeitergebnissen der britischen CLASICC-Studie publiziert, die trotz initial problematischer Surrogat-Parameter in der Untergruppe der Rektumkarzinome [REF] die onkologische Sicherheit der laparoskopischen Chirurgie sowohl für das Kolon<span class=\"diff_chg\">karzinom als auch das</span> Rektumkarzinom belegen konnten [REF].</div><div nowrap=\"nowrap\">Inzwischen wurden aber reife Langzeitergebnissen der britischen CLASICC-Studie publiziert, die trotz initial problematischer Surrogat-Parameter in der Untergruppe der Rektumkarzinome [REF] die onkologische Sicherheit der laparoskopischen Chirurgie sowohl für das Kolon<span class=\"diff_chg\">- als auch das</span> Rektumkarzinom belegen konnten [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "99;02_kolorektales-karzinom_0281.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ein Ileus in Verbindung mit einem Rektumkarzinom geht in der Regel mit weit fortgeschrittenen Karzinomen einher, so dass fast immer eine neoadjuvante Radio-/Chemotherapie anzustreben ist."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1647__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ein Ileus in Verbindung mit einem Rektumkarzinom geht in der Regel mit weit fortgeschrittenen Karzinomen einher, so dass fast immer eine neoadjuvante Radio<span class=\"diff_chg\">therapie</span>/Chemotherapie anzustreben ist.</div><div nowrap=\"nowrap\">Ein Ileus in Verbindung mit einem Rektumkarzinom geht in der Regel mit weit fortgeschrittenen Karzinomen einher, so dass fast immer eine neoadjuvante Radio<span class=\"diff_chg\">-</span>/Chemotherapie anzustreben ist.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "100;02_kolorektales-karzinom_0302.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Zusammenhang ist in Kohortenstudien immer wieder gezeigt worden, so an 3411 Patienten im Stadium II und III des sog."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1648__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Zusammenhang ist in Kohortenstudien immer wieder gezeigt worden, so an 3411 Patienten im Stadium II und <span class=\"diff_sub\">Stadium </span>III des sog.</div><div nowrap=\"nowrap\">Der Zusammenhang ist in Kohortenstudien immer wieder gezeigt worden, so an 3411 Patienten im Stadium II und III des sog.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "101;02_kolorektales-karzinom_0312.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Vorsorge- / Früherkennungs-Verfahren beinhalten die Beantwortung einiger einfacher gezielter Fragen durch den Patienten, entweder im persönlichen Kontakt oder mit Hilfe eines Fragebogens."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1649__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Vorsorge-<span class=\"diff_sub\">Verfahren</span> / Früherkennungs-Verfahren beinhalten die Beantwortung einiger einfacher gezielter Fragen durch den Patienten, entweder im persönlichen Kontakt oder mit Hilfe eines Fragebogens.</div><div nowrap=\"nowrap\">Vorsorge- / Früherkennungs-Verfahren beinhalten die Beantwortung einiger einfacher gezielter Fragen durch den Patienten, entweder im persönlichen Kontakt oder mit Hilfe eines Fragebogens.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "102;02_kolorektales-karzinom_0312.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Neuere Studien sprechen für die Wirksamkeit von Vorsorge- / Früherkennungs-basierten psychosozialen Interventionen bei Tumorpatienten [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1650__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Neuere Studien sprechen für die Wirksamkeit von Vorsorge-<span class=\"diff_sub\">basierten</span> / Früherkennungs-basierten psychosozialen Interventionen bei Tumorpatienten [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Neuere Studien sprechen für die Wirksamkeit von Vorsorge- / Früherkennungs-basierten psychosozialen Interventionen bei Tumorpatienten [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "103;02_kolorektales-karzinom_0320.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Meta-Analysen und gepoolte Analysen (Gill et al.) bei 3.303 Patienten mit einem Stadium II und III Kolonkarzinom konnten eindeutig zeigen, dass für Patienten mit einer Lymphknoten positiven Erkrankung (Stadium III) die Durchführung einer adjuvanten Chemotherapie zu einer signifikanten Prognose-verbesserung im Vergleich zur alleinigen Operationen führt [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1651__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Meta-Analysen und gepoolte Analysen (Gill et al.) bei 3.303 Patienten mit einem Stadium II und <span class=\"diff_chg\">Stadium III</span> Kolonkarzinom konnten eindeutig zeigen, dass für Patienten mit einer Lymphknoten positiven Erkrankung (Stadium III) die Durchführung einer adjuvanten Chemotherapie zu einer signifikanten Prognose-verbesserung im Vergleich zur alleinigen Operationen führt [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Meta-Analysen und gepoolte Analysen (Gill et al.) bei 3.303 Patienten mit einem Stadium II und <span class=\"diff_chg\">III</span> Kolonkarzinom konnten eindeutig zeigen, dass für Patienten mit einer Lymphknoten positiven Erkrankung (Stadium III) die Durchführung einer adjuvanten Chemotherapie zu einer signifikanten Prognose-verbesserung im Vergleich zur alleinigen Operationen führt [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "104;02_kolorektales-karzinom_0323.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Stadium II sollte in ausgewählten Risikosituationen (T4, Tumorperforation/-einriss, Operation unter Notfallbedingungen, Anzahl untersuchter Lymphknoten zu gering) eine adjuvante Chemotherapie erwogen werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1652__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Stadium II sollte in ausgewählten Risikosituationen (T4, Tumorperforation/<span class=\"diff_chg\">Tumor</span>einriss, Operation unter Notfallbedingungen, Anzahl untersuchter Lymphknoten zu gering) eine adjuvante Chemotherapie erwogen werden.</div><div nowrap=\"nowrap\">Im Stadium II sollte in ausgewählten Risikosituationen (T4, Tumorperforation/<span class=\"diff_chg\">-</span>einriss, Operation unter Notfallbedingungen, Anzahl untersuchter Lymphknoten zu gering) eine adjuvante Chemotherapie erwogen werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "105;02_kolorektales-karzinom_0324.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dieser Unterschied zeigte sich sowohl im Stadium I/II als auch im Stadium III [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1653__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dieser Unterschied zeigte sich sowohl im Stadium I/Stadium <span class=\"diff_sub\">II als auch im Stadium </span>III [REF].</div><div nowrap=\"nowrap\">Dieser Unterschied zeigte sich sowohl im Stadium I/<span class=\"diff_add\">II als auch im </span>Stadium III [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "106;02_kolorektales-karzinom_0324.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Le Voyer (INT-0089, n=3.411) untersuchte Patienten im Stadium Dukes B2 oder Dukes C mit adjuvanter Therapie mit 5-FU, Folinsäure (FS) und/oder Levamisol."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1654__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Le Voyer (INT-0089, n=3.411) untersuchte Patienten im Stadium Dukes B2 oder<span class=\"diff_sub\"> Stadium</span> Dukes C mit adjuvanter Therapie mit 5-FU, Folinsäure (FS) und/oder Levamisol.</div><div nowrap=\"nowrap\">Le Voyer (INT-0089, n=3.411) untersuchte Patienten im Stadium Dukes B2 oder Dukes C mit adjuvanter Therapie mit 5-FU, Folinsäure (FS) und/oder Levamisol.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "107;02_kolorektales-karzinom_0327.tsv;26"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch in einer spanischen Studie (Stadium II/III) und in einer koreanischen Studie (Stadium II) profitierten Patienten mit MSI Tumoren nicht von einer adjuvanten 5-FU Therapie [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1655__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch in einer spanischen Studie (Stadium II/<span class=\"diff_sub\">Stadium </span>III) und in einer koreanischen Studie (Stadium II) profitierten Patienten mit MSI Tumoren nicht von einer adjuvanten 5-FU Therapie [REF] [REF].</div><div nowrap=\"nowrap\">Auch in einer spanischen Studie (Stadium II/III) und in einer koreanischen Studie (Stadium II) profitierten Patienten mit MSI Tumoren nicht von einer adjuvanten 5-FU Therapie [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "108;02_kolorektales-karzinom_0327.tsv;36"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch im Stadium II zeigte sich eine deutliche Verbesserung des 5-J.-DFS bei CDX2-positiven (80-87 %) vs. negativen Tumoren (49-51 %)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1656__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch im Stadium II zeigte sich eine deutliche Verbesserung des 5-J.-DFS bei CDX2-positiven (80-87 %) vs. <span class=\"diff_sub\">CDX2-</span>negativen Tumoren (49-51 %).</div><div nowrap=\"nowrap\">Auch im Stadium II zeigte sich eine deutliche Verbesserung des 5-J.-DFS bei CDX2-positiven (80-87 %) vs. negativen Tumoren (49-51 %).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "109;02_kolorektales-karzinom_0327.tsv;32"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Unter FOLFOX4 konnte kein signifikant verbessertes Überleben in der dMMR-Gruppe (Stadium II/III) nachgewiesen werden (HR 0,41; 95%CI:0,16-1,07) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1657__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Unter FOLFOX4 konnte kein signifikant verbessertes Überleben in der dMMR-Gruppe (Stadium II/<span class=\"diff_sub\">Stadium </span>III) nachgewiesen werden (HR 0,41; 95%CI:0,16-1,07) [REF].</div><div nowrap=\"nowrap\">Unter FOLFOX4 konnte kein signifikant verbessertes Überleben in der dMMR-Gruppe (Stadium II/III) nachgewiesen werden (HR 0,41; 95%CI:0,16-1,07) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "110;02_kolorektales-karzinom_0327.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Differenzierungsgrad wird in manchen Arbeiten sowohl im Stadium III [REF], [REF] als auch im Stadium II und III [REF] als ein unabhängiger prognostischer Faktor gewertet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1658__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Differenzierungsgrad wird in manchen Arbeiten sowohl im Stadium III [REF], [REF] als auch im Stadium II und <span class=\"diff_sub\">Stadium </span>III [REF] als ein unabhängiger prognostischer Faktor gewertet.</div><div nowrap=\"nowrap\">Der Differenzierungsgrad wird in manchen Arbeiten sowohl im Stadium III [REF], [REF] als auch im Stadium II und III [REF] als ein unabhängiger prognostischer Faktor gewertet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "111;02_kolorektales-karzinom_0327.tsv;27"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Gegensatz dazu führte die adjuvante Chemotherapie in einer retrospektiven australischen Studie zu einer Prognoseverbesserung auch bei MSI Tumoren [REF] Auch in der PETACC-3-Studie wurde die Prognose von Pat. mit MSI-H-Kolonkarzinomen nicht durch den Therapiearm beeinflusst, d.h. in der Gruppe der 5-FU-therapierten Patienten behielten MSI-H-Tumore ihren prog¬nostischen Vorteil im Vergleich zu MSI-L/S-Tumoren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1659__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Gegensatz dazu führte die adjuvante Chemotherapie in einer retrospektiven australischen Studie zu einer Prognoseverbesserung auch bei MSI Tumoren [REF] Auch in der PETACC-3-Studie wurde die Prognose von Pat. mit MSI-H-Kolonkarzinomen nicht durch den Therapiearm beeinflusst, d.h. in der Gruppe der 5-FU-therapierten Patienten behielten MSI-H-Tumore ihren prog¬nostischen Vorteil im Vergleich zu MSI-L-Tumoren<span class=\"diff_sub\">/MSI-S-Tumoren</span>.</div><div nowrap=\"nowrap\">Im Gegensatz dazu führte die adjuvante Chemotherapie in einer retrospektiven australischen Studie zu einer Prognoseverbesserung auch bei MSI Tumoren [REF] Auch in der PETACC-3-Studie wurde die Prognose von Pat. mit MSI-H-Kolonkarzinomen nicht durch den Therapiearm beeinflusst, d.h. in der Gruppe der 5-FU-therapierten Patienten behielten MSI-H-Tumore ihren prog¬nostischen Vorteil im Vergleich zu MSI-L<span class=\"diff_add\">/S</span>-Tumoren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "112;02_kolorektales-karzinom_0327.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer ergänzenden Studie der PETACC-3-Studie (5-FU vs. FOLFIRI) wird analysiert, welchen Einfluss der Mikrosatellitenstatus auf die Prognose von Stadium-II/III-Tumoren hat (n=1.254 Pat.)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1660__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer ergänzenden Studie der PETACC-3-Studie (5-FU vs. FOLFIRI) wird analysiert, welchen Einfluss der Mikrosatellitenstatus auf die Prognose von Stadium-II<span class=\"diff_sub\">-Tumoren</span>/<span class=\"diff_sub\">Stadium-</span>III-Tumoren hat (n=1.254 Pat.).</div><div nowrap=\"nowrap\">In einer ergänzenden Studie der PETACC-3-Studie (5-FU vs. FOLFIRI) wird analysiert, welchen Einfluss der Mikrosatellitenstatus auf die Prognose von Stadium-II/III-Tumoren hat (n=1.254 Pat.).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "113;02_kolorektales-karzinom_0330.tsv;19"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das krankheitsfreie Überleben nach 4 Jahren betrug 73,2% für die FLOX-Gruppe und 67,0% für die 5-FU/FS–Behandelten [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1661__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das krankheitsfreie Überleben nach 4 Jahren betrug 73,2% für die FLOX-Gruppe und 67,0% für die 5-FU<span class=\"diff_sub\">-Behandelten</span>/FS–Behandelten [REF].</div><div nowrap=\"nowrap\">Das krankheitsfreie Überleben nach 4 Jahren betrug 73,2% für die FLOX-Gruppe und 67,0% für die 5-FU/FS–Behandelten [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "114;02_kolorektales-karzinom_0330.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In die NSABP-Studie C-07 wurden 2407 Patienten im Stadium II (28,6%) oder im Stadium III eingeschlossen und erhielten entweder das Roswell-Park-Schema mit wöchentlicher 5-FU/FS Bolusgabe (3 Zyklen à jeweils 8 Wochen) oder das gleiche 5-FU/FS-Schema mit Oxaliplatin 85 mg/m2 in Woche 1, 3 und 5 im achtwöchentlichen Rhythmus (FLOX-Schema)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1662__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In die NSABP-Studie C-07 wurden 2407 Patienten im Stadium II (28,6%) oder im Stadium III eingeschlossen und erhielten entweder das Roswell-Park-Schema mit wöchentlicher 5-FU/FS Bolusgabe (3 Zyklen à jeweils 8 Wochen) oder das gleiche 5-FU<span class=\"diff_sub\">-Schema</span>/FS-Schema mit Oxaliplatin 85 mg/m2 in Woche 1, 3 und 5 im achtwöchentlichen Rhythmus (FLOX-Schema).</div><div nowrap=\"nowrap\">In die NSABP-Studie C-07 wurden 2407 Patienten im Stadium II (28,6%) oder im Stadium III eingeschlossen und erhielten entweder das Roswell-Park-Schema mit wöchentlicher 5-FU/FS Bolusgabe (3 Zyklen à jeweils 8 Wochen) oder das gleiche 5-FU/FS-Schema mit Oxaliplatin 85 mg/m2 in Woche 1, 3 und 5 im achtwöchentlichen Rhythmus (FLOX-Schema).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "115;02_kolorektales-karzinom_0336.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der großen QUASAR 2 Studie (Kerr) wurden zwei Therapiegruppen miteinander verglichen nach kurativer Therapie eines Stadium II mit Hochrisikocharakteristika oder III Kolonkarzinoms (Capecitabine versus Capecitabine plus Bevacizumab)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1663__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der großen QUASAR 2 Studie (Kerr) wurden zwei Therapiegruppen miteinander verglichen nach kurativer Therapie eines Stadium II mit Hochrisikocharakteristika oder <span class=\"diff_chg\">Stadium III</span> Kolonkarzinoms (Capecitabine versus Capecitabine plus Bevacizumab).</div><div nowrap=\"nowrap\">In der großen QUASAR 2 Studie (Kerr) wurden zwei Therapiegruppen miteinander verglichen nach kurativer Therapie eines Stadium II mit Hochrisikocharakteristika oder <span class=\"diff_chg\">III</span> Kolonkarzinoms (Capecitabine versus Capecitabine plus Bevacizumab).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "116;02_kolorektales-karzinom_0338.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In die MOSAIC Studie wurden 2.246 Patienten nach kurativer Resektion eines Kolonkarzinoms im Stadium II (N=899) oder III aufgenommen und postoperativ entweder mit LV5FU2 oder FOLFOX4 für 12 Zyklen adjuvant behandelt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1664__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In die MOSAIC Studie wurden 2.246 Patienten nach kurativer Resektion eines Kolonkarzinoms im Stadium II (N=899) oder <span class=\"diff_chg\">Stadium III</span> aufgenommen und postoperativ entweder mit LV5FU2 oder FOLFOX4 für 12 Zyklen adjuvant behandelt.</div><div nowrap=\"nowrap\">In die MOSAIC Studie wurden 2.246 Patienten nach kurativer Resektion eines Kolonkarzinoms im Stadium II (N=899) oder <span class=\"diff_chg\">III</span> aufgenommen und postoperativ entweder mit LV5FU2 oder FOLFOX4 für 12 Zyklen adjuvant behandelt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "117;02_kolorektales-karzinom_0339.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei niedrigem Rezidivrisiko (T1-3 N1) sollte deshalb eine 3-monatige oxaliplatinhaltige Therapie nach dem CAPOX/XELOX-Schema durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1665__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei niedrigem Rezidivrisiko (T1-3 N1) sollte deshalb eine 3-monatige oxaliplatinhaltige Therapie nach dem CAPOX<span class=\"diff_sub\">-Schema</span>/XELOX-Schema durchgeführt werden.</div><div nowrap=\"nowrap\">Bei niedrigem Rezidivrisiko (T1-3 N1) sollte deshalb eine 3-monatige oxaliplatinhaltige Therapie nach dem CAPOX/XELOX-Schema durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "118;02_kolorektales-karzinom_0341.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es muss betont werden, dass keine Randomisation zwischen einer CAPOX- oder FOLFOX-Therapie stattfand."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1666__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es muss betont werden, dass keine Randomisation zwischen einer CAPOX-<span class=\"diff_sub\">Therapie</span> oder FOLFOX-Therapie stattfand.</div><div nowrap=\"nowrap\">Es muss betont werden, dass keine Randomisation zwischen einer CAPOX- oder FOLFOX-Therapie stattfand.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "119;02_kolorektales-karzinom_0341.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Grad 3/4-Neurotoxizität trat signifikant seltener nach 3 als nach 6 Monaten auf (FOLFOX: 3 % vs. 16 %; CAPOX: 3 % vs. 9 %)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1667__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Grad 3<span class=\"diff_sub\">-Neurotoxizität</span>/<span class=\"diff_sub\">Grad </span>4-Neurotoxizität trat signifikant seltener nach 3 als nach 6 Monaten auf (FOLFOX: 3 % vs. 16 %; CAPOX: 3 % vs. 9 %).</div><div nowrap=\"nowrap\">Eine Grad 3/4-Neurotoxizität trat signifikant seltener nach 3 als nach 6 Monaten auf (FOLFOX: 3 % vs. 16 %; CAPOX: 3 % vs. 9 %).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "120;02_kolorektales-karzinom_0343.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für Patienten mit tiefsitzenden T1N0-high-risk (G3/4, L1, V1, Durchmesser größer 3 cm, sm3) oder T2N0-Tumoren, die eine Exstirpation ablehnen, ist die Radio(chemo-) therapie, gefolgt von lokaler Exzision/transanaler endoskopischer Mikrochirurgie oder einer wait-and-see Strategie bei klinisch kompletter Remission eine Behandlungsoption [REF], [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1668__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für Patienten mit tiefsitzenden T1N0-high-risk (G3/<span class=\"diff_sub\">G</span>4, L1, V1, Durchmesser größer 3 cm, sm3) oder T2N0-Tumoren, die eine Exstirpation ablehnen, ist die Radio(chemo-) therapie, gefolgt von lokaler Exzision/transanaler endoskopischer Mikrochirurgie oder einer wait-and-see Strategie bei klinisch kompletter Remission eine Behandlungsoption [REF], [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Für Patienten mit tiefsitzenden T1N0-high-risk (G3/4, L1, V1, Durchmesser größer 3 cm, sm3) oder T2N0-Tumoren, die eine Exstirpation ablehnen, ist die Radio(chemo-) therapie, gefolgt von lokaler Exzision/transanaler endoskopischer Mikrochirurgie oder einer wait-and-see Strategie bei klinisch kompletter Remission eine Behandlungsoption [REF], [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "121;02_kolorektales-karzinom_0344.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In den UICC-Stadien II und III (cT3/4 und/oder cN+) soll bei Tumoren des unteren und mittleren Rektumdrittels eine neoadjuvante Radiochemotherapie oder Kurzzeit-Radiotherapie erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1669__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In den UICC-Stadien II und <span class=\"diff_sub\">UICC-Stadien </span>III (cT3/<span class=\"diff_sub\">cT</span>4 und/oder cN+) soll bei Tumoren des unteren und mittleren Rektumdrittels eine neoadjuvante Radiochemotherapie oder Kurzzeit-Radiotherapie erfolgen.</div><div nowrap=\"nowrap\">In den UICC-Stadien II und III (cT3/4 und/oder cN+) soll bei Tumoren des unteren und mittleren Rektumdrittels eine neoadjuvante Radiochemotherapie oder Kurzzeit-Radiotherapie erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "122;02_kolorektales-karzinom_0346.tsv;19"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sensitivität 77%, 57%, 79%, Spezifität 76%, 80%, 76%, [REF] wird bei cT1/2-Tumoren mit bildgebend fraglichen cN+ (formal also UICC-Stadium III) die primäre Operation als sinnvolle Option erachtet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1670__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sensitivität 77%, 57%, 79%, Spezifität 76%, 80%, 76%, [REF] wird bei cT1<span class=\"diff_sub\">-Tumoren</span>/<span class=\"diff_sub\">cT</span>2-Tumoren mit bildgebend fraglichen cN+ (formal also UICC-Stadium III) die primäre Operation als sinnvolle Option erachtet.</div><div nowrap=\"nowrap\">Sensitivität 77%, 57%, 79%, Spezifität 76%, 80%, 76%, [REF] wird bei cT1/2-Tumoren mit bildgebend fraglichen cN+ (formal also UICC-Stadium III) die primäre Operation als sinnvolle Option erachtet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "123;02_kolorektales-karzinom_0348.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die OCUM-Studiengruppe untersucht eine risikobasierte Indikationsstellung zur präoperativen Radiochemotherapie, die im Rahmen dieser nicht-randomisierten, prospektiven Beobachtungsstudie für Tumore >/= 6 cm ab Anokutanlinie unabhängig von der T- und N-Kategorie nur bei mrCRM+ Konstellation durchgeführt wird, während Patienten im unteren Drittel (<6 cm) ab einer T3-Kategorie neoadjuvant behandelt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1671__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die OCUM-Studiengruppe untersucht eine risikobasierte Indikationsstellung zur präoperativen Radiochemotherapie, die im Rahmen dieser nicht-randomisierten, prospektiven Beobachtungsstudie für Tumore &gt;/= 6 cm ab Anokutanlinie unabhängig von der T-<span class=\"diff_chg\">Kategorie und</span> N-Kategorie nur bei mrCRM+ Konstellation durchgeführt wird, während Patienten im unteren Drittel (&lt;6 cm) ab einer T3-Kategorie neoadjuvant behandelt werden.</div><div nowrap=\"nowrap\">Die OCUM-Studiengruppe untersucht eine risikobasierte Indikationsstellung zur präoperativen Radiochemotherapie, die im Rahmen dieser nicht-randomisierten, prospektiven Beobachtungsstudie für Tumore &gt;/= 6 cm ab Anokutanlinie unabhängig von der T-<span class=\"diff_chg\"> und</span> N-Kategorie nur bei mrCRM+ Konstellation durchgeführt wird, während Patienten im unteren Drittel (&lt;6 cm) ab einer T3-Kategorie neoadjuvant behandelt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "124;02_kolorektales-karzinom_0350.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei einer Risikokonstellation im oberen Rektumdrittel (z.B. T4, mrCRM+, bildgebend eindeutiger und ausgedehnter Lymphknotenbefall) kann eine präoperative Radio-/ Radiochemotherapie erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1672__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei einer Risikokonstellation im oberen Rektumdrittel (z.B. T4, mrCRM+, bildgebend eindeutiger und ausgedehnter Lymphknotenbefall) kann eine präoperative Radio<span class=\"diff_chg\">therapie</span>/ Radiochemotherapie erfolgen.</div><div nowrap=\"nowrap\">Bei einer Risikokonstellation im oberen Rektumdrittel (z.B. T4, mrCRM+, bildgebend eindeutiger und ausgedehnter Lymphknotenbefall) kann eine präoperative Radio<span class=\"diff_chg\">-</span>/ Radiochemotherapie erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "125;02_kolorektales-karzinom_0357.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die neoadjuvante 5-Fluorouracil- oder Capecitabin-basierte Radiochemotherapie unter Einschluss von Oxaliplatin zeigte in einer Vielzahl von Phase II-Studien pCR-Raten bis zu 30% (Übersicht: [REF] )."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1673__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die neoadjuvante 5-Fluorouracil-<span class=\"diff_sub\">basierte</span> oder Capecitabin-basierte Radiochemotherapie unter Einschluss von Oxaliplatin zeigte in einer Vielzahl von Phase II-Studien pCR-Raten bis zu 30% (Übersicht: [REF] ).</div><div nowrap=\"nowrap\">Die neoadjuvante 5-Fluorouracil- oder Capecitabin-basierte Radiochemotherapie unter Einschluss von Oxaliplatin zeigte in einer Vielzahl von Phase II-Studien pCR-Raten bis zu 30% (Übersicht: [REF] ).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "126;02_kolorektales-karzinom_0367.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In Phase III-Studien aus den siebziger und achtziger Jahren des 20. Jahrhunderts zur adjuvanten, multimodalen Therapie des Rektumkarzinoms im UICC-Stadium II und III (pT3-4 und/oder pN+, bis 12 cm ab Anokutanlinie) konnte durch Hinzunahme einer 5-Fluorouracil-basierten simultanen und adjuvanten Chemotherapie zu einer postoperativen Bestrahlung sowohl die Lokalrezidivrate gesenkt (absolute Differenz: 10-15%) als auch das Gesamtüberleben im Vergleich zur alleinigen Operation oder zur unimodalen Adjuvanztherapie (absolute Differenz: 5-15%) verbessert werden [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1674__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In Phase III-Studien aus den siebziger und achtziger Jahren des 20. Jahrhunderts zur adjuvanten, multimodalen Therapie des Rektumkarzinoms im UICC-Stadium II und <span class=\"diff_chg\">UICC-Stadium III</span> (pT3-4 und/oder pN+, bis 12 cm ab Anokutanlinie) konnte durch Hinzunahme einer 5-Fluorouracil-basierten simultanen und adjuvanten Chemotherapie zu einer postoperativen Bestrahlung sowohl die Lokalrezidivrate gesenkt (absolute Differenz: 10-15%) als auch das Gesamtüberleben im Vergleich zur alleinigen Operation oder zur unimodalen Adjuvanztherapie (absolute Differenz: 5-15%) verbessert werden [REF].</div><div nowrap=\"nowrap\">In Phase III-Studien aus den siebziger und achtziger Jahren des 20. Jahrhunderts zur adjuvanten, multimodalen Therapie des Rektumkarzinoms im UICC-Stadium II und <span class=\"diff_chg\">III</span> (pT3-4 und/oder pN+, bis 12 cm ab Anokutanlinie) konnte durch Hinzunahme einer 5-Fluorouracil-basierten simultanen und adjuvanten Chemotherapie zu einer postoperativen Bestrahlung sowohl die Lokalrezidivrate gesenkt (absolute Differenz: 10-15%) als auch das Gesamtüberleben im Vergleich zur alleinigen Operation oder zur unimodalen Adjuvanztherapie (absolute Differenz: 5-15%) verbessert werden [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "127;02_kolorektales-karzinom_0367.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine gepoolten Subgruppen-Analyse von fünf dieser frühen nordamerikanischen Studien legte außerdem nahe, dass insbesondere Patienten mit pT1-2N1- sowie pT3N0-Tumoren nach R0-Resektion von der zusätzlichen Bestrahlung nicht profitieren [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1675__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine gepoolten Subgruppen-Analyse von fünf dieser frühen nordamerikanischen Studien legte außerdem nahe, dass insbesondere Patienten mit pT1-2N1-<span class=\"diff_sub\">Tumoren</span> sowie pT3N0-Tumoren nach R0-Resektion von der zusätzlichen Bestrahlung nicht profitieren [REF].</div><div nowrap=\"nowrap\">Eine gepoolten Subgruppen-Analyse von fünf dieser frühen nordamerikanischen Studien legte außerdem nahe, dass insbesondere Patienten mit pT1-2N1- sowie pT3N0-Tumoren nach R0-Resektion von der zusätzlichen Bestrahlung nicht profitieren [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "128;02_kolorektales-karzinom_0367.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zum Stellenwert der adjuvanten Radiochemotherapie bei Patienten im UICC-Stadium II und III liegen seit Etablierung der neoadjuvanten Radio-/Radiochemotherapie keine modernen Studien mit qualitätsgesicherter TME-Chirurgie vor."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1676__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Zum Stellenwert der adjuvanten Radiochemotherapie bei Patienten im UICC-Stadium II und UICC-Stadium III liegen seit Etablierung der neoadjuvanten Radiotherapie/Radiochemotherapie keine modernen Studien mit qualitätsgesicherter TME-Chirurgie vor.</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Zum Stellenwert der adjuvanten Radiochemotherapie bei Patienten im UICC-Stadium II und III liegen seit Etablierung der neoadjuvanten Radio-/Radiochemotherapie keine modernen Studien mit qualitätsgesicherter TME-Chirurgie vor.</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "129;02_kolorektales-karzinom_0367.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Da die postoperative Radiochemotherapie weniger effektiv sowie deutlich nebenwirkungsreicher ist als die präoperative (siehe Hintergrundtext zu 8.18. [REF], ist das Nutzen-/Risikoverhältnis der postoperativen Radiochemotherapie bei strikter Anwendung der Prinzipien der TME nicht ausreichend geklärt [REF]. Eine generelle Empfehlung zur postoperativen Radiochemotherapie für alle Patienten mit Tumoren im UICC-Stadium II und III kann somit nicht erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1677__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Da die postoperative Radiochemotherapie weniger effektiv sowie deutlich nebenwirkungsreicher ist als die präoperative (siehe Hintergrundtext zu 8.18. [REF], ist das Nutzenverhältnis<span class=\"diff_chg\">/Risikoverhältnis der postoperativen Radiochemotherapie</span> bei strikter Anwendung der Prinzipien der TME nicht ausreichend geklärt [REF]. Eine generelle Empfehlung zur postoperativen Radiochemotherapie für alle Patienten mit Tumoren im UICC-Stadium II und <span class=\"diff_chg\">UICC-Stadium III kann somit nicht</span> erfolgen.</div><div nowrap=\"nowrap\">Da die postoperative Radiochemotherapie weniger effektiv sowie deutlich nebenwirkungsreicher ist als die präoperative (siehe Hintergrundtext zu 8.18. [REF], ist das Nutzen<span class=\"diff_add\">-/Risiko</span>verhältnis<span class=\"diff_chg\"> der postoperativen Radiochemotherapie</span> bei strikter Anwendung der Prinzipien der TME nicht ausreichend geklärt [REF]. Eine generelle Empfehlung zur postoperativen Radiochemotherapie für alle Patienten mit Tumoren im UICC-Stadium II und <span class=\"diff_chg\">III kann somit nicht</span> erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "130;02_kolorektales-karzinom_0368.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wird nach primärer R0-Resektion im Stadium II/III keine adjuvante Radiochemotherapie durchgeführt, sollte eine adjuvante Chemotherapie analog zu den Indikationskriterien und Schemata beim Kolonkarzinom erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1678__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wird nach primärer R0-Resektion im Stadium II/<span class=\"diff_chg\">Stadium III keine</span> adjuvante Radiochemotherapie durchgeführt, sollte eine adjuvante Chemotherapie analog zu den Indikationskriterien und Schemata beim Kolonkarzinom erfolgen.</div><div nowrap=\"nowrap\">Wird nach primärer R0-Resektion im Stadium II/<span class=\"diff_chg\">III keine</span> adjuvante Radiochemotherapie durchgeführt, sollte eine adjuvante Chemotherapie analog zu den Indikationskriterien und Schemata beim Kolonkarzinom erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "131;02_kolorektales-karzinom_0371.tsv;19"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auf Grundlage der beschriebenen Phase III-Daten und Meta-Analysen kann somit keine eindeutige Empfehlung für oder gegen eine adjuvante Chemotherapie nach erfolgter präoperativer Radio-/Radiochemotherapie gemacht werden und auch keine Subgruppe identifiziert werden, die davon präferentiell profitiert."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1679__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auf Grundlage der beschriebenen Phase III-Daten und Meta-Analysen kann somit keine eindeutige Empfehlung für oder gegen eine adjuvante Chemotherapie nach erfolgter präoperativer Radio<span class=\"diff_chg\">therapie</span>/Radiochemotherapie gemacht werden und auch keine Subgruppe identifiziert werden, die davon präferentiell profitiert.</div><div nowrap=\"nowrap\">Auf Grundlage der beschriebenen Phase III-Daten und Meta-Analysen kann somit keine eindeutige Empfehlung für oder gegen eine adjuvante Chemotherapie nach erfolgter präoperativer Radio<span class=\"diff_chg\">-</span>/Radiochemotherapie gemacht werden und auch keine Subgruppe identifiziert werden, die davon präferentiell profitiert.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "132;02_kolorektales-karzinom_0371.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine randomisierte Phase II-Studie aus Südkorea (ADORE) fand ein signifikant verbessertes Krankheitsfreies Überleben für Patienten im ypTNM-Stadium II/III nach neoadjuvanter 5-Fluorouracil-basierter Radiochemotherapie für die adjuvante Chemo-therapie mit FOLFOX versus 5-FU/Folinsäure-Bolus-Regime [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1680__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Eine randomisierte Phase II-Studie aus Südkorea (ADORE) fand ein signifikant verbessertes Krankheitsfreies Überleben für Patienten im ypTNM-Stadium II/ypTNM-Stadium III nach neoadjuvanter 5-Fluorouracil-basierter Radiochemotherapie für die adjuvante Chemo-therapie mit FOLFOX versus 5-FU-Bolus-Regime/Folinsäure-Bolus-Regime [REF].</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Eine randomisierte Phase II-Studie aus Südkorea (ADORE) fand ein signifikant verbessertes Krankheitsfreies Überleben für Patienten im ypTNM-Stadium II/III nach neoadjuvanter 5-Fluorouracil-basierter Radiochemotherapie für die adjuvante Chemo-therapie mit FOLFOX versus 5-FU/Folinsäure-Bolus-Regime [REF].</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "133;02_kolorektales-karzinom_0371.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Weitere Meta-Analysen zur Rolle der adjuvanten Chemotherapie nach neoadjuvanter Radio-/Radiochemotherapie mit Inklusion überwiegend nicht-randomisierter, retrospektiver Serien ließen einen Benefit der adjuvanten Chemotherapie für die Subgruppe von Patienten mit Downstaging [REF], bzw. mit ypN0 (weniger für Patienten mit ypT0N0 oder ypN+ vermuten [REF]. Die Evidenz dieser retrospektiven Daten und Meta-Analysen ist allerdings als niedrig zu bewerten und das Risiko für Verzerrungen hoch. Die 10-Jahres-Daten der randomisierten EORTC 22921 bestätigten deren initiale Beobachtung jedenfalls nicht, dass insbesondere Patienten mit Downstaging (ypT0-2) nach neoadjuvanter Therapie von der adjuvanten Chemotherapie profitieren [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1681__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Weitere Meta-Analysen zur Rolle der adjuvanten Chemotherapie nach neoadjuvanter Radio<span class=\"diff_chg\">therapie</span>/Radiochemotherapie mit Inklusion überwiegend nicht-randomisierter, retrospektiver Serien ließen einen Benefit der adjuvanten Chemotherapie für die Subgruppe von Patienten mit Downstaging [REF], bzw. mit ypN0 (weniger für Patienten mit ypT0N0 oder ypN+ vermuten [REF]. Die Evidenz dieser retrospektiven Daten und Meta-Analysen ist allerdings als niedrig zu bewerten und das Risiko für Verzerrungen hoch. Die 10-Jahres-Daten der randomisierten EORTC 22921 bestätigten deren initiale Beobachtung jedenfalls nicht, dass insbesondere Patienten mit Downstaging (ypT0-2) nach neoadjuvanter Therapie von der adjuvanten Chemotherapie profitieren [REF].</div><div nowrap=\"nowrap\">Weitere Meta-Analysen zur Rolle der adjuvanten Chemotherapie nach neoadjuvanter Radio<span class=\"diff_chg\">-</span>/Radiochemotherapie mit Inklusion überwiegend nicht-randomisierter, retrospektiver Serien ließen einen Benefit der adjuvanten Chemotherapie für die Subgruppe von Patienten mit Downstaging [REF], bzw. mit ypN0 (weniger für Patienten mit ypT0N0 oder ypN+ vermuten [REF]. Die Evidenz dieser retrospektiven Daten und Meta-Analysen ist allerdings als niedrig zu bewerten und das Risiko für Verzerrungen hoch. Die 10-Jahres-Daten der randomisierten EORTC 22921 bestätigten deren initiale Beobachtung jedenfalls nicht, dass insbesondere Patienten mit Downstaging (ypT0-2) nach neoadjuvanter Therapie von der adjuvanten Chemotherapie profitieren [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "134;02_kolorektales-karzinom_0383.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die molekular-pathologischen Untersuchungen kolorektaler Karzinome umfassen essentiell eine Analyse des Mutationszustands der RAS-Gene KRAS und NRAS (hotspot-Regionen der Exone 2, 3 und 4), des BRAF-Gens (hotspot region in Exon 15) sowie des Status der Mikrosatelliteninstabilität (MSS, Mikrosatelliten-stabil; MSI-H, hochgradig Mikro-satelliten-instabil)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1682__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die molekular-pathologischen Untersuchungen kolorektaler Karzinome umfassen essentiell eine Analyse des Mutationszustands der RAS-Gene KRAS und NRAS (hotspot-Regionen der Exone 2, <span class=\"diff_sub\">Exone </span>3 und<span class=\"diff_sub\"> Exone</span> 4), des BRAF-Gens (hotspot region in Exon 15) sowie des Status der Mikrosatelliteninstabilität (MSS, Mikrosatelliten-stabil; MSI-H, hochgradig Mikro-satelliten-instabil).</div><div nowrap=\"nowrap\">Die molekular-pathologischen Untersuchungen kolorektaler Karzinome umfassen essentiell eine Analyse des Mutationszustands der RAS-Gene KRAS und NRAS (hotspot-Regionen der Exone 2, 3 und 4), des BRAF-Gens (hotspot region in Exon 15) sowie des Status der Mikrosatelliteninstabilität (MSS, Mikrosatelliten-stabil; MSI-H, hochgradig Mikro-satelliten-instabil).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "135;02_kolorektales-karzinom_0386.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "BRAF V600 Mutationen treten häufiger zusammen mit MSI- als mit MSS-Status auf [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1683__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">BRAF V600 Mutationen treten häufiger zusammen mit MSI-<span class=\"diff_sub\">Status</span> als mit MSS-Status auf [REF].</div><div nowrap=\"nowrap\">BRAF V600 Mutationen treten häufiger zusammen mit MSI- als mit MSS-Status auf [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "136;02_kolorektales-karzinom_0432.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auf dem Boden der gegenwärtigen Datenlage wird bei rechtsseitigen Primärtumoren in der Erstlinientherapie der metastasierten Erkrankung eine Chemotherapie-Doublette oder Triplette (+/- Bev) empfohlen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1684__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auf dem Boden der gegenwärtigen Datenlage wird bei rechtsseitigen Primärtumoren in der Erstlinientherapie der metastasierten Erkrankung eine Chemotherapie-Doublette oder <span class=\"diff_sub\">Chemotherapie-</span>Triplette (+/- Bev) empfohlen.</div><div nowrap=\"nowrap\">Auf dem Boden der gegenwärtigen Datenlage wird bei rechtsseitigen Primärtumoren in der Erstlinientherapie der metastasierten Erkrankung eine Chemotherapie-Doublette oder Triplette (+/- Bev) empfohlen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "137;02_kolorektales-karzinom_0444.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In dieser Population wurde Bevacizumab plus 5-FU/LV mit einer alleinigen 5-FU/LV-Behandlung verglichen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1685__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In dieser Population wurde Bevacizumab plus 5-FU/LV mit einer alleinigen 5-FU<span class=\"diff_sub\">-Behandlung</span>/LV-Behandlung verglichen.</div><div nowrap=\"nowrap\">In dieser Population wurde Bevacizumab plus 5-FU/LV mit einer alleinigen 5-FU/LV-Behandlung verglichen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "138;02_kolorektales-karzinom_0453.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "* ohne Hurwitz, Guan, Kabbinavar (keine 5-FU- Bolus oder -Kurzzeit-Regime)"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1686__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">* ohne Hurwitz, Guan, Kabbinavar (keine 5-FU- Bolus oder <span class=\"diff_sub\">5-FU</span>-Kurzzeit-Regime)</div><div nowrap=\"nowrap\">* ohne Hurwitz, Guan, Kabbinavar (keine 5-FU- Bolus oder -Kurzzeit-Regime)</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "139;02_kolorektales-karzinom_0482.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "3-, 5- und 8-Jahren Überleben waren, 57%, 43% und 36% für die Kombination SR+RFA+Chemotherapie versus 55%, 30% und 9% für die Chemotherapie allein."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1687__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">3-Jahren Überleben<span class=\"diff_sub\">, 5-Jahren Überleben und 8-Jahren Überleben</span> waren, 57%, 43% und 36% für die Kombination SR+RFA+Chemotherapie versus 55%, 30% und 9% für die Chemotherapie allein.</div><div nowrap=\"nowrap\">3<span class=\"diff_add\">-, 5- und 8</span>-Jahren Überleben waren, 57%, 43% und 36% für die Kombination SR+RFA+Chemotherapie versus 55%, 30% und 9% für die Chemotherapie allein.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "140;02_kolorektales-karzinom_0491.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wenn auch die Datenlage überschaubar ist, so zeigte sich in einer prospektiv rando-misierten Studie in der palliativen Situation bei Patienten mit Progress nach 2. und 3.-Linien Chemotherapie ein verbessertes Überleben mit besserer Lebensqualität nach intraarterieller Applikation Irinotecan-beladener Partikeln [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1688__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wenn auch die Datenlage überschaubar ist, so zeigte sich in einer prospektiv rando-misierten Studie in der palliativen Situation bei Patienten mit Progress nach 2.<span class=\"diff_chg\">-Linien Chemotherapie und</span> 3.-Linien Chemotherapie ein verbessertes Überleben mit besserer Lebensqualität nach intraarterieller Applikation Irinotecan-beladener Partikeln [REF].</div><div nowrap=\"nowrap\">Wenn auch die Datenlage überschaubar ist, so zeigte sich in einer prospektiv rando-misierten Studie in der palliativen Situation bei Patienten mit Progress nach 2.<span class=\"diff_chg\"> und</span> 3.-Linien Chemotherapie ein verbessertes Überleben mit besserer Lebensqualität nach intraarterieller Applikation Irinotecan-beladener Partikeln [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "141;02_kolorektales-karzinom_0498.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Abweichend kann im Einzelfall nach leitliniengerechter Therapie bei Annahme eines hohen lokalen Rezidivrisikos aufgrund des endoskopischen oder intraoperativen Befundes (z. B. nach intraoperativer Tumoreröffnung) oder eines pathologischen Befundes (z. B. erhöhtes Risiko für Fernmetastasen bei Invasion perikolischer Venen [REF], [REF], angiolymphatischer Invasion [REF], [REF], G3/G4 Tumoren oder pT2-Tumoren) eine engmaschigere Nachsorge angezeigt sein."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1689__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Abweichend kann im Einzelfall nach leitliniengerechter Therapie bei Annahme eines hohen lokalen Rezidivrisikos aufgrund des endoskopischen oder intraoperativen Befundes (z. B. nach intraoperativer Tumoreröffnung) oder eines pathologischen Befundes (z. B. erhöhtes Risiko für Fernmetastasen bei Invasion perikolischer Venen [REF], [REF], angiolymphatischer Invasion [REF], [REF], G3<span class=\"diff_sub\"> Tumoren</span>/G4 Tumoren oder pT2-Tumoren) eine engmaschigere Nachsorge angezeigt sein.</div><div nowrap=\"nowrap\">Abweichend kann im Einzelfall nach leitliniengerechter Therapie bei Annahme eines hohen lokalen Rezidivrisikos aufgrund des endoskopischen oder intraoperativen Befundes (z. B. nach intraoperativer Tumoreröffnung) oder eines pathologischen Befundes (z. B. erhöhtes Risiko für Fernmetastasen bei Invasion perikolischer Venen [REF], [REF], angiolymphatischer Invasion [REF], [REF], G3/G4 Tumoren oder pT2-Tumoren) eine engmaschigere Nachsorge angezeigt sein.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "142;02_kolorektales-karzinom_0501.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei regelmäßiger Nachsorge war im Vergleich zu den anderen Gruppen das 5 und 10-Jahres-Überleben statistisch signifikant besser."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1690__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei regelmäßiger Nachsorge war im Vergleich zu den anderen Gruppen das 5<span class=\"diff_sub\">-Jahres-Überleben</span> und 10-Jahres-Überleben statistisch signifikant besser.</div><div nowrap=\"nowrap\">Bei regelmäßiger Nachsorge war im Vergleich zu den anderen Gruppen das 5 und 10-Jahres-Überleben statistisch signifikant besser.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "143;03_lungenkarzinom_0008.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Männern lag das Risiko, an Lungenkrebs zu erkranken, für einen Zigarren-/Zigarilloraucher bzw. Pfeifenraucher 8fach bzw. 9fach höher im Vergleich zum Nichtraucher [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1691__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Männern lag das Risiko, an Lungenkrebs zu erkranken, für einen Zigarren<span class=\"diff_chg\">raucher</span>/Zigarilloraucher bzw. Pfeifenraucher 8fach bzw. 9fach höher im Vergleich zum Nichtraucher [REF].</div><div nowrap=\"nowrap\">Bei Männern lag das Risiko, an Lungenkrebs zu erkranken, für einen Zigarren<span class=\"diff_chg\">-</span>/Zigarilloraucher bzw. Pfeifenraucher 8fach bzw. 9fach höher im Vergleich zum Nichtraucher [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "144;03_lungenkarzinom_0014.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Mit zunehmender Verwendung der synthetischen Fasern wurden auf der Basis von in vitro Untersuchungen an isolierten Zellen und tierexperimentellen Studien deutlich, dass diese Fasern eine inflammatorische und je nach der gewählten Expositionskonzentration, -dauer und dem Expositionsort auch eine kanzerogene Wirkung besitzen können."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1692__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Mit zunehmender Verwendung der synthetischen Fasern wurden auf der Basis von in vitro Untersuchungen an isolierten Zellen und tierexperimentellen Studien deutlich, dass diese Fasern eine inflammatorische und je nach der gewählten Expositionskonzentration, Expositions<span class=\"diff_chg\">dauer und dem Expositionsort auch eine</span> kanzerogene Wirkung besitzen können.</div><div nowrap=\"nowrap\">Mit zunehmender Verwendung der synthetischen Fasern wurden auf der Basis von in vitro Untersuchungen an isolierten Zellen und tierexperimentellen Studien deutlich, dass diese Fasern eine inflammatorische und je nach der gewählten Expositionskonzentration, <span class=\"diff_add\">-dauer und dem </span>Expositions<span class=\"diff_chg\">ort auch eine</span> kanzerogene Wirkung besitzen können.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "145;03_lungenkarzinom_0017.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch durch die Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe der Deutschen Forschungsgemeinschaft wurde 1999 die krebserzeugende Wirkung von \"Siliziumdioxid, kristallin - Quarz-, Cristobalit-, Tridymitstaub (alveolengängiger Anteil - identisch mit der älteren Definition ‘Feinstaub‘ - Formel SiO2)\" nach Kategorie 1 als für den Menschen gesichert krebserzeugend eingestuft."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1693__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch durch die Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe der Deutschen Forschungsgemeinschaft wurde 1999 die krebserzeugende Wirkung von \"Siliziumdioxid, kristallin<span class=\"diff_chg\">staub </span> Quarz<span class=\"diff_chg\">staub</span>, Cristobalit<span class=\"diff_chg\">staub</span>, Tridymitstaub (alveolengängiger Anteil - identisch mit der älteren Definition ‘Feinstaub‘ - Formel SiO2)\" nach Kategorie 1 als für den Menschen gesichert krebserzeugend eingestuft.</div><div nowrap=\"nowrap\">Auch durch die Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe der Deutschen Forschungsgemeinschaft wurde 1999 die krebserzeugende Wirkung von \"Siliziumdioxid, kristallin<span class=\"diff_chg\"> -</span> Quarz<span class=\"diff_chg\">-</span>, Cristobalit<span class=\"diff_chg\">-</span>, Tridymitstaub (alveolengängiger Anteil - identisch mit der älteren Definition ‘Feinstaub‘ - Formel SiO2)\" nach Kategorie 1 als für den Menschen gesichert krebserzeugend eingestuft.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "146;03_lungenkarzinom_0035.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten mit NSCLC im Stadium I und II, die sich einer Strahlentherapie unterzogen, war Tabakrauchen ein unabhängiger Prädiktor der Mortalität [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1694__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten mit NSCLC im Stadium I und <span class=\"diff_sub\">Stadium </span>II, die sich einer Strahlentherapie unterzogen, war Tabakrauchen ein unabhängiger Prädiktor der Mortalität [REF].</div><div nowrap=\"nowrap\">Bei Patienten mit NSCLC im Stadium I und II, die sich einer Strahlentherapie unterzogen, war Tabakrauchen ein unabhängiger Prädiktor der Mortalität [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "147;03_lungenkarzinom_0055.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Z.n. Lungenkarzinom [REF], positive Familienanamnese für ein Lungenkarzinom [REF], Z.n. HNO-Malignom oder anderer Rauchen-assoziierter Malignome [REF], [REF], Z. n. Hodgkin- [REF] und Non-Hodkin-Lymphomerkrankung [REF], Asbestexposition [REF], COPD [REF] und Lungenfibrose [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1695__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Z.n. Lungenkarzinom [REF], positive Familienanamnese für ein Lungenkarzinom [REF], Z.n. HNO-Malignom oder anderer Rauchen-assoziierter Malignome [REF], [REF], Z. n. Hodgkin-Lymphomerkrankung [REF]<span class=\"diff_chg\"> und Non-Hodkin-Lymphomerkrankung [REF],</span> Asbestexposition [REF], COPD [REF] und Lungenfibrose [REF].</div><div nowrap=\"nowrap\">Z.n. Lungenkarzinom [REF], positive Familienanamnese für ein Lungenkarzinom [REF], Z.n. HNO-Malignom oder anderer Rauchen-assoziierter Malignome [REF], [REF], Z. n. Hodg<span class=\"diff_add\">kin- [REF] und Non-Hod</span>kin-Lymphomerkrankung [REF]<span class=\"diff_chg\">,</span> Asbestexposition [REF], COPD [REF] und Lungenfibrose [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "148;03_lungenkarzinom_0057.tsv;19"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Sensitivitäten der genannten Tumormarker liegen für die Tumorstadien I und II zwischen 20 und 30 %, maximal bei 67 %."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1696__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Sensitivitäten der genannten Tumormarker liegen für die Tumorstadien I und <span class=\"diff_sub\">Tumorstadien </span>II zwischen 20 und 30 %, maximal bei 67 %.</div><div nowrap=\"nowrap\">Die Sensitivitäten der genannten Tumormarker liegen für die Tumorstadien I und II zwischen 20 und 30 %, maximal bei 67 %.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "149;03_lungenkarzinom_0073.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Radiologische Kriterien für die Operabilität sind bestimmte T3- (z.B. Thoraxwandinfiltration) oder T4-Situationen (z.B. Infiltration von Mediastinalorganen)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1697__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Radiologische Kriterien für die Operabilität sind bestimmte T3-<span class=\"diff_sub\">Situationen</span> (z.B. Thoraxwandinfiltration) oder T4-Situationen (z.B. Infiltration von Mediastinalorganen).</div><div nowrap=\"nowrap\">Radiologische Kriterien für die Operabilität sind bestimmte T3- (z.B. Thoraxwandinfiltration) oder T4-Situationen (z.B. Infiltration von Mediastinalorganen).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "150;03_lungenkarzinom_0086.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei einem pleuraständigen Tumor sollte die transthorakale Nadelaspiration (TTNA) Ultraschall- oder CT- gesteuert erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1698__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei einem pleuraständigen Tumor sollte die transthorakale Nadelaspiration (TTNA) Ultraschall-gesteuert <span class=\"diff_sub\">oder CT- gesteuert </span>erfolgen.</div><div nowrap=\"nowrap\">Bei einem pleuraständigen Tumor sollte die transthorakale Nadelaspiration (TTNA) Ultraschall-<span class=\"diff_add\"> oder CT- </span>gesteuert erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "151;03_lungenkarzinom_0101.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ihre diagnostische Genauigkeit ist abhängig von der Zahl gewonnener Proben, deren Aufarbeitung sowie Tumorlage und –größe."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1699__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ihre diagnostische Genauigkeit ist abhängig von der Zahl gewonnener Proben, deren Aufarbeitung sowie Tumorlage und <span class=\"diff_chg\">Tumor</span>größe.</div><div nowrap=\"nowrap\">Ihre diagnostische Genauigkeit ist abhängig von der Zahl gewonnener Proben, deren Aufarbeitung sowie Tumorlage und <span class=\"diff_chg\">–</span>größe.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "152;03_lungenkarzinom_0113.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sofern eine kurative Behandlungsintention besteht, soll im Falle einer im bildgebenden Verfahren (CT, PET oder PET/CT) nachgewiesenen mediastinalen Lymphknoten-Veränderung bzw. –Vergrößerung eine definitive Evaluation des Lymphknotenstatus erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1700__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sofern eine kurative Behandlungsintention besteht, soll im Falle einer im bildgebenden Verfahren (CT, PET oder PET/CT) nachgewiesenen mediastinalen Lymphknoten-Veränderung bzw. Lymphknoten<span class=\"diff_chg\">-Vergrößerung eine definitive Evaluation des Lymphknotenstatus</span> erfolgen.</div><div nowrap=\"nowrap\">Sofern eine kurative Behandlungsintention besteht, soll im Falle einer im bildgebenden Verfahren (CT, PET oder PET/CT) nachgewiesenen mediastinalen Lymphknoten-Veränderung bzw. <span class=\"diff_add\">–Vergrößerung eine definitive Evaluation des </span>Lymphknoten<span class=\"diff_chg\">status</span> erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "153;03_lungenkarzinom_0114.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zur pathologischen Evaluation des mediastinalen Lymphknotenstatus sollen als Methoden der ersten Wahl endoskopische Untersuchungsverfahren mit Ultraschallgesteuerter Probenentnahme (Bronchoskopie mit endobronchialem Ultraschall und mit Nadelbiopsie/-aspiration [EBUS-TBNA]; Ösophagoskopie mit ösophagealem Ultraschall und Nadelbiopsie/-aspiration [EUS-FNA]; Kombination aus EBUS-/EUS-Verfahren) eingesetzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1701__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zur pathologischen Evaluation des mediastinalen Lymphknotenstatus sollen als Methoden der ersten Wahl endoskopische Untersuchungsverfahren mit Ultraschallgesteuerter Probenentnahme (Bronchoskopie mit endobronchialem Ultraschall und mit Nadelbiopsie/<span class=\"diff_chg\">Nadelaspiration</span> [EBUS-TBNA]; Ösophagoskopie mit ösophagealem Ultraschall und Nadelbiopsie/<span class=\"diff_chg\">Nadelaspiration</span> [EUS-FNA]; Kombination aus EBUS-<span class=\"diff_sub\">Verfahren</span>/EUS-Verfahren) eingesetzt werden.</div><div nowrap=\"nowrap\">Zur pathologischen Evaluation des mediastinalen Lymphknotenstatus sollen als Methoden der ersten Wahl endoskopische Untersuchungsverfahren mit Ultraschallgesteuerter Probenentnahme (Bronchoskopie mit endobronchialem Ultraschall und mit Nadelbiopsie/<span class=\"diff_chg\">-aspiration</span> [EBUS-TBNA]; Ösophagoskopie mit ösophagealem Ultraschall und Nadelbiopsie/<span class=\"diff_chg\">-aspiration</span> [EUS-FNA]; Kombination aus EBUS-/EUS-Verfahren) eingesetzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "154;03_lungenkarzinom_0115.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Falle einer im bildgebenden Verfahren (CT, PET oder PET/CT) nachgewiesenen mediastinalen Lymphknoten-Veränderung bzw. –Vergrößerung und eines negativen pathologischen Befundes des Nadelaspirationsverfahrens (EBUS, EUS, TBNA, TTNA) soll eine Mediastinoskopie, eine VATS oder ein geeignetes chirurgisches Verfahren durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1702__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Falle einer im bildgebenden Verfahren (CT, PET oder PET/CT) nachgewiesenen mediastinalen Lymphknoten-Veränderung bzw. <span class=\"diff_chg\">Lymphknoten-</span>Vergrößerung und eines negativen pathologischen Befundes des Nadelaspirationsverfahrens (EBUS, EUS, TBNA, TTNA) soll eine Mediastinoskopie, eine VATS oder ein geeignetes chirurgisches Verfahren durchgeführt werden.</div><div nowrap=\"nowrap\">Im Falle einer im bildgebenden Verfahren (CT, PET oder PET/CT) nachgewiesenen mediastinalen Lymphknoten-Veränderung bzw. <span class=\"diff_chg\">–</span>Vergrößerung und eines negativen pathologischen Befundes des Nadelaspirationsverfahrens (EBUS, EUS, TBNA, TTNA) soll eine Mediastinoskopie, eine VATS oder ein geeignetes chirurgisches Verfahren durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "155;03_lungenkarzinom_0144.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die aktuelle Klassifikation – basierend auf der Auswertung von nahezu 100 000 Patienten - wurde von IASLC/AJCC und UICC erarbeitet und ist mit Wirkung vom 01. 01. 2017 in Kraft getreten (siehe Tabelle 22 für TNM- Klassifikation und Tabelle 23 für die Klassifikation der Tumorstadien [REF]. Ein minimaler Unterschied zwischen SCLC und NSCLC besteht insofern, dass beim SCLC für das metastasierte Stadium eine Unterteilung des Stadium IV in IVA und IVB nicht notwendig ist [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1703__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die aktuelle Klassifikation – basierend auf der Auswertung von nahezu 100 000 Patienten - wurde von IASLC/AJCC und UICC erarbeitet und ist mit Wirkung vom 01. 01. 2017 in Kraft getreten (siehe Tabelle 22 für TNM- Klassifikation und Tabelle 23 für die Klassifikation der Tumorstadien [REF]. Ein minimaler Unterschied zwischen SCLC und NSCLC besteht insofern, dass beim SCLC für das metastasierte Stadium eine Unterteilung des Stadium IV in<span class=\"diff_sub\"> Stadium</span> IVA und<span class=\"diff_sub\"> Stadium</span> IVB nicht notwendig ist [REF] [REF].</div><div nowrap=\"nowrap\">Die aktuelle Klassifikation – basierend auf der Auswertung von nahezu 100 000 Patienten - wurde von IASLC/AJCC und UICC erarbeitet und ist mit Wirkung vom 01. 01. 2017 in Kraft getreten (siehe Tabelle 22 für TNM- Klassifikation und Tabelle 23 für die Klassifikation der Tumorstadien [REF]. Ein minimaler Unterschied zwischen SCLC und NSCLC besteht insofern, dass beim SCLC für das metastasierte Stadium eine Unterteilung des Stadium IV in IVA und IVB nicht notwendig ist [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "156;03_lungenkarzinom_0165.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nach vorausgegangener Radio- und/oder Chemotherapie sollte im Resektat das Ausmaß der therapieinduzierten Tumorregression mikroskopisch ermittelt und entsprechend dem Regressionsgrading nach Junker angegeben werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1704__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nach vorausgegangener Radio<span class=\"diff_chg\">therapie</span> und/oder Chemotherapie sollte im Resektat das Ausmaß der therapieinduzierten Tumorregression mikroskopisch ermittelt und entsprechend dem Regressionsgrading nach Junker angegeben werden.</div><div nowrap=\"nowrap\">Nach vorausgegangener Radio<span class=\"diff_chg\">-</span> und/oder Chemotherapie sollte im Resektat das Ausmaß der therapieinduzierten Tumorregression mikroskopisch ermittelt und entsprechend dem Regressionsgrading nach Junker angegeben werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "157;03_lungenkarzinom_0166.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nach vorausgegangener Radio- und/oder Chemotherapie stellt das Ausmaß der therapieinduzierten Tumorregression im Bereich des Primärtumors und der regionären Lymphknoten einen unabhängigen Prognosefaktor dar [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1705__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nach vorausgegangener Radiotherapie<span class=\"diff_sub\"> und/oder Chemotherapie</span> stellt das Ausmaß der therapieinduzierten Tumorregression im Bereich des Primärtumors und der regionären Lymphknoten einen unabhängigen Prognosefaktor dar [REF], [REF].</div><div nowrap=\"nowrap\">Nach vorausgegangener Radio<span class=\"diff_add\">- und/oder Chemo</span>therapie stellt das Ausmaß der therapieinduzierten Tumorregression im Bereich des Primärtumors und der regionären Lymphknoten einen unabhängigen Prognosefaktor dar [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "158;03_lungenkarzinom_0174.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Da mittlerweile gegen PD-1 oder PD-L1 gerichtete monoklonale Antikörper für das Lungenkarzinom zugelassen sind (siehe Kapitel 8.6.2), ist diese Testung bedeutsam für die Therapieplanung (siehe die Abbildung unten)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1706__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Da mittlerweile gegen PD-1 <span class=\"diff_chg\">gerichtete oder gegen</span> PD-L1 gerichtete monoklonale Antikörper für das Lungenkarzinom zugelassen sind (siehe Kapitel 8.6.2), ist diese Testung bedeutsam für die Therapieplanung (siehe die Abbildung unten).</div><div nowrap=\"nowrap\">Da mittlerweile gegen PD-1 <span class=\"diff_chg\">oder</span> PD-L1 gerichtete monoklonale Antikörper für das Lungenkarzinom zugelassen sind (siehe Kapitel 8.6.2), ist diese Testung bedeutsam für die Therapieplanung (siehe die Abbildung unten).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "159;03_lungenkarzinom_0174.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei nicht-kleinzelligen Lungenkarzinomen mit nachgewiesener aktivierender EGFR-Mutation und Tumorprogress unter einer Therapie mit einem entsprechenden Tyrosinkinaseinhibitor ist bei Durchführung einer erneuten Mutationsanalyse insbesondere auf s. g. Resistenzmutationen (insbesondere T790M-Mutation, Met Amplifikation, Her2Amplifikation und –Mutation sowie ggf. weitere Targets) zu achten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1707__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei nicht-kleinzelligen Lungenkarzinomen mit nachgewiesener aktivierender EGFR-Mutation und Tumorprogress unter einer Therapie mit einem entsprechenden Tyrosinkinaseinhibitor ist bei Durchführung einer erneuten Mutationsanalyse insbesondere auf s. g. Resistenzmutationen (insbesondere T790M-Mutation, Met Amplifikation, Her2Amplifikation und <span class=\"diff_chg\">Her2Mutation</span> sowie ggf. weitere Targets) zu achten.</div><div nowrap=\"nowrap\">Bei nicht-kleinzelligen Lungenkarzinomen mit nachgewiesener aktivierender EGFR-Mutation und Tumorprogress unter einer Therapie mit einem entsprechenden Tyrosinkinaseinhibitor ist bei Durchführung einer erneuten Mutationsanalyse insbesondere auf s. g. Resistenzmutationen (insbesondere T790M-Mutation, Met Amplifikation, Her2Amplifikation und <span class=\"diff_chg\">–Mutation</span> sowie ggf. weitere Targets) zu achten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "160;03_lungenkarzinom_0180.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten, die basierend auf FEV1- und TLCO-Werten nicht eindeutig operabel sind, sollten eine Ganzkörperplethysmographie, eine Blutgasanalyse in Ruhe, eine quantitative Lungenperfusionsszintigrafie und eine Spiroergometrie durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1708__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten, die basierend auf FEV1-<span class=\"diff_chg\">Werten und</span> TLCO-Werten nicht eindeutig operabel sind, sollten eine Ganzkörperplethysmographie, eine Blutgasanalyse in Ruhe, eine quantitative Lungenperfusionsszintigrafie und eine Spiroergometrie durchgeführt werden.</div><div nowrap=\"nowrap\">Bei Patienten, die basierend auf FEV1-<span class=\"diff_chg\"> und</span> TLCO-Werten nicht eindeutig operabel sind, sollten eine Ganzkörperplethysmographie, eine Blutgasanalyse in Ruhe, eine quantitative Lungenperfusionsszintigrafie und eine Spiroergometrie durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "161;03_lungenkarzinom_0187.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zwei Studien ergaben ein erhöhtes perioperatives Morbiditäts – und Letalitätsrisiko für VO2max-Werte <15 ml/kg/min [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1709__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zwei Studien ergaben ein erhöhtes perioperatives Morbiditäts<span class=\"diff_chg\">risiko </span> und Letalitätsrisiko für VO2max-Werte &lt;15 ml/kg/min [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Zwei Studien ergaben ein erhöhtes perioperatives Morbiditäts<span class=\"diff_chg\"> –</span> und Letalitätsrisiko für VO2max-Werte &lt;15 ml/kg/min [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "162;03_lungenkarzinom_0209.tsv;35"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der palliativen Behandlungssituation stehen beim zentralen Wunsch der Patienten nach Lebensverlängerung bei guter Lebensqualität bzw. Symptomlinderung sehr unterschiedliche prinzipielle Therapieoptionen und - sequenzen im Fokus."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1710__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der palliativen Behandlungssituation stehen beim zentralen Wunsch der Patienten nach Lebensverlängerung bei guter Lebensqualität bzw. Symptomlinderung sehr unterschiedliche prinzipielle Therapieoptionen und <span class=\"diff_chg\"> Therapie</span>sequenzen im Fokus.</div><div nowrap=\"nowrap\">In der palliativen Behandlungssituation stehen beim zentralen Wunsch der Patienten nach Lebensverlängerung bei guter Lebensqualität bzw. Symptomlinderung sehr unterschiedliche prinzipielle Therapieoptionen und <span class=\"diff_chg\">- </span>sequenzen im Fokus.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "163;03_lungenkarzinom_0211.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "„Schwerwiegende Veränderungen im Krankheitsverlauf durch das Wiederauftreten oder Fortschreiten der Tumorerkrankung, den ausbleibenden Erfolg der Tumortherapie oder der nahende Tod konfrontieren Patienten mit Begrenzungen von Lebenszeit und - perspektiven und können krisenhaftes Erleben auslösen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1711__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">„Schwerwiegende Veränderungen im Krankheitsverlauf durch das Wiederauftreten oder Fortschreiten der Tumorerkrankung, den ausbleibenden Erfolg der Tumortherapie oder der nahende Tod konfrontieren Patienten mit Begrenzungen von Lebenszeit und <span class=\"diff_chg\"> L</span>eben<span class=\"diff_chg\">sperspektiven und k</span>ö<span class=\"diff_chg\">nnen krisenhaftes Erleben auslösen</span> [REF].</div><div nowrap=\"nowrap\">„Schwerwiegende Veränderungen im Krankheitsverlauf durch das Wiederauftreten oder Fortschreiten der Tumorerkrankung, den ausbleibenden Erfolg der Tumortherapie oder der nahende Tod konfrontieren Patienten mit Begrenzungen von Lebenszeit und <span class=\"diff_chg\">- perspektiven und können krisenhaftes Erl</span>eben<span class=\"diff_chg\"> ausl</span>ö<span class=\"diff_chg\">sen</span> [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "164;03_lungenkarzinom_0211.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für die Aufklärung von Tumorrezidiven nach kurativer Therapie bzw. über ein Nicht- bzw. nicht ausreichendes Ansprechen auf die tumorspezifische Therapie in einer palliativen Erkrankungssituation gelten die Grundlagen der patientenzentrierten Kommunikation [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1712__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für die Aufklärung von Tumorrezidiven nach kurativer Therapie bzw. über ein Nicht<span class=\"diff_chg\">ansprechen</span> bzw. nicht ausreichendes Ansprechen auf die tumorspezifische Therapie in einer palliativen Erkrankungssituation gelten die Grundlagen der patientenzentrierten Kommunikation [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Für die Aufklärung von Tumorrezidiven nach kurativer Therapie bzw. über ein Nicht<span class=\"diff_chg\">-</span> bzw. nicht ausreichendes Ansprechen auf die tumorspezifische Therapie in einer palliativen Erkrankungssituation gelten die Grundlagen der patientenzentrierten Kommunikation [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "165;03_lungenkarzinom_0216.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Äußerung eines Sterbe-/Todeswunsches eines Patienten mit einer nicht heilbaren Krebserkrankung soll mit Empathie und Gesprächsbereitschaft begegnet werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1713__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Äußerung eines Sterbe<span class=\"diff_chg\">wunsches</span>/Todeswunsches eines Patienten mit einer nicht heilbaren Krebserkrankung soll mit Empathie und Gesprächsbereitschaft begegnet werden.</div><div nowrap=\"nowrap\">Der Äußerung eines Sterbe<span class=\"diff_chg\">-</span>/Todeswunsches eines Patienten mit einer nicht heilbaren Krebserkrankung soll mit Empathie und Gesprächsbereitschaft begegnet werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "166;03_lungenkarzinom_0217.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Gespräche über Sterbe-/Todeswünsche sollten ebenfalls proaktiv erfolgen [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1714__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Gespräche über Sterbe<span class=\"diff_chg\">wünsche</span>/Todeswünsche sollten ebenfalls proaktiv erfolgen [REF], [REF].</div><div nowrap=\"nowrap\">Gespräche über Sterbe<span class=\"diff_chg\">-</span>/Todeswünsche sollten ebenfalls proaktiv erfolgen [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "167;03_lungenkarzinom_0230.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das Stadium IIA, IIB (N1-Status) beschreibt den Befall intrapulmonaler und/oder hilärer Lymphknoten in Gegenwart eines T1- oder T2-Tumors."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1715__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das Stadium IIA, <span class=\"diff_sub\">Stadium </span>IIB (N1-Status) beschreibt den Befall intrapulmonaler und/oder hilärer Lymphknoten in Gegenwart eines T1-<span class=\"diff_sub\">Tumors</span> oder T2-Tumors.</div><div nowrap=\"nowrap\">Das Stadium IIA, IIB (N1-Status) beschreibt den Befall intrapulmonaler und/oder hilärer Lymphknoten in Gegenwart eines T1- oder T2-Tumors.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "168;03_lungenkarzinom_0230.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Operation in Form der Lobektomie, ergänzt durch ipsilaterale Lymphknotendissektion, ist Bestandteil der Behandlung im Stadium IIA und IIB (N1)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1716__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Operation in Form der Lobektomie, ergänzt durch ipsilaterale Lymphknotendissektion, ist Bestandteil der Behandlung im Stadium IIA und <span class=\"diff_sub\">Stadium </span>IIB (N1).</div><div nowrap=\"nowrap\">Die Operation in Form der Lobektomie, ergänzt durch ipsilaterale Lymphknotendissektion, ist Bestandteil der Behandlung im Stadium IIA und IIB (N1).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "169;03_lungenkarzinom_0236.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die erste Übersichtsarbeit fasst 10 retrospektive Studien zusammen (Evidenzgrad 3a) (n=1083), wobei nicht immer der pT- oder pN-Status angegeben wurde und somit die Studien hinsichtlich der therapierten Tumorstadien schlecht beurteilt werden können."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1717__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die erste Übersichtsarbeit fasst 10 retrospektive Studien zusammen (Evidenzgrad 3a) (n=1083), wobei nicht immer der pT-<span class=\"diff_chg\">Status oder</span> pN-Status angegeben wurde und somit die Studien hinsichtlich der therapierten Tumorstadien schlecht beurteilt werden können.</div><div nowrap=\"nowrap\">Die erste Übersichtsarbeit fasst 10 retrospektive Studien zusammen (Evidenzgrad 3a) (n=1083), wobei nicht immer der pT-<span class=\"diff_chg\"> oder</span> pN-Status angegeben wurde und somit die Studien hinsichtlich der therapierten Tumorstadien schlecht beurteilt werden können.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "170;03_lungenkarzinom_0251.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Fall einer inkompletten Resektion (R1/R2-Situation) sollte – wenn möglich – eine Nachresektion mit dem Ziel der R0-Resektion erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1718__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Fall einer inkompletten Resektion (R1<span class=\"diff_sub\">-Situation</span>/R2-Situation) sollte – wenn möglich – eine Nachresektion mit dem Ziel der R0-Resektion erfolgen.</div><div nowrap=\"nowrap\">Im Fall einer inkompletten Resektion (R1/R2-Situation) sollte – wenn möglich – eine Nachresektion mit dem Ziel der R0-Resektion erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "171;03_lungenkarzinom_0253.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei adäquater Lungenfunktion und fehlenden Kontraindikationen wird im Stadium I / II eine radikale Resektion empfohlen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1719__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei adäquater Lungenfunktion und fehlenden Kontraindikationen wird im Stadium I /<span class=\"diff_sub\"> Stadium</span> II eine radikale Resektion empfohlen.</div><div nowrap=\"nowrap\">Bei adäquater Lungenfunktion und fehlenden Kontraindikationen wird im Stadium I / II eine radikale Resektion empfohlen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "172;03_lungenkarzinom_0254.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Stadium I/II ist bei ausreichender kardiopulmonaler Funktion die Lappenresektion der empfohlene Resektionstyp."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1720__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Stadium I/<span class=\"diff_sub\">Stadium </span>II ist bei ausreichender kardiopulmonaler Funktion die Lappenresektion der empfohlene Resektionstyp.</div><div nowrap=\"nowrap\">Im Stadium I/II ist bei ausreichender kardiopulmonaler Funktion die Lappenresektion der empfohlene Resektionstyp.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "173;03_lungenkarzinom_0266.tsv;25"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Subgruppenanalysen für Stadium I und II waren aufgrund fehlender OS-Daten für die Gruppen in den allermeisten Studien nicht möglich."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1721__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Subgruppenanalysen für Stadium I und <span class=\"diff_sub\">Stadium </span>II waren aufgrund fehlender OS-Daten für die Gruppen in den allermeisten Studien nicht möglich.</div><div nowrap=\"nowrap\">Subgruppenanalysen für Stadium I und II waren aufgrund fehlender OS-Daten für die Gruppen in den allermeisten Studien nicht möglich.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "174;03_lungenkarzinom_0266.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In zwei weiteren randomisierten Phase-III-Studien wurde die Effektivität einer neoadjuvanten Chemotherapie bei Patienten mit einem NSCLC im Stadium I – IIIA geprüft, wobei die meisten Patienten sich im Stadium I und II befanden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1722__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In zwei weiteren randomisierten Phase-III-Studien wurde die Effektivität einer neoadjuvanten Chemotherapie bei Patienten mit einem NSCLC im Stadium I – IIIA geprüft, wobei die meisten Patienten sich im Stadium I und <span class=\"diff_chg\">Stadium II</span> befanden.</div><div nowrap=\"nowrap\">In zwei weiteren randomisierten Phase-III-Studien wurde die Effektivität einer neoadjuvanten Chemotherapie bei Patienten mit einem NSCLC im Stadium I – IIIA geprüft, wobei die meisten Patienten sich im Stadium I und <span class=\"diff_chg\">II</span> befanden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "175;03_lungenkarzinom_0266.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Operationsraten, die Mortalitäts und Morbiditätsraten waren in den drei Armen identisch."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1723__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Operationsraten, die Mortalitäts<span class=\"diff_sub\">raten</span> und Morbiditätsraten waren in den drei Armen identisch.</div><div nowrap=\"nowrap\">Die Operationsraten, die Mortalitäts und Morbiditätsraten waren in den drei Armen identisch.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "176;03_lungenkarzinom_0266.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Insbesondere im Stadium IIB/IIIA, in dem die adjuvante Therapie einen signifikanten Effekt aufweist, betrug die 3 Jahres PFS Rate 55,5% vs. 36,1%, p=0,002."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1724__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Insbesondere im Stadium IIB/<span class=\"diff_sub\">Stadium </span>IIIA, in dem die adjuvante Therapie einen signifikanten Effekt aufweist, betrug die 3 Jahres PFS Rate 55,5% vs. 36,1%, p=0,002.</div><div nowrap=\"nowrap\">Insbesondere im Stadium IIB/IIIA, in dem die adjuvante Therapie einen signifikanten Effekt aufweist, betrug die 3 Jahres PFS Rate 55,5% vs. 36,1%, p=0,002.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "177;03_lungenkarzinom_0266.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer post-hoc Analyse nur der Stadien II/IIIA betrug die HR für die Induktionstherapie vs. alleinige Operation 0,88 ((95% CI, 0,69 -1,12; p=0,31)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1725__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer post-hoc Analyse nur der Stadien II/<span class=\"diff_sub\">Stadien </span>IIIA betrug die HR für die Induktionstherapie vs. alleinige Operation 0,88 ((95% CI, 0,69 -1,12; p=0,31).</div><div nowrap=\"nowrap\">In einer post-hoc Analyse nur der Stadien II/IIIA betrug die HR für die Induktionstherapie vs. alleinige Operation 0,88 ((95% CI, 0,69 -1,12; p=0,31).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "178;03_lungenkarzinom_0270.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der positive Effekt der adjuvanten Chemotherapie wurde beobachtet bei Kollektiven mit Patienten im Stadium IB, II und IIIA inzidentell (d.h. operativ diagnostizierter mediastinaler Lymphknotenbefall bei unauffälliger zytologisch/histologisch oder bildgebender präoperativer mediastinaler Diagnostik)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1726__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der positive Effekt der adjuvanten Chemotherapie wurde beobachtet bei Kollektiven mit Patienten im Stadium IB, <span class=\"diff_chg\">Stadium II und Stadium</span> IIIA inzidentell (d.h. operativ diagnostizierter mediastinaler Lymphknotenbefall bei unauffälliger zytologisch/histologisch oder bildgebender präoperativer mediastinaler Diagnostik).</div><div nowrap=\"nowrap\">Der positive Effekt der adjuvanten Chemotherapie wurde beobachtet bei Kollektiven mit Patienten im Stadium IB, <span class=\"diff_chg\">II und</span> IIIA inzidentell (d.h. operativ diagnostizierter mediastinaler Lymphknotenbefall bei unauffälliger zytologisch/histologisch oder bildgebender präoperativer mediastinaler Diagnostik).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "179;03_lungenkarzinom_0270.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bestätigt wurden diese Daten durch die Metaanalyse von Pignon mit einer signifikanten Verlängerung der Überlebenszeit im Stadium II (HR 0.83) und komplett reseziertem IIIA (HR 0.83), nicht jedoch im Stadium IA (HR 1.41) oder IB (HR 0.92) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1727__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bestätigt wurden diese Daten durch die Metaanalyse von Pignon mit einer signifikanten Verlängerung der Überlebenszeit im Stadium II (HR 0.83) und komplett reseziertem <span class=\"diff_sub\">Stadium </span>IIIA (HR 0.83), nicht jedoch im Stadium IA (HR 1.41) oder<span class=\"diff_sub\"> Stadium</span> IB (HR 0.92) [REF].</div><div nowrap=\"nowrap\">Bestätigt wurden diese Daten durch die Metaanalyse von Pignon mit einer signifikanten Verlängerung der Überlebenszeit im Stadium II (HR 0.83) und komplett reseziertem IIIA (HR 0.83), nicht jedoch im Stadium IA (HR 1.41) oder IB (HR 0.92) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "180;03_lungenkarzinom_0274.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nach R0-Resektion und systematischer Lymphknotendissektion sollten Patienten im Stadium II bzw. IIIA1 / IIIA2 (vgl. 8.5.1) in gutem Allgemeinzustand (ECOG 0/1) eine adjuvante Chemotherapie erhalten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1728__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nach R0-Resektion und systematischer Lymphknotendissektion sollten Patienten im Stadium II bzw.<span class=\"diff_sub\"> Stadium</span> IIIA1 /<span class=\"diff_sub\"> Stadium</span> IIIA2 (vgl. 8.5.1) in gutem Allgemeinzustand (ECOG 0/1) eine adjuvante Chemotherapie erhalten.</div><div nowrap=\"nowrap\">Nach R0-Resektion und systematischer Lymphknotendissektion sollten Patienten im Stadium II bzw. IIIA1 / IIIA2 (vgl. 8.5.1) in gutem Allgemeinzustand (ECOG 0/1) eine adjuvante Chemotherapie erhalten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "181;03_lungenkarzinom_0281.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nach Daten von retrospektiven und prospektiv randomisierten Studien über die lokoregionale Effektivität der postoperativen Strahlentherapie wird diese im Stadium IIIA, einem individuell als hoch eingestuften Lokalrezidivrisiko oder nach R1/R2 Resektion im Einzelfall – bei Verwendung strahlentherapeutischer Methoden mit möglichst geringer Lungenbelastung – empfohlen [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1729__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nach Daten von retrospektiven und prospektiv randomisierten Studien über die lokoregionale Effektivität der postoperativen Strahlentherapie wird diese im Stadium IIIA, einem individuell als hoch eingestuften Lokalrezidivrisiko oder nach R1<span class=\"diff_sub\"> Resektion</span>/R2 Resektion im Einzelfall – bei Verwendung strahlentherapeutischer Methoden mit möglichst geringer Lungenbelastung – empfohlen [REF], [REF].</div><div nowrap=\"nowrap\">Nach Daten von retrospektiven und prospektiv randomisierten Studien über die lokoregionale Effektivität der postoperativen Strahlentherapie wird diese im Stadium IIIA, einem individuell als hoch eingestuften Lokalrezidivrisiko oder nach R1/R2 Resektion im Einzelfall – bei Verwendung strahlentherapeutischer Methoden mit möglichst geringer Lungenbelastung – empfohlen [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "182;03_lungenkarzinom_0281.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es gab signifikante Inkonsistenzen zwischen den Resultaten der verschiedenen Studien im Stadium I und II."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1730__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es gab signifikante Inkonsistenzen zwischen den Resultaten der verschiedenen Studien im Stadium I und <span class=\"diff_sub\">Stadium </span>II.</div><div nowrap=\"nowrap\">Es gab signifikante Inkonsistenzen zwischen den Resultaten der verschiedenen Studien im Stadium I und II.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "183;03_lungenkarzinom_0283.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Stadium I, II wird nach R0-Resektion eine adjuvante Strahlentherapie nicht empfohlen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1731__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Stadium I, <span class=\"diff_sub\">Stadium </span>II wird nach R0-Resektion eine adjuvante Strahlentherapie nicht empfohlen.</div><div nowrap=\"nowrap\">Im Stadium I, II wird nach R0-Resektion eine adjuvante Strahlentherapie nicht empfohlen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "184;03_lungenkarzinom_0284.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Stadium I, II wird nach R0-Resektion eine simultane adjuvante Chemoradiotherapie nicht empfohlen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1732__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Stadium I, <span class=\"diff_sub\">Stadium </span>II wird nach R0-Resektion eine simultane adjuvante Chemoradiotherapie nicht empfohlen.</div><div nowrap=\"nowrap\">Im Stadium I, II wird nach R0-Resektion eine simultane adjuvante Chemoradiotherapie nicht empfohlen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "185;03_lungenkarzinom_0285.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Strahlentherapie ist die effektivste Therapie des NSCLC im Stadium I/II bei „funktionell“ inoperablen Patienten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1733__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Strahlentherapie ist die effektivste Therapie des NSCLC im Stadium I/<span class=\"diff_sub\">Stadium </span>II bei „funktionell“ inoperablen Patienten.</div><div nowrap=\"nowrap\">Die Strahlentherapie ist die effektivste Therapie des NSCLC im Stadium I/II bei „funktionell“ inoperablen Patienten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "186;03_lungenkarzinom_0285.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Chirurgie und Strahlentherapie sind bisher im Stadium I/II nur durch nicht aussagekräftige Phase-II-Studien verglichen worden [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1734__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Chirurgie und Strahlentherapie sind bisher im Stadium I/<span class=\"diff_sub\">Stadium </span>II nur durch nicht aussagekräftige Phase-II-Studien verglichen worden [REF].</div><div nowrap=\"nowrap\">Chirurgie und Strahlentherapie sind bisher im Stadium I/II nur durch nicht aussagekräftige Phase-II-Studien verglichen worden [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "187;03_lungenkarzinom_0285.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Darüber hinaus wurde in verschiedenen nicht randomisierten Phase-II-Studien die Durchführbarkeit und Effektivität einer konformalen stereotaktisch oder bildgeführten hypofraktionierten Strahlentherapie bei inoperablen Patienten im Stadium I geprüft [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1735__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Darüber hinaus wurde in verschiedenen nicht randomisierten Phase-II-Studien die Durchführbarkeit und Effektivität einer konformalen stereotaktischgeführten oder bildgeführten hypofraktionierten Strahlentherapie bei inoperablen Patienten im Stadium I geprüft [REF].</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Darüber hinaus wurde in verschiedenen nicht randomisierten Phase-II-Studien die Durchführbarkeit und Effektivität einer konformalen stereotaktisch oder bildgeführten hypofraktionierten Strahlentherapie bei inoperablen Patienten im Stadium I geprüft [REF].</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "188;03_lungenkarzinom_0286.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch das Ergebnis der CHART-Studie zeigt, dass mit einer Intensivierung der Strahlenherapie im Stadium I/II, dort mit einer hyperfraktionierten akzelerierten Bestrahlung bis 54 Gy in 36 Fraktionen über 12 Tage, im Vergleich zu einer konventionellen Bestrahlung mit 60 Gy in 30 Fraktionen über 42 Tage beobachtet eine Verbesserung der Überlebenszeit erzielt werden kann [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1736__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch das Ergebnis der CHART-Studie zeigt, dass mit einer Intensivierung der Strahlenherapie im Stadium I/<span class=\"diff_sub\">Stadium </span>II, dort mit einer hyperfraktionierten akzelerierten Bestrahlung bis 54 Gy in 36 Fraktionen über 12 Tage, im Vergleich zu einer konventionellen Bestrahlung mit 60 Gy in 30 Fraktionen über 42 Tage beobachtet eine Verbesserung der Überlebenszeit erzielt werden kann [REF].</div><div nowrap=\"nowrap\">Auch das Ergebnis der CHART-Studie zeigt, dass mit einer Intensivierung der Strahlenherapie im Stadium I/II, dort mit einer hyperfraktionierten akzelerierten Bestrahlung bis 54 Gy in 36 Fraktionen über 12 Tage, im Vergleich zu einer konventionellen Bestrahlung mit 60 Gy in 30 Fraktionen über 42 Tage beobachtet eine Verbesserung der Überlebenszeit erzielt werden kann [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "189;03_lungenkarzinom_0286.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine strukturierte Literaturrecherche ermittelte 21 Publikationen mit insgesamt über 1800 Patienten, die bei medizinischer Inoperabilität im Stadium I/(II)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1737__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine strukturierte Literaturrecherche ermittelte 21 Publikationen mit insgesamt über 1800 Patienten, die bei medizinischer Inoperabilität im Stadium I/(<span class=\"diff_sub\">Stadium </span>II).</div><div nowrap=\"nowrap\">Eine strukturierte Literaturrecherche ermittelte 21 Publikationen mit insgesamt über 1800 Patienten, die bei medizinischer Inoperabilität im Stadium I/(II).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "190;03_lungenkarzinom_0289.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Stadium I und II gibt es keine Evidenz, dass durch eine elektive Mediastinalbestrahlung die Prognose verbessert werden kann [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1738__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Stadium I und <span class=\"diff_sub\">Stadium </span>II gibt es keine Evidenz, dass durch eine elektive Mediastinalbestrahlung die Prognose verbessert werden kann [REF].</div><div nowrap=\"nowrap\">Im Stadium I und II gibt es keine Evidenz, dass durch eine elektive Mediastinalbestrahlung die Prognose verbessert werden kann [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "191;03_lungenkarzinom_0296.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "* * pN1 impliziert ein hohes systemisches Rezidivrisiko; nach R0-Resektion profitieren Patienten mit pN1 (pT1-3) am besten von einer adjuvanten Chemotherapie, daher kann diese im Einzelfall auch nach Abschluss der Lokaltherapie bei vorangegangener R1/2-Resektion empfohlen werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1739__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">* * pN1 impliziert ein hohes systemisches Rezidivrisiko; nach R0-Resektion profitieren Patienten mit pN1 (pT1-3) am besten von einer adjuvanten Chemotherapie, daher kann diese im Einzelfall auch nach Abschluss der Lokaltherapie bei vorangegangener R1<span class=\"diff_sub\">-Resektion</span>/<span class=\"diff_sub\">R</span>2-Resektion empfohlen werden.</div><div nowrap=\"nowrap\">* * pN1 impliziert ein hohes systemisches Rezidivrisiko; nach R0-Resektion profitieren Patienten mit pN1 (pT1-3) am besten von einer adjuvanten Chemotherapie, daher kann diese im Einzelfall auch nach Abschluss der Lokaltherapie bei vorangegangener R1/2-Resektion empfohlen werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "192;03_lungenkarzinom_0297.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die R0/R1 Resektionsrate betrug 92 % mit 28 % pCR."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1740__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die R0 Resektionsrate<span class=\"diff_sub\">/R1 Resektionsrate</span> betrug 92 % mit 28 % pCR.</div><div nowrap=\"nowrap\">Die R0<span class=\"diff_add\">/R1</span> Resektionsrate betrug 92 % mit 28 % pCR.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "193;03_lungenkarzinom_0297.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die entscheidenden Faktoren dafür sind hierbei die unterschiedlichen Tumorstadien (IIB, IIIA, IIIB), wobei dem mediastinalen Lymphknotenbefall eine dominante prognostische Bedeutung zukommt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1741__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die entscheidenden Faktoren dafür sind hierbei die unterschiedlichen Tumorstadien (<span class=\"diff_sub\">Tumorstadien </span>IIB,<span class=\"diff_sub\"> Tumorstadien</span> IIIA,<span class=\"diff_sub\"> Tumorstadien</span> IIIB), wobei dem mediastinalen Lymphknotenbefall eine dominante prognostische Bedeutung zukommt.</div><div nowrap=\"nowrap\">Die entscheidenden Faktoren dafür sind hierbei die unterschiedlichen Tumorstadien (IIB, IIIA, IIIB), wobei dem mediastinalen Lymphknotenbefall eine dominante prognostische Bedeutung zukommt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "194;03_lungenkarzinom_0297.tsv;28"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einigen Studien wurden auch sequentielle Ansätze (Chemotherapie gefolgt von simultaner Radio- / Chemotherapie) verfolgt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1742__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einigen Studien wurden auch sequentielle Ansätze (Chemotherapie gefolgt von simultaner Radio<span class=\"diff_chg\">therapie</span> / Chemotherapie) verfolgt.</div><div nowrap=\"nowrap\">In einigen Studien wurden auch sequentielle Ansätze (Chemotherapie gefolgt von simultaner Radio<span class=\"diff_chg\">-</span> / Chemotherapie) verfolgt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "195;03_lungenkarzinom_0302.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten mit technischer oder funktioneller Inoperabilität sollten eine definitive Radio-/Chemotherapie erhalten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1743__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten mit technischer oder funktioneller Inoperabilität sollten eine definitive Radio<span class=\"diff_chg\">therapie</span>/Chemotherapie erhalten.</div><div nowrap=\"nowrap\">Patienten mit technischer oder funktioneller Inoperabilität sollten eine definitive Radio<span class=\"diff_chg\">-</span>/Chemotherapie erhalten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "196;03_lungenkarzinom_0305.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während im Stadium IIIA1 / IIIA2 - wenn technisch durchführbar - die primäre Resektion und nachgehend adjuvante Behandlung erfolgen kann, ist das Stadium IIIA3 Gegenstand der klinischen Forschung (adjuvante versus neoadjuvante Systemtherapie unter Einbindung der Operation; Radiotherapie versus Operation zur lokalen Kontrolle; Trimodalitätenbehandlung)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1744__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während im Stadium IIIA1 /<span class=\"diff_sub\"> Stadium</span> IIIA2 - wenn technisch durchführbar - die primäre Resektion und nachgehend adjuvante Behandlung erfolgen kann, ist das Stadium IIIA3 Gegenstand der klinischen Forschung (adjuvante versus neoadjuvante Systemtherapie unter Einbindung der Operation; Radiotherapie versus Operation zur lokalen Kontrolle; Trimodalitätenbehandlung).</div><div nowrap=\"nowrap\">Während im Stadium IIIA1 / IIIA2 - wenn technisch durchführbar - die primäre Resektion und nachgehend adjuvante Behandlung erfolgen kann, ist das Stadium IIIA3 Gegenstand der klinischen Forschung (adjuvante versus neoadjuvante Systemtherapie unter Einbindung der Operation; Radiotherapie versus Operation zur lokalen Kontrolle; Trimodalitätenbehandlung).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "197;03_lungenkarzinom_0310.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten, bei denen ein Stadium IIIA (T4N0/1) komplett reseziert worden ist, gibt es keine klare Evidenzlage zur Indikation einer adjuvanten Chemotherapie."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1745__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten, bei denen ein Stadium IIIA (T4N0/<span class=\"diff_sub\">T4N</span>1) komplett reseziert worden ist, gibt es keine klare Evidenzlage zur Indikation einer adjuvanten Chemotherapie.</div><div nowrap=\"nowrap\">Patienten, bei denen ein Stadium IIIA (T4N0/1) komplett reseziert worden ist, gibt es keine klare Evidenzlage zur Indikation einer adjuvanten Chemotherapie.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "198;03_lungenkarzinom_0311.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für Patienten mit mediastinalem Lymphknotenbefall im Stadium IIIA1 bzw. IIIA2 sollte zusätzlich zur adjuvanten Chemotherapie die Indikation für eine postoperative Mediastinalbestrahlung geprüft werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1746__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für Patienten mit mediastinalem Lymphknotenbefall im Stadium IIIA1 bzw. <span class=\"diff_sub\">Stadium </span>IIIA2 sollte zusätzlich zur adjuvanten Chemotherapie die Indikation für eine postoperative Mediastinalbestrahlung geprüft werden.</div><div nowrap=\"nowrap\">Für Patienten mit mediastinalem Lymphknotenbefall im Stadium IIIA1 bzw. IIIA2 sollte zusätzlich zur adjuvanten Chemotherapie die Indikation für eine postoperative Mediastinalbestrahlung geprüft werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "199;03_lungenkarzinom_0311.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In dem Stadium IIIA (T4N0/1) ist die primäre Operation bei medizinischer und funktioneller Operabilität in folgenden Fällen möglich:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1747__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In dem Stadium IIIA (T4N0/<span class=\"diff_sub\">T4N</span>1) ist die primäre Operation bei medizinischer und funktioneller Operabilität in folgenden Fällen möglich:</div><div nowrap=\"nowrap\">In dem Stadium IIIA (T4N0/1) ist die primäre Operation bei medizinischer und funktioneller Operabilität in folgenden Fällen möglich:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "200;03_lungenkarzinom_0314.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Intergroup-Studie (INT 0139) wurden Patienten mit prätherapeutisch nachgewiesenem N2- Status und primär resektabler Tumorausdehnung (T1-3 N2 M0) randomisiert auf eine Behandlung mit einer definitiven simultanen Chemo-/ Radiotherapie (def. CT/RT) versus simultane Chemo-/Radiotherapie gefolgt von Operation (RT/CT-OP)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1748__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Intergroup-Studie (INT 0139) wurden Patienten mit prätherapeutisch nachgewiesenem N2- Status und primär resektabler Tumorausdehnung (T1-3 N2 M0) randomisiert auf eine Behandlung mit einer definitiven simultanen Chemo<span class=\"diff_chg\">therapie</span>/ Radiotherapie (def. CT/RT) versus simultane Chemo<span class=\"diff_chg\">therapie</span>/Radiotherapie gefolgt von Operation (RT<span class=\"diff_sub\">-OP</span>/CT-OP).</div><div nowrap=\"nowrap\">In der Intergroup-Studie (INT 0139) wurden Patienten mit prätherapeutisch nachgewiesenem N2- Status und primär resektabler Tumorausdehnung (T1-3 N2 M0) randomisiert auf eine Behandlung mit einer definitiven simultanen Chemo<span class=\"diff_chg\">-</span>/ Radiotherapie (def. CT/RT) versus simultane Chemo<span class=\"diff_chg\">-</span>/Radiotherapie gefolgt von Operation (RT/CT-OP).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "201;03_lungenkarzinom_0314.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten mit prätherapeutisch (histologisch/zytologisch) nachgewiesenem N2-Status wurde in mehreren randomisierten Studien der Stellenwert der Lokaltherapie in Form der Operation gegenüber der Radiotherapie – entweder als alleinige Therapieform, oder nach induktiver Chemotherapie bzw. Radio- / Chemotherapie – verglichen [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1749__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten mit prätherapeutisch (histologisch/zytologisch) nachgewiesenem N2-Status wurde in mehreren randomisierten Studien der Stellenwert der Lokaltherapie in Form der Operation gegenüber der Radiotherapie – entweder als alleinige Therapieform, oder nach induktiver Chemotherapie bzw. Radio<span class=\"diff_chg\">therapie</span> / Chemotherapie – verglichen [REF], [REF].</div><div nowrap=\"nowrap\">Bei Patienten mit prätherapeutisch (histologisch/zytologisch) nachgewiesenem N2-Status wurde in mehreren randomisierten Studien der Stellenwert der Lokaltherapie in Form der Operation gegenüber der Radiotherapie – entweder als alleinige Therapieform, oder nach induktiver Chemotherapie bzw. Radio<span class=\"diff_chg\">-</span> / Chemotherapie – verglichen [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "202;03_lungenkarzinom_0321.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Vielzahl von Phase-II-Studien, eine randomisierte Phase-II-Studie und mittlerweile zwei randomisierte Phase-III-Studien haben dieses intensivere Konzept in unterschiedlichen Patientenkollektiven (Stadium IIIA/IIIB) getestet [REF], [REF], [REF], [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1750__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Vielzahl von Phase-II-Studien, eine randomisierte Phase-II-Studie und mittlerweile zwei randomisierte Phase-III-Studien haben dieses intensivere Konzept in unterschiedlichen Patientenkollektiven (Stadium IIIA/<span class=\"diff_sub\">Stadium </span>IIIB) getestet [REF], [REF], [REF], [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Eine Vielzahl von Phase-II-Studien, eine randomisierte Phase-II-Studie und mittlerweile zwei randomisierte Phase-III-Studien haben dieses intensivere Konzept in unterschiedlichen Patientenkollektiven (Stadium IIIA/IIIB) getestet [REF], [REF], [REF], [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "203;03_lungenkarzinom_0325.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Überlegenheit gegenüber einer definitiven simultanen Chemoradiotherapie ist hinsichtlich des Gesamtüberleben nicht ableitbar; allerdings zeigte bei primär resektablen Patienten ein Ansatz aus Radio-/Chemotherapie gefolgt von Operation im Vergleich zur definitiven Radio-/Chemotherapie ohne Operation eine signifikante Verlängerung des progressionsfreien Überlebens [REF] (Evidenzgrad 1b)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1751__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Überlegenheit gegenüber einer definitiven simultanen Chemoradiotherapie ist hinsichtlich des Gesamtüberleben nicht ableitbar; allerdings zeigte bei primär resektablen Patienten ein Ansatz aus Radio<span class=\"diff_chg\">therapie</span>/Chemotherapie gefolgt von Operation im Vergleich zur definitiven Radio<span class=\"diff_chg\">therapie</span>/Chemotherapie ohne Operation eine signifikante Verlängerung des progressionsfreien Überlebens [REF] (Evidenzgrad 1b).</div><div nowrap=\"nowrap\">Eine Überlegenheit gegenüber einer definitiven simultanen Chemoradiotherapie ist hinsichtlich des Gesamtüberleben nicht ableitbar; allerdings zeigte bei primär resektablen Patienten ein Ansatz aus Radio<span class=\"diff_chg\">-</span>/Chemotherapie gefolgt von Operation im Vergleich zur definitiven Radio<span class=\"diff_chg\">-</span>/Chemotherapie ohne Operation eine signifikante Verlängerung des progressionsfreien Überlebens [REF] (Evidenzgrad 1b).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "204;03_lungenkarzinom_0330.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für Patienten mit mediastinalem Lymphknotenbefall im Stadium IIIA1 bzw. IIIA2 sollte zusätzlich zur adjuvanten Chemotherapie die Indikation zur postoperativen Mediastinalbestrahlung geprüft werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1752__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für Patienten mit mediastinalem Lymphknotenbefall im Stadium IIIA1 bzw.<span class=\"diff_sub\"> Stadium</span> IIIA2 sollte zusätzlich zur adjuvanten Chemotherapie die Indikation zur postoperativen Mediastinalbestrahlung geprüft werden.</div><div nowrap=\"nowrap\">Für Patienten mit mediastinalem Lymphknotenbefall im Stadium IIIA1 bzw. IIIA2 sollte zusätzlich zur adjuvanten Chemotherapie die Indikation zur postoperativen Mediastinalbestrahlung geprüft werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "205;03_lungenkarzinom_0336.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Stadium IIIA3 – insbesondere bei multiplem N2-Befall – können gleichermaßen mit einer Kombination aus Strahlentherapie und Chemotherapie (definitive Chemo-/Radiotherapie) behandelt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1753__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im Stadium IIIA3 – insbesondere bei multiplem N2-Befall – können gleichermaßen mit einer Kombination aus Strahlentherapie und Chemotherapie (definitive Chemo<span class=\"diff_chg\">therapie</span>/Radiotherapie) behandelt werden.</div><div nowrap=\"nowrap\">Patienten im Stadium IIIA3 – insbesondere bei multiplem N2-Befall – können gleichermaßen mit einer Kombination aus Strahlentherapie und Chemotherapie (definitive Chemo<span class=\"diff_chg\">-</span>/Radiotherapie) behandelt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "206;03_lungenkarzinom_0348.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Angesichts der Tatsache, dass durch eine „Systemtherapie“ sowohl im Stadium II eine Verbesserung der Überlebenszeiten über eine Verminderung der Fernmetastasierung erreicht werden kann als auch im Stadium IIIB/IV eine signifikante Verlängerung der Überlebenszeiten durch die Integration einer Chemotherapie erreicht wird, steht zu vermuten, dass sie auch im Stadium III einen Einfluss auf die Behandlungsergebnisse haben dürfte."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1754__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Angesichts der Tatsache, dass durch eine „Systemtherapie“ sowohl im Stadium II eine Verbesserung der Überlebenszeiten über eine Verminderung der Fernmetastasierung erreicht werden kann als auch im Stadium IIIB/Stadium IV eine signifikante Verlängerung der Überlebenszeiten durch die Integration einer Chemotherapie erreicht wird, steht zu vermuten, dass sie auch im Stadium III einen Einfluss auf die Behandlungsergebnisse haben dürfte.</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Angesichts der Tatsache, dass durch eine „Systemtherapie“ sowohl im Stadium II eine Verbesserung der Überlebenszeiten über eine Verminderung der Fernmetastasierung erreicht werden kann als auch im Stadium IIIB/IV eine signifikante Verlängerung der Überlebenszeiten durch die Integration einer Chemotherapie erreicht wird, steht zu vermuten, dass sie auch im Stadium III einen Einfluss auf die Behandlungsergebnisse haben dürfte.</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "207;03_lungenkarzinom_0348.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Anzumerken ist jedoch, dass im Rahmen von Studien im Stadium IIIB (SWOG 9905) und im Stadium IIIA(N2) (INT 0139) nach definitiver simultaner Chemo-/Radiotherapie eine konsolidierende Chemotherapie auf Basis von Cisplatin / Etoposid (zwei Zyklen) mit gutem Ergebnis und vertretbarer Morbidität durchführbar war [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1755__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Anzumerken ist jedoch, dass im Rahmen von Studien im Stadium IIIB (SWOG 9905) und im Stadium IIIA(N2) (INT 0139) nach definitiver simultaner Chemo<span class=\"diff_chg\">therapie</span>/Radiotherapie eine konsolidierende Chemotherapie auf Basis von Cisplatin / Etoposid (zwei Zyklen) mit gutem Ergebnis und vertretbarer Morbidität durchführbar war [REF], [REF].</div><div nowrap=\"nowrap\">Anzumerken ist jedoch, dass im Rahmen von Studien im Stadium IIIB (SWOG 9905) und im Stadium IIIA(N2) (INT 0139) nach definitiver simultaner Chemo<span class=\"diff_chg\">-</span>/Radiotherapie eine konsolidierende Chemotherapie auf Basis von Cisplatin / Etoposid (zwei Zyklen) mit gutem Ergebnis und vertretbarer Morbidität durchführbar war [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "208;03_lungenkarzinom_0348.tsv;19"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Langzeitüberlebensraten aus diesen Studien gehören auch in den Stadien IIIB und IIIA(N2) zu den besten, die bisher mitgeteilt wurden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1756__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Langzeitüberlebensraten aus diesen Studien gehören auch in den Stadien IIIB und<span class=\"diff_sub\"> Stadien</span> IIIA(N2) zu den besten, die bisher mitgeteilt wurden.</div><div nowrap=\"nowrap\">Die Langzeitüberlebensraten aus diesen Studien gehören auch in den Stadien IIIB und IIIA(N2) zu den besten, die bisher mitgeteilt wurden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "209;03_lungenkarzinom_0348.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sowohl die sequentielle (2 - 4 platinbasierte Chemotherapiezyklen gefolgt von 60 bis 66 Gy konventionell fraktionierter Radiotherapie) als auch die simultane Chemo- / Radiotherapie (Cisplatin-basierte Chemotherapie und simultane Radiotherapie zwischen 60 und 66 Gy) verbessern medianes und Langzeitüberleben von Patienten im Stadium III signifikant [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1757__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sowohl die sequentielle (2 - 4 platinbasierte Chemotherapiezyklen gefolgt von 60 bis 66 Gy konventionell fraktionierter Radiotherapie) als auch die simultane Chemo<span class=\"diff_chg\">therapie</span> / Radiotherapie (Cisplatin-basierte Chemotherapie und simultane Radiotherapie zwischen 60 und 66 Gy) verbessern medianes <span class=\"diff_chg\">Überleben und</span> Langzeitüberleben von Patienten im Stadium III signifikant [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Sowohl die sequentielle (2 - 4 platinbasierte Chemotherapiezyklen gefolgt von 60 bis 66 Gy konventionell fraktionierter Radiotherapie) als auch die simultane Chemo<span class=\"diff_chg\">-</span> / Radiotherapie (Cisplatin-basierte Chemotherapie und simultane Radiotherapie zwischen 60 und 66 Gy) verbessern medianes <span class=\"diff_chg\">und</span> Langzeitüberleben von Patienten im Stadium III signifikant [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "210;03_lungenkarzinom_0348.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während eine Induktionschemotherapie mit Carboplatin-basierten Protokollen zusätzlich zur simultanen Chemo-/Radiotherapie die Ergebnisse bisher nicht verbessern konnte, wurde in einer multizentrischen Phase-II-Studie mit einer Konsolidierungschemotherapie (3 Zyklen Docetaxel) im Nachgang zur simultanen Radiochemotherapie (61 Gy, 2 Zyklen Cisplatin Etoposid) ein medianes Überleben von 26 Monaten und ein 3-Jahres Überleben von 37 % erreicht [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1758__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während eine Induktionschemotherapie mit Carboplatin-basierten Protokollen zusätzlich zur simultanen Chemo<span class=\"diff_chg\">therapie</span>/Radiotherapie die Ergebnisse bisher nicht verbessern konnte, wurde in einer multizentrischen Phase-II-Studie mit einer Konsolidierungschemotherapie (3 Zyklen Docetaxel) im Nachgang zur simultanen Radiochemotherapie (61 Gy, 2 Zyklen Cisplatin Etoposid) ein medianes Überleben von 26 Monaten und ein 3-Jahres Überleben von 37 % erreicht [REF].</div><div nowrap=\"nowrap\">Während eine Induktionschemotherapie mit Carboplatin-basierten Protokollen zusätzlich zur simultanen Chemo<span class=\"diff_chg\">-</span>/Radiotherapie die Ergebnisse bisher nicht verbessern konnte, wurde in einer multizentrischen Phase-II-Studie mit einer Konsolidierungschemotherapie (3 Zyklen Docetaxel) im Nachgang zur simultanen Radiochemotherapie (61 Gy, 2 Zyklen Cisplatin Etoposid) ein medianes Überleben von 26 Monaten und ein 3-Jahres Überleben von 37 % erreicht [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "211;03_lungenkarzinom_0348.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Deshalb wurden bei Patienten mit günstigem Komorbiditätsprofil Konzepte der sequentiellen und simultanen Chemo- / Radiotherapie geprüft."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1759__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Deshalb wurden bei Patienten mit günstigem Komorbiditätsprofil Konzepte der sequentiellen und simultanen Chemo<span class=\"diff_chg\">therapie</span> / Radiotherapie geprüft.</div><div nowrap=\"nowrap\">Deshalb wurden bei Patienten mit günstigem Komorbiditätsprofil Konzepte der sequentiellen und simultanen Chemo<span class=\"diff_chg\">-</span> / Radiotherapie geprüft.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "212;03_lungenkarzinom_0351.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das britische CHART-Protokoll mit einer auf 12 Tage verkürzten Behandlungszeit und dreimal täglicher Bestrahlung (54 Gy in 12 Tagen versus 60 Gy in 6 Wochen; 30 % der Patienten in Stadium II) erzielte einen signifikanten Vorteil für progressionsfreies und Gesamtüberleben [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1760__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das britische CHART-Protokoll mit einer auf 12 Tage verkürzten Behandlungszeit und dreimal täglicher Bestrahlung (54 Gy in 12 Tagen versus 60 Gy in 6 Wochen; 30 % der Patienten in Stadium II) erzielte einen signifikanten Vorteil für progressionsfreies <span class=\"diff_chg\">Überleben und</span> Gesamtüberleben [REF].</div><div nowrap=\"nowrap\">Das britische CHART-Protokoll mit einer auf 12 Tage verkürzten Behandlungszeit und dreimal täglicher Bestrahlung (54 Gy in 12 Tagen versus 60 Gy in 6 Wochen; 30 % der Patienten in Stadium II) erzielte einen signifikanten Vorteil für progressionsfreies <span class=\"diff_chg\">und</span> Gesamtüberleben [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "213;03_lungenkarzinom_0354.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Stadium IIIA4/IIIB sollten – wenn Allgemeinzustand und Tumorausdehnung dies zulassen – eine Kombination aus Strahlentherapie und Chemotherapie erhalten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1761__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im Stadium IIIA4/<span class=\"diff_sub\">Stadium </span>IIIB sollten – wenn Allgemeinzustand und Tumorausdehnung dies zulassen – eine Kombination aus Strahlentherapie und Chemotherapie erhalten.</div><div nowrap=\"nowrap\">Patienten im Stadium IIIA4/IIIB sollten – wenn Allgemeinzustand und Tumorausdehnung dies zulassen – eine Kombination aus Strahlentherapie und Chemotherapie erhalten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "214;03_lungenkarzinom_0354.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im direkten Vergleich ist bei geeigneten Patienten die simultane Radio-/ Chemotherapie der sequentiellen Therapie überlegen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1762__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im direkten Vergleich ist bei geeigneten Patienten die simultane Radio<span class=\"diff_chg\">therapie</span>/ Chemotherapie der sequentiellen Therapie überlegen.</div><div nowrap=\"nowrap\">Im direkten Vergleich ist bei geeigneten Patienten die simultane Radio<span class=\"diff_chg\">-</span>/ Chemotherapie der sequentiellen Therapie überlegen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "215;03_lungenkarzinom_0355.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Stadium IIIA3 – insbesondere bei multiplem N2-Befall – können mit einer Kombination aus Strahlentherapie und Chemotherapie (definitive Chemo-/Radiotherapie) behandelt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1763__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im Stadium IIIA3 – insbesondere bei multiplem N2-Befall – können mit einer Kombination aus Strahlentherapie und Chemotherapie (definitive Chemo<span class=\"diff_chg\">therapie</span>/Radiotherapie) behandelt werden.</div><div nowrap=\"nowrap\">Patienten im Stadium IIIA3 – insbesondere bei multiplem N2-Befall – können mit einer Kombination aus Strahlentherapie und Chemotherapie (definitive Chemo<span class=\"diff_chg\">-</span>/Radiotherapie) behandelt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "216;03_lungenkarzinom_0356.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Stadium IIIA4 / IIIB sollten – wenn Allgemeinzustand und Tumorausdehnung dies zulassen – eine Kombination aus Strahlentherapie und Chemotherapie erhalten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1764__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im Stadium IIIA4 /<span class=\"diff_sub\"> Stadium</span> IIIB sollten – wenn Allgemeinzustand und Tumorausdehnung dies zulassen – eine Kombination aus Strahlentherapie und Chemotherapie erhalten.</div><div nowrap=\"nowrap\">Patienten im Stadium IIIA4 / IIIB sollten – wenn Allgemeinzustand und Tumorausdehnung dies zulassen – eine Kombination aus Strahlentherapie und Chemotherapie erhalten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "217;03_lungenkarzinom_0357.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für selektionierte Patienten im Stadium IIIA4 / IIIB kann im begründeten Ausnahmefall ein multimodaler Behandlungsansatz unter Integration der Operation (möglichst nur in Studien) erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1765__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für selektionierte Patienten im Stadium IIIA4 /<span class=\"diff_sub\"> Stadium</span> IIIB kann im begründeten Ausnahmefall ein multimodaler Behandlungsansatz unter Integration der Operation (möglichst nur in Studien) erfolgen.</div><div nowrap=\"nowrap\">Für selektionierte Patienten im Stadium IIIA4 / IIIB kann im begründeten Ausnahmefall ein multimodaler Behandlungsansatz unter Integration der Operation (möglichst nur in Studien) erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "218;03_lungenkarzinom_0358.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im direkten Vergleich ist bei geeigneten Patienten die simultane Radio-/Chemotherapie der sequentiellen überlegen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1766__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im direkten Vergleich ist bei geeigneten Patienten die simultane Radio<span class=\"diff_chg\">therapie</span>/Chemotherapie der sequentiellen überlegen.</div><div nowrap=\"nowrap\">Im direkten Vergleich ist bei geeigneten Patienten die simultane Radio<span class=\"diff_chg\">-</span>/Chemotherapie der sequentiellen überlegen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "219;03_lungenkarzinom_0363.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Vergleich zur alleinigen simultanen Chemo- / Radiotherapie ist der Stellenwert einer zusätzlichen konsolidierenden Chemotherapie in randomisierten Studien bisher nicht belegt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1767__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Vergleich zur alleinigen simultanen Chemo<span class=\"diff_chg\">therapie</span> / Radiotherapie ist der Stellenwert einer zusätzlichen konsolidierenden Chemotherapie in randomisierten Studien bisher nicht belegt.</div><div nowrap=\"nowrap\">Im Vergleich zur alleinigen simultanen Chemo<span class=\"diff_chg\">-</span> / Radiotherapie ist der Stellenwert einer zusätzlichen konsolidierenden Chemotherapie in randomisierten Studien bisher nicht belegt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "220;03_lungenkarzinom_0363.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die zusätzliche Konsolidierung in Form der Monotherapie mit einem Taxan nach stattgehabter Radio-/Chemotherapie führt zu deutlicher und inak-zeptabler Toxizität und wird nicht empfohlen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1768__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die zusätzliche Konsolidierung in Form der Monotherapie mit einem Taxan nach stattgehabter Radio<span class=\"diff_chg\">therapie</span>/Chemotherapie führt zu deutlicher und inak-zeptabler Toxizität und wird nicht empfohlen.</div><div nowrap=\"nowrap\">Die zusätzliche Konsolidierung in Form der Monotherapie mit einem Taxan nach stattgehabter Radio<span class=\"diff_chg\">-</span>/Chemotherapie führt zu deutlicher und inak-zeptabler Toxizität und wird nicht empfohlen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "221;03_lungenkarzinom_0369.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Insbesondere im Stadium IIIA3/IIIA4 sollte die Durchführung an Zentren mit entsprechender Erfahrung und hinreichendem Behandlungsvolumen erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1769__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Insbesondere im Stadium IIIA3/<span class=\"diff_sub\">Stadium </span>IIIA4 sollte die Durchführung an Zentren mit entsprechender Erfahrung und hinreichendem Behandlungsvolumen erfolgen.</div><div nowrap=\"nowrap\">Insbesondere im Stadium IIIA3/IIIA4 sollte die Durchführung an Zentren mit entsprechender Erfahrung und hinreichendem Behandlungsvolumen erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "222;03_lungenkarzinom_0369.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "III A1/2:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1770__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">III A1/<span class=\"diff_sub\">III A</span>2:</div><div nowrap=\"nowrap\">III A1/2:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "223;03_lungenkarzinom_0371.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die mediane Überlebenszeit von Patienten im Stadium IIIB/IV beträgt bei unselektionierter Behandlung 8-18 Monate und ist deutlich günstiger bei der zielgerichteten Therapie von ausgewählten, therapeutisch angehbaren molekularen Veränderungen (Median bis > 4 Jahre)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1771__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die mediane Überlebenszeit von Patienten im Stadium IIIB/<span class=\"diff_sub\">Stadium </span>IV beträgt bei unselektionierter Behandlung 8-18 Monate und ist deutlich günstiger bei der zielgerichteten Therapie von ausgewählten, therapeutisch angehbaren molekularen Veränderungen (Median bis &gt; 4 Jahre).</div><div nowrap=\"nowrap\">Die mediane Überlebenszeit von Patienten im Stadium IIIB/IV beträgt bei unselektionierter Behandlung 8-18 Monate und ist deutlich günstiger bei der zielgerichteten Therapie von ausgewählten, therapeutisch angehbaren molekularen Veränderungen (Median bis &gt; 4 Jahre).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "224;03_lungenkarzinom_0380.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten im Stadium IV (neu: IV B) in gutem Allgemeinzustand (ECOG 0-1) soll eine platinbasierte Kombinationschemotherapie angeboten werden, vorzugsweise mit Cisplatin."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1772__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten im Stadium IV (neu: <span class=\"diff_sub\">Stadium </span>IV B) in gutem Allgemeinzustand (ECOG 0-1) soll eine platinbasierte Kombinationschemotherapie angeboten werden, vorzugsweise mit Cisplatin.</div><div nowrap=\"nowrap\">Bei Patienten im Stadium IV (neu: IV B) in gutem Allgemeinzustand (ECOG 0-1) soll eine platinbasierte Kombinationschemotherapie angeboten werden, vorzugsweise mit Cisplatin.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "225;03_lungenkarzinom_0382.tsv;73"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Mono- versus Kombinationschemotherapie"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1773__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Mono<span class=\"diff_chg\">chemotherapie</span> versus Kombinationschemotherapie</div><div nowrap=\"nowrap\">Mono<span class=\"diff_chg\">-</span> versus Kombinationschemotherapie</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "226;03_lungenkarzinom_0382.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ziele der Behandlung im Stadium IIIB/IV (neu: IVB) sind:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1774__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ziele der Behandlung im Stadium IIIB/<span class=\"diff_sub\">Stadium </span>IV (neu: <span class=\"diff_sub\">Stadium </span>IVB) sind:</div><div nowrap=\"nowrap\">Ziele der Behandlung im Stadium IIIB/IV (neu: IVB) sind:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "227;03_lungenkarzinom_0382.tsv;49"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Nutzen von Nab-Paclitaxel (=nab = nanoparticle albumin bound) wurde in einer Phase-III-Studie bei 1052 Patienten mit Stadium IIIB und IV untersucht [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1775__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Nutzen von Nab-Paclitaxel (=nab = nanoparticle albumin bound) wurde in einer Phase-III-Studie bei 1052 Patienten mit Stadium IIIB und <span class=\"diff_sub\">Stadium </span>IV untersucht [REF], [REF].</div><div nowrap=\"nowrap\">Der Nutzen von Nab-Paclitaxel (=nab = nanoparticle albumin bound) wurde in einer Phase-III-Studie bei 1052 Patienten mit Stadium IIIB und IV untersucht [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "228;03_lungenkarzinom_0382.tsv;52"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Studienpatienten waren stratifiziert nach Stadium IIIB vs. IV, Alter (unter oder über 70 Jahre), Geschlecht, Histologie (Plattenepithel- vs. Adenokarzinom vs. andere) und geographische Region (Nordamerika vs. Russland/Ukraine vs. Japan vs. Australien)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1776__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Studienpatienten waren stratifiziert nach Stadium IIIB vs.<span class=\"diff_sub\"> Stadium</span> IV, Alter (unter oder über 70 Jahre), Geschlecht, Histologie (Plattenepithelkarzinom vs.<span class=\"diff_sub\"> Adenokarzinom vs.</span> andere) und geographische Region (Nordamerika vs. Russland/Ukraine vs. Japan vs. Australien).</div><div nowrap=\"nowrap\">Die Studienpatienten waren stratifiziert nach Stadium IIIB vs. IV, Alter (unter oder über 70 Jahre), Geschlecht, Histologie (Plattenepithel<span class=\"diff_add\">- vs. Adeno</span>karzinom vs. andere) und geographische Region (Nordamerika vs. Russland/Ukraine vs. Japan vs. Australien).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "229;03_lungenkarzinom_0382.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Somit kann bei Patienten im Stadium IIIB/IV (neu: IVB) eine Chemotherapie zur Verbesserung der Überlebenszeit, der Krankheitskontrolle und der Lebensqualität als Therapieoption angeboten werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1777__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Somit kann bei Patienten im Stadium IIIB/<span class=\"diff_sub\">Stadium </span>IV (neu: <span class=\"diff_sub\">Stadium </span>IVB) eine Chemotherapie zur Verbesserung der Überlebenszeit, der Krankheitskontrolle und der Lebensqualität als Therapieoption angeboten werden.</div><div nowrap=\"nowrap\">Somit kann bei Patienten im Stadium IIIB/IV (neu: IVB) eine Chemotherapie zur Verbesserung der Überlebenszeit, der Krankheitskontrolle und der Lebensqualität als Therapieoption angeboten werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "230;03_lungenkarzinom_0384.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Wirksamkeit des anti-VEGF Antikörpers Bevacizumab in Kombination mit einer platinbasierten Chemotherapie wurde in einer Reihe von randomisierten Phase III Studien bei selektionierten nicht vorbehandelten Patienten mit einem fortgeschrittenen (Stadium IIIb/IV) nicht plattenepithelialen Lungenkarzinom untersucht."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1778__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Wirksamkeit des anti-VEGF Antikörpers Bevacizumab in Kombination mit einer platinbasierten Chemotherapie wurde in einer Reihe von randomisierten Phase III Studien bei selektionierten nicht vorbehandelten Patienten mit einem fortgeschrittenen (Stadium IIIb/<span class=\"diff_sub\">Stadium </span>IV) nicht plattenepithelialen Lungenkarzinom untersucht.</div><div nowrap=\"nowrap\">Die Wirksamkeit des anti-VEGF Antikörpers Bevacizumab in Kombination mit einer platinbasierten Chemotherapie wurde in einer Reihe von randomisierten Phase III Studien bei selektionierten nicht vorbehandelten Patienten mit einem fortgeschrittenen (Stadium IIIb/IV) nicht plattenepithelialen Lungenkarzinom untersucht.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "231;03_lungenkarzinom_0391.tsv;29"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Beim Vergleich der Mono- mit der Kombinationstherapie ergab die Kombination ein signifikant besseres 1- und 2-Jahresüberleben (1-J-ÜL: 10% vs.18%; HR = 0.60)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1779__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Beim Vergleich der Mono<span class=\"diff_chg\">therapie</span> mit der Kombinationstherapie ergab die Kombination ein signifikant besseres 1-<span class=\"diff_sub\">Jahresüberleben</span> und 2-Jahresüberleben (1-J-ÜL: 10% vs.18%; HR = 0.60).</div><div nowrap=\"nowrap\">Beim Vergleich der Mono<span class=\"diff_chg\">-</span> mit der Kombinationstherapie ergab die Kombination ein signifikant besseres 1- und 2-Jahresüberleben (1-J-ÜL: 10% vs.18%; HR = 0.60).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "232;03_lungenkarzinom_0391.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Bilingham (2001) MIC im PS2 oder 0-1 [REF] :"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1780__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Bilingham (2001) MIC im PS2 oder <span class=\"diff_sub\">PS</span>0-1 [REF] :</div><div nowrap=\"nowrap\">- Bilingham (2001) MIC im PS2 oder 0-1 [REF] :</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "233;03_lungenkarzinom_0391.tsv;107"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Studienergebnisse zum ECOG 2 zum Vergleich der Mono- mit der Kombinationstherapie sind widersprüchlich."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1781__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Studienergebnisse zum ECOG 2 zum Vergleich der Mono<span class=\"diff_chg\">therapie</span> mit der Kombinationstherapie sind widersprüchlich.</div><div nowrap=\"nowrap\">Die Studienergebnisse zum ECOG 2 zum Vergleich der Mono<span class=\"diff_chg\">-</span> mit der Kombinationstherapie sind widersprüchlich.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "234;03_lungenkarzinom_0395.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der ersten Studie (JMEN) wurde nach 4 Zyklen einer Kombinationschemotherapie und bei ausbleibendem Progress in einen Pemetrexed oder Placebo Arm randomisiert (switch maintenance)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1782__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der ersten Studie (JMEN) wurde nach 4 Zyklen einer Kombinationschemotherapie und bei ausbleibendem Progress in einen Pemetrexed <span class=\"diff_sub\">Arm </span>oder Placebo Arm randomisiert (switch maintenance).</div><div nowrap=\"nowrap\">In der ersten Studie (JMEN) wurde nach 4 Zyklen einer Kombinationschemotherapie und bei ausbleibendem Progress in einen Pemetrexed oder Placebo Arm randomisiert (switch maintenance).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "235;03_lungenkarzinom_0395.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Chemotherapie-assoziierten Grad 3,4 Nebenwirkungen betrugen im Pemetrexed /Placebo Arm:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1783__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Chemotherapie-assoziierten Grad 3,4 Nebenwirkungen betrugen im Pemetrexed <span class=\"diff_sub\">Arm </span>/Placebo Arm:</div><div nowrap=\"nowrap\">Die Chemotherapie-assoziierten Grad 3,4 Nebenwirkungen betrugen im Pemetrexed /Placebo Arm:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "236;03_lungenkarzinom_0420.tsv;168"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Diese Gruppe wies unter Afatinib ORR (77,1%) -, PFS (10,7 Monate)- und OS (19,4 Monate)-Daten ähnlich wie bei „common mutations“ auf."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1784__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Diese Gruppe wies unter Afatinib ORR (77,1%)-<span class=\"diff_sub\">Daten </span>, PFS (10,7 Monate)-Daten <span class=\"diff_sub\">und OS (19,4 Monate)-Daten </span>ähnlich wie bei „common mutations“ auf.</div><div nowrap=\"nowrap\">Diese Gruppe wies unter Afatinib ORR (77,1%)<span class=\"diff_add\"> </span>-, PFS (10,7<span class=\"diff_add\"> Monate)- und OS (19,4</span> Monate)-Daten ähnlich wie bei „common mutations“ auf.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "237;03_lungenkarzinom_0420.tsv;77"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Studie wurden 174 Patienten mit einer nachgewiesenen aktivierenden EGFR Mutation der Exons 19 oder 21 eingeschlossen, diese mussten mit 2 molekularbiologischen Methoden (Sanger-Sequenzierung und Fragment-Längen-Polymorphismus für Exon 19 Deletionen/Insertionen und TaqMan Ansatz für Exon 21 Muationen) nachgewiesen sein."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1785__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Studie wurden 174 Patienten mit einer nachgewiesenen aktivierenden EGFR Mutation der Exons 19 oder 21 eingeschlossen, diese mussten mit 2 molekularbiologischen Methoden (Sanger-Sequenzierung und Fragment-Längen-Polymorphismus für Exon 19 Deletionen/Exon <span class=\"diff_chg\">19 Insertionen und Taq</span>M<span class=\"diff_sub\">an Ansatz für Exon 21 M</span>uationen) nachgewiesen sein.</div><div nowrap=\"nowrap\">In der Studie wurden 174 Patienten mit einer nachgewiesenen aktivierenden EGFR Mutation der Exons 19 oder 21 eingeschlossen, diese mussten mit 2 molekularbiologischen Methoden (Sanger-Sequenzierung und Fragment-Längen-Polymorphismus für Exon 19 Deletionen/<span class=\"diff_add\">Insertionen und TaqMan Ansatz für </span>Exon <span class=\"diff_chg\">21 </span>Muationen) nachgewiesen sein.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "238;03_lungenkarzinom_0420.tsv;64"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "aktivierende Exon 19 und 21 Mutationen wurden mit unterschiedlichen Methoden wie RFLP-Analyse, Cycleave Methode, Sanger Sequencing und peptide nucleic acid-locked nucleic acid PCR clamp20 bzw. PCR invader21 nachgewiesen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1786__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">aktivierende Exon 19 <span class=\"diff_chg\">Mutationen und Exon</span> 21 Mutationen wurden mit unterschiedlichen Methoden wie RFLP-Analyse, Cycleave Methode, Sanger Sequencing und peptide nucleic acid-locked nucleic acid PCR clamp20 bzw. PCR invader21 nachgewiesen.</div><div nowrap=\"nowrap\">aktivierende Exon 19 <span class=\"diff_chg\">und</span> 21 Mutationen wurden mit unterschiedlichen Methoden wie RFLP-Analyse, Cycleave Methode, Sanger Sequencing und peptide nucleic acid-locked nucleic acid PCR clamp20 bzw. PCR invader21 nachgewiesen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "239;03_lungenkarzinom_0420.tsv;46"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In zwei japanischen Studien wurden Patienten aufgrund nachgewiesener aktivierender EGFR Exon 19 und 21 Mutationen (PNA-LNA PCR clamp Methode) eingeschlossen:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1787__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In zwei japanischen Studien wurden Patienten aufgrund nachgewiesener aktivierender EGFR Exon 19 Mutationen <span class=\"diff_sub\">und Exon 21 Mutationen </span>(PNA-LNA PCR clamp Methode) eingeschlossen:</div><div nowrap=\"nowrap\">In zwei japanischen Studien wurden Patienten aufgrund nachgewiesener aktivierender EGFR Exon 19<span class=\"diff_add\"> und 21</span> Mutationen (PNA-LNA PCR clamp Methode) eingeschlossen:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "240;03_lungenkarzinom_0430.tsv;16"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Lebensqualitätsanalysen wurden mit den QLQ-C30-, QLQ-LC13 und EQ-5D Scores gemessen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1788__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Lebensqualitätsanalysen wurden mit den QLQ-C30-<span class=\"diff_sub\">Scores</span>, QLQ-LC13 und EQ-5D Scores gemessen.</div><div nowrap=\"nowrap\">Lebensqualitätsanalysen wurden mit den QLQ-C30-, QLQ-LC13 und EQ-5D Scores gemessen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "241;03_lungenkarzinom_0430.tsv;34"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Lebensqualitätsanalysen wurden mit den LCSS, QLQ-C30-, QLQ-LC13 und EQ-5D Scores durchgeführt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1789__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Lebensqualitätsanalysen wurden mit den LCSS, QLQ-C30-<span class=\"diff_sub\">Scores</span>, QLQ-LC13 und EQ-5D Scores durchgeführt.</div><div nowrap=\"nowrap\">Lebensqualitätsanalysen wurden mit den LCSS, QLQ-C30-, QLQ-LC13 und EQ-5D Scores durchgeführt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "242;03_lungenkarzinom_0430.tsv;68"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "10 % vs. 0 %, Muskel und Knochenschmerzen:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1790__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">10 % vs. 0 %, Muskel<span class=\"diff_sub\">schmerzen</span> und Knochenschmerzen:</div><div nowrap=\"nowrap\">10 % vs. 0 %, Muskel und Knochenschmerzen:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "243;03_lungenkarzinom_0433.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "ALK-Inhibitoren der zweiten Generation sollen ALK positiven NSCLC Patienten bei Crizotinib/ALK-TKI Versagen angeboten werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1791__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">ALK-Inhibitoren der zweiten Generation sollen ALK positiven NSCLC Patienten bei Crizotinib Versagen<span class=\"diff_sub\">/ALK-TKI Versagen</span> angeboten werden.</div><div nowrap=\"nowrap\">ALK-Inhibitoren der zweiten Generation sollen ALK positiven NSCLC Patienten bei Crizotinib<span class=\"diff_add\">/ALK-TKI</span> Versagen angeboten werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "244;03_lungenkarzinom_0440.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch wenn zum Vergleich von Crizotinib mit Chemotherapie keine randomisierten Studienergebnisse vorliegen, ist die Empfehlung aufgrund der im Vergleich sowohl zu Erstlinien- als auch zur Rezidivchemotherapie (s.o.) überragenden Wirksamkeit eindeutig zugunsten des Crizotinib."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1792__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch wenn zum Vergleich von Crizotinib mit Chemotherapie keine randomisierten Studienergebnisse vorliegen, ist die Empfehlung aufgrund der im Vergleich sowohl zu Erstlinienchemotherapie<span class=\"diff_sub\"> als auch zur Rezidivchemotherapie</span> (s.o.) überragenden Wirksamkeit eindeutig zugunsten des Crizotinib.</div><div nowrap=\"nowrap\">Auch wenn zum Vergleich von Crizotinib mit Chemotherapie keine randomisierten Studienergebnisse vorliegen, ist die Empfehlung aufgrund der im Vergleich sowohl zu Erstlinien<span class=\"diff_add\">- als auch zur Rezidiv</span>chemotherapie (s.o.) überragenden Wirksamkeit eindeutig zugunsten des Crizotinib.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "245;03_lungenkarzinom_0444.tsv;41"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Entsprechend der Zulassung kann die Kombination aus Dabrafenib und Trametinib linienunabhängig eingesetzt werden, d.h. die Kombination kann sowohl im Rahmen einer Erstlinien- oder z.B. Zweitliniensystemtherapie zur Anwendung kommen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1793__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Entsprechend der Zulassung kann die Kombination aus Dabrafenib und Trametinib linienunabhängig eingesetzt werden, d.h. die Kombination kann sowohl im Rahmen einer Erstliniensystemtherapie <span class=\"diff_sub\">oder </span>z<span class=\"diff_chg\">.B. Zweitliniensystemtherapie zur</span> Anwendung kommen.</div><div nowrap=\"nowrap\">Entsprechend der Zulassung kann die Kombination aus Dabrafenib und Trametinib linienunabhängig eingesetzt werden, d.h. die Kombination kann sowohl im Rahmen einer Erstlinien<span class=\"diff_add\">- oder z.B. Zweitlinien</span>systemtherapie z<span class=\"diff_chg\">ur</span> Anwendung kommen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "246;03_lungenkarzinom_0446.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten mit Wildtypkonfiguration für EGFR, ALK und ROS1 sowie BRAF V600 Mutationen sollte eine umfassende Genotypisierung auf bekannte Treibermutatio-nen stattfinden, um bei dem Nachweis einer solchen eine zielgerichtete Therapie im Rahmen der Zulassung (z.B. für BRAF-V600 Mutationen), einer Studie oder im Off-Label-Use zu ermöglichen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1794__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten mit Wildtypkonfiguration für EGFR<span class=\"diff_sub\"> Mutationen</span>, ALK <span class=\"diff_chg\">Mutationen und</span> ROS1 <span class=\"diff_sub\">Mutationen </span>sowie BRAF V600 Mutationen sollte eine umfassende Genotypisierung auf bekannte Treibermutatio-nen stattfinden, um bei dem Nachweis einer solchen eine zielgerichtete Therapie im Rahmen der Zulassung (z.B. für BRAF-V600 Mutationen), einer Studie oder im Off-Label-Use zu ermöglichen.</div><div nowrap=\"nowrap\">Bei Patienten mit Wildtypkonfiguration für EGFR, ALK <span class=\"diff_chg\">und</span> ROS1 sowie BRAF V600 Mutationen sollte eine umfassende Genotypisierung auf bekannte Treibermutatio-nen stattfinden, um bei dem Nachweis einer solchen eine zielgerichtete Therapie im Rahmen der Zulassung (z.B. für BRAF-V600 Mutationen), einer Studie oder im Off-Label-Use zu ermöglichen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "247;03_lungenkarzinom_0447.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Weitere Treibermutationen werden zur Zeit als therapeutische Targets in zahlreichen klinischen Studien evaluiert (z.B. NTRK 1/2/3-Fusionen, DDR2-Mutationen, FGFR1-Mutationen/-amplifikationen u.a)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1795__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Weitere Treibermutationen werden zur Zeit als therapeutische Targets in zahlreichen klinischen Studien evaluiert (z.B. NTRK 1/2/3-Fusionen, DDR2-Mutationen, FGFR1-Mutationen/<span class=\"diff_sub\">FGFR1</span>-amplifikationen u.a).</div><div nowrap=\"nowrap\">Weitere Treibermutationen werden zur Zeit als therapeutische Targets in zahlreichen klinischen Studien evaluiert (z.B. NTRK 1/2/3-Fusionen, DDR2-Mutationen, FGFR1-Mutationen/-amplifikationen u.a).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "248;03_lungenkarzinom_0453.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Innerhalb der Tumorstadien IIIA und IIIB ergab sich dadurch eine heterogene Subsummierung unterschiedlicher Tumorsituationen, die auch lokal fortgeschrittene Tumorstadien beinhalteten und damit Verläufe, die sich auf die Prognose positiv auswirkten [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1796__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Innerhalb der Tumorstadien IIIA und Tumorstadien IIIB ergab sich dadurch eine heterogene Subsummierung unterschiedlicher Tumorsituationen, die auch lokal fortgeschrittene Tumorstadien beinhalteten und damit Verläufe, die sich auf die Prognose positiv auswirkten [REF] [REF].</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Innerhalb der Tumorstadien IIIA und IIIB ergab sich dadurch eine heterogene Subsummierung unterschiedlicher Tumorsituationen, die auch lokal fortgeschrittene Tumorstadien beinhalteten und damit Verläufe, die sich auf die Prognose positiv auswirkten [REF] [REF].</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "249;03_lungenkarzinom_0461.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Situation eines nicht operablen Tumors (T4 oder N2m-N3) sollten die Therapiealgorithmen wie im Stadium IIIA oder IIIB eingesetzt werden, d.h. eine Radio-Chemotherapie."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1797__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Situation eines nicht operablen Tumors (T4 oder N2m-N3) sollten die Therapiealgorithmen wie im Stadium IIIA oder <span class=\"diff_sub\">Stadium </span>IIIB eingesetzt werden, d.h. eine Radio-Chemotherapie.</div><div nowrap=\"nowrap\">In der Situation eines nicht operablen Tumors (T4 oder N2m-N3) sollten die Therapiealgorithmen wie im Stadium IIIA oder IIIB eingesetzt werden, d.h. eine Radio-Chemotherapie.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "250;03_lungenkarzinom_0463.tsv;25"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Da der größere Teil der Patienten eine histologisch verifizierte N2- oder N3-Metastasierung aufwies, erfolgte in der Mehrzahl der Patienten die definitive Chemostrahlentherapie."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1798__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Da der größere Teil der Patienten eine histologisch verifizierte N2-<span class=\"diff_sub\">Metastasierung</span> oder N3-Metastasierung aufwies, erfolgte in der Mehrzahl der Patienten die definitive Chemostrahlentherapie.</div><div nowrap=\"nowrap\">Da der größere Teil der Patienten eine histologisch verifizierte N2- oder N3-Metastasierung aufwies, erfolgte in der Mehrzahl der Patienten die definitive Chemostrahlentherapie.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "251;03_lungenkarzinom_0463.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der weitaus größte Teil dieser Patienten hatte einen positiven N2 bzw. N3-Nodalstatus (29 Patienten, entsprechend 74% mit lokalem Stadium III)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1799__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der weitaus größte Teil dieser Patienten hatte einen positiven N2<span class=\"diff_sub\">-Nodalstatus</span> bzw. N3-Nodalstatus (29 Patienten, entsprechend 74% mit lokalem Stadium III).</div><div nowrap=\"nowrap\">Der weitaus größte Teil dieser Patienten hatte einen positiven N2 bzw. N3-Nodalstatus (29 Patienten, entsprechend 74% mit lokalem Stadium III).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "252;03_lungenkarzinom_0473.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei nachgewiesenem N2- oder N-3 Befall im Rahmen des initialen Stagings und Vorliegen von mehreren Fernmetastasen in einem Organsystem (2-4) sind nach Integration einer definitiven Lokaltherapie im Bereich des Primärtumors und Mediastinums bei selektionierten Patienten in einzelnen retrosepktiven Serien ausreichend, so dass eine deratige Lokaltherapie bei selktionierten Patienten gerechtfertigt ist [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1800__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei nachgewiesenem N2<span class=\"diff_chg\"> Befall oder</span> N-3 Befall im Rahmen des initialen Stagings und Vorliegen von mehreren Fernmetastasen in einem Organsystem (2-4) sind nach Integration einer definitiven Lokaltherapie im Bereich des Primärtumors und Mediastinums bei selektionierten Patienten in einzelnen retrosepktiven Serien ausreichend, so dass eine deratige Lokaltherapie bei selktionierten Patienten gerechtfertigt ist [REF], [REF].</div><div nowrap=\"nowrap\">Bei nachgewiesenem N2<span class=\"diff_chg\">- oder</span> N-3 Befall im Rahmen des initialen Stagings und Vorliegen von mehreren Fernmetastasen in einem Organsystem (2-4) sind nach Integration einer definitiven Lokaltherapie im Bereich des Primärtumors und Mediastinums bei selektionierten Patienten in einzelnen retrosepktiven Serien ausreichend, so dass eine deratige Lokaltherapie bei selktionierten Patienten gerechtfertigt ist [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "253;03_lungenkarzinom_0475.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wie im Stadium IIIA und IIIB, besteht auch bei Patienten mit OMDein besonders hohes systemisches Risiko [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1801__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wie im Stadium IIIA und<span class=\"diff_sub\"> Stadium</span> IIIB, besteht auch bei Patienten mit OMDein besonders hohes systemisches Risiko [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Wie im Stadium IIIA und IIIB, besteht auch bei Patienten mit OMDein besonders hohes systemisches Risiko [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "254;03_lungenkarzinom_0475.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Alle Studien, die eine konsolidierende Chemotherapie nach Radio-Chemotherapie in den Stadien IIIA und IIIB gegen Beobachtung geprüft haben, erbrachten hinsichtlich der Endpunkte PFS und OS keinen Vorteil."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1802__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Alle Studien, die eine konsolidierende Chemotherapie nach Radio-Chemotherapie in den Stadien IIIA und<span class=\"diff_sub\"> Stadien</span> IIIB gegen Beobachtung geprüft haben, erbrachten hinsichtlich der Endpunkte PFS und OS keinen Vorteil.</div><div nowrap=\"nowrap\">Alle Studien, die eine konsolidierende Chemotherapie nach Radio-Chemotherapie in den Stadien IIIA und IIIB gegen Beobachtung geprüft haben, erbrachten hinsichtlich der Endpunkte PFS und OS keinen Vorteil.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "255;03_lungenkarzinom_0491.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Falle einer R1/2 Resektion wird ebenfalls eine zusätzliche Mediastinalbestrahlung empfohlen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1803__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Falle einer R1 Resektion<span class=\"diff_sub\">/R2 Resektion</span> wird ebenfalls eine zusätzliche Mediastinalbestrahlung empfohlen.</div><div nowrap=\"nowrap\">Im Falle einer R1<span class=\"diff_add\">/2</span> Resektion wird ebenfalls eine zusätzliche Mediastinalbestrahlung empfohlen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "256;03_lungenkarzinom_0497.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In diesem Falle ist eine Weiterbehandlung analog dem klinischen Stadium T3-4 oder N2-3 in Form einer kombinierten Chemo-Strahlentherapie durchzuführen (siehe Kapitel 5)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1804__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In diesem Falle ist eine Weiterbehandlung analog dem klinischen Stadium T3-4 oder <span class=\"diff_sub\">Stadium </span>N2-3 in Form einer kombinierten Chemo-Strahlentherapie durchzuführen (siehe Kapitel 5).</div><div nowrap=\"nowrap\">In diesem Falle ist eine Weiterbehandlung analog dem klinischen Stadium T3-4 oder N2-3 in Form einer kombinierten Chemo-Strahlentherapie durchzuführen (siehe Kapitel 5).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "257;03_lungenkarzinom_0497.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Falle einer nodal positiven Erkrankung oder einer R1/R2-Situation sollte parallel zur Schädelbestrahlung eine Mediastinalbestrahlung mit 50 bis 60 Gy durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1805__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Falle einer nodal positiven Erkrankung oder einer R1<span class=\"diff_sub\">-Situation</span>/R2-Situation sollte parallel zur Schädelbestrahlung eine Mediastinalbestrahlung mit 50 bis 60 Gy durchgeführt werden.</div><div nowrap=\"nowrap\">Im Falle einer nodal positiven Erkrankung oder einer R1/R2-Situation sollte parallel zur Schädelbestrahlung eine Mediastinalbestrahlung mit 50 bis 60 Gy durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "258;03_lungenkarzinom_0501.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Metaanalysen randomisierter Studien mit einem Vergleich von Cisplatin- und/oder etoposidhaltigen Schemata versus Cisplatin- und/oder etoposidfreien Regimen zeigen signifikante Überlebensvorteile für den Einschluss von Cisplatin und/oder Etoposid."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1806__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Metaanalysen randomisierter Studien mit einem Vergleich von Cisplatin<span class=\"diff_chg\">haltigen</span> und/oder etoposidhaltigen Schemata versus Cisplatinfreien <span class=\"diff_chg\">und/oder etoposid</span>f<span class=\"diff_sub\">reien Regimen zeigen signif</span>ikante Überlebensvorteile für den Einschluss von Cisplatin und/oder Etoposid.</div><div nowrap=\"nowrap\">Metaanalysen randomisierter Studien mit einem Vergleich von Cisplatin<span class=\"diff_chg\">-</span> und/oder etoposidhaltigen Schemata versus Cisplatin<span class=\"diff_add\">- und/oder etoposid</span>freien <span class=\"diff_chg\">Regimen zeigen signi</span>fikante Überlebensvorteile für den Einschluss von Cisplatin und/oder Etoposid.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "259;03_lungenkarzinom_0504.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Applikation der Strahlentherapie in denTumorstadien T3-4 N0-1 und T1-4N2-3M0 (Limited disease) sollte nach Möglichkeit simultan zur Chemotherapie mit Cisplatin und Etoposid erfolgen (Evidenzgrad 1b)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1807__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Applikation der Strahlentherapie in denTumorstadien T3-4 N0-1 und<span class=\"diff_sub\"> Tumorstadien</span> T1-4N2-3M0 (Limited disease) sollte nach Möglichkeit simultan zur Chemotherapie mit Cisplatin und Etoposid erfolgen (Evidenzgrad 1b).</div><div nowrap=\"nowrap\">Die Applikation der Strahlentherapie in denTumorstadien T3-4 N0-1 und T1-4N2-3M0 (Limited disease) sollte nach Möglichkeit simultan zur Chemotherapie mit Cisplatin und Etoposid erfolgen (Evidenzgrad 1b).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "260;03_lungenkarzinom_0514.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es wurden 8 Patienten in den Stadien I+II mit alleiniger neoadjuvanter Chemotherapie (4xPE) und 38 Patienten in den Stadien IIIA und IIIB mit 4 Zyklen PE und simultaner hyperfraktionierter Radiotherapie mit 45 Gy behandelt und anschließend operiert."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1808__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es wurden 8 Patienten in den Stadien I+<span class=\"diff_chg\">Stadien II mit</span> alleiniger neoadjuvanter Chemotherapie (4xPE) und 38 Patienten in den Stadien IIIA und<span class=\"diff_sub\"> Stadien</span> IIIB mit 4 Zyklen PE und simultaner hyperfraktionierter Radiotherapie mit 45 Gy behandelt und anschließend operiert.</div><div nowrap=\"nowrap\">Es wurden 8 Patienten in den Stadien I+<span class=\"diff_chg\">II mit</span> alleiniger neoadjuvanter Chemotherapie (4xPE) und 38 Patienten in den Stadien IIIA und IIIB mit 4 Zyklen PE und simultaner hyperfraktionierter Radiotherapie mit 45 Gy behandelt und anschließend operiert.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "261;03_lungenkarzinom_0514.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die R0-Resektion betrug 100 % in den Stadien I+II, 73 % (16/22) im Stadium IIIA und 13 % (2/16) im Stadium IIIB."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1809__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die R0-Resektion betrug 100 % in den Stadien I+<span class=\"diff_sub\">Stadien </span>II, 73 % (16/22) im Stadium IIIA und 13 % (2/16) im Stadium IIIB.</div><div nowrap=\"nowrap\">Die R0-Resektion betrug 100 % in den Stadien I+II, 73 % (16/22) im Stadium IIIA und 13 % (2/16) im Stadium IIIB.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "262;03_lungenkarzinom_0516.tsv;27"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die randomisierte Studie von Arriagada et al. 1993 [REF] konnte bei 105 LD-Patienten mit einer um 20 % erhöhten Cyclophosphamid- (1000mg/m²) und Cisplatin- (100mg/m²) Dosierung im 1. Zyklus eine höhere CR-Rate (67 % vs. 54 %) und eine verbesserte 2-Jahres-Überlebensrate (43 % vs. 26 %) im Vergleich zum Standard zeigen (Evidenzgrad 1b)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1810__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die randomisierte Studie von Arriagada et al. 1993 [REF] konnte bei 105 LD-Patienten mit einer um 20 % erhöhten Cyclophosphamid- (1000mg/m²) Dosierung <span class=\"diff_chg\">und Cisplatin- (100mg/m²) Dosierung im 1.</span> Zyklus eine höhere CR-Rate (67 % vs. 54 %) und eine verbesserte 2-Jahres-Überlebensrate (43 % vs. 26 %) im Vergleich zum Standard zeigen (Evidenzgrad 1b).</div><div nowrap=\"nowrap\">Die randomisierte Studie von Arriagada et al. 1993 [REF] konnte bei 105 LD-Patienten mit einer um 20 % erhöhten Cyclophosphamid- (1000mg/m²) <span class=\"diff_add\">und Cisplatin- (100mg/m²) </span>Dosierung <span class=\"diff_chg\">im 1.</span> Zyklus eine höhere CR-Rate (67 % vs. 54 %) und eine verbesserte 2-Jahres-Überlebensrate (43 % vs. 26 %) im Vergleich zum Standard zeigen (Evidenzgrad 1b).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "263;03_lungenkarzinom_0544.tsv;30"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nach 6 Zyklen Chemotherapie wurde die Thalidomid/ Placebo-Einnahme als Erhaltungstherapie fortgesetzt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1811__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nach 6 Zyklen Chemotherapie wurde die Thalidomid<span class=\"diff_sub\">-Einnahme</span>/ Placebo-Einnahme als Erhaltungstherapie fortgesetzt.</div><div nowrap=\"nowrap\">Nach 6 Zyklen Chemotherapie wurde die Thalidomid/ Placebo-Einnahme als Erhaltungstherapie fortgesetzt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "264;03_lungenkarzinom_0553.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Paclitaxel- [REF] und Irinotecan- [REF], [REF] haltige Protokolle sind lediglich in Phase-II-Studien getestet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1812__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Paclitaxel-<span class=\"diff_sub\">haltige</span> [REF] und Irinotecan- [REF], [REF] haltige Protokolle sind lediglich in Phase-II-Studien getestet.</div><div nowrap=\"nowrap\">Paclitaxel- [REF] und Irinotecan- [REF], [REF] haltige Protokolle sind lediglich in Phase-II-Studien getestet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "265;03_lungenkarzinom_0573.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Beim therapienaiven kleinzelligen Lungenkarzinom ist primär eine Chemo- und/oder Radiotherapie angezeigt, die Stentimplantation ist Patienten mit therapierefraktärem oder rezidivierendem Vena-cava-superior-Syndrom vorbehalten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1813__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Beim therapienaiven kleinzelligen Lungenkarzinom ist primär eine Chemo<span class=\"diff_chg\">therapie</span> und/oder Radiotherapie angezeigt, die Stentimplantation ist Patienten mit therapierefraktärem oder rezidivierendem Vena-cava-superior-Syndrom vorbehalten.</div><div nowrap=\"nowrap\">Beim therapienaiven kleinzelligen Lungenkarzinom ist primär eine Chemo<span class=\"diff_chg\">-</span> und/oder Radiotherapie angezeigt, die Stentimplantation ist Patienten mit therapierefraktärem oder rezidivierendem Vena-cava-superior-Syndrom vorbehalten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "266;03_lungenkarzinom_0602.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Psychische Störungen gemäß ICD-10 /DSM-IV-Klassifikation"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1814__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Psychische Störungen gemäß ICD-10<span class=\"diff_sub\">-Klassifikation</span> /DSM-IV-Klassifikation</div><div nowrap=\"nowrap\">- Psychische Störungen gemäß ICD-10 /DSM-IV-Klassifikation</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "267;03_lungenkarzinom_0607.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Aufgrund der teils widersprüchlichen, teils unklaren Datenlage sollten Stoffe mit antioxidativen Wirkungen, wie z.B. Selen, Vitamin C, β-Karotin oder Vitamin E, nicht in höheren Dosierungen zeitgleich zur Radio- und/oder Chemotherapie gegeben werden [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1815__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Aufgrund der teils widersprüchlichen, teils unklaren Datenlage sollten Stoffe mit antioxidativen Wirkungen, wie z.B. Selen, Vitamin C, β-Karotin oder Vitamin E, nicht in höheren Dosierungen zeitgleich zur Radiotherapie <span class=\"diff_sub\">und/oder Chemotherapie </span>gegeben werden [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Aufgrund der teils widersprüchlichen, teils unklaren Datenlage sollten Stoffe mit antioxidativen Wirkungen, wie z.B. Selen, Vitamin C, β-Karotin oder Vitamin E, nicht in höheren Dosierungen zeitgleich zur Radi<span class=\"diff_add\">o- und/oder Chem</span>otherapie gegeben werden [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "268;03_lungenkarzinom_0639.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei belastender Symptomatik können in der Sterbephase z. B. Symptomerfassung/-abfrage (inkl. Erfassung von Symptomen, die nur nonverbal aus-gedrückt werden), Mundpflege bei Mundtrockenheit, Körperpflege, Wundversorgung, Abführmaßnahmen, Inkontinenzversorgung, ggf."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1816__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei belastender Symptomatik können in der Sterbephase z. B. Symptomerfassung/Symptom<span class=\"diff_chg\">abfrage (inkl. Erfassung von Symptomen, die nur nonverbal</span> aus-gedrückt werden), Mundpflege bei Mundtrockenheit, Körperpflege, Wundversorgung, Abführmaßnahmen, Inkontinenzversorgung, ggf.</div><div nowrap=\"nowrap\">Bei belastender Symptomatik können in der Sterbephase z. B. Symptomerfassung/<span class=\"diff_add\">-abfrage (inkl. Erfassung von </span>Symptom<span class=\"diff_chg\">en, die nur nonverbal</span> aus-gedrückt werden), Mundpflege bei Mundtrockenheit, Körperpflege, Wundversorgung, Abführmaßnahmen, Inkontinenzversorgung, ggf.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "269;04_praevention-zervixkarzinom_0001.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die genitalen HPV Typen werden entsprechend ihres Risikopotentials für die Induzierung von invasiven Zervixkarzinomen in Hochrisiko (HR)- und Niedrigrisiko (low risk, LR)-Typen eingeteilt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1817__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die genitalen HPV Typen werden entsprechend ihres Risikopotentials für die Induzierung von invasiven Zervixkarzinomen in Hochrisiko (HR)-<span class=\"diff_sub\">Typen</span> und Niedrigrisiko (low risk, LR)-Typen eingeteilt.</div><div nowrap=\"nowrap\">Die genitalen HPV Typen werden entsprechend ihres Risikopotentials für die Induzierung von invasiven Zervixkarzinomen in Hochrisiko (HR)- und Niedrigrisiko (low risk, LR)-Typen eingeteilt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "270;04_praevention-zervixkarzinom_0008.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Anspruch der seit 2014 gültigen Klassifikation ist es, 1.) die „klassische“ Dysplasiegradierung (anhand struktureller und zellulärer Atypien) um die pathogenetisch bzw. zellbiologisch relevanten Charakteristika der HPV-Assoziation zu erweitern, und damit 2.) die unterschiedliche Tendenz zur Progression dieser Läsionen, in Abhängigkeit einer high-risk- oder low-risk-HPV-Infektion zu berücksichtigen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1818__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Anspruch der seit 2014 gültigen Klassifikation ist es, 1.) die „klassische“ Dysplasiegradierung (anhand struktureller und zellulärer Atypien) um die pathogenetisch bzw. zellbiologisch relevanten Charakteristika der HPV-Assoziation zu erweitern, und damit 2.) die unterschiedliche Tendenz zur Progression dieser Läsionen, in Abhängigkeit einer high-risk-HPV-Infektion <span class=\"diff_chg\">oder low-risk-HPV-Infektion zu</span> berücksichtigen.</div><div nowrap=\"nowrap\">Der Anspruch der seit 2014 gültigen Klassifikation ist es, 1.) die „klassische“ Dysplasiegradierung (anhand struktureller und zellulärer Atypien) um die pathogenetisch bzw. zellbiologisch relevanten Charakteristika der HPV-Assoziation zu erweitern, und damit 2.) die unterschiedliche Tendenz zur Progression dieser Läsionen, in Abhängigkeit einer high<span class=\"diff_add\">-risk- oder low</span>-risk-HPV-Infektion <span class=\"diff_chg\">zu</span> berücksichtigen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "271;04_praevention-zervixkarzinom_0008.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "b. High grade; CIN2/3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1819__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">b. High grade; CIN2/<span class=\"diff_sub\">CIN</span>3</div><div nowrap=\"nowrap\">b. High grade; CIN2/3</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "272;04_praevention-zervixkarzinom_0010.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Die Subsumierung von CIN2 in die Gruppe der hochgradigen SIL (CIN2/3) impliziert eine therapeutische Indikationsstellung, d.h. sie verleitet zur Konisation im Stadium CIN2, welches in über 50% der Fälle spontan regredient verläuft."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1820__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Die Subsumierung von CIN2 in die Gruppe der hochgradigen SIL (CIN2/<span class=\"diff_sub\">CIN</span>3) impliziert eine therapeutische Indikationsstellung, d.h. sie verleitet zur Konisation im Stadium CIN2, welches in über 50% der Fälle spontan regredient verläuft.</div><div nowrap=\"nowrap\">- Die Subsumierung von CIN2 in die Gruppe der hochgradigen SIL (CIN2/3) impliziert eine therapeutische Indikationsstellung, d.h. sie verleitet zur Konisation im Stadium CIN2, welches in über 50% der Fälle spontan regredient verläuft.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "273;04_praevention-zervixkarzinom_0020.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Von diesen wurden 1,58% (n=255.013) zweifelhafte oder positive Befunde (PAP III (n=43.279), IIID (n=181.903), IVa, b (n=27.178), V (n=2.662), Münchner Nomenklatur II) festgestellt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1821__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Von diesen wurden 1,58% (n=255.013) zweifelhafte oder positive Befunde (PAP III (n=43.279), IIID (n=181.903), IVa, <span class=\"diff_sub\">IV</span>b (n=27.178), V (n=2.662), Münchner Nomenklatur II) festgestellt.</div><div nowrap=\"nowrap\">Von diesen wurden 1,58% (n=255.013) zweifelhafte oder positive Befunde (PAP III (n=43.279), IIID (n=181.903), IVa, b (n=27.178), V (n=2.662), Münchner Nomenklatur II) festgestellt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "274;04_praevention-zervixkarzinom_0028.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die S3-Leitlinie befasst sich mit der prophylaktischen Vakzinierung gegen die HPV 16 und HPV 18 bzw. HPV 6 und HPV 11 Infektion und damit mit der Prävention des Zervixkarzinoms, des Vulvakarzinoms, Vaginalkarzinoms, Analkarzinoms und deren Vorstufen sowie der primären Prävention der Condylomata acuminata und Larynxpapillome."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1822__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die S3-Leitlinie befasst sich mit der prophylaktischen Vakzinierung gegen die HPV 16 und<span class=\"diff_sub\"> gegen die</span> HPV 18 bzw. HPV 6 <span class=\"diff_chg\">Infektion und</span> HPV 11 Infektion und damit mit der Prävention des Zervixkarzinoms, des Vulvakarzinoms, Vaginalkarzinoms, Analkarzinoms und deren Vorstufen sowie der primären Prävention der Condylomata acuminata und Larynxpapillome.</div><div nowrap=\"nowrap\">Die S3-Leitlinie befasst sich mit der prophylaktischen Vakzinierung gegen die HPV 16 und HPV 18 bzw. HPV 6 <span class=\"diff_chg\">und</span> HPV 11 Infektion und damit mit der Prävention des Zervixkarzinoms, des Vulvakarzinoms, Vaginalkarzinoms, Analkarzinoms und deren Vorstufen sowie der primären Prävention der Condylomata acuminata und Larynxpapillome.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "275;04_praevention-zervixkarzinom_0035.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ohne Berücksichtigung des HPV-Status bei Studienbeginn sank dieser Effekt auf 71% in Bezug auf die Prävention von impftypassoziierter VIN/VAIN Grad 2/3."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1823__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ohne Berücksichtigung des HPV-Status bei Studienbeginn sank dieser Effekt auf 71% in Bezug auf die Prävention von impftypassoziierter VIN/VAIN Grad 2/<span class=\"diff_sub\">Grad </span>3.</div><div nowrap=\"nowrap\">Ohne Berücksichtigung des HPV-Status bei Studienbeginn sank dieser Effekt auf 71% in Bezug auf die Prävention von impftypassoziierter VIN/VAIN Grad 2/3.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "276;04_praevention-zervixkarzinom_0035.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Diese Seren enthielten Antikörper die, wenn auch weniger effektiv, an die Kapside der mit HPV16 und 18 nahe verwandten HPV-Typen HPV31, 45, 52, 58 binden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1824__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Diese Seren enthielten Antikörper die, wenn auch weniger effektiv, an die Kapside der mit HPV16 und <span class=\"diff_sub\">HPV</span>18 nahe verwandten HPV-Typen HPV31, <span class=\"diff_sub\">HPV</span>45, <span class=\"diff_sub\">HPV</span>52, <span class=\"diff_sub\">HPV</span>58 binden.</div><div nowrap=\"nowrap\">Diese Seren enthielten Antikörper die, wenn auch weniger effektiv, an die Kapside der mit HPV16 und 18 nahe verwandten HPV-Typen HPV31, 45, 52, 58 binden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "277;04_praevention-zervixkarzinom_0035.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine teilweise Kreuzprotektion über die Impfgenotypen HPV16 und 18 hinaus konnte für nahe verwandte Genotypen HPV31 und 45 in der Phase-II-Studie mit dem bivalenten Impfstoff belegt werden [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1825__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine teilweise Kreuzprotektion über die Impfgenotypen HPV16 und <span class=\"diff_sub\">HPV</span>18 hinaus konnte für nahe verwandte Genotypen HPV31 und <span class=\"diff_sub\">HPV</span>45 in der Phase-II-Studie mit dem bivalenten Impfstoff belegt werden [REF].</div><div nowrap=\"nowrap\">Eine teilweise Kreuzprotektion über die Impfgenotypen HPV16 und 18 hinaus konnte für nahe verwandte Genotypen HPV31 und 45 in der Phase-II-Studie mit dem bivalenten Impfstoff belegt werden [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "278;04_praevention-zervixkarzinom_0035.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Neue Analysen der end-of-study-Daten aus der PATRICIA-Studie zeigten eine konsistente Effektivität gegen persistierende Infektionen und CIN2 oder höhergradige Läsionen in Subkohorten für HPV31, 33, 45 und 51. Eine Vakzineffizienz gegen 12 nicht in der Vakzine enthaltene HPV-Typen (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, und 68) betrug zusammengenommen 46,8% für die according-to-protocol (ATP) Population, 56,2% in der TVC-naiven Population (alle Geimpften die im Monat 7 HPV-negativ waren) und 34,2% für alle mindestens einmalig geimpften Probandinnen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1826__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Neue Analysen der end-of-study-Daten aus der PATRICIA-Studie zeigten eine konsistente Effektivität gegen persistierende Infektionen und CIN2 oder höhergradige Läsionen in Subkohorten für HPV31, <span class=\"diff_chg\">HPV33, HPV</span>45 und <span class=\"diff_sub\">HPV</span>51. Eine Vakzineffizienz gegen 12 nicht in der Vakzine enthaltene HPV-Typen (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, und 68) betrug zusammengenommen 46,8% für die according-to-protocol (ATP) Population, 56,2% in der TVC-naiven Population (alle Geimpften die im Monat 7 HPV-negativ waren) und 34,2% für alle mindestens einmalig geimpften Probandinnen.</div><div nowrap=\"nowrap\">Neue Analysen der end-of-study-Daten aus der PATRICIA-Studie zeigten eine konsistente Effektivität gegen persistierende Infektionen und CIN2 oder höhergradige Läsionen in Subkohorten für HPV31, <span class=\"diff_chg\">33, </span>45 und 51. Eine Vakzineffizienz gegen 12 nicht in der Vakzine enthaltene HPV-Typen (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, und 68) betrug zusammengenommen 46,8% für die according-to-protocol (ATP) Population, 56,2% in der TVC-naiven Population (alle Geimpften die im Monat 7 HPV-negativ waren) und 34,2% für alle mindestens einmalig geimpften Probandinnen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "279;04_praevention-zervixkarzinom_0035.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Alle VIN/VAIN-1-Läsionen ließen sich unabhängig vom HPV-Typ in 18%, die VIN/VAIN 2/3 in 26% verhindern."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1827__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Alle VIN<span class=\"diff_sub\">-1-Läsionen</span>/VAIN-1-Läsionen ließen sich unabhängig vom HPV-Typ in 18%, die VIN/VAIN 2/3 in 26% verhindern.</div><div nowrap=\"nowrap\">Alle VIN/VAIN-1-Läsionen ließen sich unabhängig vom HPV-Typ in 18%, die VIN/VAIN 2/3 in 26% verhindern.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "280;04_praevention-zervixkarzinom_0036.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Erste Daten zur Häufigkeit von Präkanzerosen der Zervix deuten an, dass in einer Population mit hoher Impfrate auch Infektionen mit HPV16 und 18 effizient verhindert werden können [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1828__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Erste Daten zur Häufigkeit von Präkanzerosen der Zervix deuten an, dass in einer Population mit hoher Impfrate auch Infektionen mit HPV16 und <span class=\"diff_sub\">HPV</span>18 effizient verhindert werden können [REF].</div><div nowrap=\"nowrap\">Erste Daten zur Häufigkeit von Präkanzerosen der Zervix deuten an, dass in einer Population mit hoher Impfrate auch Infektionen mit HPV16 und 18 effizient verhindert werden können [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "281;04_praevention-zervixkarzinom_0051.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das ThinPrep-System wurde in 10 Studien [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF] verwendet, die AutoCyte/SurePath Prozedur in zwei anderen Studien [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1829__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das ThinPrep-System wurde in 10 Studien [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF] verwendet, die AutoCyte<span class=\"diff_sub\"> Prozedur</span>/SurePath Prozedur in zwei anderen Studien [REF], [REF].</div><div nowrap=\"nowrap\">Das ThinPrep-System wurde in 10 Studien [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF] verwendet, die AutoCyte/SurePath Prozedur in zwei anderen Studien [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "282;04_praevention-zervixkarzinom_0058.tsv;24"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies ist nicht irrelevant, da sich hinter zytologischen LSIL- und ASC-US-Diagnosen die Mehrzahl der histologischen CIN2+ verbergen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1830__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies ist nicht irrelevant, da sich hinter zytologischen LSIL-<span class=\"diff_sub\">Diagnosen</span> und ASC-US-Diagnosen die Mehrzahl der histologischen CIN2+ verbergen [REF].</div><div nowrap=\"nowrap\">Dies ist nicht irrelevant, da sich hinter zytologischen LSIL- und ASC-US-Diagnosen die Mehrzahl der histologischen CIN2+ verbergen [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "283;04_praevention-zervixkarzinom_0058.tsv;28"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ebenso war die ASC/SIL-Rate in allen Studien, welche hierzu Angaben machten [REF], [REF], [REF], [REF], [REF], [REF], [REF], nicht signifikant erhöht."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1831__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ebenso war die ASC<span class=\"diff_sub\">-Rate</span>/SIL-Rate in allen Studien, welche hierzu Angaben machten [REF], [REF], [REF], [REF], [REF], [REF], [REF], nicht signifikant erhöht.</div><div nowrap=\"nowrap\">Ebenso war die ASC/SIL-Rate in allen Studien, welche hierzu Angaben machten [REF], [REF], [REF], [REF], [REF], [REF], [REF], nicht signifikant erhöht.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "284;04_praevention-zervixkarzinom_0064.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Mehrere Studien weisen auf mindestens Äquivalenz dieses Modus zum manuellen Screening bei konventionellen und SP-Präparaten hin."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1832__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Mehrere Studien weisen auf mindestens Äquivalenz dieses Modus zum manuellen Screening bei konventionellen <span class=\"diff_sub\">Präparaten </span>und SP-Präparaten hin.</div><div nowrap=\"nowrap\">Mehrere Studien weisen auf mindestens Äquivalenz dieses Modus zum manuellen Screening bei konventionellen und SP-Präparaten hin.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "285;04_praevention-zervixkarzinom_0084.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "HPV basiertes Screening bzw. HPV + Zytologie basiertes Screening mit Intervallen von 3 oder 5 Jahren führt im Vergleich zum Zytologie Screening mit Intervallen von 3 oder 5 Jahren zur Detektion von mehr CIN 2."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1833__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">HPV basiertes Screening bzw. HPV <span class=\"diff_sub\">basiertes </span>+ Zytologie basiertes Screening mit Intervallen von 3 oder 5 Jahren führt im Vergleich zum Zytologie Screening mit Intervallen von 3 oder 5 Jahren zur Detektion von mehr CIN 2.</div><div nowrap=\"nowrap\">HPV basiertes Screening bzw. HPV + Zytologie basiertes Screening mit Intervallen von 3 oder 5 Jahren führt im Vergleich zum Zytologie Screening mit Intervallen von 3 oder 5 Jahren zur Detektion von mehr CIN 2.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "286;04_praevention-zervixkarzinom_0095.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Erfolgte bei HPV-Positiven eine Genotypisierung plus Zytologie ergab sich für HPV 16 und/oder 18 positive und/oder zytologische Befunde ab LSIL ein PPV von 13,9% und eine Sensitivität von 72,2% [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1834__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Erfolgte bei HPV-Positiven eine Genotypisierung plus Zytologie ergab sich für HPV 16 <span class=\"diff_sub\">positive </span>und/oder<span class=\"diff_sub\"> HPV</span> 18 positive und/oder zytologische Befunde ab LSIL ein PPV von 13,9% und eine Sensitivität von 72,2% [REF].</div><div nowrap=\"nowrap\">Erfolgte bei HPV-Positiven eine Genotypisierung plus Zytologie ergab sich für HPV 16 und/oder 18 positive und/oder zytologische Befunde ab LSIL ein PPV von 13,9% und eine Sensitivität von 72,2% [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "287;04_praevention-zervixkarzinom_0103.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "zusätzlich durchgeführte Suche nach kontrollierten Beobachtungsstudien zur Frage des optimalen Screeningalters und intervalls konnte keine relevante Arbeit zu dieser Fragestellung identifizieren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1835__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">zusätzlich durchgeführte Suche nach kontrollierten Beobachtungsstudien zur Frage des optimalen Screeningalters und <span class=\"diff_sub\">Screening</span>intervalls konnte keine relevante Arbeit zu dieser Fragestellung identifizieren.</div><div nowrap=\"nowrap\">zusätzlich durchgeführte Suche nach kontrollierten Beobachtungsstudien zur Frage des optimalen Screeningalters und intervalls konnte keine relevante Arbeit zu dieser Fragestellung identifizieren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "288;04_praevention-zervixkarzinom_0108.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Vergleich zu 18-24 jährigen Frauen vor Einführung der Impfung ergab sich bei geimpften Frauen ein weitgehendes Verschwinden von HPV 6,11,16 und 18 Infektionen (Reduktion um 86%) aber auch der HPV Typen 31, 33 und 45 (Reduktion 58%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1836__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Vergleich zu 18-24 jährigen Frauen vor Einführung der Impfung ergab sich bei geimpften Frauen ein weitgehendes Verschwinden von HPV 6,11,16 Infektionen<span class=\"diff_sub\"> und HPV 18 Infektionen</span> (Reduktion um 86%) aber auch der HPV Typen 31, 33 und 45 (Reduktion 58%).</div><div nowrap=\"nowrap\">Im Vergleich zu 18-24 jährigen Frauen vor Einführung der Impfung ergab sich bei geimpften Frauen ein weitgehendes Verschwinden von HPV 6,11,16 <span class=\"diff_add\">und 18 </span>Infektionen (Reduktion um 86%) aber auch der HPV Typen 31, 33 und 45 (Reduktion 58%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "289;04_praevention-zervixkarzinom_0114.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Immunsupprimierte Frauen mit auffälligen Screeningbefunden sollen an eine zertifizierte Dysplasiesprechstunde /-einheit überwiesen werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1837__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Immunsupprimierte Frauen mit auffälligen Screeningbefunden sollen an eine zertifizierte Dysplasiesprechstunde /<span class=\"diff_chg\">Dysplasie</span>einheit überwiesen werden.</div><div nowrap=\"nowrap\">Immunsupprimierte Frauen mit auffälligen Screeningbefunden sollen an eine zertifizierte Dysplasiesprechstunde /<span class=\"diff_chg\">-</span>einheit überwiesen werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "290;04_praevention-zervixkarzinom_0119.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es wurden nur Studien eingeschlossen, in denen ein Biomarker-Testverfahren (E6/E7 mRNA, MCM2 TOP2A, p16 ELISA, p16/Ki67 Dual Stain, Methylierungsmarker, hTERC, etc.) an Zervixproben von Screening-Kohorten eingesetzt wurde."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1838__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es wurden nur Studien eingeschlossen, in denen ein Biomarker-Testverfahren (E6 mRNA<span class=\"diff_chg\">/E7 mRNA,</span> MCM2 TOP2A, p16 ELISA, p16/Ki67 Dual Stain, Methylierungsmarker, hTERC, etc.) an Zervixproben von Screening-Kohorten eingesetzt wurde.</div><div nowrap=\"nowrap\">Es wurden nur Studien eingeschlossen, in denen ein Biomarker-Testverfahren (E6<span class=\"diff_add\">/E7</span> mRNA<span class=\"diff_chg\">,</span> MCM2 TOP2A, p16 ELISA, p16/Ki67 Dual Stain, Methylierungsmarker, hTERC, etc.) an Zervixproben von Screening-Kohorten eingesetzt wurde.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "291;04_praevention-zervixkarzinom_0120.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Insgesamt waren nur 10 Studien [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF] kompatibel mit den o.g. PICOS und damit relevant für die Metaanalyse, darunter befanden sich ganz überwiegend E6/E7-mRNA Studien (n = 6) für 5 [REF], [REF] oder mehr [REF], [REF], [REF], [REF], [REF], [REF] HPV-Typen, danach folgten Nachweisverfahren für das p16INK4a-Protein (1 anti p16 ELISA-Assay [REF] und 1 immunzytochemisches (p16-/Ki67-) Doppelmarkierung-Verfahren = “Dual Stain“ [REF], sowie ein immunzytochemisches Verfahren zum Nachweis der TOP2A- MCM2 Proteine [REF] (ProExC, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) und ein immunchromatographischer Nachweis der E6 Proteine von HPV 16/18/45 [REF] (OncoE6, Arbor Vita Corporation, Fremont, CA, USA)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1839__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Insgesamt waren nur 10 Studien [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF] kompatibel mit den o.g. PICOS und damit relevant für die Metaanalyse, darunter befanden sich ganz überwiegend E6-mRNA<span class=\"diff_sub\">/E7-mRNA</span> Studien (n = 6) für 5 [REF], [REF] oder mehr [REF], [REF], [REF], [REF], [REF], [REF] HPV-Typen, danach folgten Nachweisverfahren für das p16INK4a-Protein (1 anti p16 ELISA-Assay [REF] und 1 immunzytochemisches (p16-/Ki67-) Doppelmarkierung-Verfahren = “Dual Stain“ [REF], sowie ein immunzytochemisches Verfahren zum Nachweis der TOP2A- MCM2 Proteine [REF] (ProExC, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) und ein immunchromatographischer Nachweis der E6 Proteine von HPV 16/18/45 [REF] (OncoE6, Arbor Vita Corporation, Fremont, CA, USA).</div><div nowrap=\"nowrap\">Insgesamt waren nur 10 Studien [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF], [REF] kompatibel mit den o.g. PICOS und damit relevant für die Metaanalyse, darunter befanden sich ganz überwiegend E6<span class=\"diff_add\">/E7</span>-mRNA Studien (n = 6) für 5 [REF], [REF] oder mehr [REF], [REF], [REF], [REF], [REF], [REF] HPV-Typen, danach folgten Nachweisverfahren für das p16INK4a-Protein (1 anti p16 ELISA-Assay [REF] und 1 immunzytochemisches (p16-/Ki67-) Doppelmarkierung-Verfahren = “Dual Stain“ [REF], sowie ein immunzytochemisches Verfahren zum Nachweis der TOP2A- MCM2 Proteine [REF] (ProExC, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) und ein immunchromatographischer Nachweis der E6 Proteine von HPV 16/18/45 [REF] (OncoE6, Arbor Vita Corporation, Fremont, CA, USA).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "292;04_praevention-zervixkarzinom_0128.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Interessanterweise wurde in dieser Studie eine vergleichbare Sensitivität und Spezifität bei Frauen unter und über 30 Jahren beschrieben, so dass das Verfahren eventuell für jüngere Frauen angewendet werden könnte, bei denen der primäre Hochrisiko-HPV DNA Test wegen geringer Spezifität nicht empfohlen wird."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1840__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Interessanterweise wurde in dieser Studie eine vergleichbare Sensitivität und Spezifität bei Frauen unter 30 Jahren <span class=\"diff_sub\">und über 30 Jahren </span>beschrieben, so dass das Verfahren eventuell für jüngere Frauen angewendet werden könnte, bei denen der primäre Hochrisiko-HPV DNA Test wegen geringer Spezifität nicht empfohlen wird.</div><div nowrap=\"nowrap\">Interessanterweise wurde in dieser Studie eine vergleichbare Sensitivität und Spezifität bei Frauen unter<span class=\"diff_add\"> und über</span> 30 Jahren beschrieben, so dass das Verfahren eventuell für jüngere Frauen angewendet werden könnte, bei denen der primäre Hochrisiko-HPV DNA Test wegen geringer Spezifität nicht empfohlen wird.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "293;04_praevention-zervixkarzinom_0137.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei HPV-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1841__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei HPV-Negativität sollte eine zytologische <span class=\"diff_sub\">Kontrolle </span>und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div><div nowrap=\"nowrap\">Bei HPV-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "294;04_praevention-zervixkarzinom_0138.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei p16/Ki-67-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1842__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei p16<span class=\"diff_sub\">-Negativität</span>/Ki-67-Negativität sollte eine zytologische <span class=\"diff_sub\">Kontrolle </span>und HPV-Kontrolle nach 12 Monaten durchgeführt werden</div><div nowrap=\"nowrap\">Bei p16/Ki-67-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "295;04_praevention-zervixkarzinom_0138.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ist dieser p16/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1843__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ist dieser p16<span class=\"diff_sub\">-Nachweis</span>/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen.</div><div nowrap=\"nowrap\">Ist dieser p16/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "296;04_praevention-zervixkarzinom_0140.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei HPV-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1844__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei HPV-Negativität sollte eine zytologische <span class=\"diff_sub\">Kontrolle </span>und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div><div nowrap=\"nowrap\">Bei HPV-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "297;04_praevention-zervixkarzinom_0141.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei p16/Ki-67-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1845__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei p16<span class=\"diff_sub\">-Negativität</span>/Ki-67-Negativität sollte eine zytologische <span class=\"diff_sub\">Kontrolle </span>und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div><div nowrap=\"nowrap\">Bei p16/Ki-67-Negativität sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "298;04_praevention-zervixkarzinom_0141.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ist dieser p16/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1846__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ist dieser p16<span class=\"diff_sub\">-Nachweis</span>/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen.</div><div nowrap=\"nowrap\">Ist dieser p16/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "299;04_praevention-zervixkarzinom_0142.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Testung auf HPV-16 und HPV-16/18, p16 und ProExC waren zwar deutlich spezifischer als die HPV-Basistests aber hatten eine unzureichende Sensitivität."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1847__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Testung auf HPV-16 und HPV-16/<span class=\"diff_sub\">HPV-</span>18, p16 und ProExC waren zwar deutlich spezifischer als die HPV-Basistests aber hatten eine unzureichende Sensitivität.</div><div nowrap=\"nowrap\">Testung auf HPV-16 und HPV-16/18, p16 und ProExC waren zwar deutlich spezifischer als die HPV-Basistests aber hatten eine unzureichende Sensitivität.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "300;04_praevention-zervixkarzinom_0143.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Negativität der Abklärungstests sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1848__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Negativität der Abklärungstests sollte eine zytologische <span class=\"diff_sub\">Kontrolle </span>und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div><div nowrap=\"nowrap\">Bei Negativität der Abklärungstests sollte eine zytologische und HPV-Kontrolle nach 12 Monaten durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "301;04_praevention-zervixkarzinom_0143.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Befunden der Gruppe III-p, III-x * , III-e * oder III-g im organisierten zytologischen Screening kann eine Abklärung mittels HR-HPV-Test oder p16/Ki-67-Immunzytochemie innerhalb von 3 Monaten erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1849__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Bei Befunden der Gruppe III-p, Gruppe III-x * , Gruppe III-e * oder Gruppe III-g im organisierten zytologischen Screening kann eine Abklärung mittels HR-HPV-Test oder p16-Immunzytochemie/Ki-67-Immunzytochemie innerhalb von 3 Monaten erfolgen.</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Bei Befunden der Gruppe III-p, III-x * , III-e * oder III-g im organisierten zytologischen Screening kann eine Abklärung mittels HR-HPV-Test oder p16/Ki-67-Immunzytochemie innerhalb von 3 Monaten erfolgen.</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "302;04_praevention-zervixkarzinom_0143.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ist dieser HR-HPV-Test oder der p16/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1850__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ist dieser HR-HPV-Test oder der p16<span class=\"diff_sub\">-Nachweis</span>/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen.</div><div nowrap=\"nowrap\">Ist dieser HR-HPV-Test oder der p16/Ki-67-Nachweis positiv, sollte eine kolposkopische Abklärung innerhalb von 3 Monaten erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "303;04_praevention-zervixkarzinom_0148.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei einem positiven HPV-16/18 Testergebnis im HPV-basierten Screening sollte eine kolposkopische Abklärung erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1851__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei einem positiven HPV-16 Testergebnis<span class=\"diff_sub\">/HPV-18 Testergebnis</span> im HPV-basierten Screening sollte eine kolposkopische Abklärung erfolgen.</div><div nowrap=\"nowrap\">Bei einem positiven HPV-16<span class=\"diff_add\">/18</span> Testergebnis im HPV-basierten Screening sollte eine kolposkopische Abklärung erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "304;04_praevention-zervixkarzinom_0150.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zusätzliche HPV-16-Testung vs. zusätzliche HPV-16/18-Testung resultiert in einem Verlust von 5% an Sensitivität und einem Gewinn von 7% an Spezifität."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1852__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zusätzliche HPV-16-Testung vs. zusätzliche HPV-16<span class=\"diff_sub\">-Testung</span>/<span class=\"diff_sub\">HPV-</span>18-Testung resultiert in einem Verlust von 5% an Sensitivität und einem Gewinn von 7% an Spezifität.</div><div nowrap=\"nowrap\">Zusätzliche HPV-16-Testung vs. zusätzliche HPV-16/18-Testung resultiert in einem Verlust von 5% an Sensitivität und einem Gewinn von 7% an Spezifität.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "305;04_praevention-zervixkarzinom_0150.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nur die ATHENA-Studie untersuchte die parallele Durchführung von Zytologie und HPV-16/18-Testung [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1853__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nur die ATHENA-Studie untersuchte die parallele Durchführung von Zytologie und HPV-16<span class=\"diff_sub\">-Testung</span>/<span class=\"diff_sub\">HPV-</span>18-Testung [REF].</div><div nowrap=\"nowrap\">Nur die ATHENA-Studie untersuchte die parallele Durchführung von Zytologie und HPV-16/18-Testung [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "306;04_praevention-zervixkarzinom_0151.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Sensitivität kann erhöht werden (auf Kosten der Spezifität) durch eine parallele Testung auf HPV-16 oder HPV-16/18."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1854__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Sensitivität kann erhöht werden (auf Kosten der Spezifität) durch eine parallele Testung auf HPV-16 oder HPV-16/<span class=\"diff_sub\">HPV-</span>18.</div><div nowrap=\"nowrap\">Die Sensitivität kann erhöht werden (auf Kosten der Spezifität) durch eine parallele Testung auf HPV-16 oder HPV-16/18.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "307;04_praevention-zervixkarzinom_0158.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei der Abklärungskolposkopie sollten bei Typ 1 und Typ 2 TZ kolposkopisch gesteuerte Biopsien aus der/den schwerstgradigen Läsion/en entnommen werden, bei Typ 3 TZ sollte eine endozervikale Curettage erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1855__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei der Abklärungskolposkopie sollten bei Typ 1 und Typ 2 TZ kolposkopisch gesteuerte Biopsien aus der/den schwerstgradigen Läsion/<span class=\"diff_chg\">Läsionen</span> entnommen werden, bei Typ 3 TZ sollte eine endozervikale Curettage erfolgen.</div><div nowrap=\"nowrap\">Bei der Abklärungskolposkopie sollten bei Typ 1 und Typ 2 TZ kolposkopisch gesteuerte Biopsien aus der/den schwerstgradigen Läsion/<span class=\"diff_chg\">en</span> entnommen werden, bei Typ 3 TZ sollte eine endozervikale Curettage erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "308;04_praevention-zervixkarzinom_0159.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während Screeningtests und Triagetests dazu dienen, Frauen mit einem Risiko für das Vorliegen einer CIN3+ von ≥10% zu identifizieren, erfolgt die Diagnosestellung durch Abklärungskolposkopie mit Entnahme von Biopsien aus allen erkennbaren Läsionen bei Typ 1 und 2 TZ und/oder endozervikaler Curettage bei Typ3 TZ."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1856__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während Screeningtests und Triagetests dazu dienen, Frauen mit einem Risiko für das Vorliegen einer CIN3+ von ≥10% zu identifizieren, erfolgt die Diagnosestellung durch Abklärungskolposkopie mit Entnahme von Biopsien aus allen erkennbaren Läsionen bei Typ 1 und Typ<span class=\"diff_sub\"> 2 TZ und/oder endozervikaler Curettage bei Typ</span>3 TZ.</div><div nowrap=\"nowrap\">Während Screeningtests und Triagetests dazu dienen, Frauen mit einem Risiko für das Vorliegen einer CIN3+ von ≥10% zu identifizieren, erfolgt die Diagnosestellung durch Abklärungskolposkopie mit Entnahme von Biopsien aus allen erkennbaren Läsionen bei Typ 1 und<span class=\"diff_add\"> 2 TZ und/oder endozervikaler Curettage bei</span> Typ3 TZ.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "309;04_praevention-zervixkarzinom_0164.tsv;24"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Typ 1 und 2 TZ Entnahme von Biopsien aus minor und major changes; bei Typ 3 TZ obligate Durchführung einer endozervikalen Kürettage, bei Pap IV+ oder V.a. glanduläre Läsionen oder bei tief-endozervikaler CIN 2 bzw. „major changes“ obligate Konisation."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1857__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Bei Typ 1 und Typ 2 TZ Entnahme von Biopsien aus minor und major changes; bei Typ 3 TZ obligate Durchführung einer endozervikalen Kürettage, bei Pap IV+ oder V.a. glanduläre Läsionen oder bei tief-endozervikaler CIN 2 bzw. „major changes“ obligate Konisation.</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Bei Typ 1 und 2 TZ Entnahme von Biopsien aus minor und major changes; bei Typ 3 TZ obligate Durchführung einer endozervikalen Kürettage, bei Pap IV+ oder V.a. glanduläre Läsionen oder bei tief-endozervikaler CIN 2 bzw. „major changes“ obligate Konisation.</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "310;04_praevention-zervixkarzinom_0170.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nach der gynäkologischen Untersuchung und bei Vorliegen eines auffälligen Vorsorgebefundes wird die Patientin bei entsprechender Expertise entweder vor Ort oder in einer Gynäkologischen Dysplasie-Sprechstunde/- Einheit (zertifiziert) weiter histologisch abgeklärt (s. Abbildung Versorgungskette)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1858__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nach der gynäkologischen Untersuchung und bei Vorliegen eines auffälligen Vorsorgebefundes wird die Patientin bei entsprechender Expertise entweder vor Ort oder in einer Gynäkologischen Dysplasie-Sprechstunde/<span class=\"diff_sub\"> Dysplasie</span>-Einheit (zertifiziert) weiter histologisch abgeklärt (s. Abbildung Versorgungskette).</div><div nowrap=\"nowrap\">Nach der gynäkologischen Untersuchung und bei Vorliegen eines auffälligen Vorsorgebefundes wird die Patientin bei entsprechender Expertise entweder vor Ort oder in einer Gynäkologischen Dysplasie-Sprechstunde/-<span class=\"diff_add\"> </span>Einheit (zertifiziert) weiter histologisch abgeklärt (s. Abbildung Versorgungskette).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "311;04_praevention-zervixkarzinom_0170.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Hierzu werden derzeit kooperative Strukturmodelle (Gynäkologische Dysplasie- Sprechstunde/-Einheit) der Deutschen Krebsgesellschaft (DKG) mit der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) mit der Arbeitsgemeinschaft für Zervixpathologie und Kolposkopie (AG-CPC) umgesetzt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1859__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Hierzu werden derzeit kooperative Strukturmodelle (Gynäkologische Dysplasie- Sprechstunde/<span class=\"diff_sub\">Dysplasie</span>-Einheit) der Deutschen Krebsgesellschaft (DKG) mit der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) mit der Arbeitsgemeinschaft für Zervixpathologie und Kolposkopie (AG-CPC) umgesetzt.</div><div nowrap=\"nowrap\">Hierzu werden derzeit kooperative Strukturmodelle (Gynäkologische Dysplasie- Sprechstunde/-Einheit) der Deutschen Krebsgesellschaft (DKG) mit der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) mit der Arbeitsgemeinschaft für Zervixpathologie und Kolposkopie (AG-CPC) umgesetzt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "312;04_praevention-zervixkarzinom_0185.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ein organisiertes Screening mit populationsbasierter Einladung und stringenter Qualitätssicherung kann zu einer effektiveren und sozial- wie altersbezogen ausgewogeneren Vorsorge führen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1860__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ein organisiertes Screening mit populationsbasierter Einladung und stringenter Qualitätssicherung kann zu einer effektiveren und sozial<span class=\"diff_chg\">bezogen</span> wie altersbezogen ausgewogeneren Vorsorge führen.</div><div nowrap=\"nowrap\">Ein organisiertes Screening mit populationsbasierter Einladung und stringenter Qualitätssicherung kann zu einer effektiveren und sozial<span class=\"diff_chg\">-</span> wie altersbezogen ausgewogeneren Vorsorge führen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "313;04_praevention-zervixkarzinom_0216.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei einer T Zone Typ 2 oder 3 kann die Tiefe der Läsion in den Endozervikalkanal durch Aufspreizen oder Endocervikoskopie bestimmt, und bis zu dieser Tiefe die Veränderung im Gesunden entfernt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1861__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei einer T Zone Typ 2 oder<span class=\"diff_sub\"> Typ</span> 3 kann die Tiefe der Läsion in den Endozervikalkanal durch Aufspreizen oder Endocervikoskopie bestimmt, und bis zu dieser Tiefe die Veränderung im Gesunden entfernt werden.</div><div nowrap=\"nowrap\">Bei einer T Zone Typ 2 oder 3 kann die Tiefe der Läsion in den Endozervikalkanal durch Aufspreizen oder Endocervikoskopie bestimmt, und bis zu dieser Tiefe die Veränderung im Gesunden entfernt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "314;04_praevention-zervixkarzinom_0223.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der entscheidende Ergebnisparameter für eine Dysplasiesprechstunde/-einheit ist jedoch nicht der R-Status, sondern die Rate an Rezidiven von CIN 2 oder CIN 3 nach operativer Behandlung, die nicht höher als 5% in einem postoperativen Nachsorge-Zeitraum von 12 Monaten liegen sollte ( [REF], S.44-45)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1862__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der entscheidende Ergebnisparameter für eine Dysplasiesprechstunde/<span class=\"diff_chg\">Dysplasieeinheit ist</span> jedoch nicht der R-Status, sondern die Rate an Rezidiven von CIN 2 oder CIN 3 nach operativer Behandlung, die nicht höher als 5% in einem postoperativen Nachsorge-Zeitraum von 12 Monaten liegen sollte ( [REF], S.44-45).</div><div nowrap=\"nowrap\">Der entscheidende Ergebnisparameter für eine Dysplasiesprechstunde/<span class=\"diff_chg\">-einheit ist</span> jedoch nicht der R-Status, sondern die Rate an Rezidiven von CIN 2 oder CIN 3 nach operativer Behandlung, die nicht höher als 5% in einem postoperativen Nachsorge-Zeitraum von 12 Monaten liegen sollte ( [REF], S.44-45).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "315;04_praevention-zervixkarzinom_0238.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das Risiko einer Progression einer CIN2/3 zu einem invasivem Karzinom während der Schwangerschaft ist sehr niedrig (0 – 0,4%), wogegen die Chance für eine spontane Regression bei 48 – 70% liegt [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1863__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das Risiko einer Progression einer CIN2/<span class=\"diff_sub\">CIN</span>3 zu einem invasivem Karzinom während der Schwangerschaft ist sehr niedrig (0 – 0,4%), wogegen die Chance für eine spontane Regression bei 48 – 70% liegt [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Das Risiko einer Progression einer CIN2/3 zu einem invasivem Karzinom während der Schwangerschaft ist sehr niedrig (0 – 0,4%), wogegen die Chance für eine spontane Regression bei 48 – 70% liegt [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "316;04_praevention-zervixkarzinom_0238.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Aus diesem Grund – und aufgrund der möglichen Komplikationen einer operativen Therapie (siehe unten) – soll während einer Schwangerschaft keine operative Therapie einer CIN2/3 erfolgen, wenn das Vorliegen eines invasiven Karzinoms mit hoher Sicherheit (Zytologie, Kolposkopie, Biopsie) ausgeschlossen werden kann."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1864__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Aus diesem Grund – und aufgrund der möglichen Komplikationen einer operativen Therapie (siehe unten) – soll während einer Schwangerschaft keine operative Therapie einer CIN2/<span class=\"diff_sub\">CIN</span>3 erfolgen, wenn das Vorliegen eines invasiven Karzinoms mit hoher Sicherheit (Zytologie, Kolposkopie, Biopsie) ausgeschlossen werden kann.</div><div nowrap=\"nowrap\">Aus diesem Grund – und aufgrund der möglichen Komplikationen einer operativen Therapie (siehe unten) – soll während einer Schwangerschaft keine operative Therapie einer CIN2/3 erfolgen, wenn das Vorliegen eines invasiven Karzinoms mit hoher Sicherheit (Zytologie, Kolposkopie, Biopsie) ausgeschlossen werden kann.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "317;04_praevention-zervixkarzinom_0239.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während einer Schwangerschaft soll bei einer CIN2/3 oder einem ACIS keine operative Therapie erfolgen, wenn das Vorliegen eines invasiven Karzinoms mit hoher Sicherheit ausgeschlossen wurde."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1865__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während einer Schwangerschaft soll bei einer CIN2/<span class=\"diff_sub\">CIN</span>3 oder einem ACIS keine operative Therapie erfolgen, wenn das Vorliegen eines invasiven Karzinoms mit hoher Sicherheit ausgeschlossen wurde.</div><div nowrap=\"nowrap\">Während einer Schwangerschaft soll bei einer CIN2/3 oder einem ACIS keine operative Therapie erfolgen, wenn das Vorliegen eines invasiven Karzinoms mit hoher Sicherheit ausgeschlossen wurde.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "318;04_praevention-zervixkarzinom_0240.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während einer Schwangerschaft sollen bei einer CIN2/3 oder einem ACIS kolposkopische Kontrollen erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1866__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während einer Schwangerschaft sollen bei einer CIN2/<span class=\"diff_sub\">CIN</span>3 oder einem ACIS kolposkopische Kontrollen erfolgen.</div><div nowrap=\"nowrap\">Während einer Schwangerschaft sollen bei einer CIN2/3 oder einem ACIS kolposkopische Kontrollen erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "319;04_praevention-zervixkarzinom_0244.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das Vorliegen einer CIN2/3 soll keinen Einfluss auf die Entscheidungsfindung hinsichtlich des Geburtsmodus haben."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1867__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das Vorliegen einer CIN2/<span class=\"diff_sub\">CIN</span>3 soll keinen Einfluss auf die Entscheidungsfindung hinsichtlich des Geburtsmodus haben.</div><div nowrap=\"nowrap\">Das Vorliegen einer CIN2/3 soll keinen Einfluss auf die Entscheidungsfindung hinsichtlich des Geburtsmodus haben.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "320;04_praevention-zervixkarzinom_0251.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die absolute Sensitivität bzw. Spezifität des Follow up mittels Zytologie hinsichtlich der Vorhersage eines Rezidivs einer therapierten CIN 2/3 Läsion lag bei 72% (95%CI: 65,6 -77,5%) bzw. 84,6% (95%CI: 80,7 – 87,9%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1868__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die absolute Sensitivität bzw. Spezifität des Follow up mittels Zytologie hinsichtlich der Vorhersage eines Rezidivs einer therapierten CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span> lag bei 72% (95%CI: 65,6 -77,5%) bzw. 84,6% (95%CI: 80,7 – 87,9%).</div><div nowrap=\"nowrap\">Die absolute Sensitivität bzw. Spezifität des Follow up mittels Zytologie hinsichtlich der Vorhersage eines Rezidivs einer therapierten CIN 2<span class=\"diff_add\">/3</span> Läsion lag bei 72% (95%CI: 65,6 -77,5%) bzw. 84,6% (95%CI: 80,7 – 87,9%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "321;04_praevention-zervixkarzinom_0251.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Therapiemaßnahmen umfassen sowohl Exzisionsbiopsien wie Laser-, elektrochirurgische und Messerkonisation als auch ablative Verfahren wie Kryotherapie, Laserablation und Elektrovaporisation [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1869__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Therapiemaßnahmen umfassen sowohl Exzisionsbiopsien wie Laser<span class=\"diff_chg\">konisation</span>, elektrochirurgische <span class=\"diff_sub\">Konisation </span>und Messerkonisation als auch ablative Verfahren wie Kryotherapie, Laserablation und Elektrovaporisation [REF].</div><div nowrap=\"nowrap\">Die Therapiemaßnahmen umfassen sowohl Exzisionsbiopsien wie Laser<span class=\"diff_chg\">-</span>, elektrochirurgische und Messerkonisation als auch ablative Verfahren wie Kryotherapie, Laserablation und Elektrovaporisation [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "322;04_praevention-zervixkarzinom_0251.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei den Studien, bei denen das HC2-Verfahren [5,19,20,23-28] zur Rezidivdiagnostik eines CIN 2/3 Läsion eingesetzt wurde, lag die gepoolte Sensitivität bzw. Spezifität bei 95,6% (95% CI: 89,7 bis 98,2%) bzw. 81,9% (95% CI: 75,3 bis 87,1%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1870__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei den Studien, bei denen das HC2-Verfahren [5,19,20,23-28] zur Rezidivdiagnostik eines CIN 2 Läsion<span class=\"diff_chg\">/CIN 3 Läsion eingesetzt</span> wurde, lag die gepoolte Sensitivität bzw. Spezifität bei 95,6% (95% CI: 89,7 bis 98,2%) bzw. 81,9% (95% CI: 75,3 bis 87,1%).</div><div nowrap=\"nowrap\">Bei den Studien, bei denen das HC2-Verfahren [5,19,20,23-28] zur Rezidivdiagnostik eines CIN 2<span class=\"diff_add\">/3</span> Läsion<span class=\"diff_chg\"> eingesetzt</span> wurde, lag die gepoolte Sensitivität bzw. Spezifität bei 95,6% (95% CI: 89,7 bis 98,2%) bzw. 81,9% (95% CI: 75,3 bis 87,1%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "323;04_praevention-zervixkarzinom_0251.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Verglichen mit der Zytologie war der hrHPV-Test zwischen 3 und 9 Monaten nach Therapie signifikant sensitiver verbunden mit einer signifikant geringeren Spezifität für die Vorhersage eines CIN 2/3-Rezidivs."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1871__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Verglichen mit der Zytologie war der hrHPV-Test zwischen 3 und 9 Monaten nach Therapie signifikant sensitiver verbunden mit einer signifikant geringeren Spezifität für die Vorhersage eines CIN 2<span class=\"diff_sub\">-Rezidivs</span>/<span class=\"diff_sub\">CIN </span>3-Rezidivs.</div><div nowrap=\"nowrap\">Verglichen mit der Zytologie war der hrHPV-Test zwischen 3 und 9 Monaten nach Therapie signifikant sensitiver verbunden mit einer signifikant geringeren Spezifität für die Vorhersage eines CIN 2/3-Rezidivs.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "324;04_praevention-zervixkarzinom_0251.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es wurden alle prospektiven und Fallkontroll-Studien, in denen Patientinnen mit histologisch nachgewiesener CIN 2/3 Läsion mittels Exzisionsbiopsie oder ablativen Verfahren behandelt wurden, evaluiert."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1872__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es wurden alle prospektiven und Fallkontroll-Studien, in denen Patientinnen mit histologisch nachgewiesener CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span> mittels Exzisionsbiopsie oder ablativen Verfahren behandelt wurden, evaluiert.</div><div nowrap=\"nowrap\">Es wurden alle prospektiven und Fallkontroll-Studien, in denen Patientinnen mit histologisch nachgewiesener CIN 2<span class=\"diff_add\">/3</span> Läsion mittels Exzisionsbiopsie oder ablativen Verfahren behandelt wurden, evaluiert.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "325;04_praevention-zervixkarzinom_0253.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Demnach ist ein negatives Testverfahren 6 Monaten nach Therapie einer CIN2/3 mit einem 10 Jahresrisiko eines CIN3 Rezidivs von 2,1% (wenn hrHPV negativ ist), von 2,8% (wenn Zytologie negativ ist) und von 1,4% (wenn der Kombinationstest negativ ist) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1873__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Demnach ist ein negatives Testverfahren 6 Monaten nach Therapie einer CIN2/CIN3 <span class=\"diff_sub\">mit einem 10 Jahresrisiko eines CIN3 </span>Rezidivs von 2,1% (wenn hrHPV negativ ist), von 2,8% (wenn Zytologie negativ ist) und von 1,4% (wenn der Kombinationstest negativ ist) [REF].</div><div nowrap=\"nowrap\">Demnach ist ein negatives Testverfahren 6 Monaten nach Therapie einer CIN2/<span class=\"diff_add\">3 mit einem 10 Jahresrisiko eines </span>CIN3 Rezidivs von 2,1% (wenn hrHPV negativ ist), von 2,8% (wenn Zytologie negativ ist) und von 1,4% (wenn der Kombinationstest negativ ist) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "326;04_praevention-zervixkarzinom_0253.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der hrHPV-Test und die Kombination aus hrHPV-Test und Zytologie führen zu einer deutlich verbesserten Detektion eines Rezidivs einer therapierten CIN 2/3 Läsion."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1874__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der hrHPV-Test und die Kombination aus hrHPV-Test und Zytologie führen zu einer deutlich verbesserten Detektion eines Rezidivs einer therapierten CIN 2<span class=\"diff_sub\"> Läsion</span>/<span class=\"diff_sub\">CIN </span>3 Läsion.</div><div nowrap=\"nowrap\">Der hrHPV-Test und die Kombination aus hrHPV-Test und Zytologie führen zu einer deutlich verbesserten Detektion eines Rezidivs einer therapierten CIN 2/3 Läsion.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "327;04_praevention-zervixkarzinom_0255.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- histologisch nachgewiesene CIN 2/3 Läsion"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1875__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- histologisch nachgewiesene CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span></div><div nowrap=\"nowrap\">- histologisch nachgewiesene CIN 2<span class=\"diff_add\">/3</span> Läsion</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "328;04_praevention-zervixkarzinom_0255.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ein positiver Absetzungsrand lag in 24,7% der 1912 Patientinnen mit CIN 2/3 Läsion vor."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1876__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ein positiver Absetzungsrand lag in 24,7% der 1912 Patientinnen mit CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span> vor.</div><div nowrap=\"nowrap\">Ein positiver Absetzungsrand lag in 24,7% der 1912 Patientinnen mit CIN 2<span class=\"diff_add\">/3</span> Läsion vor.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "329;04_praevention-zervixkarzinom_0255.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In 8,2% traten Rezidive der CIN 2/3 Läsionen auf."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1877__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In 8,2% traten Rezidive der CIN 2 Läsionen<span class=\"diff_sub\">/CIN 3 Läsionen</span> auf.</div><div nowrap=\"nowrap\">In 8,2% traten Rezidive der CIN 2<span class=\"diff_add\">/3</span> Läsionen auf.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "330;04_praevention-zervixkarzinom_0255.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die absolute Sensitivität bzw. Spezifität des Absetzungsrandes zur Vorhersage eines Rezidivs einer CIN 2/3 Läsion betrug 58,6% (95 CI: 48,4 bis 68,1%) bzw. 80,4% (95% CI: 74,7 bis 85,1%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1878__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die absolute Sensitivität bzw. Spezifität des Absetzungsrandes zur Vorhersage eines Rezidivs einer CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span> betrug 58,6% (95 CI: 48,4 bis 68,1%) bzw. 80,4% (95% CI: 74,7 bis 85,1%).</div><div nowrap=\"nowrap\">Die absolute Sensitivität bzw. Spezifität des Absetzungsrandes zur Vorhersage eines Rezidivs einer CIN 2<span class=\"diff_add\">/3</span> Läsion betrug 58,6% (95 CI: 48,4 bis 68,1%) bzw. 80,4% (95% CI: 74,7 bis 85,1%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "331;04_praevention-zervixkarzinom_0255.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ein positiver Absetzungsrand zeigt verglichen mit der Zytologie im Zeitraum von 3 bis 9 Monaten nach Therapie einer CIN 2/3 Läsion in Bezug auf die Vorhersage eines Rezidivs eine geringere Sensitivität und Spezifität (Ratio 0,90 (95% CI: 0,75 bis 1,10) und 0,95 (95% CI: 0,85 bis 1,07)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1879__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Ein positiver Absetzungsrand zeigt verglichen mit der Zytologie im Zeitraum von 3 bis 9 Monaten nach Therapie einer CIN 2 Läsion/CIN 3 Läsion in Bezug auf die Vorhersage eines Rezidivs eine geringere Sensitivität und Spezifität (Ratio 0,90 (95% CI: 0,75 bis 1,10) und 0,95 (95% CI: 0,85 bis 1,07).</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Ein positiver Absetzungsrand zeigt verglichen mit der Zytologie im Zeitraum von 3 bis 9 Monaten nach Therapie einer CIN 2/3 Läsion in Bezug auf die Vorhersage eines Rezidivs eine geringere Sensitivität und Spezifität (Ratio 0,90 (95% CI: 0,75 bis 1,10) und 0,95 (95% CI: 0,85 bis 1,07).</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "332;04_praevention-zervixkarzinom_0255.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zusammenfassend zeigen die gepoolten Daten der 9 Studien eine schwache Sensitivität von 60% für den Vorhersagewert des positiven Absetzungsrandes bezüglich eines CIN 2/3 Rezidivs."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1880__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zusammenfassend zeigen die gepoolten Daten der 9 Studien eine schwache Sensitivität von 60% für den Vorhersagewert des positiven Absetzungsrandes bezüglich eines CIN 2<span class=\"diff_sub\"> Rezidivs</span>/<span class=\"diff_sub\">CIN </span>3 Rezidivs.</div><div nowrap=\"nowrap\">Zusammenfassend zeigen die gepoolten Daten der 9 Studien eine schwache Sensitivität von 60% für den Vorhersagewert des positiven Absetzungsrandes bezüglich eines CIN 2/3 Rezidivs.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "333;04_praevention-zervixkarzinom_0255.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Bedeutung des tumorfreien Absetzungsrandes zur Vorhersage eines Rezidivs einer therapierten CIN 2/3 Läsion wird kontrovers diskutiert, insbesondere seitdem eine direkte Beziehung zwischen dem Ausmaß der Exzisionsbiopsie und dem geburtshilflichen Outcome gezeigt werden konnte [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1881__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Bedeutung des tumorfreien Absetzungsrandes zur Vorhersage eines Rezidivs einer therapierten CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span> wird kontrovers diskutiert, insbesondere seitdem eine direkte Beziehung zwischen dem Ausmaß der Exzisionsbiopsie und dem geburtshilflichen Outcome gezeigt werden konnte [REF], [REF].</div><div nowrap=\"nowrap\">Die Bedeutung des tumorfreien Absetzungsrandes zur Vorhersage eines Rezidivs einer therapierten CIN 2<span class=\"diff_add\">/3</span> Läsion wird kontrovers diskutiert, insbesondere seitdem eine direkte Beziehung zwischen dem Ausmaß der Exzisionsbiopsie und dem geburtshilflichen Outcome gezeigt werden konnte [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "334;04_praevention-zervixkarzinom_0256.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Biomarker (mRNA für 5 HPV Typen, HPV Typen-spezifische Persistenz) sollen in der Nachbetreuung von therapierten CIN 2/3 Läsionen nicht eingesetzt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1882__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Biomarker (mRNA für 5 HPV Typen, HPV Typen-spezifische Persistenz) sollen in der Nachbetreuung von therapierten CIN 2 Läsionen<span class=\"diff_sub\">/CIN 3 Läsionen</span> nicht eingesetzt werden.</div><div nowrap=\"nowrap\">Biomarker (mRNA für 5 HPV Typen, HPV Typen-spezifische Persistenz) sollen in der Nachbetreuung von therapierten CIN 2<span class=\"diff_add\">/3</span> Läsionen nicht eingesetzt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "335;04_praevention-zervixkarzinom_0257.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wurde dieses Testverfahren in bis zu 6 Monaten nach Therapie eingesetzt, so war eine geringere Sensitivität der HPV Typen spezifischen Persistenz zur Vorhersage eines CIN 2/3 Rezidivs zu beobachten verglichen mit der Positivität eines HPV Tests für irgendeinen Hochrisiko-HPV Typ (78% versus 91% und 39% versus 54%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1883__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wurde dieses Testverfahren in bis zu 6 Monaten nach Therapie eingesetzt, so war eine geringere Sensitivität der HPV Typen spezifischen Persistenz zur Vorhersage eines CIN 2 Rezidivs<span class=\"diff_chg\">/CIN 3 Rezidivs zu</span> beobachten verglichen mit der Positivität eines HPV Tests für irgendeinen Hochrisiko-HPV Typ (78% versus 91% und 39% versus 54%).</div><div nowrap=\"nowrap\">Wurde dieses Testverfahren in bis zu 6 Monaten nach Therapie eingesetzt, so war eine geringere Sensitivität der HPV Typen spezifischen Persistenz zur Vorhersage eines CIN 2<span class=\"diff_add\">/3</span> Rezidivs<span class=\"diff_chg\"> zu</span> beobachten verglichen mit der Positivität eines HPV Tests für irgendeinen Hochrisiko-HPV Typ (78% versus 91% und 39% versus 54%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "336;04_praevention-zervixkarzinom_0257.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die geringe Evidenzlage und die ausgeprägte Heterogenität der Studien erlauben derzeit nicht den Einsatz von Biomarker in der Nachsorge von therapierten CIN 2/3 Läsionen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1884__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die geringe Evidenzlage und die ausgeprägte Heterogenität der Studien erlauben derzeit nicht den Einsatz von Biomarker in der Nachsorge von therapierten CIN 2<span class=\"diff_sub\"> Läsionen</span>/<span class=\"diff_sub\">CIN </span>3 Läsionen.</div><div nowrap=\"nowrap\">Die geringe Evidenzlage und die ausgeprägte Heterogenität der Studien erlauben derzeit nicht den Einsatz von Biomarker in der Nachsorge von therapierten CIN 2/3 Läsionen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "337;04_praevention-zervixkarzinom_0257.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "2 Studien untersuchten die Sensitivität und Spezifität des mRNA Tests nach Therapie einer CIN 2/3 Läsion zur Vorhersage eines Rezidivs [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1885__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">2 Studien untersuchten die Sensitivität und Spezifität des mRNA Tests nach Therapie einer CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span> zur Vorhersage eines Rezidivs [REF], [REF].</div><div nowrap=\"nowrap\">2 Studien untersuchten die Sensitivität und Spezifität des mRNA Tests nach Therapie einer CIN 2<span class=\"diff_add\">/3</span> Läsion zur Vorhersage eines Rezidivs [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "338;04_praevention-zervixkarzinom_0257.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Beide Studien setzten den auf der Detektion von E6/E7 mRNA der 5 Hochrisiko-HPV Typen (HPV 16/18/31/33/45) basierenden Assay ein [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1886__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Beide Studien setzten den auf der Detektion von E6 mRNA<span class=\"diff_sub\">/E7 mRNA</span> der 5 Hochrisiko-HPV Typen (HPV 16/<span class=\"diff_sub\">HPV </span>18/<span class=\"diff_sub\">HPV </span>31/<span class=\"diff_sub\">HPV </span>33/<span class=\"diff_sub\">HPV </span>45) basierenden Assay ein [REF].</div><div nowrap=\"nowrap\">Beide Studien setzten den auf der Detektion von E6<span class=\"diff_add\">/E7</span> mRNA der 5 Hochrisiko-HPV Typen (HPV 16/18/31/33/45) basierenden Assay ein [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "339;04_praevention-zervixkarzinom_0257.tsv;16"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die aktuelle Datenlage zeigt eine hohe Variabilität von Sensitivität und Spezifität der Biomarker (mRNA für 5 HPV Typen, HPV Typenspezifische Persistenz) bezüglich des Vorhersagewertes eines Rezidivs einer therapierten CIN 2/3 Läsion."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1887__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die aktuelle Datenlage zeigt eine hohe Variabilität von Sensitivität und Spezifität der Biomarker (mRNA für 5 HPV Typen, HPV Typenspezifische Persistenz) bezüglich des Vorhersagewertes eines Rezidivs einer therapierten CIN 2 Läsion<span class=\"diff_sub\">/CIN 3 Läsion</span>.</div><div nowrap=\"nowrap\">Die aktuelle Datenlage zeigt eine hohe Variabilität von Sensitivität und Spezifität der Biomarker (mRNA für 5 HPV Typen, HPV Typenspezifische Persistenz) bezüglich des Vorhersagewertes eines Rezidivs einer therapierten CIN 2<span class=\"diff_add\">/3</span> Läsion.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "340;04_praevention-zervixkarzinom_0257.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "4 Studien untersuchten die Sensitivität und Spezifität der HPV Typen-spezifischen Persistenz zur Vorhersage der CIN 2/3 Rezidivrate nach Therapie [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1888__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">4 Studien untersuchten die Sensitivität und Spezifität der HPV Typen-spezifischen Persistenz zur Vorhersage der CIN 2 Rezidivrate<span class=\"diff_sub\">/CIN 3 Rezidivrate</span> nach Therapie [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">4 Studien untersuchten die Sensitivität und Spezifität der HPV Typen-spezifischen Persistenz zur Vorhersage der CIN 2<span class=\"diff_add\">/3</span> Rezidivrate nach Therapie [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "341;04_praevention-zervixkarzinom_0261.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch mögliche seelische Probleme, die zum Krankheitsgeschehen beitragen könnten, sollen durch Gesprächs-, Verhaltens- oder auch künstlerischen Therapien behandelt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1889__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch mögliche seelische Probleme, die zum Krankheitsgeschehen beitragen könnten, sollen durch Gesprächs<span class=\"diff_chg\">therapien</span>, Verhaltens<span class=\"diff_chg\">therapien</span> oder auch künstlerischen Therapien behandelt werden.</div><div nowrap=\"nowrap\">Auch mögliche seelische Probleme, die zum Krankheitsgeschehen beitragen könnten, sollen durch Gesprächs<span class=\"diff_chg\">-</span>, Verhaltens<span class=\"diff_chg\">-</span> oder auch künstlerischen Therapien behandelt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "342;04_praevention-zervixkarzinom_0263.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zwei doppel-blinde, plazebo-kontrollierte, randomisierte Studien, die den Effekt von 30 mg ß-Karotin und/oder 500 mg Vitamin C auf Zervixatypien und CIN 1-Läsionen bzw. CIN II und III-Läsionen prüften, ergaben jedoch, dass die genannten Vitamine in der Intervention keinen positiven Einfluss auf die Problematik der Zervixdysplasie haben [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1890__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zwei doppel-blinde, plazebo-kontrollierte, randomisierte Studien, die den Effekt von 30 mg ß-Karotin und/oder 500 mg Vitamin C auf Zervixatypien und CIN 1-Läsionen bzw. CIN II-Läsionen <span class=\"diff_sub\">und CIN III-Läsionen </span>prüften, ergaben jedoch, dass die genannten Vitamine in der Intervention keinen positiven Einfluss auf die Problematik der Zervixdysplasie haben [REF], [REF].</div><div nowrap=\"nowrap\">Zwei doppel-blinde, plazebo-kontrollierte, randomisierte Studien, die den Effekt von 30 mg ß-Karotin und/oder 500 mg Vitamin C auf Zervixatypien und CIN 1-Läsionen bzw. CIN <span class=\"diff_add\">II und I</span>II-Läsionen prüften, ergaben jedoch, dass die genannten Vitamine in der Intervention keinen positiven Einfluss auf die Problematik der Zervixdysplasie haben [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "343;04_praevention-zervixkarzinom_0270.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ein besseres Verständnis dieser Zusammenhänge führt dann zu einer höheren Bereitschaft, am Früherkennungs- oder/und Impfprogramm teilzunehmen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1891__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ein besseres Verständnis dieser Zusammenhänge führt dann zu einer höheren Bereitschaft, am Früherkennungs<span class=\"diff_chg\">programm</span> oder/und Impfprogramm teilzunehmen.</div><div nowrap=\"nowrap\">Ein besseres Verständnis dieser Zusammenhänge führt dann zu einer höheren Bereitschaft, am Früherkennungs<span class=\"diff_chg\">-</span> oder/und Impfprogramm teilzunehmen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "344;04_praevention-zervixkarzinom_0292.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies führt zu einer zu optimistischen Beurteilung der 1- und 2-jährlichen zytologischen Screeningverfahren im Vergleich zu den HPV-basierten Strategien."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1892__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies führt zu einer zu optimistischen Beurteilung der 1-<span class=\"diff_sub\">jährlichen</span> und 2-jährlichen zytologischen Screeningverfahren im Vergleich zu den HPV-basierten Strategien.</div><div nowrap=\"nowrap\">Dies führt zu einer zu optimistischen Beurteilung der 1- und 2-jährlichen zytologischen Screeningverfahren im Vergleich zu den HPV-basierten Strategien.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "345;04_praevention-zervixkarzinom_0297.tsv;36"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Immunochromatografischer Lateral Flow Assay zum Nachweis des HR-HPV Oncoproteins E6 von HPV16, 18 und 45, dessen Expression charakteristisch für dysplastische Zellen ist [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1893__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Immunochromatografischer Lateral Flow Assay zum Nachweis des HR-HPV Oncoproteins E6 von HPV16, <span class=\"diff_sub\">HPV</span>18 und <span class=\"diff_sub\">HPV</span>45, dessen Expression charakteristisch für dysplastische Zellen ist [REF].</div><div nowrap=\"nowrap\">Immunochromatografischer Lateral Flow Assay zum Nachweis des HR-HPV Oncoproteins E6 von HPV16, 18 und 45, dessen Expression charakteristisch für dysplastische Zellen ist [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "346;04_praevention-zervixkarzinom_0297.tsv;32"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Detektion der E6/E7 mRNA von 13 HR-HPV Typen und HPV 66 allerdings ohne Genotypisierung."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1894__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Detektion der E6 mRNA<span class=\"diff_sub\">/E7 mRNA</span> von 13 HR-HPV Typen und HPV 66 allerdings ohne Genotypisierung.</div><div nowrap=\"nowrap\">Detektion der E6<span class=\"diff_add\">/E7</span> mRNA von 13 HR-HPV Typen und HPV 66 allerdings ohne Genotypisierung.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "347;04_praevention-zervixkarzinom_0297.tsv;34"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Detektion der E6/E7 mRNA von fünf HR-HPV Genotypen (HPV 16, 18, 31, 33, und 45)"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1895__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Detektion der E6 mRNA<span class=\"diff_sub\">/E7 mRNA</span> von fünf HR-HPV Genotypen (HPV 16, <span class=\"diff_sub\">HPV </span>18, <span class=\"diff_sub\">HPV </span>31, <span class=\"diff_sub\">HPV </span>33, und <span class=\"diff_sub\">HPV </span>45)</div><div nowrap=\"nowrap\">Detektion der E6<span class=\"diff_add\">/E7</span> mRNA von fünf HR-HPV Genotypen (HPV 16, 18, 31, 33, und 45)</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "348;04_praevention-zervixkarzinom_0297.tsv;28"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "HR-HPV E6/E7 mRNA Tests:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1896__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">HR-HPV E6 mRNA Tests/HR-HPV E7 mRNA Tests:</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">HR-HPV E6/E7 mRNA Tests:</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "349;05_zervixkarzinom_0002.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch in einer Metaanalyse mit 20 Studien aus neun Ländern mit 16.600 Frauen, die gegen HPV geimpft worden sind, konnte eine Reduktion der Inzidenz von Infektionen mit HPV 16 und 18 um 64 % bei den Frauen zwischen 13 und 19 Jahren gezeigt werden (RR ,36 (95 % KI 0,25–0,53)) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1897__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch in einer Metaanalyse mit 20 Studien aus neun Ländern mit 16.600 Frauen, die gegen HPV geimpft worden sind, konnte eine Reduktion der Inzidenz von Infektionen mit HPV 16 und<span class=\"diff_sub\"> HPV</span> 18 um 64 % bei den Frauen zwischen 13 und 19 Jahren gezeigt werden (RR ,36 (95 % KI 0,25–0,53)) [REF].</div><div nowrap=\"nowrap\">Auch in einer Metaanalyse mit 20 Studien aus neun Ländern mit 16.600 Frauen, die gegen HPV geimpft worden sind, konnte eine Reduktion der Inzidenz von Infektionen mit HPV 16 und 18 um 64 % bei den Frauen zwischen 13 und 19 Jahren gezeigt werden (RR ,36 (95 % KI 0,25–0,53)) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "350;05_zervixkarzinom_0004.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In Tabelle Relative 5-und 10-Jahres-Überlebensraten sind die vom Krebsregister Bayern für den Zeitraum 1988 - 2011 errechneten relativen 5-und 10-Jahres-Überlebensraten in Abhängigkeit vom UICC-Stadium dargestellt (N=14.606)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1898__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In Tabelle Relative 5-Jahres-Überlebensraten<span class=\"diff_chg\">und 10-Jahres-Überlebensraten sind die</span> vom Krebsregister Bayern für den Zeitraum 1988 - 2011 errechneten relativen 5-Jahres-Überlebensraten<span class=\"diff_chg\">und 10-Jahres-Überlebensraten in</span> Abhängigkeit vom UICC-Stadium dargestellt (N=14.606).</div><div nowrap=\"nowrap\">In Tabelle Relative 5-<span class=\"diff_add\">und 10-</span>Jahres-Überlebensraten<span class=\"diff_chg\"> sind die</span> vom Krebsregister Bayern für den Zeitraum 1988 - 2011 errechneten relativen 5-<span class=\"diff_add\">und 10-</span>Jahres-Überlebensraten<span class=\"diff_chg\"> in</span> Abhängigkeit vom UICC-Stadium dargestellt (N=14.606).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "351;05_zervixkarzinom_0007.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Infektion mit humanem Papilloma-Virus (hauptsächlich HPV Typ 16+18, siehe Abschnitt 3.4.1)"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1899__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Infektion mit humanem Papilloma-Virus (hauptsächlich HPV Typ 16+<span class=\"diff_sub\">Typ </span>18, siehe Abschnitt 3.4.1)</div><div nowrap=\"nowrap\">- Infektion mit humanem Papilloma-Virus (hauptsächlich HPV Typ 16+18, siehe Abschnitt 3.4.1)</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "352;05_zervixkarzinom_0010.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Möglicherweise haben Ernährungsfaktoren eine gewisse protektive Rolle (Zitrusfrüchte, gemüsereiche Kost, Knoblauch, Zwiebeln, Vitamin C, E und A1)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1900__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Möglicherweise haben Ernährungsfaktoren eine gewisse protektive Rolle (Zitrusfrüchte, gemüsereiche Kost, Knoblauch, Zwiebeln, Vitamin C, <span class=\"diff_sub\">Vitamin </span>E und<span class=\"diff_sub\"> Vitamin</span> A1).</div><div nowrap=\"nowrap\">Möglicherweise haben Ernährungsfaktoren eine gewisse protektive Rolle (Zitrusfrüchte, gemüsereiche Kost, Knoblauch, Zwiebeln, Vitamin C, E und A1).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "353;05_zervixkarzinom_0014.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Rund 60 % aller hochgradigen zervikalen intraepithelialen Neoplasien (CIN2/3) waren in deutschen Studien mit HPV 16 und 18 assoziiert [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1901__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Rund 60 % aller hochgradigen zervikalen intraepithelialen Neoplasien (CIN2/<span class=\"diff_sub\">CIN</span>3) waren in deutschen Studien mit HPV 16 und 18 assoziiert [REF].</div><div nowrap=\"nowrap\">Rund 60 % aller hochgradigen zervikalen intraepithelialen Neoplasien (CIN2/3) waren in deutschen Studien mit HPV 16 und 18 assoziiert [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "354;05_zervixkarzinom_0042.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patientinnen mit einem Zervixkarzinom ab mindestens FIGO IB2 bis einschließlich FIGO III bei denen aus technischen Gründen ein MRT-Becken nicht durchgeführt werden kann, sollte die lokoregionäe Bildgebung im Rahmen des Staging CT Thorax/Abdomen/Becken erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1902__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patientinnen mit einem Zervixkarzinom ab mindestens FIGO IB2 bis einschließlich FIGO III bei denen aus technischen Gründen ein MRT-Becken nicht durchgeführt werden kann, sollte die lokoregionäe Bildgebung im Rahmen des Staging CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen/<span class=\"diff_chg\">CT Becken</span> erfolgen.</div><div nowrap=\"nowrap\">Bei Patientinnen mit einem Zervixkarzinom ab mindestens FIGO IB2 bis einschließlich FIGO III bei denen aus technischen Gründen ein MRT-Becken nicht durchgeführt werden kann, sollte die lokoregionäe Bildgebung im Rahmen des Staging CT Thorax/Abdomen/<span class=\"diff_chg\">Becken</span> erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "355;05_zervixkarzinom_0044.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies geht aufgrund der somit vorliegenden Tumorbiologie/-ausdehnung mit einer schlechteren Prognose für die Patientin (Mortalität) bzw. mit höheren Therapienebenwirkungen (Morbidität) einher."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1903__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies geht aufgrund der somit vorliegenden Tumorbiologie/<span class=\"diff_chg\">Tumor</span>ausdehnung mit einer schlechteren Prognose für die Patientin (Mortalität) bzw. mit höheren Therapienebenwirkungen (Morbidität) einher.</div><div nowrap=\"nowrap\">Dies geht aufgrund der somit vorliegenden Tumorbiologie/<span class=\"diff_chg\">-</span>ausdehnung mit einer schlechteren Prognose für die Patientin (Mortalität) bzw. mit höheren Therapienebenwirkungen (Morbidität) einher.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "356;05_zervixkarzinom_0044.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ansonsten kam die Leitliniengruppe überein für die Tumorstadien, wo dies möglich war, die genauen TNM und/oder FIGO-Stadien anzugeben und auf Begriffe wie fortgeschrittenes, lokal (weit) fortgeschritten und frühes Zervixkarzinom möglichst zu verzichten oder zumindest die gemeinten Stadien mitanzuführen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1904__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ansonsten kam die Leitliniengruppe überein für die Tumorstadien, wo dies möglich war, die genauen TNM<span class=\"diff_sub\">-Stadien</span> und/oder FIGO-Stadien anzugeben und auf Begriffe wie fortgeschrittenes, lokal (weit) fortgeschritten und frühes Zervixkarzinom möglichst zu verzichten oder zumindest die gemeinten Stadien mitanzuführen.</div><div nowrap=\"nowrap\">Ansonsten kam die Leitliniengruppe überein für die Tumorstadien, wo dies möglich war, die genauen TNM und/oder FIGO-Stadien anzugeben und auf Begriffe wie fortgeschrittenes, lokal (weit) fortgeschritten und frühes Zervixkarzinom möglichst zu verzichten oder zumindest die gemeinten Stadien mitanzuführen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "357;05_zervixkarzinom_0044.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch die Unterscheidung in regionäre und Fernmetastasen sieht die Leitliniengruppe als durch die TNM/UICC-Klassifikation 2010 [REF] ausreichend definiert an."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1905__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch die Unterscheidung in regionäre <span class=\"diff_sub\">Metastasen </span>und Fernmetastasen sieht die Leitliniengruppe als durch die TNM<span class=\"diff_sub\">-Klassifikation</span>/UICC-Klassifikation 2010 [REF] ausreichend definiert an.</div><div nowrap=\"nowrap\">Auch die Unterscheidung in regionäre und Fernmetastasen sieht die Leitliniengruppe als durch die TNM/UICC-Klassifikation 2010 [REF] ausreichend definiert an.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "358;05_zervixkarzinom_0044.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ziel ist eine möglichst genaue Beschreibung der Tumormerkmale und –Ausdehnung um eine optimale an das Erkrankungsstadium angepasste Therapie zu ermöglichen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1906__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ziel ist eine möglichst genaue Beschreibung der Tumormerkmale und <span class=\"diff_chg\">Tumor</span>Ausdehnung um eine optimale an das Erkrankungsstadium angepasste Therapie zu ermöglichen.</div><div nowrap=\"nowrap\">Ziel ist eine möglichst genaue Beschreibung der Tumormerkmale und <span class=\"diff_chg\">–</span>Ausdehnung um eine optimale an das Erkrankungsstadium angepasste Therapie zu ermöglichen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "359;05_zervixkarzinom_0046.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch der Röntgenthorax ist weitgehend durch das Staging CT Thorax/Abdomen abgelöst worden, das Patientinnen ab einem lokal begrenzten Tumor > 4cm (FIGO IB2) nach Leitlinie erhalten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1907__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch der Röntgenthorax ist weitgehend durch das Staging CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen abgelöst worden, das Patientinnen ab einem lokal begrenzten Tumor &gt; 4cm (FIGO IB2) nach Leitlinie erhalten.</div><div nowrap=\"nowrap\">Auch der Röntgenthorax ist weitgehend durch das Staging CT Thorax/Abdomen abgelöst worden, das Patientinnen ab einem lokal begrenzten Tumor &gt; 4cm (FIGO IB2) nach Leitlinie erhalten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "360;05_zervixkarzinom_0050.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patientinnen ab mindestens FIGO IB2 bis einschließlich III, bei denen aus technischen Gründen eine MRT-Becken nicht durchgeführt werden kann, sollte das lokoregionäre bildgebende Staging des Beckens im Rahmen der Staging CT Thorax/Abdomen/Becken-Untersuchung erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1908__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patientinnen ab mindestens FIGO IB2 bis einschließlich III, bei denen aus technischen Gründen eine MRT-Becken nicht durchgeführt werden kann, sollte das lokoregionäre bildgebende Staging des Beckens im Rahmen der Staging CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen/<span class=\"diff_sub\">CT </span>Becken-Untersuchung erfolgen.</div><div nowrap=\"nowrap\">Patientinnen ab mindestens FIGO IB2 bis einschließlich III, bei denen aus technischen Gründen eine MRT-Becken nicht durchgeführt werden kann, sollte das lokoregionäre bildgebende Staging des Beckens im Rahmen der Staging CT Thorax/Abdomen/Becken-Untersuchung erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "361;05_zervixkarzinom_0051.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für Stadien kleiner IB2 sieht die Leitliniengruppe die Rolle der MRT/CT-Diagnostik zur Einschätzung des Primärtumors kritisch."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1909__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für Stadien kleiner IB2 sieht die Leitliniengruppe die Rolle der MRT<span class=\"diff_sub\">-Diagnostik</span>/CT-Diagnostik zur Einschätzung des Primärtumors kritisch.</div><div nowrap=\"nowrap\">Für Stadien kleiner IB2 sieht die Leitliniengruppe die Rolle der MRT/CT-Diagnostik zur Einschätzung des Primärtumors kritisch.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "362;05_zervixkarzinom_0051.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patientinnen, bei denen aus technischen Gründen eine MRT nicht durchführbar ist, beispielsweise wegen eines Herzschrittmachers, sollten ab dem FIGO Stadium IB2 nicht mehr eine CT des Beckens als Äquivalent, sondern nur das Staging mittels CT Thorax/Abdomen erhalten, das bis einschließlich Symphyse gefahren wird und damit das Becken beinhaltet (zur genauen Identifizierung als CT Thorax/Abdomen/Becken bezeichnet)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1910__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patientinnen, bei denen aus technischen Gründen eine MRT nicht durchführbar ist, beispielsweise wegen eines Herzschrittmachers, sollten ab dem FIGO Stadium IB2 nicht mehr eine CT des Beckens als Äquivalent, sondern nur das Staging mittels CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen erhalten, das bis einschließlich Symphyse gefahren wird und damit das Becken beinhaltet (zur genauen Identifizierung als CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen/<span class=\"diff_sub\">CT </span>Becken bezeichnet).</div><div nowrap=\"nowrap\">Bei Patientinnen, bei denen aus technischen Gründen eine MRT nicht durchführbar ist, beispielsweise wegen eines Herzschrittmachers, sollten ab dem FIGO Stadium IB2 nicht mehr eine CT des Beckens als Äquivalent, sondern nur das Staging mittels CT Thorax/Abdomen erhalten, das bis einschließlich Symphyse gefahren wird und damit das Becken beinhaltet (zur genauen Identifizierung als CT Thorax/Abdomen/Becken bezeichnet).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "363;05_zervixkarzinom_0052.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patientinnen im Stadium FIGO IVA, bei denen aus technischen Gründen eine MRT-Becken nicht durchgeführt werden kann, sollte das lokoregionäre bildgebende Staging des Beckens im Rahmen der Staging CT Thorax/Abdomen/Becken-Untersuchung erfolgen"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1911__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patientinnen im Stadium FIGO IVA, bei denen aus technischen Gründen eine MRT-Becken nicht durchgeführt werden kann, sollte das lokoregionäre bildgebende Staging des Beckens im Rahmen der Staging CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen/<span class=\"diff_sub\">CT </span>Becken-Untersuchung erfolgen</div><div nowrap=\"nowrap\">Bei Patientinnen im Stadium FIGO IVA, bei denen aus technischen Gründen eine MRT-Becken nicht durchgeführt werden kann, sollte das lokoregionäre bildgebende Staging des Beckens im Rahmen der Staging CT Thorax/Abdomen/Becken-Untersuchung erfolgen</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "364;05_zervixkarzinom_0053.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patientinnen mit histologisch gesichertem Zervixkarzinom ab mindestens FIGO-Stadium IB2 sollten ein CT-Thorax/Abdomen/Becken zur Beurteilung der Tumorausbreitung erhalten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1912__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patientinnen mit histologisch gesichertem Zervixkarzinom ab mindestens FIGO-Stadium IB2 sollten ein CT-Thorax/<span class=\"diff_sub\">CT-</span>Abdomen/<span class=\"diff_sub\">CT-</span>Becken zur Beurteilung der Tumorausbreitung erhalten.</div><div nowrap=\"nowrap\">Patientinnen mit histologisch gesichertem Zervixkarzinom ab mindestens FIGO-Stadium IB2 sollten ein CT-Thorax/Abdomen/Becken zur Beurteilung der Tumorausbreitung erhalten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "365;05_zervixkarzinom_0054.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bezogen auf den vermehrten Einsatz des CT Thorax/Abdomen zum Staging und ein Verlassen der Lebersonographie und des Röntgen-Thorax-Untersuchung sind die Empfehlungen der aktuellen Leitlinie mit der SIGN-Leitlinie von 2008 übereinstimmend [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1913__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bezogen auf den vermehrten Einsatz des CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen zum Staging und ein Verlassen der Lebersonographie und des Röntgen-Thorax-Untersuchung sind die Empfehlungen der aktuellen Leitlinie mit der SIGN-Leitlinie von 2008 übereinstimmend [REF].</div><div nowrap=\"nowrap\">Bezogen auf den vermehrten Einsatz des CT Thorax/Abdomen zum Staging und ein Verlassen der Lebersonographie und des Röntgen-Thorax-Untersuchung sind die Empfehlungen der aktuellen Leitlinie mit der SIGN-Leitlinie von 2008 übereinstimmend [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "366;05_zervixkarzinom_0057.tsv;28"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Metastasen die CT-Thorax/Abdomen/Becken."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1914__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Metastasen die CT-Thorax/<span class=\"diff_sub\">CT-</span>Abdomen/<span class=\"diff_sub\">CT-</span>Becken.</div><div nowrap=\"nowrap\">Metastasen die CT-Thorax/Abdomen/Becken.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "367;05_zervixkarzinom_0097.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Entsprechend der UICC- und TNM-Klassifikation sind Mikrometastasen definiert als der histologische Nachweis von Tumorzellen im Lymphknoten von ≥ 0,2 mm, aber nicht größer als 0,2 cm [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1915__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Entsprechend der UICC-<span class=\"diff_sub\">Klassifikation</span> und TNM-Klassifikation sind Mikrometastasen definiert als der histologische Nachweis von Tumorzellen im Lymphknoten von ≥ 0,2 mm, aber nicht größer als 0,2 cm [REF] [REF].</div><div nowrap=\"nowrap\">Entsprechend der UICC- und TNM-Klassifikation sind Mikrometastasen definiert als der histologische Nachweis von Tumorzellen im Lymphknoten von ≥ 0,2 mm, aber nicht größer als 0,2 cm [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "368;05_zervixkarzinom_0108.tsv;47"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die HPV-Bestimmung bzw. –Typisierung ist nur in Einzelfällen notwendig."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1916__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die HPV-Bestimmung bzw. <span class=\"diff_chg\">HPV-</span>Typisierung ist nur in Einzelfällen notwendig.</div><div nowrap=\"nowrap\">Die HPV-Bestimmung bzw. <span class=\"diff_chg\">–</span>Typisierung ist nur in Einzelfällen notwendig.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "369;05_zervixkarzinom_0108.tsv;50"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zur Relevanz molekularer Marker und der auf molekularen Untersuchungen des The Cancer Genome Atlas-Projektes beruhende TCGA-Klassifikation (keratin-low versus –high Plattenepithelkarzinome) stehen derzeit nur eingeschränkte Daten zur Verfügung [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1917__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zur Relevanz molekularer Marker und der auf molekularen Untersuchungen des The Cancer Genome Atlas-Projektes beruhende TCGA-Klassifikation (keratin-low versus <span class=\"diff_chg\">keratin-high</span> Plattenepithelkarzinome) stehen derzeit nur eingeschränkte Daten zur Verfügung [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Zur Relevanz molekularer Marker und der auf molekularen Untersuchungen des The Cancer Genome Atlas-Projektes beruhende TCGA-Klassifikation (keratin-low versus <span class=\"diff_chg\">–high</span> Plattenepithelkarzinome) stehen derzeit nur eingeschränkte Daten zur Verfügung [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "370;05_zervixkarzinom_0112.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zu dieser Therapie muss eine positive Risiko-/Nutzenkonstellation vorliegen und zur Bewertung müssen Daten zu Technik, Nutzen und Risiko vorliegen, die auf ausreichend sicheren Daten basieren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1918__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zu dieser Therapie muss eine positive Risiko<span class=\"diff_chg\">konstellation</span>/Nutzenkonstellation vorliegen und zur Bewertung müssen Daten zu Technik, Nutzen und Risiko vorliegen, die auf ausreichend sicheren Daten basieren.</div><div nowrap=\"nowrap\">Zu dieser Therapie muss eine positive Risiko<span class=\"diff_chg\">-</span>/Nutzenkonstellation vorliegen und zur Bewertung müssen Daten zu Technik, Nutzen und Risiko vorliegen, die auf ausreichend sicheren Daten basieren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "371;05_zervixkarzinom_0119.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Alternativ kann zur prätherapeutischen Diagnostik auch interventionelle Diagnostik wie z.B. eine CT-, MRT- oder sonographiegesteuerte Stanzbiopsie oder Feinnadelzytologie angewendet werden, um metastasenverdächtige Läsionen histologisch abzuklären."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1919__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Alternativ kann zur prätherapeutischen Diagnostik auch interventionelle Diagnostik wie z.B. eine CT-<span class=\"diff_sub\">gesteuerte</span>, MRT-<span class=\"diff_chg\">gesteuerte oder sonographiegesteuerte</span> Stanzbiopsie oder Feinnadelzytologie angewendet werden, um metastasenverdächtige Läsionen histologisch abzuklären.</div><div nowrap=\"nowrap\">Alternativ kann zur prätherapeutischen Diagnostik auch interventionelle Diagnostik wie z.B. eine CT-, MRT-<span class=\"diff_chg\"> oder sonographiegesteuerte</span> Stanzbiopsie oder Feinnadelzytologie angewendet werden, um metastasenverdächtige Läsionen histologisch abzuklären.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "372;05_zervixkarzinom_0138.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ansonsten kam die Leitliniengruppe überein für die Tumorstadien, wo dies möglich war, die genauen TNM und/oder FIGO-Stadien anzugeben und auf die unklar definierten Begrifflichkeiten möglichst zu verzichten oder zumindest die gemeinten Stadien mitanzuführen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1920__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ansonsten kam die Leitliniengruppe überein für die Tumorstadien, wo dies möglich war, die genauen TNM<span class=\"diff_sub\">-Stadien</span> und/oder FIGO-Stadien anzugeben und auf die unklar definierten Begrifflichkeiten möglichst zu verzichten oder zumindest die gemeinten Stadien mitanzuführen.</div><div nowrap=\"nowrap\">Ansonsten kam die Leitliniengruppe überein für die Tumorstadien, wo dies möglich war, die genauen TNM und/oder FIGO-Stadien anzugeben und auf die unklar definierten Begrifflichkeiten möglichst zu verzichten oder zumindest die gemeinten Stadien mitanzuführen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "373;05_zervixkarzinom_0138.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies geht aufgrund der somit vorliegenden Tumorbiologie/-ausdehnung mit einer schlechteren Prognose für die Patientin bei höheren Therapienebenwirkungen einher."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1921__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies geht aufgrund der somit vorliegenden Tumorbiologie/<span class=\"diff_chg\">Tumor</span>ausdehnung mit einer schlechteren Prognose für die Patientin bei höheren Therapienebenwirkungen einher.</div><div nowrap=\"nowrap\">Dies geht aufgrund der somit vorliegenden Tumorbiologie/<span class=\"diff_chg\">-</span>ausdehnung mit einer schlechteren Prognose für die Patientin bei höheren Therapienebenwirkungen einher.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "374;05_zervixkarzinom_0170.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Diese Prinzipien und Techniken überschneiden sich in einigen Bereichen (siehe Abbildung \"Operative Therapietechniken und –prinzipien\")."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1922__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Diese Prinzipien und Techniken überschneiden sich in einigen Bereichen (siehe Abbildung \"Operative Therapietechniken und <span class=\"diff_chg\">Therapie</span>prinzipien\").</div><div nowrap=\"nowrap\">Diese Prinzipien und Techniken überschneiden sich in einigen Bereichen (siehe Abbildung \"Operative Therapietechniken und <span class=\"diff_chg\">–</span>prinzipien\").</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "375;05_zervixkarzinom_0171.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Diese wird stadienabhängig in der Klassifikation nach Piver-Ruthledge et al. 1974 [REF] in Anlehnung an die Empfehlungen von Wertheim, Meigs, Latzko, Okabayashi und anderen durchgeführt (siehe Abbildung \"Operative Therapietechniken und –prinzipien\" und und Klassifikation der radikalen Hysterektomie)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1923__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Diese wird stadienabhängig in der Klassifikation nach Piver-Ruthledge et al. 1974 [REF] in Anlehnung an die Empfehlungen von Wertheim, Meigs, Latzko, Okabayashi und anderen durchgeführt (siehe Abbildung \"Operative Therapietechniken und <span class=\"diff_chg\">Therapie</span>prinzipien\" und und Klassifikation der radikalen Hysterektomie).</div><div nowrap=\"nowrap\">Diese wird stadienabhängig in der Klassifikation nach Piver-Ruthledge et al. 1974 [REF] in Anlehnung an die Empfehlungen von Wertheim, Meigs, Latzko, Okabayashi und anderen durchgeführt (siehe Abbildung \"Operative Therapietechniken und <span class=\"diff_chg\">–</span>prinzipien\" und und Klassifikation der radikalen Hysterektomie).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "376;05_zervixkarzinom_0215.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine weitere Option für die Second-line oder höhere Therapielinie ist der Checkpointinhibitor Pembrolizumab (200 mg q3w) für Patientinnen mit PD-L1 positivem Zervixkarzinom (Combined positive score (CPS) >=1)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1924__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine weitere Option für die Second-line Therapielinie <span class=\"diff_chg\">oder höhere Therapielinie ist der</span> Checkpointinhibitor Pembrolizumab (200 mg q3w) für Patientinnen mit PD-L1 positivem Zervixkarzinom (Combined positive score (CPS) &gt;=1).</div><div nowrap=\"nowrap\">Eine weitere Option für die Second-line <span class=\"diff_add\">oder höhere </span>Therapielinie <span class=\"diff_chg\">ist der</span> Checkpointinhibitor Pembrolizumab (200 mg q3w) für Patientinnen mit PD-L1 positivem Zervixkarzinom (Combined positive score (CPS) &gt;=1).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "377;05_zervixkarzinom_0278.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Diagnostik der Folgestörungen von Krebserkrankung und –therapie"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1925__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Diagnostik der Folgestörungen von Krebserkrankung und <span class=\"diff_chg\">Krebs</span>therapie</div><div nowrap=\"nowrap\">- Diagnostik der Folgestörungen von Krebserkrankung und <span class=\"diff_chg\">–</span>therapie</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "378;05_zervixkarzinom_0288.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Entstauungsfördernde Sport-/Bewegungstherapie"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1926__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Entstauungsfördernde Sport<span class=\"diff_chg\">therapie</span>/Bewegungstherapie</div><div nowrap=\"nowrap\">- Entstauungsfördernde Sport<span class=\"diff_chg\">-</span>/Bewegungstherapie</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "379;05_zervixkarzinom_0289.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Fatigue sollte den Patientinnen aktive Trainingsformen (Kraft- und/oder Ausdauertraining) angeboten werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1927__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Fatigue sollte den Patientinnen aktive Trainingsformen (Kraft<span class=\"diff_chg\">training</span> und/oder Ausdauertraining) angeboten werden.</div><div nowrap=\"nowrap\">Bei Fatigue sollte den Patientinnen aktive Trainingsformen (Kraft<span class=\"diff_chg\">-</span> und/oder Ausdauertraining) angeboten werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "380;05_zervixkarzinom_0323.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Therapieerfolg ist aber geringer (5-Jahres-Gesamtüberleben beim zentralen Rezidiv 55 bis 69 %, beim Beckenwandrezidiv 13 bis 28 % [REF], [REF], [REF]. Im Vorfeld einer Salvage-Radio-/Radiochemotherapie sollte zur Abschätzung der Prognose die Ermittlung der relevanten Faktoren (Zeitintervall zwischen Primärtherapie und Auftreten des Rezidivs, Ausdehnung und Lokalisation des Rezidivs) und insbesondere der Ausschluss von Organmetastasen erfolgen. Studien zur Optimierung der Radio-/Radiochemotherapie in der Rezidivsituation durch Anwendung alternativer Bestrahlungstechniken (IORT, 3D radiation therapy, intensity modulated whole pelvis radiation therapy, stereotactic body RT, image guided interstitial brachytherapy, 3D conformal brachytherapy, interstitial brachytherapy) [REF], [REF], [REF], [REF], sowie betreffend die Kombination mit systemischen Therapien und/oder lokoregionärer Hyperthermie sind publiziert [REF], [REF], [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1928__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Therapieerfolg ist aber geringer (5-Jahres-Gesamtüberleben beim zentralen Rezidiv 55 bis 69 %, beim Beckenwandrezidiv 13 bis 28 % [REF], [REF], [REF]. Im Vorfeld einer Salvage-Radio<span class=\"diff_chg\">therapie</span>/Radiochemotherapie sollte zur Abschätzung der Prognose die Ermittlung der relevanten Faktoren (Zeitintervall zwischen Primärtherapie und Auftreten des Rezidivs, Ausdehnung und Lokalisation des Rezidivs) und insbesondere der Ausschluss von Organmetastasen erfolgen. Studien zur Optimierung der Radio<span class=\"diff_chg\">therapie</span>/Radiochemotherapie in der Rezidivsituation durch Anwendung alternativer Bestrahlungstechniken (IORT, 3D radiation therapy, intensity modulated whole pelvis radiation therapy, stereotactic body RT, image guided interstitial brachytherapy, 3D conformal brachytherapy, interstitial brachytherapy) [REF], [REF], [REF], [REF], sowie betreffend die Kombination mit systemischen Therapien und/oder lokoregionärer Hyperthermie sind publiziert [REF], [REF], [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Der Therapieerfolg ist aber geringer (5-Jahres-Gesamtüberleben beim zentralen Rezidiv 55 bis 69 %, beim Beckenwandrezidiv 13 bis 28 % [REF], [REF], [REF]. Im Vorfeld einer Salvage-Radio<span class=\"diff_chg\">-</span>/Radiochemotherapie sollte zur Abschätzung der Prognose die Ermittlung der relevanten Faktoren (Zeitintervall zwischen Primärtherapie und Auftreten des Rezidivs, Ausdehnung und Lokalisation des Rezidivs) und insbesondere der Ausschluss von Organmetastasen erfolgen. Studien zur Optimierung der Radio<span class=\"diff_chg\">-</span>/Radiochemotherapie in der Rezidivsituation durch Anwendung alternativer Bestrahlungstechniken (IORT, 3D radiation therapy, intensity modulated whole pelvis radiation therapy, stereotactic body RT, image guided interstitial brachytherapy, 3D conformal brachytherapy, interstitial brachytherapy) [REF], [REF], [REF], [REF], sowie betreffend die Kombination mit systemischen Therapien und/oder lokoregionärer Hyperthermie sind publiziert [REF], [REF], [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "381;05_zervixkarzinom_0325.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In Publikationen von Höckel M et al (2003, 2008, 2012) wurde mit der LEER ein Therapiekonzept mit dem Versuch der Kuration beim Beckenwandrezidiv nach Radio-/Radiochemotherapie für eine selektionierte Patientinnenpopulation vorgestellt [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1929__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In Publikationen von Höckel M et al (2003, 2008, 2012) wurde mit der LEER ein Therapiekonzept mit dem Versuch der Kuration beim Beckenwandrezidiv nach Radio<span class=\"diff_chg\">therapie</span>/Radiochemotherapie für eine selektionierte Patientinnenpopulation vorgestellt [REF], [REF], [REF].</div><div nowrap=\"nowrap\">In Publikationen von Höckel M et al (2003, 2008, 2012) wurde mit der LEER ein Therapiekonzept mit dem Versuch der Kuration beim Beckenwandrezidiv nach Radio<span class=\"diff_chg\">-</span>/Radiochemotherapie für eine selektionierte Patientinnenpopulation vorgestellt [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "382;05_zervixkarzinom_0326.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Daten von Chou et al. 2001 zeigten, dass bei Anwendung der Radiochemotherapie (sofern das Rezidiv nicht im ursprünglichen Strahlenfeld einer primären Radio-/Radiochemotherapie liegt) ein 5-Jahres-Gesamtüberleben von 51 % erreicht werden konnte [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1930__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Daten von Chou et al. 2001 zeigten, dass bei Anwendung der Radiochemotherapie (sofern das Rezidiv nicht im ursprünglichen Strahlenfeld einer primären Radio<span class=\"diff_chg\">therapie</span>/Radiochemotherapie liegt) ein 5-Jahres-Gesamtüberleben von 51 % erreicht werden konnte [REF].</div><div nowrap=\"nowrap\">Die Daten von Chou et al. 2001 zeigten, dass bei Anwendung der Radiochemotherapie (sofern das Rezidiv nicht im ursprünglichen Strahlenfeld einer primären Radio<span class=\"diff_chg\">-</span>/Radiochemotherapie liegt) ein 5-Jahres-Gesamtüberleben von 51 % erreicht werden konnte [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "383;05_zervixkarzinom_0336.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies und die in Absolutwerten geringe Zahl an Patientinnen mit isolierter Organmetastasierung ohne simultanes Lokalrezidiv macht Aussagen zur Therapiewahl bzw. –effektivität nur eingeschränkt möglich."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1931__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies und die in Absolutwerten geringe Zahl an Patientinnen mit isolierter Organmetastasierung ohne simultanes Lokalrezidiv macht Aussagen zur Therapiewahl bzw. <span class=\"diff_chg\">Therapie</span>effektivität nur eingeschränkt möglich.</div><div nowrap=\"nowrap\">Dies und die in Absolutwerten geringe Zahl an Patientinnen mit isolierter Organmetastasierung ohne simultanes Lokalrezidiv macht Aussagen zur Therapiewahl bzw. <span class=\"diff_chg\">–</span>effektivität nur eingeschränkt möglich.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "384;05_zervixkarzinom_0366.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Vorliegen differentialdiagnostisch relevanter Komorbiditäten, wie z. B. kardialen Vorerkrankungen, Beinvenenthrombose, Postthrombotischem Syndrom oder Hypo-/Dysproteinämie und/ oder nicht eindeutigen Ergebnissen der klinischen Untersuchung sollten in Abhängigkeit von Allgemeinzustand des Patienten und seiner Belastbarkeit zur Diagnosesicherung geeignete Verfahren ergänzend durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1932__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Vorliegen differentialdiagnostisch relevanter Komorbiditäten, wie z. B. kardialen Vorerkrankungen, Beinvenenthrombose, Postthrombotischem Syndrom oder Hypo<span class=\"diff_chg\">proteinämie</span>/Dysproteinämie und/ oder nicht eindeutigen Ergebnissen der klinischen Untersuchung sollten in Abhängigkeit von Allgemeinzustand des Patienten und seiner Belastbarkeit zur Diagnosesicherung geeignete Verfahren ergänzend durchgeführt werden.</div><div nowrap=\"nowrap\">Bei Vorliegen differentialdiagnostisch relevanter Komorbiditäten, wie z. B. kardialen Vorerkrankungen, Beinvenenthrombose, Postthrombotischem Syndrom oder Hypo<span class=\"diff_chg\">-</span>/Dysproteinämie und/ oder nicht eindeutigen Ergebnissen der klinischen Untersuchung sollten in Abhängigkeit von Allgemeinzustand des Patienten und seiner Belastbarkeit zur Diagnosesicherung geeignete Verfahren ergänzend durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "385;05_zervixkarzinom_0370.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im späteren Verlauf kann es zu Belastungen durch Stomaprolaps, Stomaretraktion, -stenose und parastomale Hernien kommen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1933__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im späteren Verlauf kann es zu Belastungen durch Stomaprolaps, Stomaretraktion, <span class=\"diff_chg\">Stoma</span>stenose und parastomale Hernien kommen.</div><div nowrap=\"nowrap\">Im späteren Verlauf kann es zu Belastungen durch Stomaprolaps, Stomaretraktion, <span class=\"diff_chg\">-</span>stenose und parastomale Hernien kommen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "386;05_zervixkarzinom_0387.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Handlungsbedarf hängt ab vom Stadium der Erkrankung, Lymphknoten-Status, histologischem Subtyp, Gestationsalter, Wachstumsdynamik, akuten Symptomen (z.B. Blutungen) und dem Kinder- u. Fertilitätswunsch der Patientin [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1934__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Handlungsbedarf hängt ab vom Stadium der Erkrankung, Lymphknoten-Status, histologischem Subtyp, Gestationsalter, Wachstumsdynamik, akuten Symptomen (z.B. Blutungen) und dem Kinderwunsch <span class=\"diff_chg\">u. Fertilitätswunsch der</span> Patientin [REF].</div><div nowrap=\"nowrap\">Der Handlungsbedarf hängt ab vom Stadium der Erkrankung, Lymphknoten-Status, histologischem Subtyp, Gestationsalter, Wachstumsdynamik, akuten Symptomen (z.B. Blutungen) und dem Kinder<span class=\"diff_add\">- u. Fertilitäts</span>wunsch <span class=\"diff_chg\">der</span> Patientin [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "387;05_zervixkarzinom_0388.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Mikroinvasion (Stadium IA1 oder IA2) ist eine Therapieverzögerung vertretbar ohne Einfluss auf den Krankheitsverlauf, aber regelmäßige klinische Kontrollen des Lokalbefundes sind zu fordern [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1935__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Mikroinvasion (Stadium IA1 oder<span class=\"diff_sub\"> Stadium</span> IA2) ist eine Therapieverzögerung vertretbar ohne Einfluss auf den Krankheitsverlauf, aber regelmäßige klinische Kontrollen des Lokalbefundes sind zu fordern [REF], [REF].</div><div nowrap=\"nowrap\">Bei Mikroinvasion (Stadium IA1 oder IA2) ist eine Therapieverzögerung vertretbar ohne Einfluss auf den Krankheitsverlauf, aber regelmäßige klinische Kontrollen des Lokalbefundes sind zu fordern [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "388;05_zervixkarzinom_0389.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "FIGO-Stadien II, III und IV werden selten in der Schwangerschaft erstdiagnostiziert."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1936__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">FIGO-Stadien II, <span class=\"diff_sub\">FIGO-Stadien </span>III und <span class=\"diff_sub\">FIGO-Stadien </span>IV werden selten in der Schwangerschaft erstdiagnostiziert.</div><div nowrap=\"nowrap\">FIGO-Stadien II, III und IV werden selten in der Schwangerschaft erstdiagnostiziert.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "389;05_zervixkarzinom_0407.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Hierzu wurden wie in der Vorgängerversion bereits gefordert kooperative Strukturmodelle (Gynäkologische Dysplasie-Sprechstunde/-Einheit) der Deutschen Krebsgesellschaft (DKG) mit der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) mit der Arbeitsgemeinschaft für Zervixpathologie und Kolposkopie (AGCPC) umgesetzt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1937__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Hierzu wurden wie in der Vorgängerversion bereits gefordert kooperative Strukturmodelle (Gynäkologische Dysplasie-Sprechstunde/<span class=\"diff_sub\">Dysplasie</span>-Einheit) der Deutschen Krebsgesellschaft (DKG) mit der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) mit der Arbeitsgemeinschaft für Zervixpathologie und Kolposkopie (AGCPC) umgesetzt.</div><div nowrap=\"nowrap\">Hierzu wurden wie in der Vorgängerversion bereits gefordert kooperative Strukturmodelle (Gynäkologische Dysplasie-Sprechstunde/-Einheit) der Deutschen Krebsgesellschaft (DKG) mit der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) mit der Arbeitsgemeinschaft für Zervixpathologie und Kolposkopie (AGCPC) umgesetzt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "390;05_zervixkarzinom_0408.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Darüber hinaus ändert sich das Verhältnis von in situ- zu invasiven Karzinomen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1938__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Darüber hinaus ändert sich das Verhältnis von in situ-<span class=\"diff_sub\">Karzinomen</span> zu invasiven Karzinomen.</div><div nowrap=\"nowrap\">Darüber hinaus ändert sich das Verhältnis von in situ- zu invasiven Karzinomen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "391;05_zervixkarzinom_0413.tsv;37"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "(Ausmaß, anatomische Struktur, infra/supramesenterial)"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1939__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">(Ausmaß, anatomische Struktur, infra<span class=\"diff_sub\">mesenterial</span>/supramesenterial)</div><div nowrap=\"nowrap\">(Ausmaß, anatomische Struktur, infra/supramesenterial)</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "392;06_hautkrebspraevention_0012.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Historisch wird dieser Wellenlängenbereich in UVC- (100-200 nm), UVB- (200-315 nm) und UVA-Strahlung (315–400 nm) unterteilt [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1940__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Historisch wird dieser Wellenlängenbereich in UVC-<span class=\"diff_sub\">Strahlung</span> (100-200 nm), UVB-<span class=\"diff_sub\">Strahlung</span> (200-315 nm) und UVA-Strahlung (315–400 nm) unterteilt [REF].</div><div nowrap=\"nowrap\">Historisch wird dieser Wellenlängenbereich in UVC- (100-200 nm), UVB- (200-315 nm) und UVA-Strahlung (315–400 nm) unterteilt [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "393;06_hautkrebspraevention_0012.tsv;44"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "UV-spezifische „signature-mutations“ (C→T, Transitions-Mutationen) wurden in den p53-, PTCH- und smoothened-Genen gefunden [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1941__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">UV-spezifische „signature-mutations“ (C→T, Transitions-Mutationen) wurden in den p53-<span class=\"diff_sub\">Genen</span>, PTCH-<span class=\"diff_sub\">Genen</span> und smoothened-Genen gefunden [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF].</div><div nowrap=\"nowrap\">UV-spezifische „signature-mutations“ (C→T, Transitions-Mutationen) wurden in den p53-, PTCH- und smoothened-Genen gefunden [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF]; [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "394;06_hautkrebspraevention_0012.tsv;117"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es gilt mittlerweile als gesichert, dass dieses Gen ein Prädispositions-Gen für das MM darstellt [REF]; [REF]; [REF] p16INK4A inhibiert die Progression von Zellen durch die G1-Phase des Zellzyklus, indem es die Bindung von Cyclin D1 an CDK4/6 unterdrückt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1942__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es gilt mittlerweile als gesichert, dass dieses Gen ein Prädispositions-Gen für das MM darstellt [REF]; [REF]; [REF] p16INK4A inhibiert die Progression von Zellen durch die G1-Phase des Zellzyklus, indem es die Bindung von Cyclin D1 an CDK4/<span class=\"diff_sub\">CDK</span>6 unterdrückt.</div><div nowrap=\"nowrap\">Es gilt mittlerweile als gesichert, dass dieses Gen ein Prädispositions-Gen für das MM darstellt [REF]; [REF]; [REF] p16INK4A inhibiert die Progression von Zellen durch die G1-Phase des Zellzyklus, indem es die Bindung von Cyclin D1 an CDK4/6 unterdrückt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "395;06_hautkrebspraevention_0015.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Verfahren zur Bestimmung der T-, N-, M-Kategorien sind:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1943__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Verfahren zur Bestimmung der T-<span class=\"diff_sub\">Kategorien</span>, N-<span class=\"diff_sub\">Kategorien</span>, M-Kategorien sind:</div><div nowrap=\"nowrap\">Verfahren zur Bestimmung der T-, N-, M-Kategorien sind:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "396;06_hautkrebspraevention_0026.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Somit sind diese Krebsregister in der Lage neben der Inzidenz der invasiven auch die der in situ-Tumore zu beschreiben."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1944__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Somit sind diese Krebsregister in der Lage neben der Inzidenz der invasiven <span class=\"diff_sub\">Tumore </span>auch die der in situ-Tumore zu beschreiben.</div><div nowrap=\"nowrap\">Somit sind diese Krebsregister in der Lage neben der Inzidenz der invasiven auch die der in situ-Tumore zu beschreiben.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "397;06_hautkrebspraevention_0040.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Heilungsprozesse können mit pflegenden und antibiotischen Augensalben/-tropfen unterstützt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1945__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Heilungsprozesse können mit pflegenden und antibiotischen Augensalben/<span class=\"diff_chg\">Augen</span>tropfen unterstützt werden.</div><div nowrap=\"nowrap\">Heilungsprozesse können mit pflegenden und antibiotischen Augensalben/<span class=\"diff_chg\">-</span>tropfen unterstützt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "398;06_hautkrebspraevention_0046.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Zellfreie Tumor-DNA/-RNA"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1946__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Zellfreie Tumor-DNA/<span class=\"diff_sub\">Tumor</span>-RNA</div><div nowrap=\"nowrap\">- Zellfreie Tumor-DNA/-RNA</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "399;06_hautkrebspraevention_0164.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Darüber hinaus sollten solche Evaluationsparameter gewählt werden, die einen nachgewiesenen Zusammenhang zu klinischen Endpunkten (d.h. Risikofaktoren und –indikatoren von Hautkrebs) aufweisen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1947__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Darüber hinaus sollten solche Evaluationsparameter gewählt werden, die einen nachgewiesenen Zusammenhang zu klinischen Endpunkten (d.h. Risikofaktoren und <span class=\"diff_chg\">Risiko</span>indikatoren von Hautkrebs) aufweisen.</div><div nowrap=\"nowrap\">Darüber hinaus sollten solche Evaluationsparameter gewählt werden, die einen nachgewiesenen Zusammenhang zu klinischen Endpunkten (d.h. Risikofaktoren und <span class=\"diff_chg\">–</span>indikatoren von Hautkrebs) aufweisen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "400;06_hautkrebspraevention_0237.tsv;71"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Empfehlungen für Screeningintervalle und –dauer für Hochrisikogruppen basieren auf EK."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1948__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Empfehlungen für Screeningintervalle und <span class=\"diff_chg\">Screening</span>dauer für Hochrisikogruppen basieren auf EK.</div><div nowrap=\"nowrap\">Empfehlungen für Screeningintervalle und <span class=\"diff_chg\">–</span>dauer für Hochrisikogruppen basieren auf EK.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "401;06_hautkrebspraevention_0263.tsv;63"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Schwere Verläufe (definiert als Fälle mit LK und/oder Fernmetastasen und/oder Interferon-Behandlung) waren bei Nicht-Screeningteilnehmern häufiger als bei Screeningteilnehmern, wobei die Unterschiede jeweils nicht signifikant waren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1949__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Schwere Verläufe (definiert als Fälle mit LK<span class=\"diff_sub\">-Metastasen</span> und/oder Fernmetastasen und/oder Interferon-Behandlung) waren bei Nicht-Screeningteilnehmern häufiger als bei Screeningteilnehmern, wobei die Unterschiede jeweils nicht signifikant waren.</div><div nowrap=\"nowrap\">Schwere Verläufe (definiert als Fälle mit LK und/oder Fernmetastasen und/oder Interferon-Behandlung) waren bei Nicht-Screeningteilnehmern häufiger als bei Screeningteilnehmern, wobei die Unterschiede jeweils nicht signifikant waren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "402;06_hautkrebspraevention_0368.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ungefähr die Hälfte der Stadium III- und 56-58% der Stadium IV-Patienten gelten als hoch bzw. ernsthaft gestresst (zwei Artikel)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1950__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ungefähr die Hälfte der Stadium III-<span class=\"diff_sub\">Patienten</span> und 56-58% der Stadium IV-Patienten gelten als hoch bzw. ernsthaft gestresst (zwei Artikel).</div><div nowrap=\"nowrap\">Ungefähr die Hälfte der Stadium III- und 56-58% der Stadium IV-Patienten gelten als hoch bzw. ernsthaft gestresst (zwei Artikel).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "403;07_malignes-melanom_0002.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Hier wurden auf Basis einer multivariaten Analyse 30 946 Patienten mit malignem Melanom in den Stadien I, II, III und 7972 Patienten im Stadium IV untersucht."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1951__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Hier wurden auf Basis einer multivariaten Analyse 30 946 Patienten mit malignem Melanom in den Stadien I,<span class=\"diff_sub\"> Stadien</span> II, <span class=\"diff_sub\">Stadien </span>III und 7972 Patienten im Stadium IV untersucht.</div><div nowrap=\"nowrap\">Hier wurden auf Basis einer multivariaten Analyse 30 946 Patienten mit malignem Melanom in den Stadien I, II, III und 7972 Patienten im Stadium IV untersucht.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "404;07_malignes-melanom_0023.tsv;19"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dies betrifft sowohl die R1- als auch die R2-Situation."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1952__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dies betrifft sowohl die R1-<span class=\"diff_sub\">Situation</span> als auch die R2-Situation.</div><div nowrap=\"nowrap\">Dies betrifft sowohl die R1- als auch die R2-Situation.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "405;07_malignes-melanom_0023.tsv;25"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Nachresektion (Re-Dissektion) bei R1/R2-Situation zur Erreichung einer R0-Situation sollte durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1953__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Nachresektion (Re-Dissektion) bei R1<span class=\"diff_sub\">-Situation</span>/R2-Situation zur Erreichung einer R0-Situation sollte durchgeführt werden.</div><div nowrap=\"nowrap\">Eine Nachresektion (Re-Dissektion) bei R1/R2-Situation zur Erreichung einer R0-Situation sollte durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "406;07_malignes-melanom_0023.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Aufgrund der prognostischen Bedeutung wird sie auch für Fernmetastasen nach chirurgischer oder Kombinationstherapie angewendet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1954__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Aufgrund der prognostischen Bedeutung wird sie auch für Fernmetastasen nach chirurgischer <span class=\"diff_sub\">Therapie </span>oder Kombinationstherapie angewendet.</div><div nowrap=\"nowrap\">Aufgrund der prognostischen Bedeutung wird sie auch für Fernmetastasen nach chirurgischer oder Kombinationstherapie angewendet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "407;07_malignes-melanom_0052.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In zahlreichen Studien wurde gezeigt, dass die Spiegel gewisser Serummarker mit dem krankheitsfreien oder Gesamtüberleben der Patienten korrelieren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1955__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In zahlreichen Studien wurde gezeigt, dass die Spiegel gewisser Serummarker mit dem krankheitsfreien <span class=\"diff_sub\">Überleben </span>oder Gesamtüberleben der Patienten korrelieren.</div><div nowrap=\"nowrap\">In zahlreichen Studien wurde gezeigt, dass die Spiegel gewisser Serummarker mit dem krankheitsfreien oder Gesamtüberleben der Patienten korrelieren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "408;07_malignes-melanom_0052.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer Studie an 112 Melanompatienten [REF], 350 klinisch tumorfreien Patienten nach chirurgischer Entfernung eines Melanoms sowie 72 gesunden Kontrollpersonen und 316 Kontrollpersonen mit anderen Erkrankungen war der MIA-Spiegel bei allen 50 Melanompatienten in Stadium III und IV erhöht (> 95. Perzentile der gesunden Kontrollen = 6,5 ng/ml), dagegen nur bei 13 % in Stadium I und 23 % in Stadium II."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1956__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer Studie an 112 Melanompatienten [REF], 350 klinisch tumorfreien Patienten nach chirurgischer Entfernung eines Melanoms sowie 72 gesunden Kontrollpersonen und 316 Kontrollpersonen mit anderen Erkrankungen war der MIA-Spiegel bei allen 50 Melanompatienten in Stadium III und<span class=\"diff_sub\"> Stadium</span> IV erhöht (&gt; 95. Perzentile der gesunden Kontrollen = 6,5 ng/ml), dagegen nur bei 13 % in Stadium I und 23 % in Stadium II.</div><div nowrap=\"nowrap\">In einer Studie an 112 Melanompatienten [REF], 350 klinisch tumorfreien Patienten nach chirurgischer Entfernung eines Melanoms sowie 72 gesunden Kontrollpersonen und 316 Kontrollpersonen mit anderen Erkrankungen war der MIA-Spiegel bei allen 50 Melanompatienten in Stadium III und IV erhöht (&gt; 95. Perzentile der gesunden Kontrollen = 6,5 ng/ml), dagegen nur bei 13 % in Stadium I und 23 % in Stadium II.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "409;07_malignes-melanom_0052.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für Patienten in den Stadien I bis III sind dabei weder eine relevante Heterogenität der Studien noch ein Publikationsbias nachzuweisen, jedoch wurden nur in zwei der eingeschlossenen Studien Patienten in den Stadien I und II separat ausgewertet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1957__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für Patienten in den Stadien I bis III sind dabei weder eine relevante Heterogenität der Studien noch ein Publikationsbias nachzuweisen, jedoch wurden nur in zwei der eingeschlossenen Studien Patienten in den Stadien I und <span class=\"diff_chg\">Stadien II</span> separat ausgewertet.</div><div nowrap=\"nowrap\">Für Patienten in den Stadien I bis III sind dabei weder eine relevante Heterogenität der Studien noch ein Publikationsbias nachzuweisen, jedoch wurden nur in zwei der eingeschlossenen Studien Patienten in den Stadien I und <span class=\"diff_chg\">II</span> separat ausgewertet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "410;07_malignes-melanom_0052.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer größeren Studie mit 1079 Patienten der Stadien I und II [REF] wurden verschiedene Cut-off-Werte für MIA getestet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1958__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer größeren Studie mit 1079 Patienten der Stadien I und <span class=\"diff_sub\">Stadien </span>II [REF] wurden verschiedene Cut-off-Werte für MIA getestet.</div><div nowrap=\"nowrap\">In einer größeren Studie mit 1079 Patienten der Stadien I und II [REF] wurden verschiedene Cut-off-Werte für MIA getestet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "411;07_malignes-melanom_0052.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer Untersuchung an 296 klinisch tumorfreien Patienten in den Stadien II und III [REF] zeigte sich, dass ein erhöhter MIA-Wert (> 95. Perzentile der 120 gesunden Kontrollpersonen = 10,49 ng/ml) eine Sensitivität bezüglich eines Rezidivs von 0,22 (schlechter als S100B, jedoch besser als AP und LDH), jedoch von allen untersuchten Parametern mit 0,97 die höchste Spezifität hatte."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1959__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer Untersuchung an 296 klinisch tumorfreien Patienten in den Stadien II und <span class=\"diff_chg\">Stadien III</span> [REF] zeigte sich, dass ein erhöhter MIA-Wert (&gt; 95. Perzentile der 120 gesunden Kontrollpersonen = 10,49 ng/ml) eine Sensitivität bezüglich eines Rezidivs von 0,22 (schlechter als S100B, jedoch besser als AP und LDH), jedoch von allen untersuchten Parametern mit 0,97 die höchste Spezifität hatte.</div><div nowrap=\"nowrap\">In einer Untersuchung an 296 klinisch tumorfreien Patienten in den Stadien II und <span class=\"diff_chg\">III</span> [REF] zeigte sich, dass ein erhöhter MIA-Wert (&gt; 95. Perzentile der 120 gesunden Kontrollpersonen = 10,49 ng/ml) eine Sensitivität bezüglich eines Rezidivs von 0,22 (schlechter als S100B, jedoch besser als AP und LDH), jedoch von allen untersuchten Parametern mit 0,97 die höchste Spezifität hatte.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "412;07_malignes-melanom_0053.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "PET und PET/CT sollen nicht routinemäßig als initiale Staginguntersuchungen bis Stadium IIA/IIB durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1960__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">PET und PET/CT sollen nicht routinemäßig als initiale Staginguntersuchungen bis Stadium IIA/<span class=\"diff_sub\">Stadium </span>IIB durchgeführt werden.</div><div nowrap=\"nowrap\">PET und PET/CT sollen nicht routinemäßig als initiale Staginguntersuchungen bis Stadium IIA/IIB durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "413;07_malignes-melanom_0054.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Stadium IIC hingegen haben im Vergleich zu Patienten in den Stadien IIA bzw. IIB ein deutlich höheres Rezidivrisiko und sollen daher hinsichtlich des diagnostischen Prozederes genauso behandelt werden wie Patienten im Stadium III (siehe Kapitel 6.1)"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1961__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\"><span class=\"diff_sub\">Patienten im Stadium IIC hingegen haben im Vergleich zu Patienten in den Stadien IIA bzw. Stadien IIB ein deutlich höheres Rezidivrisiko und sollen daher hinsichtlich des diagnostischen Prozederes genauso behandelt werden wie Patienten im Stadium III (siehe Kapitel 6.1)</span></div><div nowrap=\"nowrap\"><span class=\"diff_add\">Patienten im Stadium IIC hingegen haben im Vergleich zu Patienten in den Stadien IIA bzw. IIB ein deutlich höheres Rezidivrisiko und sollen daher hinsichtlich des diagnostischen Prozederes genauso behandelt werden wie Patienten im Stadium III (siehe Kapitel 6.1)</span></div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "414;07_malignes-melanom_0055.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Skelettszintigraphie soll beim Initialstaging bei Patienten bis Stadium IIA/IIB nicht als Standard durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1962__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Skelettszintigraphie soll beim Initialstaging bei Patienten bis Stadium IIA/<span class=\"diff_sub\">Stadium </span>IIB nicht als Standard durchgeführt werden.</div><div nowrap=\"nowrap\">Die Skelettszintigraphie soll beim Initialstaging bei Patienten bis Stadium IIA/IIB nicht als Standard durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "415;07_malignes-melanom_0057.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zur Stadienzuordnung soll die Wächterlymphknoten-Biopsie ab einer Tumordicke von 1,0 mm und ohne Hinweis auf lokoregionale oder Fernmetastasierung durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1963__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zur Stadienzuordnung soll die Wächterlymphknoten-Biopsie ab einer Tumordicke von 1,0 mm und ohne Hinweis auf lokoregionale <span class=\"diff_sub\">Metastasierung </span>oder Fernmetastasierung durchgeführt werden.</div><div nowrap=\"nowrap\">Zur Stadienzuordnung soll die Wächterlymphknoten-Biopsie ab einer Tumordicke von 1,0 mm und ohne Hinweis auf lokoregionale oder Fernmetastasierung durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "416;07_malignes-melanom_0071.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Behandlungs-/Betreuungseinrichtungen"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1964__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Behandlungs<span class=\"diff_chg\">einrichtungen</span>/Betreuungseinrichtungen</div><div nowrap=\"nowrap\">- Behandlungs<span class=\"diff_chg\">-</span>/Betreuungseinrichtungen</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "417;07_malignes-melanom_0075.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das Stadium der lokoregionalen Metastasierung (AJCC 2009 Stadium IIIA, IIIB und IIIC) umfasst eine klinisch und prognostisch sehr heterogene Patientengruppe."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1965__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das Stadium der lokoregionalen Metastasierung (AJCC 2009 Stadium IIIA, <span class=\"diff_sub\">Stadium </span>IIIB und<span class=\"diff_sub\"> Stadium</span> IIIC) umfasst eine klinisch und prognostisch sehr heterogene Patientengruppe.</div><div nowrap=\"nowrap\">Das Stadium der lokoregionalen Metastasierung (AJCC 2009 Stadium IIIA, IIIB und IIIC) umfasst eine klinisch und prognostisch sehr heterogene Patientengruppe.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "418;07_malignes-melanom_0077.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die 5-Jahres-Überlebensrate von Patienten im Stadium IIC beträgt in der Studie von Balch et al. 53 %, die Überlebensraten von denen im Stadium III betragen 78 %, 59 % bzw. 40 % für Patienten im Stadium IIIA, IIIB bzw. IIIC [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1966__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die 5-Jahres-Überlebensrate von Patienten im Stadium IIC beträgt in der Studie von Balch et al. 53 %, die Überlebensraten von denen im Stadium III betragen 78 %, 59 % bzw. 40 % für Patienten im Stadium IIIA, <span class=\"diff_sub\">Stadium </span>IIIB bzw. <span class=\"diff_sub\">Stadium </span>IIIC [REF].</div><div nowrap=\"nowrap\">Die 5-Jahres-Überlebensrate von Patienten im Stadium IIC beträgt in der Studie von Balch et al. 53 %, die Überlebensraten von denen im Stadium III betragen 78 %, 59 % bzw. 40 % für Patienten im Stadium IIIA, IIIB bzw. IIIC [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "419;07_malignes-melanom_0078.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Untersuchungsmethoden im Stadium IIC und III"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1967__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und <span class=\"diff_sub\">Stadium </span>III</div><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und III</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "420;07_malignes-melanom_0079.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Untersuchungsmethoden im Stadium IIC und III"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1968__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und <span class=\"diff_sub\">Stadium </span>III</div><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und III</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "421;07_malignes-melanom_0080.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Untersuchungsmethoden im Stadium IIC und III"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1969__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und <span class=\"diff_sub\">Stadium </span>III</div><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und III</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "422;07_malignes-melanom_0081.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Untersuchungsmethoden im Stadium IIC und III"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1970__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und <span class=\"diff_sub\">Stadium </span>III</div><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und III</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "423;07_malignes-melanom_0082.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Untersuchungsmethoden im Stadium IIC und III"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1971__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und <span class=\"diff_sub\">Stadium </span>III</div><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und III</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "424;07_malignes-melanom_0083.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Untersuchungsmethoden im Stadium IIC und III"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1972__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und <span class=\"diff_sub\">Stadium </span>III</div><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und III</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "425;07_malignes-melanom_0084.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Untersuchungsmethoden im Stadium IIC und III"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1973__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und <span class=\"diff_sub\">Stadium </span>III</div><div nowrap=\"nowrap\">Untersuchungsmethoden im Stadium IIC und III</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "426;07_malignes-melanom_0098.tsv;16"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In anderen Untersuchungen wurden die Tumorstadien III und IV zusammen ausgewertet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1974__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In anderen Untersuchungen wurden die Tumorstadien III und <span class=\"diff_sub\">Tumorstadien </span>IV zusammen ausgewertet.</div><div nowrap=\"nowrap\">In anderen Untersuchungen wurden die Tumorstadien III und IV zusammen ausgewertet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "427;07_malignes-melanom_0098.tsv;41"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der bereits oben erwähnten Studie von Krahn et al. zeigten sich erhöhte MIA-Werte in 6 von 19 tumorfreien Patienten im Stadium III bzw. IV und in 16 von 20 Patienten mit neu aufgetretenen Metastasen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1975__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der bereits oben erwähnten Studie von Krahn et al. zeigten sich erhöhte MIA-Werte in 6 von 19 tumorfreien Patienten im Stadium III bzw. <span class=\"diff_sub\">Stadium </span>IV und in 16 von 20 Patienten mit neu aufgetretenen Metastasen.</div><div nowrap=\"nowrap\">In der bereits oben erwähnten Studie von Krahn et al. zeigten sich erhöhte MIA-Werte in 6 von 19 tumorfreien Patienten im Stadium III bzw. IV und in 16 von 20 Patienten mit neu aufgetretenen Metastasen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "428;07_malignes-melanom_0098.tsv;30"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Melanom-Stadium III/IV wiesen höhere LDH-Spiegel auf als Patienten im Stadium I/II [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1976__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im Melanom-Stadium III/<span class=\"diff_sub\">Melanom-Stadium </span>IV wiesen höhere LDH-Spiegel auf als Patienten im Stadium I/<span class=\"diff_sub\">Stadium </span>II [REF], [REF].</div><div nowrap=\"nowrap\">Patienten im Melanom-Stadium III/IV wiesen höhere LDH-Spiegel auf als Patienten im Stadium I/II [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "429;07_malignes-melanom_0098.tsv;19"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer Studie von Krahn wurden verschiedene Tumormarker miteinander bei 373 Melanompatienten (284 Stadium I/II, 89 Stadium III/IV) verglichen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1977__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer Studie von Krahn wurden verschiedene Tumormarker miteinander bei 373 Melanompatienten (284 Stadium I/Stadium <span class=\"diff_sub\">II, 89 Stadium </span>III/<span class=\"diff_sub\">Stadium </span>IV) verglichen.</div><div nowrap=\"nowrap\">In einer Studie von Krahn wurden verschiedene Tumormarker miteinander bei 373 Melanompatienten (284 Stadium I/<span class=\"diff_add\">II, 89 </span>Stadium III/IV) verglichen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "430;07_malignes-melanom_0098.tsv;44"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch Stahlecker und Guba et al. wiesen bei Patienten im Stadium III und IV höhere MIA-Konzentrationen nach als bei Patienten im Stadium I und II [REF] :"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1978__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch Stahlecker und Guba et al. wiesen bei Patienten im Stadium III und <span class=\"diff_sub\">Stadium </span>IV höhere MIA-Konzentrationen nach als bei Patienten im Stadium I und <span class=\"diff_sub\">Stadium </span>II [REF] :</div><div nowrap=\"nowrap\">Auch Stahlecker und Guba et al. wiesen bei Patienten im Stadium III und IV höhere MIA-Konzentrationen nach als bei Patienten im Stadium I und II [REF] :</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "431;07_malignes-melanom_0098.tsv;47"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Einschränkend muss erwähnt werden, dass der Anteil an Melanompatienten im Stadium III und IV in der Studie von Stahlecker et al. nur sehr klein war (5 Patienten im Stadium 3, 19 im Stadium IV)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1979__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Einschränkend muss erwähnt werden, dass der Anteil an Melanompatienten im Stadium III und <span class=\"diff_sub\">Stadium </span>IV in der Studie von Stahlecker et al. nur sehr klein war (5 Patienten im Stadium 3, 19 im Stadium IV).</div><div nowrap=\"nowrap\">Einschränkend muss erwähnt werden, dass der Anteil an Melanompatienten im Stadium III und IV in der Studie von Stahlecker et al. nur sehr klein war (5 Patienten im Stadium 3, 19 im Stadium IV).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "432;07_malignes-melanom_0098.tsv;48"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Studie von Guba et al. zeigte sich keine Signifikanz hinsichtlich kürzerer Überlebenszeiten von Patienten mit erhöhten MIA-Leveln im Stadium III und IV."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1980__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Studie von Guba et al. zeigte sich keine Signifikanz hinsichtlich kürzerer Überlebenszeiten von Patienten mit erhöhten MIA-Leveln im Stadium III und <span class=\"diff_sub\">Stadium </span>IV.</div><div nowrap=\"nowrap\">In der Studie von Guba et al. zeigte sich keine Signifikanz hinsichtlich kürzerer Überlebenszeiten von Patienten mit erhöhten MIA-Leveln im Stadium III und IV.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "433;07_malignes-melanom_0104.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es wurden zwar vielfach Daten zum krankheitsfreien oder Gesamtüberleben nach LAD publiziert."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1981__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es wurden zwar vielfach Daten zum krankheitsfreien <span class=\"diff_sub\">Überleben </span>oder Gesamtüberleben nach LAD publiziert.</div><div nowrap=\"nowrap\">Es wurden zwar vielfach Daten zum krankheitsfreien oder Gesamtüberleben nach LAD publiziert.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "434;07_malignes-melanom_0104.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten mit klinisch eindeutigen Hinweisen auf Lymphknotenmetastasen soll eine Lymphknotendissektion des betreffenden Abflussgebietes vorgenommen werden (Stadium IIIB und IIIC)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1982__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten mit klinisch eindeutigen Hinweisen auf Lymphknotenmetastasen soll eine Lymphknotendissektion des betreffenden Abflussgebietes vorgenommen werden (Stadium IIIB und<span class=\"diff_sub\"> Stadium</span> IIIC).</div><div nowrap=\"nowrap\">Bei Patienten mit klinisch eindeutigen Hinweisen auf Lymphknotenmetastasen soll eine Lymphknotendissektion des betreffenden Abflussgebietes vorgenommen werden (Stadium IIIB und IIIC).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "435;07_malignes-melanom_0109.tsv;16"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer retrospektiven matched-pair-Analyse von Patienten mit geringer Tumorlast im WLK (<0.1mm Durchmesser), zeigte sich kein Unterschied im rezidivfreien und im Gesamt-Überleben zwischen Patienten, die eine CLND erhalten hatten bzw. nicht erhalten hatten [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1983__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer retrospektiven matched-pair-Analyse von Patienten mit geringer Tumorlast im WLK (&lt;0.1mm Durchmesser), zeigte sich kein Unterschied im rezidivfreien <span class=\"diff_sub\">Überleben </span>und im Gesamt-Überleben zwischen Patienten, die eine CLND erhalten hatten bzw. nicht erhalten hatten [REF].</div><div nowrap=\"nowrap\">In einer retrospektiven matched-pair-Analyse von Patienten mit geringer Tumorlast im WLK (&lt;0.1mm Durchmesser), zeigte sich kein Unterschied im rezidivfreien und im Gesamt-Überleben zwischen Patienten, die eine CLND erhalten hatten bzw. nicht erhalten hatten [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "436;07_malignes-melanom_0111.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wegen der hohen Rezidivneigung einer Metastasierung in den genannten Lymphknotenregionen (Lymphknoten- und/oder Weichgewebsmetastasen) werden die Komplikationen dieser Operation und eine erhöhte Morbidität in Kauf genommen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1984__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wegen der hohen Rezidivneigung einer Metastasierung in den genannten Lymphknotenregionen (Lymphknoten<span class=\"diff_chg\">metastasen</span> und/oder Weichgewebsmetastasen) werden die Komplikationen dieser Operation und eine erhöhte Morbidität in Kauf genommen.</div><div nowrap=\"nowrap\">Wegen der hohen Rezidivneigung einer Metastasierung in den genannten Lymphknotenregionen (Lymphknoten<span class=\"diff_chg\">-</span> und/oder Weichgewebsmetastasen) werden die Komplikationen dieser Operation und eine erhöhte Morbidität in Kauf genommen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "437;07_malignes-melanom_0119.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Frage nach der Wertigkeit des rezidivfreien Überlebens auf das Gesamtüberleben wurde für Interferon-basierte Studien mit einem hohen Korrelationskoeffi-zienten der Hazard ratios für das rezdivfreie und Gesamtüberleben (R² = 0.91) belegt [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1985__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Frage nach der Wertigkeit des rezidivfreien Überlebens auf das Gesamtüberleben wurde für Interferon-basierte Studien mit einem hohen Korrelationskoeffi-zienten der Hazard ratios für das rezdivfreie <span class=\"diff_chg\">Überleben und</span> Gesamtüberleben (R² = 0.91) belegt [REF].</div><div nowrap=\"nowrap\">Die Frage nach der Wertigkeit des rezidivfreien Überlebens auf das Gesamtüberleben wurde für Interferon-basierte Studien mit einem hohen Korrelationskoeffi-zienten der Hazard ratios für das rezdivfreie <span class=\"diff_chg\">und</span> Gesamtüberleben (R² = 0.91) belegt [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "438;07_malignes-melanom_0121.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Tumorstadium IIB/C soll eine adjuvante Interferontherapie angeboten werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1986__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im Tumorstadium IIB/<span class=\"diff_sub\">Tumorstadium II</span>C soll eine adjuvante Interferontherapie angeboten werden.</div><div nowrap=\"nowrap\">Patienten im Tumorstadium IIB/C soll eine adjuvante Interferontherapie angeboten werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "439;07_malignes-melanom_0124.tsv;32"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bis jetzt konnte für kein Interferon Schema gegenüber einem anderen Interferon Schema eine klare signifikante Überlegenheit weder im progressionsfreien noch im Gesamtüberleben gezeigt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1987__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bis jetzt konnte für kein Interferon Schema gegenüber einem anderen Interferon Schema eine klare signifikante Überlegenheit weder im progressionsfreien <span class=\"diff_sub\">Überleben </span>noch im Gesamtüberleben gezeigt werden.</div><div nowrap=\"nowrap\">Bis jetzt konnte für kein Interferon Schema gegenüber einem anderen Interferon Schema eine klare signifikante Überlegenheit weder im progressionsfreien noch im Gesamtüberleben gezeigt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "440;07_malignes-melanom_0125.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im Stadium IIIB und IIIC hatten keine in-transit Metastasen (AJCC 2009)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1988__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im Stadium IIIB und<span class=\"diff_sub\"> Stadium</span> IIIC hatten keine in-transit Metastasen (AJCC 2009).</div><div nowrap=\"nowrap\">Patienten im Stadium IIIB und IIIC hatten keine in-transit Metastasen (AJCC 2009).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "441;07_malignes-melanom_0125.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Hier wurden Patienten mit malignem Melanom im resezierten Stadium IIIB, IIIC, oder IV eingeschlossen (AJCC 2009)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1989__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Hier wurden Patienten mit malignem Melanom im resezierten Stadium IIIB, <span class=\"diff_sub\">Stadium </span>IIIC, oder <span class=\"diff_sub\">Stadium </span>IV eingeschlossen (AJCC 2009).</div><div nowrap=\"nowrap\">Hier wurden Patienten mit malignem Melanom im resezierten Stadium IIIB, IIIC, oder IV eingeschlossen (AJCC 2009).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "442;07_malignes-melanom_0125.tsv;35"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Checkmate-238-Studie wurden in 14,4 % der Patienten über eine Toxizität Grad 3 oder 4 berichtet In 9,7 % aller Fälle wurde die Therapie aufgrund von Nebenwirkungen vorzeitig abgebrochen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1990__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Checkmate-238-Studie wurden in 14,4 % der Patienten über eine Toxizität Grad 3 oder <span class=\"diff_sub\">Grad </span>4 berichtet In 9,7 % aller Fälle wurde die Therapie aufgrund von Nebenwirkungen vorzeitig abgebrochen.</div><div nowrap=\"nowrap\">In der Checkmate-238-Studie wurden in 14,4 % der Patienten über eine Toxizität Grad 3 oder 4 berichtet In 9,7 % aller Fälle wurde die Therapie aufgrund von Nebenwirkungen vorzeitig abgebrochen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "443;07_malignes-melanom_0127.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten im AJCC 2017 Tumorstadium III A-D mit einer BRAF V600E oder V600K Mutation soll eine adjuvante Therapie mit einem BRAF‐ und MEK-Inhibitor angeboten werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1991__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten im AJCC 2017 Tumorstadium III A-D mit einer BRAF V600E Mutation <span class=\"diff_sub\">oder BRAF V600K Mutation </span>soll eine adjuvante Therapie mit einem BRAF<span class=\"diff_sub\">-Inhibitor</span>‐ und MEK-Inhibitor angeboten werden.</div><div nowrap=\"nowrap\">Patienten im AJCC 2017 Tumorstadium III A-D mit einer BRAF V600E<span class=\"diff_add\"> oder V600K</span> Mutation soll eine adjuvante Therapie mit einem BRAF‐ und MEK-Inhibitor angeboten werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "444;07_malignes-melanom_0129.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer randomisierten, doppel-blinden, Placebo-kontrollierten Phase 3 Studie erhielten Patienten im Stadium IIC+IIIA+IIIB (Kohorte 1) oder IIIC (Kohorte 2) mit einer BRAF V600 Mutation für insgesamt 52 Wochen Vemurafenib 960mg 2x/täglich, oder eine vergleichbare Placebo-Behandlung [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1992__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer randomisierten, doppel-blinden, Placebo-kontrollierten Phase 3 Studie erhielten Patienten im Stadium IIC+<span class=\"diff_sub\">Stadium </span>IIIA+<span class=\"diff_sub\">Stadium </span>IIIB (Kohorte 1) oder<span class=\"diff_sub\"> Stadium</span> IIIC (Kohorte 2) mit einer BRAF V600 Mutation für insgesamt 52 Wochen Vemurafenib 960mg 2x/täglich, oder eine vergleichbare Placebo-Behandlung [REF].</div><div nowrap=\"nowrap\">In einer randomisierten, doppel-blinden, Placebo-kontrollierten Phase 3 Studie erhielten Patienten im Stadium IIC+IIIA+IIIB (Kohorte 1) oder IIIC (Kohorte 2) mit einer BRAF V600 Mutation für insgesamt 52 Wochen Vemurafenib 960mg 2x/täglich, oder eine vergleichbare Placebo-Behandlung [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "445;07_malignes-melanom_0129.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die häufigsten Nebenwirkungen der Kombinationstherapie waren Pyrexie (alle Grade, 63 %; Grad 3 oder 4, 5 %), Fatigue (alle Grade, 47 %; Grad 3 oder 4, 4 %), und Nausea (alle Grade, 40 %; Grad 3 oder 4, <1 %)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1993__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die häufigsten Nebenwirkungen der Kombinationstherapie waren Pyrexie (alle Grade, 63 %; Grad 3 oder <span class=\"diff_chg\">Grad 4, Grad</span> 5 %), Fatigue (alle Grade, 47 %; Grad 3 oder <span class=\"diff_chg\">Grad 4, 4</span> %), und Nausea (alle Grade, 40 %; Grad 3 oder <span class=\"diff_chg\">Grad 4,</span> &lt;1 %).</div><div nowrap=\"nowrap\">Die häufigsten Nebenwirkungen der Kombinationstherapie waren Pyrexie (alle Grade, 63 %; Grad 3 oder <span class=\"diff_chg\">4,</span> 5 %), Fatigue (alle Grade, 47 %; Grad 3 oder <span class=\"diff_chg\">4, 4</span> %), und Nausea (alle Grade, 40 %; Grad 3 oder <span class=\"diff_chg\">4,</span> &lt;1 %).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "446;07_malignes-melanom_0129.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer randomisierten, doppelblinden, placebokontrollierten Phase-3-Studie [REF] erhielten Patienten in den Stadien IIIA (Mindestdurchmesser im betroffenen Lymphknoten > 1mm) - IIIC (AJCC 2009) mit einer BRAF V600E oder V600K Mutation für insgesamt 12 Monate Dabrafenib 150mg 2x/täglich und Trametinib 2mg 1x/täglich, oder eine vergleichbare Placebo-Behandlung."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1994__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer randomisierten, doppelblinden, placebokontrollierten Phase-3-Studie [REF] erhielten Patienten in den Stadien IIIA (Mindestdurchmesser im betroffenen Lymphknoten &gt; 1mm) - IIIC (AJCC 2009) mit einer BRAF V600E <span class=\"diff_chg\">Mutation oder BRAF</span> V600K Mutation für insgesamt 12 Monate Dabrafenib 150mg 2x/täglich und Trametinib 2mg 1x/täglich, oder eine vergleichbare Placebo-Behandlung.</div><div nowrap=\"nowrap\">In einer randomisierten, doppelblinden, placebokontrollierten Phase-3-Studie [REF] erhielten Patienten in den Stadien IIIA (Mindestdurchmesser im betroffenen Lymphknoten &gt; 1mm) - IIIC (AJCC 2009) mit einer BRAF V600E <span class=\"diff_chg\">oder</span> V600K Mutation für insgesamt 12 Monate Dabrafenib 150mg 2x/täglich und Trametinib 2mg 1x/täglich, oder eine vergleichbare Placebo-Behandlung.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "447;07_malignes-melanom_0129.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer Studie wurde die kombinierte Gabe der BRAF- und MEK-Inhibitoren Dabrafenib und Trametinib [REF], und in einer zweiten Studie die adjuvante Therapie mit dem BRAF-Inhibitor Vemurafenib allein untersucht [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1995__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer Studie wurde die kombinierte Gabe der BRAF-<span class=\"diff_chg\">Inhibitoren und</span> MEK-Inhibitoren Dabrafenib und Trametinib [REF], und in einer zweiten Studie die adjuvante Therapie mit dem BRAF-Inhibitor Vemurafenib allein untersucht [REF].</div><div nowrap=\"nowrap\">In einer Studie wurde die kombinierte Gabe der BRAF-<span class=\"diff_chg\"> und</span> MEK-Inhibitoren Dabrafenib und Trametinib [REF], und in einer zweiten Studie die adjuvante Therapie mit dem BRAF-Inhibitor Vemurafenib allein untersucht [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "448;07_malignes-melanom_0134.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zusammen mit der primären Analyse zeigen die Ergebnisse der Studie, dass die Behandlung mit Ipilimumab zu einem längeren rezidivfreien und Gesamtüberleben führt als die Behandlung mit Placebo, mit einer geringen Beeinträchtigung der HRQoL trotz der vom Prüfer gemeldeten Grad 3/4 Nebenwirkungen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1996__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zusammen mit der primären Analyse zeigen die Ergebnisse der Studie, dass die Behandlung mit Ipilimumab zu einem längeren rezidivfreien <span class=\"diff_chg\">Überleben und</span> Gesamtüberleben führt als die Behandlung mit Placebo, mit einer geringen Beeinträchtigung der HRQoL trotz der vom Prüfer gemeldeten Grad 3 Nebenwirkungen<span class=\"diff_sub\">/Grad 4 Nebenwirkungen</span>.</div><div nowrap=\"nowrap\">Zusammen mit der primären Analyse zeigen die Ergebnisse der Studie, dass die Behandlung mit Ipilimumab zu einem längeren rezidivfreien <span class=\"diff_chg\">und</span> Gesamtüberleben führt als die Behandlung mit Placebo, mit einer geringen Beeinträchtigung der HRQoL trotz der vom Prüfer gemeldeten Grad 3<span class=\"diff_add\">/4</span> Nebenwirkungen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "449;07_malignes-melanom_0134.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer großen Studie mit 855 Stadium II/III Patienten und >80% Rücklaufquote der Fragebögen (EORTC QLC-C30) wurden drei Therapiearme evaluiert:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1997__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer großen Studie mit 855 Stadium II/<span class=\"diff_sub\">Stadium </span>III Patienten und &gt;80% Rücklaufquote der Fragebögen (EORTC QLC-C30) wurden drei Therapiearme evaluiert:</div><div nowrap=\"nowrap\">In einer großen Studie mit 855 Stadium II/III Patienten und &gt;80% Rücklaufquote der Fragebögen (EORTC QLC-C30) wurden drei Therapiearme evaluiert:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "450;07_malignes-melanom_0136.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "21 % aller metastasierten Patienten zeigen zunächst In-transit- oder Satellitenmetastasen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1998__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">21 % aller metastasierten Patienten zeigen zunächst In-transit-<span class=\"diff_sub\">Metastasen</span> oder Satellitenmetastasen [REF].</div><div nowrap=\"nowrap\">21 % aller metastasierten Patienten zeigen zunächst In-transit- oder Satellitenmetastasen [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "451;07_malignes-melanom_0136.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Primärmelanomen mit In-transit- und Satellitenmetastasen wird in 41 % auch ein positiver Wächterlymphknoten beobachtet [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to1999__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Primärmelanomen mit In-transit-<span class=\"diff_sub\">Metastasen</span> und Satellitenmetastasen wird in 41 % auch ein positiver Wächterlymphknoten beobachtet [REF].</div><div nowrap=\"nowrap\">Bei Primärmelanomen mit In-transit- und Satellitenmetastasen wird in 41 % auch ein positiver Wächterlymphknoten beobachtet [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "452;07_malignes-melanom_0136.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die folgenden Empfehlungen beziehen sich auf kutane und subkutane lokoregionale Metastasen (In-transit- und Satellitenmetastasen)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2000__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die folgenden Empfehlungen beziehen sich auf kutane und subkutane lokoregionale Metastasen (In-transit-<span class=\"diff_sub\">Metastasen</span> und Satellitenmetastasen).</div><div nowrap=\"nowrap\">Die folgenden Empfehlungen beziehen sich auf kutane und subkutane lokoregionale Metastasen (In-transit- und Satellitenmetastasen).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "453;07_malignes-melanom_0138.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In-transit- und Satellitenmetastasen können eine Indikation für eine palliative Strahlentherapie darstellen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2001__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In-transit-<span class=\"diff_sub\">Metastasen</span> und Satellitenmetastasen können eine Indikation für eine palliative Strahlentherapie darstellen.</div><div nowrap=\"nowrap\">In-transit- und Satellitenmetastasen können eine Indikation für eine palliative Strahlentherapie darstellen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "454;07_malignes-melanom_0143.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Indikation zur isolierten Extremitätenperfusion („isolated limb perfusion“, ILP) kann prinzipiell in den Stadien IIIB, IIIC und IV gestellt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2002__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Indikation zur isolierten Extremitätenperfusion („isolated limb perfusion“, ILP) kann prinzipiell in den Stadien IIIB, <span class=\"diff_sub\">Stadien </span>IIIC und <span class=\"diff_sub\">Stadien </span>IV gestellt werden.</div><div nowrap=\"nowrap\">Die Indikation zur isolierten Extremitätenperfusion („isolated limb perfusion“, ILP) kann prinzipiell in den Stadien IIIB, IIIC und IV gestellt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "455;07_malignes-melanom_0156.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Metaanalyse [REF] von 12 Studien mit insgesamt 6642 Patienten im Stadium AJCC I–II (5 Studien), III (6 Studien) und IV (1 Studie) belegt, dass hinsichtlich der Detektion von Lymphknotenmetastasen die Lymphknoten-Sonographie der Palpation überlegen ist."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2003__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Metaanalyse [REF] von 12 Studien mit insgesamt 6642 Patienten im Stadium AJCC I–II (5 Studien), <span class=\"diff_chg\">Stadium III</span> (6 Studien) und<span class=\"diff_sub\"> Stadium</span> IV (1 Studie) belegt, dass hinsichtlich der Detektion von Lymphknotenmetastasen die Lymphknoten-Sonographie der Palpation überlegen ist.</div><div nowrap=\"nowrap\">Eine Metaanalyse [REF] von 12 Studien mit insgesamt 6642 Patienten im Stadium AJCC I–II (5 Studien), <span class=\"diff_chg\">III</span> (6 Studien) und IV (1 Studie) belegt, dass hinsichtlich der Detektion von Lymphknotenmetastasen die Lymphknoten-Sonographie der Palpation überlegen ist.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "456;07_malignes-melanom_0165.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die 1- und 2-Jahres-Überlebensraten für Stadium-IV-Patienten mit normalen Serum-LDH-Spiegeln zum Zeitpunkt der Diagnose betrugen 65 % bzw. 40 % verglichen mit 32 % bzw. 18 % für Patienten mit erhöhten Serum-LDH-Leveln (p < 0,0001)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2004__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die 1-Jahres-Überlebensraten<span class=\"diff_sub\"> und 2-Jahres-Überlebensraten</span> für Stadium-IV-Patienten mit normalen Serum-LDH-Spiegeln zum Zeitpunkt der Diagnose betrugen 65 % bzw. 40 % verglichen mit 32 % bzw. 18 % für Patienten mit erhöhten Serum-LDH-Leveln (p &lt; 0,0001).</div><div nowrap=\"nowrap\">Die 1-<span class=\"diff_add\"> und 2-</span>Jahres-Überlebensraten für Stadium-IV-Patienten mit normalen Serum-LDH-Spiegeln zum Zeitpunkt der Diagnose betrugen 65 % bzw. 40 % verglichen mit 32 % bzw. 18 % für Patienten mit erhöhten Serum-LDH-Leveln (p &lt; 0,0001).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "457;07_malignes-melanom_0167.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es ist wahrscheinlich, dass eine komplette Regression in 10–20 % der Melanome erfolgt, obwohl nur diejenigen Tumorerkrankungen diagnostizierbar sind, bei denen der Primärtumor Metastasen gebildet hatte (ungefähr 5 % der Melanome).“ Zwei Studien konnten für Patienten mit okkultem Melanom eine bessere 5- [REF] bzw. 1-Jahres-Überlebensrate [REF] nachweisen als für Patienten mit bekanntem Primarius."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2005__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es ist wahrscheinlich, dass eine komplette Regression in 10–20 % der Melanome erfolgt, obwohl nur diejenigen Tumorerkrankungen diagnostizierbar sind, bei denen der Primärtumor Metastasen gebildet hatte (ungefähr 5 % der Melanome).“ Zwei Studien konnten für Patienten mit okkultem Melanom eine bessere 5-<span class=\"diff_sub\">Jahres-Überlebensrate</span> [REF] bzw. 1-Jahres-Überlebensrate [REF] nachweisen als für Patienten mit bekanntem Primarius.</div><div nowrap=\"nowrap\">Es ist wahrscheinlich, dass eine komplette Regression in 10–20 % der Melanome erfolgt, obwohl nur diejenigen Tumorerkrankungen diagnostizierbar sind, bei denen der Primärtumor Metastasen gebildet hatte (ungefähr 5 % der Melanome).“ Zwei Studien konnten für Patienten mit okkultem Melanom eine bessere 5- [REF] bzw. 1-Jahres-Überlebensrate [REF] nachweisen als für Patienten mit bekanntem Primarius.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "458;07_malignes-melanom_0168.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Beim Nachweis von BRAF-, NRAS- und c-kit-Mutationen stehen therapeutisch spezifische Inhibitoren zur Verfügung."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2006__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Beim Nachweis von BRAF-<span class=\"diff_sub\">Mutationen</span>, NRAS-<span class=\"diff_sub\">Mutationen</span> und c-kit-Mutationen stehen therapeutisch spezifische Inhibitoren zur Verfügung.</div><div nowrap=\"nowrap\">Beim Nachweis von BRAF-, NRAS- und c-kit-Mutationen stehen therapeutisch spezifische Inhibitoren zur Verfügung.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "459;07_malignes-melanom_0173.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Aktuell liegen keine Daten zur besten sequentiellen Therapie von BRAF/MEK-Inhibitoren und Checkpoint-Inhibitoren vor."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2007__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Aktuell liegen keine Daten zur besten sequentiellen Therapie von BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren und Checkpoint-Inhibitoren vor.</div><div nowrap=\"nowrap\">Aktuell liegen keine Daten zur besten sequentiellen Therapie von BRAF/MEK-Inhibitoren und Checkpoint-Inhibitoren vor.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "460;07_malignes-melanom_0174.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine Metaanalyse von 16 randomisierten Studien mit BRAF- oder/und MEK-Inhibitoren bestätigt die Überlegenheit der Kombinationstherapie mit einem BRAF-Inhibitor und einem MEK-Inhibitor gegenüber einer Monotherapie mit einem BRAF-Inhibitor oder einem MEK-Inhibitor [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2008__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine Metaanalyse von 16 randomisierten Studien mit BRAF-<span class=\"diff_sub\">Inhibitoren</span> oder/und MEK-Inhibitoren bestätigt die Überlegenheit der Kombinationstherapie mit einem BRAF-Inhibitor und einem MEK-Inhibitor gegenüber einer Monotherapie mit einem BRAF-Inhibitor oder einem MEK-Inhibitor [REF].</div><div nowrap=\"nowrap\">Eine Metaanalyse von 16 randomisierten Studien mit BRAF- oder/und MEK-Inhibitoren bestätigt die Überlegenheit der Kombinationstherapie mit einem BRAF-Inhibitor und einem MEK-Inhibitor gegenüber einer Monotherapie mit einem BRAF-Inhibitor oder einem MEK-Inhibitor [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "461;07_malignes-melanom_0174.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer Phase-III-Studie wurden 423 therapienaive Patienten mit BRAF-V600E-/ V600K-mutiertem metastasierten Melanomen mit Dabrafenib plus Trametinib oder mit Dabrafenib plus Placebo behandelt [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2009__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer Phase-III-Studie wurden 423 therapienaive Patienten mit BRAF-V600E-<span class=\"diff_sub\">mutiertem</span>/ <span class=\"diff_sub\">BRAF-</span>V600K-mutiertem metastasierten Melanomen mit Dabrafenib plus Trametinib oder mit Dabrafenib plus Placebo behandelt [REF].</div><div nowrap=\"nowrap\">In einer Phase-III-Studie wurden 423 therapienaive Patienten mit BRAF-V600E-/ V600K-mutiertem metastasierten Melanomen mit Dabrafenib plus Trametinib oder mit Dabrafenib plus Placebo behandelt [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "462;07_malignes-melanom_0174.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Unter der Kombination des BRAF- und MEK-Inhibitors im Vergleich zur BRAF-Inhibitor-Monotherapie traten seltener Keratoakanthome beziehungsweise Plattenepithelkarzinome auf (1% vs. 18%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2010__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Unter der Kombination des BRAF-<span class=\"diff_sub\">Inhibitors</span> und MEK-Inhibitors im Vergleich zur BRAF-Inhibitor-Monotherapie traten seltener Keratoakanthome beziehungsweise Plattenepithelkarzinome auf (1% vs. 18%).</div><div nowrap=\"nowrap\">Unter der Kombination des BRAF- und MEK-Inhibitors im Vergleich zur BRAF-Inhibitor-Monotherapie traten seltener Keratoakanthome beziehungsweise Plattenepithelkarzinome auf (1% vs. 18%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "463;07_malignes-melanom_0174.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zur BRAF- oder/und MEK-Inhibition bei Patienten mit BRAFV600-mutiertem, inoperablem Stadium IIIC oder IV Melanom lagen bis September 2015 die Ergebnisse von sieben Phase-III-Studien in Vollpublikation vor."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2011__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zur BRAF-<span class=\"diff_sub\">Inhibition</span> oder/und MEK-Inhibition bei Patienten mit BRAFV600-mutiertem, inoperablem Stadium IIIC Melanom <span class=\"diff_chg\">oder</span> S<span class=\"diff_sub\">tadium IV Melanom lagen bis S</span>eptember 2015 die Ergebnisse von sieben Phase-III-Studien in Vollpublikation vor.</div><div nowrap=\"nowrap\">Zur BRAF- oder/und MEK-Inhibition bei Patienten mit BRAFV600-mutiertem, inoperablem Stadium IIIC <span class=\"diff_add\">oder IV </span>Melanom <span class=\"diff_chg\">lagen bis</span> September 2015 die Ergebnisse von sieben Phase-III-Studien in Vollpublikation vor.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "464;07_malignes-melanom_0174.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Grad 3 oder 4 Nebenwirkungen (NCI-CTCAE) traten in beiden Behandlungsarmen ähnlich häufig auf (32% vs. 31%), mit Ausnahme der Pyrexie, die sich vorrangig unter Therapie mit Dabrafenib plus Trametinib im Vergleich zu Dabrafenib plus Placebo zeigte (52% vs. 25%)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2012__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Grad 3 Nebenwirkungen<span class=\"diff_sub\"> oder Grad 4 Nebenwirkungen</span> (NCI-CTCAE) traten in beiden Behandlungsarmen ähnlich häufig auf (32% vs. 31%), mit Ausnahme der Pyrexie, die sich vorrangig unter Therapie mit Dabrafenib plus Trametinib im Vergleich zu Dabrafenib plus Placebo zeigte (52% vs. 25%).</div><div nowrap=\"nowrap\">Grad 3 <span class=\"diff_add\">oder 4 </span>Nebenwirkungen (NCI-CTCAE) traten in beiden Behandlungsarmen ähnlich häufig auf (32% vs. 31%), mit Ausnahme der Pyrexie, die sich vorrangig unter Therapie mit Dabrafenib plus Trametinib im Vergleich zu Dabrafenib plus Placebo zeigte (52% vs. 25%).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "465;07_malignes-melanom_0178.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine c-KIT-Mutation findet sich insgesamt selten, am ehesten in akral-lentiginösen und Schleimhautmelanomen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2013__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine c-KIT-Mutation findet sich insgesamt selten, am ehesten in akral-lentiginösen <span class=\"diff_sub\">Melanomen </span>und Schleimhautmelanomen.</div><div nowrap=\"nowrap\">Eine c-KIT-Mutation findet sich insgesamt selten, am ehesten in akral-lentiginösen und Schleimhautmelanomen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "466;07_malignes-melanom_0180.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Schwere (Grad 3 oder 4) Nebenwirkungen wurden bei 56,3 % der mit Ipilimumab plus Dacarbazin behandelten Patienten bzw. bei 27,5 % der mit Dacarbazin behandelten Patienten beobachtet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2014__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Schwere (Grad 3 oder <span class=\"diff_sub\">Grad </span>4) Nebenwirkungen wurden bei 56,3 % der mit Ipilimumab plus Dacarbazin behandelten Patienten bzw. bei 27,5 % der mit Dacarbazin behandelten Patienten beobachtet.</div><div nowrap=\"nowrap\">Schwere (Grad 3 oder 4) Nebenwirkungen wurden bei 56,3 % der mit Ipilimumab plus Dacarbazin behandelten Patienten bzw. bei 27,5 % der mit Dacarbazin behandelten Patienten beobachtet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "467;07_malignes-melanom_0180.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Schwere (Grad 3 oder 4) immunvermittelte Nebenwirkungen wurden bei 10–15 % der Ipilimumab-behandelten Patienten bzw. bei 3 % der Vakzine-behandelten Patienten beobachtet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2015__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Schwere (Grad 3 oder <span class=\"diff_sub\">Grad </span>4) immunvermittelte Nebenwirkungen wurden bei 10–15 % der Ipilimumab-behandelten Patienten bzw. bei 3 % der Vakzine-behandelten Patienten beobachtet.</div><div nowrap=\"nowrap\">Schwere (Grad 3 oder 4) immunvermittelte Nebenwirkungen wurden bei 10–15 % der Ipilimumab-behandelten Patienten bzw. bei 3 % der Vakzine-behandelten Patienten beobachtet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "468;07_malignes-melanom_0181.tsv;36"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer explorativen Subgruppenanalyse für die Krankheitsstadien IIIB, IIIC und IVM1a wurde ein anhaltendes Ansprechen bei 25,2% der mit T-VEC behandelten Patienten beobachtet, gegenüber 1,2% unter GM-CSF; die Gesamtansprechrate in dieser Popula-tion betrug 40,5% vs. 2,3%, und das mediane Gesamtüberleben 41,1 Monate gegen-über 21,5 Monate (HR: 0,57 [95% KI, 0,40–0,80]; p < 0,001 [deskriptiv]) Die Zulas-sung liegt daher für das Stadium IIIB, IIIC und IVM1a vor."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2016__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer explorativen Subgruppenanalyse für die Krankheitsstadien IIIB, <span class=\"diff_sub\">Krankheitsstadien </span>IIIC und<span class=\"diff_sub\"> Krankheitsstadien</span> IVM1a wurde ein anhaltendes Ansprechen bei 25,2% der mit T-VEC behandelten Patienten beobachtet, gegenüber 1,2% unter GM-CSF; die Gesamtansprechrate in dieser Popula-tion betrug 40,5% vs. 2,3%, und das mediane Gesamtüberleben 41,1 Monate gegen-über 21,5 Monate (HR: 0,57 [95% KI, 0,40–0,80]; p &lt; 0,001 [deskriptiv]) Die Zulas-sung liegt daher für das Stadium IIIB, <span class=\"diff_sub\">Stadium </span>IIIC und<span class=\"diff_sub\"> Stadium</span> IVM1a vor.</div><div nowrap=\"nowrap\">In einer explorativen Subgruppenanalyse für die Krankheitsstadien IIIB, IIIC und IVM1a wurde ein anhaltendes Ansprechen bei 25,2% der mit T-VEC behandelten Patienten beobachtet, gegenüber 1,2% unter GM-CSF; die Gesamtansprechrate in dieser Popula-tion betrug 40,5% vs. 2,3%, und das mediane Gesamtüberleben 41,1 Monate gegen-über 21,5 Monate (HR: 0,57 [95% KI, 0,40–0,80]; p &lt; 0,001 [deskriptiv]) Die Zulas-sung liegt daher für das Stadium IIIB, IIIC und IVM1a vor.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "469;07_malignes-melanom_0181.tsv;28"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der CA209-067 Studie zeigten sich Therapie-bedingte Nebenwirkungen (CTC Grad 3 oder 4) in 16.3% Patienten der Nivolumab-Gruppe, in 55.0% der Patienten der Ipilimumab plus Nivolumab Gruppe und in 27.3% der mit Ipilimumab-behandelten Patienten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2017__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der CA209-067 Studie zeigten sich Therapie-bedingte Nebenwirkungen (CTC Grad 3 oder<span class=\"diff_sub\"> CTC Grad</span> 4) in 16.3% Patienten der Nivolumab-Gruppe, in 55.0% der Patienten der Ipilimumab plus Nivolumab Gruppe und in 27.3% der mit Ipilimumab-behandelten Patienten.</div><div nowrap=\"nowrap\">In der CA209-067 Studie zeigten sich Therapie-bedingte Nebenwirkungen (CTC Grad 3 oder 4) in 16.3% Patienten der Nivolumab-Gruppe, in 55.0% der Patienten der Ipilimumab plus Nivolumab Gruppe und in 27.3% der mit Ipilimumab-behandelten Patienten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "470;07_malignes-melanom_0181.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In Patienten die Nivolumab erhielten kam es zu weniger Grad 3/4 Toxizität (9% der mit Nivolumab behandelten Patienten, 31% in der ICC-Kohorte)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2018__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In Patienten die Nivolumab erhielten kam es zu weniger Grad 3 Toxizität<span class=\"diff_sub\">/Grad 4 Toxizität</span> (9% der mit Nivolumab behandelten Patienten, 31% in der ICC-Kohorte).</div><div nowrap=\"nowrap\">In Patienten die Nivolumab erhielten kam es zu weniger Grad 3<span class=\"diff_add\">/4</span> Toxizität (9% der mit Nivolumab behandelten Patienten, 31% in der ICC-Kohorte).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "471;07_malignes-melanom_0181.tsv;11"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Überlegenheit von Nivolumab war in PD-L1 positiven und negativen Patienten nachweisbar."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2019__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Überlegenheit von Nivolumab war in PD-L1 positiven und<span class=\"diff_sub\"> PD-L1</span> negativen Patienten nachweisbar.</div><div nowrap=\"nowrap\">Die Überlegenheit von Nivolumab war in PD-L1 positiven und negativen Patienten nachweisbar.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "472;07_malignes-melanom_0184.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Falls überlegene Therapieschemata (BRAF/MEK-Inhibitoren oder PD-1-Antikörper) nicht in Frage kommen, kann eine Monochemotherapie mit Dacarbazin als eine etablierte Systemtherapie Melanompatienten mit nicht resezierbaren Metastasen angeboten werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2020__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Falls überlegene Therapieschemata (BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren oder PD-1-Antikörper) nicht in Frage kommen, kann eine Monochemotherapie mit Dacarbazin als eine etablierte Systemtherapie Melanompatienten mit nicht resezierbaren Metastasen angeboten werden.</div><div nowrap=\"nowrap\">Falls überlegene Therapieschemata (BRAF/MEK-Inhibitoren oder PD-1-Antikörper) nicht in Frage kommen, kann eine Monochemotherapie mit Dacarbazin als eine etablierte Systemtherapie Melanompatienten mit nicht resezierbaren Metastasen angeboten werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "473;07_malignes-melanom_0185.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zudem konnten neuere Studiendaten belegen, dass PD1-Antikörper bei Patienten mit BRAF-Wildtype ebenfalls zu einer Verbesserung des progressionsfreien und Gesamtüberlebens führen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2021__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zudem konnten neuere Studiendaten belegen, dass PD1-Antikörper bei Patienten mit BRAF-Wildtype ebenfalls zu einer Verbesserung des progressionsfreien <span class=\"diff_sub\">Überleben </span>und Gesamtüberlebens führen [REF].</div><div nowrap=\"nowrap\">Zudem konnten neuere Studiendaten belegen, dass PD1-Antikörper bei Patienten mit BRAF-Wildtype ebenfalls zu einer Verbesserung des progressionsfreien und Gesamtüberlebens führen [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "474;07_malignes-melanom_0185.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Neuere Studien zeigen eine Überlegenheit hinsichtlich des Ansprechens, des progressionsfreien und Gesamtüberlebens von BRAF- und MEK-Inhibitoren gegenüber einer Therapie mit DTIC bei Patienten mit BRAFV600E/K Mutation [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2022__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Neuere Studien zeigen eine Überlegenheit hinsichtlich des Ansprechens, des progressionsfreien <span class=\"diff_chg\">Ü</span>berlebens <span class=\"diff_sub\">und Gesamtüberlebens </span>von BRAF-<span class=\"diff_chg\">Inhibitoren und</span> MEK-Inhibitoren gegenüber einer Therapie mit DTIC bei Patienten mit BRAFV600E/K Mutation [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Neuere Studien zeigen eine Überlegenheit hinsichtlich des Ansprechens, des progressionsfreien <span class=\"diff_chg\">und Gesamtü</span>berlebens von BRAF-<span class=\"diff_chg\"> und</span> MEK-Inhibitoren gegenüber einer Therapie mit DTIC bei Patienten mit BRAFV600E/K Mutation [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "475;07_malignes-melanom_0186.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Falls überlegene Therapieschemata (BRAF/MEK-Inhibitoren oder PD-1-Antikörper) nicht in Frage kommen, kann eine Polychemotherapie als eine etablierte Systemtherapie Melanompatienten mit nicht resezierbaren Metastasen angeboten werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2023__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Falls überlegene Therapieschemata (BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren oder PD-1-Antikörper) nicht in Frage kommen, kann eine Polychemotherapie als eine etablierte Systemtherapie Melanompatienten mit nicht resezierbaren Metastasen angeboten werden.</div><div nowrap=\"nowrap\">Falls überlegene Therapieschemata (BRAF/MEK-Inhibitoren oder PD-1-Antikörper) nicht in Frage kommen, kann eine Polychemotherapie als eine etablierte Systemtherapie Melanompatienten mit nicht resezierbaren Metastasen angeboten werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "476;07_malignes-melanom_0190.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Daten zur Lebensqualität sind aus den Phase III Zulassungsstudien zur Monotherapie mit BRAF-Inhibitoren (Vemurafenib / Dabrafenib) sowie den Kombinationsstudien aus BRAF/MEK-Inhibitoren (Dabrafenib+Trametinib, Vemurafenib+Cobimetinib) publiziert worden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2024__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Daten zur Lebensqualität sind aus den Phase III Zulassungsstudien zur Monotherapie mit BRAF-Inhibitoren (Vemurafenib / Dabrafenib) sowie den Kombinationsstudien aus BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren (Dabrafenib+Trametinib, Vemurafenib+Cobimetinib) publiziert worden.</div><div nowrap=\"nowrap\">Daten zur Lebensqualität sind aus den Phase III Zulassungsstudien zur Monotherapie mit BRAF-Inhibitoren (Vemurafenib / Dabrafenib) sowie den Kombinationsstudien aus BRAF/MEK-Inhibitoren (Dabrafenib+Trametinib, Vemurafenib+Cobimetinib) publiziert worden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "477;07_malignes-melanom_0191.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In diesen Studien kamen bei den Patienten verschiedene Fragebögen wie der EORTC-, der EORTC QLQ 36-, der QLQC30-Questionnaire oder der Rotterdam Checklist Symptom Questionnaire zum Einsatz."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2025__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In diesen Studien kamen bei den Patienten verschiedene Fragebögen wie der EORTC-<span class=\"diff_sub\">Questionnaire</span>, der EORTC QLQ 36-<span class=\"diff_sub\">Questionnaire</span>, der QLQC30-Questionnaire oder der Rotterdam Checklist Symptom Questionnaire zum Einsatz.</div><div nowrap=\"nowrap\">In diesen Studien kamen bei den Patienten verschiedene Fragebögen wie der EORTC-, der EORTC QLQ 36-, der QLQC30-Questionnaire oder der Rotterdam Checklist Symptom Questionnaire zum Einsatz.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "478;07_malignes-melanom_0191.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Neben Immuncheckpoint-Inhibitoren (CTLA4-und PD1-Antikörper) sind vor allem zielgerichtete Therapeutika wie BRAF und MEK-Inhibitoren in der Lage, bestehende Beschwerden der Patienten zu lindern."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2026__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Neben Immuncheckpoint-Inhibitoren (CTLA4-<span class=\"diff_sub\">Antikörper</span>und PD1-Antikörper) sind vor allem zielgerichtete Therapeutika wie BRAF<span class=\"diff_sub\">-Inhibitoren</span> und MEK-Inhibitoren in der Lage, bestehende Beschwerden der Patienten zu lindern.</div><div nowrap=\"nowrap\">Neben Immuncheckpoint-Inhibitoren (CTLA4-und PD1-Antikörper) sind vor allem zielgerichtete Therapeutika wie BRAF und MEK-Inhibitoren in der Lage, bestehende Beschwerden der Patienten zu lindern.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "479;07_malignes-melanom_0192.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sowohl unter zielgerichteter Therapie mit BRAF/MEK-Inhibitoren sowie unter Immun-Checkpoint-Inhibitoren können andere Organsysteme von Nebenwirkungen betroffen sein."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2027__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sowohl unter zielgerichteter Therapie mit BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren sowie unter Immun-Checkpoint-Inhibitoren können andere Organsysteme von Nebenwirkungen betroffen sein.</div><div nowrap=\"nowrap\">Sowohl unter zielgerichteter Therapie mit BRAF/MEK-Inhibitoren sowie unter Immun-Checkpoint-Inhibitoren können andere Organsysteme von Nebenwirkungen betroffen sein.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "480;07_malignes-melanom_0193.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Moderne Systemtherapeutika, wie BRAF/MEK-Inhibitoren oder Checkpoint-Inhibitoren werden zur Therapie des malignen Melanoms regelhaft eingesetzt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2028__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Moderne Systemtherapeutika, wie BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren oder Checkpoint-Inhibitoren werden zur Therapie des malignen Melanoms regelhaft eingesetzt.</div><div nowrap=\"nowrap\">Moderne Systemtherapeutika, wie BRAF/MEK-Inhibitoren oder Checkpoint-Inhibitoren werden zur Therapie des malignen Melanoms regelhaft eingesetzt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "481;07_malignes-melanom_0193.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "So induzieren Immun-Checkpoint-Blocker wie Ipilimumab und die PD-1/PD-L1 Antikörper vor allem autoimmune Nebenwirkungen an Haut, Darm und Leber [REF], [REF], [REF] während zielgerichtete Therapien insbesondere kutane sowie gastrointestinale Nebenwirkungen, aber auch Arthralgien und Pyrexie zur Folge haben können [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2029__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">So induzieren Immun-Checkpoint-Blocker wie Ipilimumab und die PD-1<span class=\"diff_sub\"> Antikörper</span>/PD-L1 Antikörper vor allem autoimmune Nebenwirkungen an Haut, Darm und Leber [REF], [REF], [REF] während zielgerichtete Therapien insbesondere kutane sowie gastrointestinale Nebenwirkungen, aber auch Arthralgien und Pyrexie zur Folge haben können [REF], [REF].</div><div nowrap=\"nowrap\">So induzieren Immun-Checkpoint-Blocker wie Ipilimumab und die PD-1/PD-L1 Antikörper vor allem autoimmune Nebenwirkungen an Haut, Darm und Leber [REF], [REF], [REF] während zielgerichtete Therapien insbesondere kutane sowie gastrointestinale Nebenwirkungen, aber auch Arthralgien und Pyrexie zur Folge haben können [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "482;07_malignes-melanom_0195.tsv;24"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während Chemotherapie-induzierte Nausea/Emesis bereits prophylaktisch mit antiemetischen Medikamenten therapiert werden (siehe S3 Leitlinie Supportivtherapie), reicht bei Patienten mit BRAF/MEK-Inhibitoren häufig bereits die Einnahme von Metoclopramid aus."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2030__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während Chemotherapie-induzierte Nausea/Emesis bereits prophylaktisch mit antiemetischen Medikamenten therapiert werden (siehe S3 Leitlinie Supportivtherapie), reicht bei Patienten mit BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren häufig bereits die Einnahme von Metoclopramid aus.</div><div nowrap=\"nowrap\">Während Chemotherapie-induzierte Nausea/Emesis bereits prophylaktisch mit antiemetischen Medikamenten therapiert werden (siehe S3 Leitlinie Supportivtherapie), reicht bei Patienten mit BRAF/MEK-Inhibitoren häufig bereits die Einnahme von Metoclopramid aus.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "483;07_malignes-melanom_0195.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der 3-armigen Phase 3 Studie mit Ipilimumab plus Nivolumab vs. Ipilimumab vs. Nivolumab (CheckMate 067) fanden sich gastrointestinale Grad 3-4 Nebenwirkungen bei etwa 17% der Patienten mit Nivolumab plus Ipilimumab, 15% der Patienten mit Ipilimumab und nur 3% der Patienten mit Nivolumab Monotherapie [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2031__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der 3-armigen Phase 3 Studie mit Ipilimumab plus Nivolumab vs. Ipilimumab vs. Nivolumab (CheckMate 067) fanden sich gastrointestinale Grad 3-4 Nebenwirkungen bei etwa 17% der Patienten mit Nivolumab plus Ipilimumab, 15% der Patienten mit Ipilimumab <span class=\"diff_chg\">Monotherapie und nur</span> 3% der Patienten mit Nivolumab Monotherapie [REF].</div><div nowrap=\"nowrap\">In der 3-armigen Phase 3 Studie mit Ipilimumab plus Nivolumab vs. Ipilimumab vs. Nivolumab (CheckMate 067) fanden sich gastrointestinale Grad 3-4 Nebenwirkungen bei etwa 17% der Patienten mit Nivolumab plus Ipilimumab, 15% der Patienten mit Ipilimumab <span class=\"diff_chg\">und nur</span> 3% der Patienten mit Nivolumab Monotherapie [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "484;07_malignes-melanom_0195.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sie treten bei Chemotherapien aber auch unter zielgerichteten und Immuntherapien auf und unterscheiden sich in Ihrem Spektrum und Ihrer Therapiebedürftigkeit."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2032__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sie treten bei Chemotherapien aber auch unter zielgerichteten <span class=\"diff_sub\">Therapien </span>und Immuntherapien auf und unterscheiden sich in Ihrem Spektrum und Ihrer Therapiebedürftigkeit.</div><div nowrap=\"nowrap\">Sie treten bei Chemotherapien aber auch unter zielgerichteten und Immuntherapien auf und unterscheiden sich in Ihrem Spektrum und Ihrer Therapiebedürftigkeit.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "485;07_malignes-melanom_0195.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nausea und Emesis sind insbesondere ein Chemotherapie-assoziiertes Problem und haben Tumortherapie– (emetogenes Potential) sowie patientenspezifische Risikofaktoren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2033__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nausea und Emesis sind insbesondere ein Chemotherapie-assoziiertes Problem und haben Tumortherapie<span class=\"diff_chg\">-spezifische</span> (emetogenes Potential) sowie patientenspezifische Risikofaktoren.</div><div nowrap=\"nowrap\">Nausea und Emesis sind insbesondere ein Chemotherapie-assoziiertes Problem und haben Tumortherapie<span class=\"diff_chg\">–</span> (emetogenes Potential) sowie patientenspezifische Risikofaktoren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "486;07_malignes-melanom_0195.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Reine Lipase/Amylase-Anstiege im Serum sind häufiger, ohne Hinweise für eine Pankreatitis jedoch meist ohne klinische Relevanz."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2034__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Reine Lipas<span class=\"diff_sub\">e-Anstieg</span>e/Amylase-Anstiege im Serum sind häufiger, ohne Hinweise für eine Pankreatitis jedoch meist ohne klinische Relevanz.</div><div nowrap=\"nowrap\">Reine Lipase/Amylase-Anstiege im Serum sind häufiger, ohne Hinweise für eine Pankreatitis jedoch meist ohne klinische Relevanz.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "487;07_malignes-melanom_0195.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch zielgerichtete Therapien wie die BRAF- und die MEK-Inhibitoren können Nausea/Emesis verursachen, überwiegend mit milderem Schweregrad (CTCAE Grad 1 und 2) [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2035__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch zielgerichtete Therapien wie die BRAF-<span class=\"diff_sub\">Inhibitoren</span> und die MEK-Inhibitoren können Nausea/Emesis verursachen, überwiegend mit milderem Schweregrad (CTCAE Grad 1 und <span class=\"diff_sub\">CTCAE Grad </span>2) [REF], [REF].</div><div nowrap=\"nowrap\">Auch zielgerichtete Therapien wie die BRAF- und die MEK-Inhibitoren können Nausea/Emesis verursachen, überwiegend mit milderem Schweregrad (CTCAE Grad 1 und 2) [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "488;07_malignes-melanom_0195.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Pankreatitiden werden unter BRAF/MEK-Inhibition wie auch Immun-Checkpoint-Blocker Therapie gesehen, sind aber selten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2036__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Pankreatitiden werden unter BRAF<span class=\"diff_sub\">-Inhibition</span>/MEK-Inhibition wie auch Immun-Checkpoint-Blocker Therapie gesehen, sind aber selten.</div><div nowrap=\"nowrap\">Pankreatitiden werden unter BRAF/MEK-Inhibition wie auch Immun-Checkpoint-Blocker Therapie gesehen, sind aber selten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "489;07_malignes-melanom_0197.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "BRAF/MEK-Inhibitoren führen insbesondere zu asymptomatischen Transaminasenerhöhungen bei etwa 30% der Patienten, Grad 3/4 Erhöhungen treten bei etwa 10% auf [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2037__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">BRAF<span class=\"diff_sub\">-Inhibitoren</span>/MEK-Inhibitoren führen insbesondere zu asymptomatischen Transaminasenerhöhungen bei etwa 30% der Patienten, Grad 3 Erhöhungen<span class=\"diff_sub\">/Grad 4 Erhöhungen</span> treten bei etwa 10% auf [REF], [REF].</div><div nowrap=\"nowrap\">BRAF/MEK-Inhibitoren führen insbesondere zu asymptomatischen Transaminasenerhöhungen bei etwa 30% der Patienten, Grad 3<span class=\"diff_add\">/4</span> Erhöhungen treten bei etwa 10% auf [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "490;07_malignes-melanom_0197.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der CheckMate 067 Studie zeigten bis zu 18% der Patienten meist asymptomatische Transaminasenerhöhungen, während es bei Ipilimumab und Nivolumab Monotherapie jeweils nur 4% sind [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2038__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der CheckMate 067 Studie zeigten bis zu 18% der Patienten meist asymptomatische Transaminasenerhöhungen, während es bei Ipilimumab Monotherapie <span class=\"diff_sub\">und Nivolumab Monotherapie </span>jeweils nur 4% sind [REF].</div><div nowrap=\"nowrap\">In der CheckMate 067 Studie zeigten bis zu 18% der Patienten meist asymptomatische Transaminasenerhöhungen, während es bei Ipilimumab<span class=\"diff_add\"> und Nivolumab</span> Monotherapie jeweils nur 4% sind [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "491;07_malignes-melanom_0197.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Grad 3/4 Hepatitiden sieht man bei bis zu 8% unter Ipilimumab plus Nivolumab und maximal 2% unter den Monotherapien."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2039__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Grad 3 Hepatitiden<span class=\"diff_sub\">/Grad 4 Hepatitiden</span> sieht man bei bis zu 8% unter Ipilimumab plus Nivolumab und maximal 2% unter den Monotherapien.</div><div nowrap=\"nowrap\">Grad 3<span class=\"diff_add\">/4</span> Hepatitiden sieht man bei bis zu 8% unter Ipilimumab plus Nivolumab und maximal 2% unter den Monotherapien.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "492;07_malignes-melanom_0197.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Grad 3/4 Transaminasenanstiegen unter zielgerichteten Therapien führt in der Regel eine Pausierung der Therapie zu einem Rückgang der Leberwerte."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2040__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Grad 3 Transaminasenanstiegen<span class=\"diff_sub\">/Grad 4 Transaminasenanstiegen</span> unter zielgerichteten Therapien führt in der Regel eine Pausierung der Therapie zu einem Rückgang der Leberwerte.</div><div nowrap=\"nowrap\">Bei Grad 3<span class=\"diff_add\">/4</span> Transaminasenanstiegen unter zielgerichteten Therapien führt in der Regel eine Pausierung der Therapie zu einem Rückgang der Leberwerte.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "493;07_malignes-melanom_0199.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Pneumonitis Grad I/II empfiehlt es sich die auslösende Therapie zu unterbrechen und engmaschige klinische und radiologische Kontrollen durchzuführen und einen Pneumologen zu konsultiert [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2041__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Pneumonitis Grad I/<span class=\"diff_sub\">Grad </span>II empfiehlt es sich die auslösende Therapie zu unterbrechen und engmaschige klinische und radiologische Kontrollen durchzuführen und einen Pneumologen zu konsultiert [REF], [REF].</div><div nowrap=\"nowrap\">Bei Pneumonitis Grad I/II empfiehlt es sich die auslösende Therapie zu unterbrechen und engmaschige klinische und radiologische Kontrollen durchzuführen und einen Pneumologen zu konsultiert [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "494;07_malignes-melanom_0201.tsv;38"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Regel führen endokrinologische Nebenwirkungen nur sehr selten zu einem Abbruch der Therapie mit Immun-Checkpoint-Blockern und die Therapie kann nach Rückbildung schwerer Grad 3/4 Nebenwirkungen (CTCAE) in der Regel unter entsprechender Hormonersatztherapie weiter fortgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2042__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Regel führen endokrinologische Nebenwirkungen nur sehr selten zu einem Abbruch der Therapie mit Immun-Checkpoint-Blockern und die Therapie kann nach Rückbildung schwerer Grad 3 Nebenwirkungen<span class=\"diff_sub\">/Grad 4 Nebenwirkungen</span> (CTCAE) in der Regel unter entsprechender Hormonersatztherapie weiter fortgeführt werden.</div><div nowrap=\"nowrap\">In der Regel führen endokrinologische Nebenwirkungen nur sehr selten zu einem Abbruch der Therapie mit Immun-Checkpoint-Blockern und die Therapie kann nach Rückbildung schwerer Grad 3<span class=\"diff_add\">/4</span> Nebenwirkungen (CTCAE) in der Regel unter entsprechender Hormonersatztherapie weiter fortgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "495;07_malignes-melanom_0201.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Schilddrüsenfunktionsstörungen im Sinne einer Hypo-und Hyperthyreose treten unter Therapie mit PD-1-Inhibitoren wie Pembrolizumab (5%; 4%) [REF] und Nivolumab (9%, 4%) häufiger auf als unter Therapie mit dem CTLA-4 Inhibitor Ipilimumab (4%; 1%) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2043__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Schilddrüsenfunktionsstörungen im Sinne einer Hypo-und<span class=\"diff_sub\">thyreose</span> Hyperthyreose treten unter Therapie mit PD-1-Inhibitoren wie Pembrolizumab (5%; 4%) [REF] und Nivolumab (9%, 4%) häufiger auf als unter Therapie mit dem CTLA-4 Inhibitor Ipilimumab (4%; 1%) [REF].</div><div nowrap=\"nowrap\">Schilddrüsenfunktionsstörungen im Sinne einer Hypo-und Hyperthyreose treten unter Therapie mit PD-1-Inhibitoren wie Pembrolizumab (5%; 4%) [REF] und Nivolumab (9%, 4%) häufiger auf als unter Therapie mit dem CTLA-4 Inhibitor Ipilimumab (4%; 1%) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "496;07_malignes-melanom_0203.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Auch unter der Therapie mit PD-1 und CTLA-4 Antikörpern kommt es mit bis zu 65% häufig zu kutanen Nebenwirkungen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2044__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Auch unter der Therapie mit PD-1 Antikörpern <span class=\"diff_sub\">und CTLA-4 Antikörpern </span>kommt es mit bis zu 65% häufig zu kutanen Nebenwirkungen.</div><div nowrap=\"nowrap\">Auch unter der Therapie mit PD-1<span class=\"diff_add\"> und CTLA-4</span> Antikörpern kommt es mit bis zu 65% häufig zu kutanen Nebenwirkungen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "497;07_malignes-melanom_0203.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Unter einer BRAF/MEK-Inhibitor-Therapie können folgende kutane Nebenwirkungen beobachtet werden:"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2045__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Unter einer BRAF<span class=\"diff_sub\">-Inhibitor-Therapie</span>/MEK-Inhibitor-Therapie können folgende kutane Nebenwirkungen beobachtet werden:</div><div nowrap=\"nowrap\">Unter einer BRAF/MEK-Inhibitor-Therapie können folgende kutane Nebenwirkungen beobachtet werden:</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "498;07_malignes-melanom_0203.tsv;12"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Schwerwiegende kutane Nebenwirkungen (CTCAE Grad 3/4) werden in der PD-1 Monotherapie in 1-1.5% der Fälle beobachtet, in der Kombination mit Ipilimumab in 6.6% (Pruritus) der Fälle [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2046__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Schwerwiegende kutane Nebenwirkungen (CTCAE Grad 3/<span class=\"diff_sub\">CTCAE Grad </span>4) werden in der PD-1 Monotherapie in 1-1.5% der Fälle beobachtet, in der Kombination mit Ipilimumab in 6.6% (Pruritus) der Fälle [REF], [REF].</div><div nowrap=\"nowrap\">Schwerwiegende kutane Nebenwirkungen (CTCAE Grad 3/4) werden in der PD-1 Monotherapie in 1-1.5% der Fälle beobachtet, in der Kombination mit Ipilimumab in 6.6% (Pruritus) der Fälle [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "499;07_malignes-melanom_0207.tsv;27"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Kommt es unter der BRAF/MEK-Inhibitortherapie zu einer QTc-Verlängerung im EKG, muss die Dosis reduziert, die Medikamentengabe ausgesetzt oder ganz abgebrochen werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2047__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Kommt es unter der BRAF<span class=\"diff_sub\">-Inhibitortherapie</span>/MEK-Inhibitortherapie zu einer QTc-Verlängerung im EKG, muss die Dosis reduziert, die Medikamentengabe ausgesetzt oder ganz abgebrochen werden.</div><div nowrap=\"nowrap\">Kommt es unter der BRAF/MEK-Inhibitortherapie zu einer QTc-Verlängerung im EKG, muss die Dosis reduziert, die Medikamentengabe ausgesetzt oder ganz abgebrochen werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "500;07_malignes-melanom_0207.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei Patienten unter BRAF/MEK-Inhibitortherapie müssen die Elektrolyte und das EKG vor und zunächst alle 4 Wochen nach Einleitung der Therapie bzw. nach Dosisänderungen untersucht werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2048__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei Patienten unter BRAF<span class=\"diff_sub\">-Inhibitortherapie</span>/MEK-Inhibitortherapie müssen die Elektrolyte und das EKG vor und zunächst alle 4 Wochen nach Einleitung der Therapie bzw. nach Dosisänderungen untersucht werden.</div><div nowrap=\"nowrap\">Bei Patienten unter BRAF/MEK-Inhibitortherapie müssen die Elektrolyte und das EKG vor und zunächst alle 4 Wochen nach Einleitung der Therapie bzw. nach Dosisänderungen untersucht werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "501;07_malignes-melanom_0207.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sie treten unter zielgerichteten und Immuntherapien auf und unterscheiden sich in Ihrem Spektrum und Ihrer Therapiebedürftigkeit."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2049__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sie treten unter zielgerichteten <span class=\"diff_sub\">Therapien </span>und Immuntherapien auf und unterscheiden sich in Ihrem Spektrum und Ihrer Therapiebedürftigkeit.</div><div nowrap=\"nowrap\">Sie treten unter zielgerichteten und Immuntherapien auf und unterscheiden sich in Ihrem Spektrum und Ihrer Therapiebedürftigkeit.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "502;07_malignes-melanom_0207.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Zielgerichtete Therapien wie die BRAF- und die MEK-Inhibitoren induzieren neben Reizüberleitungsstörungen eine Reduktion der Ejektionsfraktion [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2050__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Zielgerichtete Therapien wie die BRAF-<span class=\"diff_sub\">Inhibitoren</span> und die MEK-Inhibitoren induzieren neben Reizüberleitungsstörungen eine Reduktion der Ejektionsfraktion [REF].</div><div nowrap=\"nowrap\">Zielgerichtete Therapien wie die BRAF- und die MEK-Inhibitoren induzieren neben Reizüberleitungsstörungen eine Reduktion der Ejektionsfraktion [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "503;07_malignes-melanom_0220.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Ablations-, Infusions-, Perfusions- und/oder Embolisationsstrategien zeigten in Studien klinisches Ansprechen, jedoch keine grundlegende Prognoseverbesserung und können in Abhängigkeit von der Anzahl der Metastasen und deren Lokalisation angewandt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2051__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Ablations<span class=\"diff_chg\">strategien</span>, Infusions<span class=\"diff_chg\">strategien</span>, Perfusions<span class=\"diff_chg\">strategien</span> und/oder Embolisationsstrategien zeigten in Studien klinisches Ansprechen, jedoch keine grundlegende Prognoseverbesserung und können in Abhängigkeit von der Anzahl der Metastasen und deren Lokalisation angewandt werden.</div><div nowrap=\"nowrap\">Ablations<span class=\"diff_chg\">-</span>, Infusions<span class=\"diff_chg\">-</span>, Perfusions<span class=\"diff_chg\">-</span> und/oder Embolisationsstrategien zeigten in Studien klinisches Ansprechen, jedoch keine grundlegende Prognoseverbesserung und können in Abhängigkeit von der Anzahl der Metastasen und deren Lokalisation angewandt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "504;07_malignes-melanom_0221.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei perkutanen oder interstitiellen Ablationsverfahren wird durch die Applikation von Radiofrequenz(RFA)-, Laser(LITT)-, Mikrowellen(MW)- oder fokussierter Ultraschallenergie (FUS) gezielt Tumorgewebe mittels einer Noxe (Wärme) destruiert."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2052__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei perkutanen oder interstitiellen Ablationsverfahren wird durch die Applikation von Radiofrequenz<span class=\"diff_sub\">energie</span>(RFA)-, Laser<span class=\"diff_sub\">energie</span>(LITT)-, Mikrowellen<span class=\"diff_sub\">energie</span>(MW)- oder fokussierter Ultraschallenergie (FUS) gezielt Tumorgewebe mittels einer Noxe (Wärme) destruiert.</div><div nowrap=\"nowrap\">Bei perkutanen oder interstitiellen Ablationsverfahren wird durch die Applikation von Radiofrequenz(RFA)-, Laser(LITT)-, Mikrowellen(MW)- oder fokussierter Ultraschallenergie (FUS) gezielt Tumorgewebe mittels einer Noxe (Wärme) destruiert.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "505;07_malignes-melanom_0232.tsv;16"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Vergleichbare Ansprechraten (42% mit partiellem Ansprechen sowohl extra- als auch intrakraniell) wurden mit Vemurafenib erreicht [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2053__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Vergleichbare Ansprechraten (42% mit partiellem Ansprechen sowohl extra<span class=\"diff_chg\">kraniell</span> als auch intrakraniell) wurden mit Vemurafenib erreicht [REF].</div><div nowrap=\"nowrap\">Vergleichbare Ansprechraten (42% mit partiellem Ansprechen sowohl extra<span class=\"diff_chg\">-</span> als auch intrakraniell) wurden mit Vemurafenib erreicht [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "506;07_malignes-melanom_0232.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Demgegenüber ist die Anzahl objektiv ansprechender Patienten in einer ebenfalls unkontrollierten Studie für Ipilimumab bei Patienten mit asymptomatischen (Kohorte A, Kortikosteroidfreiheit) bzw. symptomatischen Hirnmetastasen (Kohorte B, Kortikosteroidstabilität) mit 10% bzw. 5% gering und die progressionsfreien sowie Gesamtüberlebensdaten im Bereich anderer, wenig effektiver Systemtherapien [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2054__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Demgegenüber ist die Anzahl objektiv ansprechender Patienten in einer ebenfalls unkontrollierten Studie für Ipilimumab bei Patienten mit asymptomatischen (Kohorte A, Kortikosteroidfreiheit) bzw. symptomatischen Hirnmetastasen (Kohorte B, Kortikosteroidstabilität) mit 10% bzw. 5% gering und die progressionsfreien<span class=\"diff_sub\"> Überlebensdaten</span> sowie Gesamtüberlebensdaten im Bereich anderer, wenig effektiver Systemtherapien [REF].</div><div nowrap=\"nowrap\">Demgegenüber ist die Anzahl objektiv ansprechender Patienten in einer ebenfalls unkontrollierten Studie für Ipilimumab bei Patienten mit asymptomatischen (Kohorte A, Kortikosteroidfreiheit) bzw. symptomatischen Hirnmetastasen (Kohorte B, Kortikosteroidstabilität) mit 10% bzw. 5% gering und die progressionsfreien sowie Gesamtüberlebensdaten im Bereich anderer, wenig effektiver Systemtherapien [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "507;07_malignes-melanom_0232.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einem systematischen Review werteten Spagnolo und Kollegen [REF] Verlaufsdaten von 2153 Patienten mit Hirnmetastasen aus, die in Phase I-III und im Rahmen der Regelversorgung mit MAP-Kinase und/oder Checkpoint Inhibitoren behandelt worden sind."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2055__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einem systematischen Review werteten Spagnolo und Kollegen [REF] Verlaufsdaten von 2153 Patienten mit Hirnmetastasen aus, die in Phase I-III und im Rahmen der Regelversorgung mit MAP-Kinase <span class=\"diff_sub\">Inhibitoren </span>und/oder Checkpoint Inhibitoren behandelt worden sind.</div><div nowrap=\"nowrap\">In einem systematischen Review werteten Spagnolo und Kollegen [REF] Verlaufsdaten von 2153 Patienten mit Hirnmetastasen aus, die in Phase I-III und im Rahmen der Regelversorgung mit MAP-Kinase und/oder Checkpoint Inhibitoren behandelt worden sind.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "508;07_malignes-melanom_0232.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Patienten mit lokal behandelten (Kohorte A) oder unbehandelten (Kohorte B) Hirnmetastasen BRAFVal600 mutierter Melanome zeigten objektives Ansprechen (A: 39.2% für die Val600Glu und 6.7% für die Val600Lys Mutation; B: 30.8% und 22.2%) bei ordentlicher Verträglichkeit [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2056__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Patienten mit lokal behandelten (Kohorte A) oder unbehandelten (Kohorte B) Hirnmetastasen BRAFVal600 mutierter Melanome zeigten objektives Ansprechen (A: 39.2% für die Val600Glu <span class=\"diff_chg\">Mutation und</span> 6.7% für die Val600Lys Mutation; B: 30.8% und 22.2%) bei ordentlicher Verträglichkeit [REF].</div><div nowrap=\"nowrap\">Patienten mit lokal behandelten (Kohorte A) oder unbehandelten (Kohorte B) Hirnmetastasen BRAFVal600 mutierter Melanome zeigten objektives Ansprechen (A: 39.2% für die Val600Glu <span class=\"diff_chg\">und</span> 6.7% für die Val600Lys Mutation; B: 30.8% und 22.2%) bei ordentlicher Verträglichkeit [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "509;07_malignes-melanom_0232.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei insgesamt geringer Effektivität der zytotoxischen Therapien wurden molekular zielgerichtete bzw. Immuntherapien in unkontrollierten Studien überprüft."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2057__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei insgesamt geringer Effektivität der zytotoxischen Therapien wurden molekular zielgerichtete <span class=\"diff_sub\">Therapien </span>bzw. Immuntherapien in unkontrollierten Studien überprüft.</div><div nowrap=\"nowrap\">Bei insgesamt geringer Effektivität der zytotoxischen Therapien wurden molekular zielgerichtete bzw. Immuntherapien in unkontrollierten Studien überprüft.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "510;07_malignes-melanom_0234.tsv;22"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Stadium IIIB/C wurde beschrieben, dass alle lokoregionalen Metastasierungen innerhalb von 40 Monaten auftraten, Fernmetastasen innerhalb von 71 Monaten und ZNS-Filiae traten in den Stadien IIIB bzw. IIIC in 7 % bzw. 23 % als Erstrezidiv und innerhalb von 23 Monaten, im Stadium IIIC traten alle Metastasen innerhalb von 24 Monaten auf [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2058__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Stadium IIIB/<span class=\"diff_sub\">Stadium III</span>C wurde beschrieben, dass alle lokoregionalen Metastasierungen innerhalb von 40 Monaten auftraten, Fernmetastasen innerhalb von 71 Monaten und ZNS-Filiae traten in den Stadien IIIB bzw. <span class=\"diff_sub\">Stadien </span>IIIC in 7 % bzw. 23 % als Erstrezidiv und innerhalb von 23 Monaten, im Stadium IIIC traten alle Metastasen innerhalb von 24 Monaten auf [REF].</div><div nowrap=\"nowrap\">Im Stadium IIIB/C wurde beschrieben, dass alle lokoregionalen Metastasierungen innerhalb von 40 Monaten auftraten, Fernmetastasen innerhalb von 71 Monaten und ZNS-Filiae traten in den Stadien IIIB bzw. IIIC in 7 % bzw. 23 % als Erstrezidiv und innerhalb von 23 Monaten, im Stadium IIIC traten alle Metastasen innerhalb von 24 Monaten auf [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "511;07_malignes-melanom_0238.tsv;62"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die deutliche Schlechterstellung, die das Stadium IIB und IIC in den Überlebensdaten der AJCC-Gruppe [REF] einnimmt, kann in anderen Untersuchungen zur Rezidivhäufigkeit im Primärstadium nicht in diesem Ausmaß bestätigt werden [REF], [REF], [REF], [REF], dennoch erscheint es sinnvoll, Patienten im Stadium IIB-C äquivalent zum Stadium III nachzusorgen [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2059__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die deutliche Schlechterstellung, die das Stadium IIB und<span class=\"diff_sub\"> Stadium</span> IIC in den Überlebensdaten der AJCC-Gruppe [REF] einnimmt, kann in anderen Untersuchungen zur Rezidivhäufigkeit im Primärstadium nicht in diesem Ausmaß bestätigt werden [REF], [REF], [REF], [REF], dennoch erscheint es sinnvoll, Patienten im Stadium IIB-C äquivalent zum Stadium III nachzusorgen [REF], [REF].</div><div nowrap=\"nowrap\">Die deutliche Schlechterstellung, die das Stadium IIB und IIC in den Überlebensdaten der AJCC-Gruppe [REF] einnimmt, kann in anderen Untersuchungen zur Rezidivhäufigkeit im Primärstadium nicht in diesem Ausmaß bestätigt werden [REF], [REF], [REF], [REF], dennoch erscheint es sinnvoll, Patienten im Stadium IIB-C äquivalent zum Stadium III nachzusorgen [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "512;07_malignes-melanom_0238.tsv;49"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wie bei anderen soliden Tumoren enthält die Stadieneinteilung beim malignen Melanom gegenwärtig die vier klinischen Stadien I (frühe Primärtumoren), II (fortgeschrittene Primärtumoren), III (lokoregionale Metastasierung) und IV (Fernmetastasierung)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2060__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wie bei anderen soliden Tumoren enthält die Stadieneinteilung beim malignen Melanom gegenwärtig die vier klinischen Stadien I (frühe Primärtumoren), <span class=\"diff_chg\">Stadien II</span> (fortgeschrittene Primärtumoren), <span class=\"diff_chg\">Stadien III</span> (lokoregionale Metastasierung) und<span class=\"diff_sub\"> Stadien</span> IV (Fernmetastasierung).</div><div nowrap=\"nowrap\">Wie bei anderen soliden Tumoren enthält die Stadieneinteilung beim malignen Melanom gegenwärtig die vier klinischen Stadien I (frühe Primärtumoren), <span class=\"diff_chg\">II</span> (fortgeschrittene Primärtumoren), <span class=\"diff_chg\">III</span> (lokoregionale Metastasierung) und IV (Fernmetastasierung).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "513;07_malignes-melanom_0238.tsv;34"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine neuere Untersuchung zur Modellierung der möglichen Diagnoseverzögerung unter zwei verschiedenen Nachsorgeschemata kommt zu dem Schluss, dass im Stadium I und II die Verlängerung der Nachsorgeintervalle von 3 bzw. 6 Monaten auf 6 bzw. 12 Monate nur in einem geringen Anteil zu relevanten Verzögerungen der Diagnose führen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2061__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine neuere Untersuchung zur Modellierung der möglichen Diagnoseverzögerung unter zwei verschiedenen Nachsorgeschemata kommt zu dem Schluss, dass im Stadium I und<span class=\"diff_sub\"> Stadium</span> II die Verlängerung der Nachsorgeintervalle von 3 bzw. 6 Monaten auf 6 bzw. 12 Monate nur in einem geringen Anteil zu relevanten Verzögerungen der Diagnose führen [REF].</div><div nowrap=\"nowrap\">Eine neuere Untersuchung zur Modellierung der möglichen Diagnoseverzögerung unter zwei verschiedenen Nachsorgeschemata kommt zu dem Schluss, dass im Stadium I und II die Verlängerung der Nachsorgeintervalle von 3 bzw. 6 Monaten auf 6 bzw. 12 Monate nur in einem geringen Anteil zu relevanten Verzögerungen der Diagnose führen [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "514;07_malignes-melanom_0238.tsv;31"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für In-loco- bzw. In-transit-Metastasen wird die Rate der „Selbstentdeckung“ relativ hoch mit 62,5 % angegeben, während Lymphknotenmetastasen und Organmetastasen mit 48,6 % bzw. 37,4 % deutlich seltener außerhalb der Nachsorge auffielen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2062__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für In-loco-Metastasen <span class=\"diff_chg\">bzw. In-transit-Metastasen wird die</span> Rate der „Selbstentdeckung“ relativ hoch mit 62,5 % angegeben, während Lymphknotenmetastasen und Organmetastasen mit 48,6 % bzw. 37,4 % deutlich seltener außerhalb der Nachsorge auffielen.</div><div nowrap=\"nowrap\">Für In-loco-<span class=\"diff_add\"> bzw. In-transit-</span>Metastasen <span class=\"diff_chg\">wird die</span> Rate der „Selbstentdeckung“ relativ hoch mit 62,5 % angegeben, während Lymphknotenmetastasen und Organmetastasen mit 48,6 % bzw. 37,4 % deutlich seltener außerhalb der Nachsorge auffielen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "515;07_malignes-melanom_0238.tsv;18"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In dieser Untersuchung wird das Risiko auf die metastatische bzw. durch die jeweilige Untersuchungsmethode betroffene Region (Lokal-/In-transit-, regionäre Lymphknotenmetastasen, viszerale Metastasen sowie Hirnmetastasen) heruntergebrochen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2063__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In dieser Untersuchung wird das Risiko auf die metastatische bzw. durch die jeweilige Untersuchungsmethode betroffene Region (Lokal<span class=\"diff_chg\">metastasen</span>/In-transit-<span class=\"diff_sub\">Metastasen</span>, regionäre Lymphknotenmetastasen, viszerale Metastasen sowie Hirnmetastasen) heruntergebrochen.</div><div nowrap=\"nowrap\">In dieser Untersuchung wird das Risiko auf die metastatische bzw. durch die jeweilige Untersuchungsmethode betroffene Region (Lokal<span class=\"diff_chg\">-</span>/In-transit-, regionäre Lymphknotenmetastasen, viszerale Metastasen sowie Hirnmetastasen) heruntergebrochen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "516;07_malignes-melanom_0240.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die körperliche Untersuchung umfasst eine gezielte Anamnese, die Inspektion des gesamten Integuments sowie Palpation der Primärnarbe, In-transit- und Lymphabstromgebiete und Lymphknotenstationen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2064__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die körperliche Untersuchung umfasst eine gezielte Anamnese, die Inspektion des gesamten Integuments sowie Palpation der Primärnarbe, <span class=\"diff_sub\">der </span>In-transit-<span class=\"diff_sub\">Gebiete</span> und<span class=\"diff_sub\"> der</span> Lymphabstromgebiete und<span class=\"diff_sub\"> der</span> Lymphknotenstationen.</div><div nowrap=\"nowrap\">Die körperliche Untersuchung umfasst eine gezielte Anamnese, die Inspektion des gesamten Integuments sowie Palpation der Primärnarbe, In-transit- und Lymphabstromgebiete und Lymphknotenstationen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "517;07_malignes-melanom_0242.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Metastasen des malignen Melanoms treten in ca. 70 % der Fälle lokoregional als Satelliten-, In-transit-Metastasen oder als lokoregionale Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionale Filiae haben die Option einer R0-Resektion."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2065__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Metastasen des malignen Melanoms treten in ca. 70 % der Fälle lokoregional als Satelliten<span class=\"diff_chg\">metastasen</span>, In-transit-Metastasen oder als lokoregionale Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionale Filiae haben die Option einer R0-Resektion.</div><div nowrap=\"nowrap\">Metastasen des malignen Melanoms treten in ca. 70 % der Fälle lokoregional als Satelliten<span class=\"diff_chg\">-</span>, In-transit-Metastasen oder als lokoregionale Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionale Filiae haben die Option einer R0-Resektion.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "518;07_malignes-melanom_0250.tsv;15"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für die Nachsorge im Stadium III und IV kann besonders bei jungen Patienten alternativ erwogen werden, MRT-Scans des Kopfes, Halses, Abdomens/Beckens als Alternativmethode einzusetzen, da hier keine Strahlenexposition erfolgt."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2066__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für die Nachsorge im Stadium III und<span class=\"diff_sub\"> Stadium</span> IV kann besonders bei jungen Patienten alternativ erwogen werden, MRT-Scans des Kopfes, Halses, Abdomens/Beckens als Alternativmethode einzusetzen, da hier keine Strahlenexposition erfolgt.</div><div nowrap=\"nowrap\">Für die Nachsorge im Stadium III und IV kann besonders bei jungen Patienten alternativ erwogen werden, MRT-Scans des Kopfes, Halses, Abdomens/Beckens als Alternativmethode einzusetzen, da hier keine Strahlenexposition erfolgt.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "519;07_malignes-melanom_0255.tsv;27"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- fehlende Rehabilitationsfähigkeit oder –prognose"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2067__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- fehlende Rehabilitationsfähigkeit oder <span class=\"diff_chg\">Rehabilitations</span>prognose</div><div nowrap=\"nowrap\">- fehlende Rehabilitationsfähigkeit oder <span class=\"diff_chg\">–</span>prognose</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "520;07_malignes-melanom_0255.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Voraussetzungen für eine medizinische Rehabilitation bei Patienten mit malignem Melanom sind das Vorliegen von Rehabilitationsbedürftigkeit und –fähigkeit."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2068__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Voraussetzungen für eine medizinische Rehabilitation bei Patienten mit malignem Melanom sind das Vorliegen von Rehabilitationsbedürftigkeit und <span class=\"diff_chg\">Rehabilitations</span>fähigkeit.</div><div nowrap=\"nowrap\">Voraussetzungen für eine medizinische Rehabilitation bei Patienten mit malignem Melanom sind das Vorliegen von Rehabilitationsbedürftigkeit und <span class=\"diff_chg\">–</span>fähigkeit.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "521;07_malignes-melanom_0255.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- Schädigung von Körperstrukturen und –funktionen bestehen (z.B. postoperativ)"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2069__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- Schädigung von Körperstrukturen und <span class=\"diff_chg\">Körper</span>funktionen bestehen (z.B. postoperativ)</div><div nowrap=\"nowrap\">- Schädigung von Körperstrukturen und <span class=\"diff_chg\">–</span>funktionen bestehen (z.B. postoperativ)</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "522;07_malignes-melanom_0260.tsv;44"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Literatur finden sich entweder nur grobe Unterteilungen in Lokalbefall, regionäre und Fernmetastasierung oder es werden Klassifikationen anderer Tumorentitäten derselben anatomischen Region, z.B. Analkarzinom, Rektumkarzinom, Urethrakarzinom, etc. übernommen [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2070__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Literatur finden sich entweder nur grobe Unterteilungen in Lokalbefall, regionäre <span class=\"diff_chg\">Metastasierung und</span> Fernmetastasierung oder es werden Klassifikationen anderer Tumorentitäten derselben anatomischen Region, z.B. Analkarzinom, Rektumkarzinom, Urethrakarzinom, etc. übernommen [REF], [REF].</div><div nowrap=\"nowrap\">In der Literatur finden sich entweder nur grobe Unterteilungen in Lokalbefall, regionäre <span class=\"diff_chg\">und</span> Fernmetastasierung oder es werden Klassifikationen anderer Tumorentitäten derselben anatomischen Region, z.B. Analkarzinom, Rektumkarzinom, Urethrakarzinom, etc. übernommen [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "523;07_malignes-melanom_0269.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Hinblick auf das 3- und 5-Jahres-Gesamtüberleben zeigte sich hingegen keine positive Assoziation (OS 3 Jahre, OR = 1.41, 95% CI = 0.94-2.09, P = 0.093; OS 5 Jahre OR = 1.06, 95% CI = 0.70-1.61, P = 0.161) [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2071__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Hinblick auf das 3-Jahres-Gesamtüberleben <span class=\"diff_sub\">und 5-Jahres-Gesamtüberleben </span>zeigte sich hingegen keine positive Assoziation (OS 3 Jahre, OR = 1.41, 95% CI = 0.94-2.09, P = 0.093; OS 5 Jahre OR = 1.06, 95% CI = 0.70-1.61, P = 0.161) [REF].</div><div nowrap=\"nowrap\">Im Hinblick auf das 3<span class=\"diff_add\">- und 5</span>-Jahres-Gesamtüberleben zeigte sich hingegen keine positive Assoziation (OS 3 Jahre, OR = 1.41, 95% CI = 0.94-2.09, P = 0.093; OS 5 Jahre OR = 1.06, 95% CI = 0.70-1.61, P = 0.161) [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "524;07_malignes-melanom_0274.tsv;44"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das mediane progressionsfreie und mediane Gesamtüberleben in Patienten mit Ansprechen oder Krankheitsstabilisierung betrug 9,0 und 15 Monate ."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2072__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das mediane progressionsfreie <span class=\"diff_sub\">Überleben </span>und mediane Gesamtüberleben in Patienten mit Ansprechen oder Krankheitsstabilisierung betrug 9,0 und 15 Monate .</div><div nowrap=\"nowrap\">Das mediane progressionsfreie und mediane Gesamtüberleben in Patienten mit Ansprechen oder Krankheitsstabilisierung betrug 9,0 und 15 Monate .</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "525;07_malignes-melanom_0274.tsv;23"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Es gibt aktuell keine Hinweise darauf, dass eine Kombinationstherapie aus einem BRAF- und MEK-Inhibitor bei Tumoren mit mukosalem Ursprung weniger wirksam ist als bei kutanen Melanomen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2073__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Es gibt aktuell keine Hinweise darauf, dass eine Kombinationstherapie aus einem BRAF-<span class=\"diff_sub\">Inhibitor</span> und MEK-Inhibitor bei Tumoren mit mukosalem Ursprung weniger wirksam ist als bei kutanen Melanomen.</div><div nowrap=\"nowrap\">Es gibt aktuell keine Hinweise darauf, dass eine Kombinationstherapie aus einem BRAF- und MEK-Inhibitor bei Tumoren mit mukosalem Ursprung weniger wirksam ist als bei kutanen Melanomen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "526;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0016.tsv;20"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Diese können vollständig fehlen, klein und plump wie bei einer Lentigo solaris bzw. senilis gestaltet oder hypertroph und mit Brückenbildung entwickelt sein."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2074__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Diese können vollständig fehlen, klein und plump wie bei einer Lentigo solaris bzw.<span class=\"diff_sub\"> Lentigo</span> senilis gestaltet oder hypertroph und mit Brückenbildung entwickelt sein.</div><div nowrap=\"nowrap\">Diese können vollständig fehlen, klein und plump wie bei einer Lentigo solaris bzw. senilis gestaltet oder hypertroph und mit Brückenbildung entwickelt sein.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "527;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0024.tsv;10"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dieser histologischen Diagnose werden (nach WHO- / UICC-Klassifikation) auch das Epithelioma cuniculatum, die orale floride Papillomatose und die sogenannten Riesencondylomata (Buschke-Löwenstein) zugeordnet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2075__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dieser histologischen Diagnose werden (nach WHO-<span class=\"diff_sub\">Klassifikation</span> / UICC-Klassifikation) auch das Epithelioma cuniculatum, die orale floride Papillomatose und die sogenannten Riesencondylomata (Buschke-Löwenstein) zugeordnet.</div><div nowrap=\"nowrap\">Dieser histologischen Diagnose werden (nach WHO- / UICC-Klassifikation) auch das Epithelioma cuniculatum, die orale floride Papillomatose und die sogenannten Riesencondylomata (Buschke-Löwenstein) zugeordnet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "528;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0024.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Im Übrigen kann die WHO- / UICC- / AJCC-Klassifikation herangezogen werden (siehe Tabellen unten)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2076__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Im Übrigen kann die WHO-<span class=\"diff_sub\">Klassifikation</span> / UICC-<span class=\"diff_sub\">Klassifikation</span> / AJCC-Klassifikation herangezogen werden (siehe Tabellen unten).</div><div nowrap=\"nowrap\">Im Übrigen kann die WHO- / UICC- / AJCC-Klassifikation herangezogen werden (siehe Tabellen unten).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "529;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0024.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei den T3 und T4-Kategorien gibt es zwischen UICC und AJCC ebenso Unterschiede."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2077__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei den T3<span class=\"diff_sub\">-Kategorien</span> und T4-Kategorien gibt es zwischen UICC und AJCC ebenso Unterschiede.</div><div nowrap=\"nowrap\">Bei den T3 und T4-Kategorien gibt es zwischen UICC und AJCC ebenso Unterschiede.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "530;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0041.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Metastasen des kutanen PEK treten in ca. 80% der Fälle lokoregionär als Satelliten-, In-transit-Metastasen oder als lokoregionäre Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionäre Filiae haben die Option einer R0-Resektion."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2078__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Metastasen des kutanen PEK treten in ca. 80% der Fälle lokoregionär als Satelliten<span class=\"diff_chg\">metastasen</span>, In-transit-Metastasen oder als lokoregionäre Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionäre Filiae haben die Option einer R0-Resektion.</div><div nowrap=\"nowrap\">Metastasen des kutanen PEK treten in ca. 80% der Fälle lokoregionär als Satelliten<span class=\"diff_chg\">-</span>, In-transit-Metastasen oder als lokoregionäre Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionäre Filiae haben die Option einer R0-Resektion.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "531;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0044.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Abdomen-Sonographie soll bei Verdacht auf oder Nachweis von lokoregionaler oder Fernmetastasierung eines PEK nicht als Standard durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2079__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Abdomen-Sonographie soll bei Verdacht auf oder Nachweis von lokoregionaler <span class=\"diff_sub\">Metastasierung </span>oder Fernmetastasierung eines PEK nicht als Standard durchgeführt werden.</div><div nowrap=\"nowrap\">Die Abdomen-Sonographie soll bei Verdacht auf oder Nachweis von lokoregionaler oder Fernmetastasierung eines PEK nicht als Standard durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "532;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0058.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In dieser Studie war die CO2-Laserablation der Kryochirurgie bezüglich der Effektivitätsendpunkte läsionsbezogene Abheilungsrate, komplettes und Teilansprechen unterlegen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2080__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In dieser Studie war die CO2-Laserablation der Kryochirurgie bezüglich der Effektivitätsendpunkte läsionsbezogene Abheilungsrate, komplettes <span class=\"diff_sub\">Ansprechen </span>und Teilansprechen unterlegen.</div><div nowrap=\"nowrap\">In dieser Studie war die CO2-Laserablation der Kryochirurgie bezüglich der Effektivitätsendpunkte läsionsbezogene Abheilungsrate, komplettes und Teilansprechen unterlegen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "533;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0070.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Randomisierung erfolgte interindividuell 1:1 zu 5-FU 5% Creme zweimal täglich über 4 Wochen bzw. bei geringerer Wirksamkeit über maximal 7 Wochen und oder zu einer ablativen Laserbehandlung mit dem Derma-K Laser (Lumenis®) im Erbium:YAG bzw. CO2-Modus."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2081__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Randomisierung erfolgte interindividuell 1:1 zu 5-FU 5% Creme zweimal täglich über 4 Wochen bzw. bei geringerer Wirksamkeit über maximal 7 Wochen und oder zu einer ablativen Laserbehandlung mit dem Derma-K Laser (Lumenis®) im Erbium:YAG<span class=\"diff_sub\">-Modus</span> bzw.<span class=\"diff_sub\"> im</span> CO2-Modus.</div><div nowrap=\"nowrap\">Die Randomisierung erfolgte interindividuell 1:1 zu 5-FU 5% Creme zweimal täglich über 4 Wochen bzw. bei geringerer Wirksamkeit über maximal 7 Wochen und oder zu einer ablativen Laserbehandlung mit dem Derma-K Laser (Lumenis®) im Erbium:YAG bzw. CO2-Modus.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "534;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0070.tsv;41"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In dieser Studie war die CO2-Laserablation der Kryochirurgie bezüglich der Effektivitätsendpunkte läsionsbezogene Abheilungsrate, komplettes und Teilansprechen unterlegen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2082__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In dieser Studie war die CO2-Laserablation der Kryochirurgie bezüglich der Effektivitätsendpunkte läsionsbezogene Abheilungsrate, komplettes <span class=\"diff_sub\">Ansprechen </span>und Teilansprechen unterlegen.</div><div nowrap=\"nowrap\">In dieser Studie war die CO2-Laserablation der Kryochirurgie bezüglich der Effektivitätsendpunkte läsionsbezogene Abheilungsrate, komplettes und Teilansprechen unterlegen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "535;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0072.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dennoch existieren retrospektive und nicht-randomisierte Studien zur Anwendung nicht-ablativer Laser wie dem Nd:YAG- sowie dem fraktionierten 1540 nm-Laser."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2083__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dennoch existieren retrospektive und nicht-randomisierte Studien zur Anwendung nicht-ablativer Laser wie dem Nd:YAG-<span class=\"diff_sub\">Laser</span> sowie dem fraktionierten 1540 nm-Laser.</div><div nowrap=\"nowrap\">Dennoch existieren retrospektive und nicht-randomisierte Studien zur Anwendung nicht-ablativer Laser wie dem Nd:YAG- sowie dem fraktionierten 1540 nm-Laser.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "536;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0076.tsv;51"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In der Studie von McEwan et al. wurde keine signifikante Überlegenheit gegenüber Vehikel bezüglich dem kompletten oder Teilansprechen beobachtet."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2084__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In der Studie von McEwan et al. wurde keine signifikante Überlegenheit gegenüber Vehikel bezüglich dem kompletten <span class=\"diff_sub\">Ansprechen </span>oder Teilansprechen beobachtet.</div><div nowrap=\"nowrap\">In der Studie von McEwan et al. wurde keine signifikante Überlegenheit gegenüber Vehikel bezüglich dem kompletten oder Teilansprechen beobachtet.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "537;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0077.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Von den 32 Patienten hatten 6 eine Leber-, 18 eine Nieren- und 8 eine Herztransplantation."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2085__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Von den 32 Patienten hatten 6 eine Leber<span class=\"diff_chg\">transplantation</span>, 18 eine Nieren<span class=\"diff_chg\">transplantation</span> und 8 eine Herztransplantation.</div><div nowrap=\"nowrap\">Von den 32 Patienten hatten 6 eine Leber<span class=\"diff_chg\">-</span>, 18 eine Nieren<span class=\"diff_chg\">-</span> und 8 eine Herztransplantation.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "538;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0091.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Simon et al. zeigten darüber hinaus die Wirksamkeit dieser Kombination auch in hyperkeratotischen und Grad-III-Läsionen, allerdings wurden hier auch mehr Nebenwirkungen gegenüber Kryochirurgie beobachtet [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2086__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Simon et al. zeigten darüber hinaus die Wirksamkeit dieser Kombination auch in hyperkeratotischen <span class=\"diff_chg\">Läsionen und</span> Grad-III-Läsionen, allerdings wurden hier auch mehr Nebenwirkungen gegenüber Kryochirurgie beobachtet [REF].</div><div nowrap=\"nowrap\">Simon et al. zeigten darüber hinaus die Wirksamkeit dieser Kombination auch in hyperkeratotischen <span class=\"diff_chg\">und</span> Grad-III-Läsionen, allerdings wurden hier auch mehr Nebenwirkungen gegenüber Kryochirurgie beobachtet [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "539;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0122.tsv;40"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bourcier et al. berichteten einen durchschnittlichen LSR-Score („lcoal skin irritation“) von 8,6±3,8 für Ingenoldisoxat 0,018%, 8,0±4,0 für Ingenoldisoxat 0,012%, 6,0±3,5 für Ingenoldisoxat 0,006% sowie 1,4±1,1 für Placebo an Tag 3. Hautrötungen und –schuppung waren insgesamt die häufigsten Nebenwirkungen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2087__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bourcier et al. berichteten einen durchschnittlichen LSR-Score („lcoal skin irritation“) von 8,6±3,8 für Ingenoldisoxat 0,018%, 8,0±4,0 für Ingenoldisoxat 0,012%, 6,0±3,5 für Ingenoldisoxat 0,006% sowie 1,4±1,1 für Placebo an Tag 3. Hautrötungen und <span class=\"diff_chg\">Haut</span>schuppung waren insgesamt die häufigsten Nebenwirkungen.</div><div nowrap=\"nowrap\">Bourcier et al. berichteten einen durchschnittlichen LSR-Score („lcoal skin irritation“) von 8,6±3,8 für Ingenoldisoxat 0,018%, 8,0±4,0 für Ingenoldisoxat 0,012%, 6,0±3,5 für Ingenoldisoxat 0,006% sowie 1,4±1,1 für Placebo an Tag 3. Hautrötungen und <span class=\"diff_chg\">–</span>schuppung waren insgesamt die häufigsten Nebenwirkungen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "540;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0123.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nikotinamid (Vitamin B3) ist ein essenzieller Kofaktor für die Bereitstellung von zellulärem ATP und DNA-Reparaturmechanismen, beispielsweise nach Schädigung durch ionisierende oder UV-Strahlung."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2088__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nikotinamid (Vitamin B3) ist ein essenzieller Kofaktor für die Bereitstellung von zellulärem ATP und DNA-Reparaturmechanismen, beispielsweise nach Schädigung durch ionisierende <span class=\"diff_sub\">Strahlung </span>oder UV-Strahlung.</div><div nowrap=\"nowrap\">Nikotinamid (Vitamin B3) ist ein essenzieller Kofaktor für die Bereitstellung von zellulärem ATP und DNA-Reparaturmechanismen, beispielsweise nach Schädigung durch ionisierende oder UV-Strahlung.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "541;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0125.tsv;17"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Sonnenschutzmittel mit wirksamen Filtern im UV-B- und UV-A-Bereich sind eine wichtige und wissenschaftlich nachgewiesene Präventionsmaßnahme von AK und nicht-melanozytärem Hautkrebs."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2089__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Sonnenschutzmittel mit wirksamen Filtern im UV-B-<span class=\"diff_sub\">Bereich</span> und UV-A-Bereich sind eine wichtige und wissenschaftlich nachgewiesene Präventionsmaßnahme von AK und nicht-melanozytärem Hautkrebs.</div><div nowrap=\"nowrap\">Sonnenschutzmittel mit wirksamen Filtern im UV-B- und UV-A-Bereich sind eine wichtige und wissenschaftlich nachgewiesene Präventionsmaßnahme von AK und nicht-melanozytärem Hautkrebs.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "542;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0134.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Dragieva et al. untersuchten in einer monozentrischen, prospektiven, doppelt-verblindeten, Placebo-kontrollierten, intra-individuellen Studie 14 nieren– und 3 herztransplantierte Patienten mit jeweils zwei läsionalen Hautarealen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2090__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Dragieva et al. untersuchten in einer monozentrischen, prospektiven, doppelt-verblindeten, Placebo-kontrollierten, intra-individuellen Studie 14 nieren<span class=\"diff_chg\">transplantierte und</span> 3 herztransplantierte Patienten mit jeweils zwei läsionalen Hautarealen.</div><div nowrap=\"nowrap\">Dragieva et al. untersuchten in einer monozentrischen, prospektiven, doppelt-verblindeten, Placebo-kontrollierten, intra-individuellen Studie 14 nieren<span class=\"diff_chg\">– und</span> 3 herztransplantierte Patienten mit jeweils zwei läsionalen Hautarealen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "543;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0136.tsv;5"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die komplette Abheilung der AK im Behandlungsareal (komplettes Ansprechen) lag in der Imiquimod-Gruppe bei 62,1% (100% in der Gruppe der Lebertransplantierten, 65% bei den Nieren- und 42,9% bei den Herztransplantierten) versus 0% unter Placebo."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2091__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die komplette Abheilung der AK im Behandlungsareal (komplettes Ansprechen) lag in der Imiquimod-Gruppe bei 62,1% (100% in der Gruppe der Lebertransplantierten, 65% bei den Nieren<span class=\"diff_chg\">transplantierten und</span> 42,9% bei den Herztransplantierten) versus 0% unter Placebo.</div><div nowrap=\"nowrap\">Die komplette Abheilung der AK im Behandlungsareal (komplettes Ansprechen) lag in der Imiquimod-Gruppe bei 62,1% (100% in der Gruppe der Lebertransplantierten, 65% bei den Nieren<span class=\"diff_chg\">- und</span> 42,9% bei den Herztransplantierten) versus 0% unter Placebo.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "544;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0136.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine europäische, multizentrische, doppelt-verblindete, interindividuell randomisierte (2:1) Studie untersuchte Imiquimod 5% Creme gegenüber Placebo bei 30 nieren-, 4 leber- und 9 herztransplantierten Patienten [REF] (Ulrich 2007)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2092__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine europäische, multizentrische, doppelt-verblindete, interindividuell randomisierte (2:1) Studie untersuchte Imiquimod 5% Creme gegenüber Placebo bei 30 nieren<span class=\"diff_chg\">transplantierten,</span> 4 leber<span class=\"diff_chg\">transplantierten und</span> 9 herztransplantierten Patienten [REF] (Ulrich 2007).</div><div nowrap=\"nowrap\">Eine europäische, multizentrische, doppelt-verblindete, interindividuell randomisierte (2:1) Studie untersuchte Imiquimod 5% Creme gegenüber Placebo bei 30 nieren<span class=\"diff_chg\">-,</span> 4 leber<span class=\"diff_chg\">- und</span> 9 herztransplantierten Patienten [REF] (Ulrich 2007).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "545;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0138.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einer 2010 publizierten, doppelt-verblindeten, Placebo-kontrollierten, randomisierten Studie wurden 32 Organtransplantierte Patienten (18 Nieren-, 8 Herz und 6 Lebertransplantierte) entweder mit Diclofenac-Natrium 3% in Hyaluronsäure 2,5% Gel oder nur Vehikel-Gel behandelt [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2093__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einer 2010 publizierten, doppelt-verblindeten, Placebo-kontrollierten, randomisierten Studie wurden 32 Organtransplantierte Patienten (18 Nieren<span class=\"diff_chg\">transplantierte,</span> 8 Herz<span class=\"diff_chg\">transplantierte und</span> 6 Lebertransplantierte) entweder mit Diclofenac-Natrium 3% in Hyaluronsäure 2,5% Gel oder nur Vehikel-Gel behandelt [REF].</div><div nowrap=\"nowrap\">In einer 2010 publizierten, doppelt-verblindeten, Placebo-kontrollierten, randomisierten Studie wurden 32 Organtransplantierte Patienten (18 Nieren<span class=\"diff_chg\">-,</span> 8 Herz<span class=\"diff_chg\"> und</span> 6 Lebertransplantierte) entweder mit Diclofenac-Natrium 3% in Hyaluronsäure 2,5% Gel oder nur Vehikel-Gel behandelt [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "546;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0141.tsv;104"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei kompletter Exzision sollte eine Aufarbeitung der Schnittränder folgen, um eine R0- oder R1-Resektion zu definieren."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2094__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei kompletter Exzision sollte eine Aufarbeitung der Schnittränder folgen, um eine R0-<span class=\"diff_sub\">Resektion</span> oder R1-Resektion zu definieren.</div><div nowrap=\"nowrap\">Bei kompletter Exzision sollte eine Aufarbeitung der Schnittränder folgen, um eine R0- oder R1-Resektion zu definieren.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "547;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0148.tsv;7"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bisherige Studien konnten noch keine Vorteile bei SLNB bezüglich krankheitsspezifischem und Gesamt-Überleben sowie metastasenfreiem Überleben mit statistischer Signifikanz beweisen [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2095__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bisherige Studien konnten noch keine Vorteile bei SLNB bezüglich krankheitsspezifischem <span class=\"diff_sub\">Überleben </span>und Gesamt-Überleben sowie metastasenfreiem Überleben mit statistischer Signifikanz beweisen [REF].</div><div nowrap=\"nowrap\">Bisherige Studien konnten noch keine Vorteile bei SLNB bezüglich krankheitsspezifischem und Gesamt-Überleben sowie metastasenfreiem Überleben mit statistischer Signifikanz beweisen [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "548;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0150.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für einige wenige Lokalisationen wird ein recht konstanter Lymphabflussbereich beschrieben, so z.B. für den Bereich der Unterlippe der Lymphabfluss in die submentalen und submandibulären Lymphknoten sowie hoch-zervikalen Lymphknoten (Level Ia, Ib und II nach Robbins et al.) [REF] [REF] [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2096__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für einige wenige Lokalisationen wird ein recht konstanter Lymphabflussbereich beschrieben, so z.B. für den Bereich der Unterlippe der Lymphabfluss in die submentalen und submandibulären Lymphknoten sowie hoch-zervikalen Lymphknoten (Level Ia, <span class=\"diff_chg\">Level Ib und Level II nach Robbins et</span> al.) [REF] [REF] [REF] [REF].</div><div nowrap=\"nowrap\">Für einige wenige Lokalisationen wird ein recht konstanter Lymphabflussbereich beschrieben, so z.B. für den Bereich der Unterlippe der Lymphabfluss in die submentalen und submandibulären Lymphknoten sowie hoch-zervikalen Lymphknoten (Level Ia, <span class=\"diff_chg\">Ib und II nach Robbins et</span> al.) [REF] [REF] [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "549;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0150.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In Analogie zum Mundhöhlenkarzinom sind die Ergebnisse einer selektiven Neck-Dissection bezüglich Tumorkontrolle, krankheitsspezifischem und Gesamt-Überleben denen einer modifiziert-radikalen oder radikalen Neck-Dissection nicht unterlegen (Adaptation aus der S3-Leitlinie zum Mundhöhlenkarzinom) [REF] [REF] [REF] [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2097__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In Analogie zum Mundhöhlenkarzinom sind die Ergebnisse einer selektiven Neck-Dissection bezüglich Tumorkontrolle, krankheitsspezifischem Überleben <span class=\"diff_chg\">und Gesamt-Überleben denen einer</span> modifiziert-radikalen oder radikalen Neck-Dissection nicht unterlegen (Adaptation aus der S3-Leitlinie zum Mundhöhlenkarzinom) [REF] [REF] [REF] [REF] [REF].</div><div nowrap=\"nowrap\">In Analogie zum Mundhöhlenkarzinom sind die Ergebnisse einer selektiven Neck-Dissection bezüglich Tumorkontrolle, krankheitsspezifischem <span class=\"diff_add\">und Gesamt-</span>Überleben <span class=\"diff_chg\">denen einer</span> modifiziert-radikalen oder radikalen Neck-Dissection nicht unterlegen (Adaptation aus der S3-Leitlinie zum Mundhöhlenkarzinom) [REF] [REF] [REF] [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "550;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0170.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Für das kutane PEK ist ein (prospektiver) Nutzen einer prophylaktischen (elektiven) Lymphknotendissektion in Bezug auf krankheitsspezifisches und Gesamtüberleben bisher nicht belegt [REF] [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2098__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Für das kutane PEK ist ein (prospektiver) Nutzen einer prophylaktischen (elektiven) Lymphknotendissektion in Bezug auf krankheitsspezifisches <span class=\"diff_sub\">Überleben </span>und Gesamtüberleben bisher nicht belegt [REF] [REF].</div><div nowrap=\"nowrap\">Für das kutane PEK ist ein (prospektiver) Nutzen einer prophylaktischen (elektiven) Lymphknotendissektion in Bezug auf krankheitsspezifisches und Gesamtüberleben bisher nicht belegt [REF] [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "551;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0174.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wie bei anderen soliden Tumoren enthält die Stadieneinteilung PEK gegenwärtig die vier klinischen Stadien I (frühe Primärtumoren), II (fortgeschrittene Primärtumoren), III (lokoregionäre Metastasierung) und IV (Fernmetastasierung)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2099__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wie bei anderen soliden Tumoren enthält die Stadieneinteilung PEK gegenwärtig die vier klinischen Stadien I (frühe Primärtumoren), <span class=\"diff_chg\">Stadien II</span> (fortgeschrittene Primärtumoren), <span class=\"diff_chg\">Stadien III</span> (lokoregionäre Metastasierung) und<span class=\"diff_sub\"> Stadien</span> IV (Fernmetastasierung).</div><div nowrap=\"nowrap\">Wie bei anderen soliden Tumoren enthält die Stadieneinteilung PEK gegenwärtig die vier klinischen Stadien I (frühe Primärtumoren), <span class=\"diff_chg\">II</span> (fortgeschrittene Primärtumoren), <span class=\"diff_chg\">III</span> (lokoregionäre Metastasierung) und IV (Fernmetastasierung).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "552;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0174.tsv;14"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "- T3- und T4-Tumoren nach AJCC 2010 zeigen ähnliche Überlebensraten [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2100__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">- T3-<span class=\"diff_sub\">Tumoren</span> und T4-Tumoren nach AJCC 2010 zeigen ähnliche Überlebensraten [REF].</div><div nowrap=\"nowrap\">- T3- und T4-Tumoren nach AJCC 2010 zeigen ähnliche Überlebensraten [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "553;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0179.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Diese umfasst eine gezielte Anamnese, die Inspektion des gesamten Integuments sowie Palpation der Primärnarbe, In-transit- und Lymphabstromgebiete und Lymphknotenstationen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2101__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Diese umfasst eine gezielte Anamnese, die Inspektion des gesamten Integuments sowie Palpation der Primärnarbe, In-transit-<span class=\"diff_sub\">Gebiete</span> und Lymphabstromgebiete und Lymphknotenstationen.</div><div nowrap=\"nowrap\">Diese umfasst eine gezielte Anamnese, die Inspektion des gesamten Integuments sowie Palpation der Primärnarbe, In-transit- und Lymphabstromgebiete und Lymphknotenstationen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "554;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0182.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Metastasen des PEK treten in ca. 80% der Fälle lokoregionär als Satelliten-, In-transit-Metastasen oder als lokoregionäre Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionäre Filiae haben die Option einer R0-Resektion."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2102__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Metastasen des PEK treten in ca. 80% der Fälle lokoregionär als Satelliten<span class=\"diff_chg\">metastasen</span>, In-transit-Metastasen oder als lokoregionäre Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionäre Filiae haben die Option einer R0-Resektion.</div><div nowrap=\"nowrap\">Metastasen des PEK treten in ca. 80% der Fälle lokoregionär als Satelliten<span class=\"diff_chg\">-</span>, In-transit-Metastasen oder als lokoregionäre Lymphknotenmetastasen auf, frühzeitig entdeckte lokoregionäre Filiae haben die Option einer R0-Resektion.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "555;08_aktinische-keratose-und-plattenepithelkarzinom-der-haut_0194.tsv;32"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Häufig bestehen beim Auftreten der Hautkrebserkrankung weitere Zeichen einer so genannten „Teer- oder Pechhauterkrankung“ (z. B. Follikulitiden, Akne, bräunlich diffuse Pigmentierung, Hyperkeratosen), die Tumoren können jedoch auch ohne diese Brückensymptome auftreten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2103__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Häufig bestehen beim Auftreten der Hautkrebserkrankung weitere Zeichen einer so genannten „Teer<span class=\"diff_chg\">hauterkrankung oder</span> Pechhauterkrankung“ (z. B. Follikulitiden, Akne, bräunlich diffuse Pigmentierung, Hyperkeratosen), die Tumoren können jedoch auch ohne diese Brückensymptome auftreten.</div><div nowrap=\"nowrap\">Häufig bestehen beim Auftreten der Hautkrebserkrankung weitere Zeichen einer so genannten „Teer<span class=\"diff_chg\">- oder</span> Pechhauterkrankung“ (z. B. Follikulitiden, Akne, bräunlich diffuse Pigmentierung, Hyperkeratosen), die Tumoren können jedoch auch ohne diese Brückensymptome auftreten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "556;09_mammakarzinom_0030.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Nach Erhebung eines mammographischen Befundes der Kategorien 0, III, IV und V sollte die weitere Abklärung innerhalb von einer Woche erfolgen, um die psychischen Belastungen der Frau möglichst gering zu halten."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2104__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Nach Erhebung eines mammographischen Befundes der Kategorien 0, <span class=\"diff_sub\">Kategorien </span>III, <span class=\"diff_sub\">Kategorien </span>IV und<span class=\"diff_sub\"> Kategorien</span> V sollte die weitere Abklärung innerhalb von einer Woche erfolgen, um die psychischen Belastungen der Frau möglichst gering zu halten.</div><div nowrap=\"nowrap\">Nach Erhebung eines mammographischen Befundes der Kategorien 0, III, IV und V sollte die weitere Abklärung innerhalb von einer Woche erfolgen, um die psychischen Belastungen der Frau möglichst gering zu halten.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "557;09_mammakarzinom_0031.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Berücksichtigt wurden bei der Erstellung der vorliegenden Aktualisierung der Empfehlungen der S3-Leitlinie die Empfehlungen der American Cancer Society ACS (ACS) [REF], der US Preventive Services Task Force [REF], [REF], [REF] und die Bewertung der Maßnahmen im Rahmen der Krebsprävention und –bekämpfung durch die International Agency for Research on Cancer (IARC) der WHO [REF], [REF], [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2105__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Berücksichtigt wurden bei der Erstellung der vorliegenden Aktualisierung der Empfehlungen der S3-Leitlinie die Empfehlungen der American Cancer Society ACS (ACS) [REF], der US Preventive Services Task Force [REF], [REF], [REF] und die Bewertung der Maßnahmen im Rahmen der Krebsprävention und <span class=\"diff_chg\">Krebs</span>bekämpfung durch die International Agency for Research on Cancer (IARC) der WHO [REF], [REF], [REF].</div><div nowrap=\"nowrap\">Berücksichtigt wurden bei der Erstellung der vorliegenden Aktualisierung der Empfehlungen der S3-Leitlinie die Empfehlungen der American Cancer Society ACS (ACS) [REF], der US Preventive Services Task Force [REF], [REF], [REF] und die Bewertung der Maßnahmen im Rahmen der Krebsprävention und <span class=\"diff_chg\">–</span>bekämpfung durch die International Agency for Research on Cancer (IARC) der WHO [REF], [REF], [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "558;09_mammakarzinom_0031.tsv;43"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die bisherigen Daten zeigen für die Kombination von 2D + 3D-Mammographie eine signifikante Erhöhung der Detektionsrate an, die bei allen Dichtegraden vorhanden war, jedoch bei den Dichtegraden ACR 2-3 am ausgeprägtesten erschien."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2106__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die bisherigen Daten zeigen für die Kombination von 2D-Mammographie <span class=\"diff_chg\">+ 3D-Mammographie eine</span> signifikante Erhöhung der Detektionsrate an, die bei allen Dichtegraden vorhanden war, jedoch bei den Dichtegraden ACR 2-3 am ausgeprägtesten erschien.</div><div nowrap=\"nowrap\">Die bisherigen Daten zeigen für die Kombination von 2<span class=\"diff_add\">D + 3</span>D-Mammographie <span class=\"diff_chg\">eine</span> signifikante Erhöhung der Detektionsrate an, die bei allen Dichtegraden vorhanden war, jedoch bei den Dichtegraden ACR 2-3 am ausgeprägtesten erschien.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "559;09_mammakarzinom_0031.tsv;47"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Fasst man diese Ergebnisse zusammen, so zeigt 2D + 3D Mammographie eine im prospektiven Screening nachgewiesene signifikant verbesserte Detektion bei vergleichbarer Spezifität und gering erhöhter Strahlenexposition."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2107__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Fasst man diese Ergebnisse zusammen, so zeigt 2D<span class=\"diff_sub\">Mammographie</span> + 3D Mammographie eine im prospektiven Screening nachgewiesene signifikant verbesserte Detektion bei vergleichbarer Spezifität und gering erhöhter Strahlenexposition.</div><div nowrap=\"nowrap\">Fasst man diese Ergebnisse zusammen, so zeigt 2D + 3D Mammographie eine im prospektiven Screening nachgewiesene signifikant verbesserte Detektion bei vergleichbarer Spezifität und gering erhöhter Strahlenexposition.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "560;09_mammakarzinom_0031.tsv;45"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bezogen auf die Einzelbefundungen zeigte die 2D + 3D-Mammographie in den meisten Studien eine Spezifitätserhöhung, allerdings nach Konsensus eine leichte Verschlechterung."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2108__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bezogen auf die Einzelbefundungen zeigte die 2D<span class=\"diff_sub\">-Mammographie</span> + 3D-Mammographie in den meisten Studien eine Spezifitätserhöhung, allerdings nach Konsensus eine leichte Verschlechterung.</div><div nowrap=\"nowrap\">Bezogen auf die Einzelbefundungen zeigte die 2D + 3D-Mammographie in den meisten Studien eine Spezifitätserhöhung, allerdings nach Konsensus eine leichte Verschlechterung.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "561;09_mammakarzinom_0031.tsv;39"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Vergleiche aller Studien betreffen fast ausschließlich den Vergleich zwischen 2D-Mammographie und 2D + 3D-Mammographie."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2109__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Vergleiche aller Studien betreffen fast ausschließlich den Vergleich zwischen 2D-Mammographie und 2D<span class=\"diff_sub\">-Mammographie</span> + 3D-Mammographie.</div><div nowrap=\"nowrap\">Die Vergleiche aller Studien betreffen fast ausschließlich den Vergleich zwischen 2D-Mammographie und 2D + 3D-Mammographie.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "562;09_mammakarzinom_0045.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während CHEK2 mit einem moderaten Brustkrebsrisiko assoziiert ist [REF], scheint PALB2 mit einem ähnlich hohen Risiko wie BRCA1/2 einherzugehen [REF], RAD51C ist primär mit einem erhöhten Ovarialkarzinomrisiko assoziiert [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2110__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während CHEK2 mit einem moderaten Brustkrebsrisiko assoziiert ist [REF], scheint PALB2 mit einem ähnlich hohen Risiko wie BRCA1/<span class=\"diff_sub\">BRCA</span>2 einherzugehen [REF], RAD51C ist primär mit einem erhöhten Ovarialkarzinomrisiko assoziiert [REF].</div><div nowrap=\"nowrap\">Während CHEK2 mit einem moderaten Brustkrebsrisiko assoziiert ist [REF], scheint PALB2 mit einem ähnlich hohen Risiko wie BRCA1/2 einherzugehen [REF], RAD51C ist primär mit einem erhöhten Ovarialkarzinomrisiko assoziiert [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "563;09_mammakarzinom_0051.tsv;6"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Der Ki-67-Proliferationsindex liegt in der Regel über 30% und die Tumorzellen zeigen oftmals eine Expression basaler Zytokeratine (CK5/6, CK14)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2111__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Der Ki-67-Proliferationsindex liegt in der Regel über 30% und die Tumorzellen zeigen oftmals eine Expression basaler Zytokeratine (CK5/<span class=\"diff_sub\">CK</span>6, CK14).</div><div nowrap=\"nowrap\">Der Ki-67-Proliferationsindex liegt in der Regel über 30% und die Tumorzellen zeigen oftmals eine Expression basaler Zytokeratine (CK5/6, CK14).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "564;09_mammakarzinom_0056.tsv;4"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Eine retrospektiv durchgeführte Mutationsanalyse von Studienpatientinnen des TNBC-Arms der Geparsixto Studie hat jedoch keinen Benefit für die BRCA1/2-Mutationsträgerinnen durch den Zusatz von Platin ergeben [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2112__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Eine retrospektiv durchgeführte Mutationsanalyse von Studienpatientinnen des TNBC-Arms der Geparsixto Studie hat jedoch keinen Benefit für die BRCA1<span class=\"diff_sub\">-Mutationsträgerinnen</span>/<span class=\"diff_sub\">BRCA</span>2-Mutationsträgerinnen durch den Zusatz von Platin ergeben [REF].</div><div nowrap=\"nowrap\">Eine retrospektiv durchgeführte Mutationsanalyse von Studienpatientinnen des TNBC-Arms der Geparsixto Studie hat jedoch keinen Benefit für die BRCA1/2-Mutationsträgerinnen durch den Zusatz von Platin ergeben [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "565;09_mammakarzinom_0056.tsv;8"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Während eine Wirksamkeit beim metastasierten BRCA1/2-assoziiertem Ovarialkarzinom bereits nachgewiesen wurde und bereits zur Zulassung von PARP-Inhibitoren führte, steht ein endgültiger Wirksamkeitsnachweis für das Mammakarzinom noch aus und wird derzeit in prospektiven klinischen Studien geprüft."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2113__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Während eine Wirksamkeit beim metastasierten BRCA1<span class=\"diff_sub\">-assoziiertem</span>/<span class=\"diff_sub\">BRCA</span>2-assoziiertem Ovarialkarzinom bereits nachgewiesen wurde und bereits zur Zulassung von PARP-Inhibitoren führte, steht ein endgültiger Wirksamkeitsnachweis für das Mammakarzinom noch aus und wird derzeit in prospektiven klinischen Studien geprüft.</div><div nowrap=\"nowrap\">Während eine Wirksamkeit beim metastasierten BRCA1/2-assoziiertem Ovarialkarzinom bereits nachgewiesen wurde und bereits zur Zulassung von PARP-Inhibitoren führte, steht ein endgültiger Wirksamkeitsnachweis für das Mammakarzinom noch aus und wird derzeit in prospektiven klinischen Studien geprüft.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "566;09_mammakarzinom_0057.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Gesunde Frauen mit einer BRCA1 oder BRCA2-Mutation haben ein lebenszeitlich erhöhtes Risiko für die Entwicklung eines Mammakarzinoms."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2114__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Gesunde Frauen mit einer BRCA1<span class=\"diff_sub\">-Mutation</span> oder BRCA2-Mutation haben ein lebenszeitlich erhöhtes Risiko für die Entwicklung eines Mammakarzinoms.</div><div nowrap=\"nowrap\">Gesunde Frauen mit einer BRCA1 oder BRCA2-Mutation haben ein lebenszeitlich erhöhtes Risiko für die Entwicklung eines Mammakarzinoms.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "567;09_mammakarzinom_0057.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Risiko-reduzierende Operation bei gesunden BRCA1/2-Mutationsträgerinnen (IARC class 4/5):"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2115__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei gesunden BRCA1<span class=\"diff_sub\">-Mutationsträgerinnen</span>/<span class=\"diff_sub\">BRCA</span>2-Mutationsträgerinnen (IARC class 4/5):</div><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei gesunden BRCA1/2-Mutationsträgerinnen (IARC class 4/5):</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "568;09_mammakarzinom_0058.tsv;13"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Rate der metachronen ipsilateralen Zweitkarzinome (neu entstandenes Karzinom gleiche Seite) scheint bei bereits erkrankten Patientinnen mit nachgewiesener BRCA1/2-Mutation nach derzeitigem Wissensstand nicht wesentlich erhöht zu sein, sodass eine brusterhaltende Therapie adäquat ist [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2116__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Rate der metachronen ipsilateralen Zweitkarzinome (neu entstandenes Karzinom gleiche Seite) scheint bei bereits erkrankten Patientinnen mit nachgewiesener BRCA1<span class=\"diff_sub\">-Mutation</span>/<span class=\"diff_sub\">BRCA</span>2-Mutation nach derzeitigem Wissensstand nicht wesentlich erhöht zu sein, sodass eine brusterhaltende Therapie adäquat ist [REF].</div><div nowrap=\"nowrap\">Die Rate der metachronen ipsilateralen Zweitkarzinome (neu entstandenes Karzinom gleiche Seite) scheint bei bereits erkrankten Patientinnen mit nachgewiesener BRCA1/2-Mutation nach derzeitigem Wissensstand nicht wesentlich erhöht zu sein, sodass eine brusterhaltende Therapie adäquat ist [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "569;09_mammakarzinom_0059.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Risiko-reduzierende Operation bei gesunden BRCA1/2- Mutationsträgerinnen (IARC class 4/5):"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2117__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei gesunden BRCA1- Mutationsträgerinnen<span class=\"diff_sub\">/BRCA2- Mutationsträgerinnen</span> (IARC class 4/<span class=\"diff_sub\">IARC class </span>5):</div><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei gesunden BRCA1<span class=\"diff_add\">/2</span>- Mutationsträgerinnen (IARC class 4/5):</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "570;09_mammakarzinom_0059.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Frauen mit einer pathogenen BRCA1 oder BRCA2-Mutation haben ein lebenszeitlich erhöhtes Risiko für ein Ovarialkarzinom, Tubenkarzinom und/oder ein primäres Peritonealkarzinom."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2118__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Frauen mit einer pathogenen BRCA1<span class=\"diff_sub\">-Mutation</span> oder BRCA2-Mutation haben ein lebenszeitlich erhöhtes Risiko für ein Ovarialkarzinom, Tubenkarzinom und/oder ein primäres Peritonealkarzinom.</div><div nowrap=\"nowrap\">Frauen mit einer pathogenen BRCA1 oder BRCA2-Mutation haben ein lebenszeitlich erhöhtes Risiko für ein Ovarialkarzinom, Tubenkarzinom und/oder ein primäres Peritonealkarzinom.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "571;09_mammakarzinom_0060.tsv;3"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bereits an Brustkrebs erkrankte Frauen mit einer pathogenen BRCA1 oder BRCA2-Genmutation haben ein erhöhtes Risiko für die Entstehung eines kontralateralen Mammakarzinoms."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2119__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bereits an Brustkrebs erkrankte Frauen mit einer pathogenen BRCA1<span class=\"diff_sub\">-Genmutation</span> oder BRCA2-Genmutation haben ein erhöhtes Risiko für die Entstehung eines kontralateralen Mammakarzinoms.</div><div nowrap=\"nowrap\">Bereits an Brustkrebs erkrankte Frauen mit einer pathogenen BRCA1 oder BRCA2-Genmutation haben ein erhöhtes Risiko für die Entstehung eines kontralateralen Mammakarzinoms.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "572;09_mammakarzinom_0060.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Risiko-reduzierende Operation bei bereits unilateral an Brustkrebserkrankten BRCA1/2-Mutationsträgerinnen (IARC class 4/5):"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2120__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei bereits unilateral an Brustkrebserkrankten BRCA1<span class=\"diff_sub\">-Mutationsträgerinnen</span>/<span class=\"diff_sub\">BRCA</span>2-Mutationsträgerinnen (IARC class 4/<span class=\"diff_sub\">IARC class </span>5):</div><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei bereits unilateral an Brustkrebserkrankten BRCA1/2-Mutationsträgerinnen (IARC class 4/5):</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "573;09_mammakarzinom_0061.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Risiko-reduzierende Operation bei Risikopersonen ohne nachgewiesene pathogene (IARC class 4/5) BRCA1/2-Mutation"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2121__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei Risikopersonen ohne nachgewiesene pathogene (IARC class 4/<span class=\"diff_sub\">IARC class </span>5) BRCA1<span class=\"diff_sub\">-Mutation</span>/<span class=\"diff_sub\">BRCA</span>2-Mutation</div><div nowrap=\"nowrap\">Risiko-reduzierende Operation bei Risikopersonen ohne nachgewiesene pathogene (IARC class 4/5) BRCA1/2-Mutation</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "574;09_mammakarzinom_0102.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Bei neu diagnostiziertem Mammakarzinom ab dem UICC Stadium II mit erhöhtem Risiko sowie III und IV ohne Symptomatik für eine Metastasierung, sollte ein Staging (Lunge, Leber, Skelett) durchgeführt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2122__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Bei neu diagnostiziertem Mammakarzinom ab dem UICC Stadium II mit erhöhtem Risiko sowie <span class=\"diff_chg\">UICC Stadium III und UICC Stadium</span> IV ohne Symptomatik für eine Metastasierung, sollte ein Staging (Lunge, Leber, Skelett) durchgeführt werden.</div><div nowrap=\"nowrap\">Bei neu diagnostiziertem Mammakarzinom ab dem UICC Stadium II mit erhöhtem Risiko sowie <span class=\"diff_chg\">III und</span> IV ohne Symptomatik für eine Metastasierung, sollte ein Staging (Lunge, Leber, Skelett) durchgeführt werden.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "575;09_mammakarzinom_0104.tsv;2"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das Ganzkörperstaging sollte mittels CT-Thorax/Abdomen und Skelettszintigraphie erfolgen."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2123__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das Ganzkörperstaging sollte mittels CT-Thorax/<span class=\"diff_sub\">CT-</span>Abdomen und Skelettszintigraphie erfolgen.</div><div nowrap=\"nowrap\">Das Ganzkörperstaging sollte mittels CT-Thorax/Abdomen und Skelettszintigraphie erfolgen.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "576;09_mammakarzinom_0104.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das Ganzkörperstaging sollte nur durchgeführt werden bei Frauen mit höherem Metastasierungsrisiko (N+, > T2) und/oder aggressiver Tumorbiologie (z. B.: HER2+, triple-negativ), klinischen Zeichen, Symptomen und bei geplanter Entscheidung zur systemischen Chemo-/Antikörpertherapie."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2124__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Das Ganzkörperstaging sollte nur durchgeführt werden bei Frauen mit höherem Metastasierungsrisiko (N+, &gt; T2) und/oder aggressiver Tumorbiologie (z. B.: HER2+, triple-negativ), klinischen Zeichen, Symptomen und bei geplanter Entscheidung zur systemischen Chemo<span class=\"diff_chg\">therapie</span>/Antikörpertherapie.</div><div nowrap=\"nowrap\">Das Ganzkörperstaging sollte nur durchgeführt werden bei Frauen mit höherem Metastasierungsrisiko (N+, &gt; T2) und/oder aggressiver Tumorbiologie (z. B.: HER2+, triple-negativ), klinischen Zeichen, Symptomen und bei geplanter Entscheidung zur systemischen Chemo<span class=\"diff_chg\">-</span>/Antikörpertherapie.</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "577;09_mammakarzinom_0105.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Wegen besserer Sensitivität und Spezifität haben als Basis-Staging-Untersuchungen CT Thorax/Abdomen und Skelettszinitgramm das frühere Staging mit Thorax-Röntgen und Abdomen-Ultraschall ersetzt (ESMO 2015/17)."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2125__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Wegen besserer Sensitivität und Spezifität haben als Basis-Staging-Untersuchungen CT Thorax/<span class=\"diff_sub\">CT </span>Abdomen und Skelettszinitgramm das frühere Staging mit Thorax-Röntgen und Abdomen-Ultraschall ersetzt (ESMO 2015/17).</div><div nowrap=\"nowrap\">Wegen besserer Sensitivität und Spezifität haben als Basis-Staging-Untersuchungen CT Thorax/Abdomen und Skelettszinitgramm das frühere Staging mit Thorax-Röntgen und Abdomen-Ultraschall ersetzt (ESMO 2015/17).</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "578;09_mammakarzinom_0108.tsv;21"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Die Bestimmung der Größe des DCIS ist für die Beurteilung der T/pT-Kategorie nach TNM nicht erforderlich, aber dennoch wichtig für die pathologisch-radiologische Korrelation und für das Management der Patientin [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2126__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">Die Bestimmung der Größe des DCIS ist für die Beurteilung der T<span class=\"diff_sub\">-Kategorie</span>/pT-Kategorie nach TNM nicht erforderlich, aber dennoch wichtig für die pathologisch-radiologische Korrelation und für das Management der Patientin [REF].</div><div nowrap=\"nowrap\">Die Bestimmung der Größe des DCIS ist für die Beurteilung der T/pT-Kategorie nach TNM nicht erforderlich, aber dennoch wichtig für die pathologisch-radiologische Korrelation und für das Management der Patientin [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "579;09_mammakarzinom_0115.tsv;9"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "In einem Niedrigrisikokollektiv (G1/G2 bis 2,5 cm) betrug die intramammäre Rezidivrate nach 12 Jahren ohne Radiotherapie 12,5% und damit ca. 1% pro Jahr [REF], und in einer weiteren prospektiv-retrospektiven Analyse von 209 Patientinnen ohne Radiotherapie mit niedrigem Risiko (Größe 2 cm oder weniger, Alter 50 Jahre oder mehr, Grad 1 oder 2) betrug die 12-Jahresintramammäre-Rezidivrate lediglich 7,8% und damit 0,65% pro Jahr [REF]."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\"\n",
       "          \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n",
       "\n",
       "<html>\n",
       "<head>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
       "<title></title>\n",
       "<style type=\"text/css\">\n",
       "        table.diff {font-family:Courier; border:medium;}\n",
       "        .diff_header {background-color:#e0e0e0}\n",
       "        td.diff_header {text-align:right}\n",
       "        .diff_next {background-color:#c0c0c0}\n",
       "        .diff_add {background-color:#aaffaa}\n",
       "        .diff_chg {background-color:#ffff77}\n",
       "        .diff_sub {background-color:#ffaaaa}\n",
       "    </style>\n",
       "</head>\n",
       "<body>\n",
       "<table cellpadding=\"0\" cellspacing=\"0\" class=\"diff\" id=\"difflib_chg_to2127__top\" rules=\"groups\">\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n",
       "<tbody>\n",
       "<tr><div nowrap=\"nowrap\">In einem Niedrigrisikokollektiv (G1/G2 bis 2,5 cm) betrug die intramammäre Rezidivrate nach 12 Jahren ohne Radiotherapie 12,5% und damit ca. 1% pro Jahr [REF], und in einer weiteren prospektiv-retrospektiven Analyse von 209 Patientinnen ohne Radiotherapie mit niedrigem Risiko (Größe 2 cm oder weniger, Alter 50 Jahre oder mehr, Grad 1 oder<span class=\"diff_sub\"> Grad</span> 2) betrug die 12-Jahresintramammäre-Rezidivrate lediglich 7,8% und damit 0,65% pro Jahr [REF].</div><div nowrap=\"nowrap\">In einem Niedrigrisikokollektiv (G1/G2 bis 2,5 cm) betrug die intramammäre Rezidivrate nach 12 Jahren ohne Radiotherapie 12,5% und damit ca. 1% pro Jahr [REF], und in einer weiteren prospektiv-retrospektiven Analyse von 209 Patientinnen ohne Radiotherapie mit niedrigem Risiko (Größe 2 cm oder weniger, Alter 50 Jahre oder mehr, Grad 1 oder 2) betrug die 12-Jahresintramammäre-Rezidivrate lediglich 7,8% und damit 0,65% pro Jahr [REF].</div></tr>\n",
       "</tbody>\n",
       "</table>\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "580;09_mammakarzinom_0117.tsv;1"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Input:__"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "Das therapeutische Konzept bei Risikoläsionen soll nach Vorliegen des histologischen Befundes aus einer Stanz-/Vakuumbiopsie interdisziplinär (Radiodiagnostik, Operateur, Pathologie) erstellt werden."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/markdown": [
       "__Error type:__ fn"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "show_errors(errors[errors.error_type == 'fn'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:ellipses]",
   "language": "python",
   "name": "conda-env-ellipses-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
